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Abstract 
Introduction: Joint hypermobility syndrome (JHS) is a heritable connective tissue 
disorder associated with multiple joint laxity and pain. JHS is a severe and disabling 
condition with a prevalence reaching 55% of patients attended physiotherapy with 
musculoskeletal symptoms. However, the literature is limited in quantity and quality to 
support the assessment and management strategies for people with JHS. Therefore, 
impairment, activity and participation were explored to identify the underlying problems. 
Methods: A cross-section design was employed to compare a group of adults with JHS 
against a matched control group. Neuromuscular impairments were explored through five 
domains: 1) pain intensity in the lower-limb joints was measured using visual analogue 
scales. 2) Achilles tendon stiffness was measured using the diagnostic ultrasound with 
strain-gauge myometer. 3) the plantar flexors strength was measured using the strain-
gauge myometer. 4) knee proprioception was explored using the angle reproduction test. 
5) gastrocnemius medius (GM) elasticity was quantified using the sonoelastography 
(SEG). Regarding the activity domain, both gait and vertical jump were analysed in terms 
of spatiotemporal, kinematics and kinetics using the Qualisys motion capture system, 
synchronised with the Kistler platform. The participation domain was assessed using the 
12-item Short Form Health Survey (SF-12) and the Bristol Impact of Hypermobility 
questionnaire (BIoH). Additionally, the feasibility of the SEG was explored, and the 
intra-rater reliabilities for examining the Achilles tendon stiffness and gait kinematics 
were determined. Statistical Package for Social Sciences (SPSS) was used to conduct the 
statistical analysis. Results: The JHS group included 29 women and two men aged 38.52 
± 14.14 years (mean ± SD), while the control group included 29 women and two men 
aged 39.06 ± 12.43 years (mean ± SD). Various statistically significant differences were 
identified in the JHS group when compared to the control group, including increased pain 
intensity (all p ≤ 0.001), reduced Achilles tendon stiffness (p = 0.03), reduced plantar 
flexors strength (p = 0.01) and reduced non-dominant knee proprioception (p range 0.001 
– 0.04). The gait and jump kinematics in the JHS group were mostly comparable to the 
control (p ≥ 0.05), with statistically significant reductions in moments (p ranged from 
0.001 - 0.04) and power generation and absorption (p ranged from 0.001- 0.04) in the 
JHS group. Significant reductions in the participation level were evidenced in the JHS 
group, obtained from SF-12 (p ranged from 0.001 - 0.002), with significant impact from 
JHS (211.51 ± 39.28)/360 (mean ± standard deviation) obtained from the BIoH. 
Sonoelastography seems a feasible tool in terms of training, examination time, patient 
tolerance, and image analysis. High intra-rater reliability was demonstrated for examining 
the Achilles tendon stiffness (ICC ranged from 0.981 – 0.984), and moderate-high intra-
rater reliability was demonstrated for examining gait kinematics (ICC ranged from 0.625 
– 0.996). Conclusion: JHS has a multi-dimensional impact, causing neuromuscular 
impairment, activity limitations and participation restrictions. Assessment strategies 
should consider this multi-dimensional impact of the condition, and management 
strategies should be multi-disciplinary, aiming to target the problems identified in the 
current study. 
Key words: Joint hypermobility syndrome, impairment, activity, participation. 
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1. CHAPTER ONE: OVERVIEW 
1.1 Overview:  
Joint hypermobility syndrome (JHS) has been recognised for over five decades as 
symptomatic multiple joint laxity (Hakim and Grahame, 2003). However, the nature of 
JHS extends from joint pain and hypermobility to multi-systemic decline (Hakim and 
Grahame, 2003; Hakim et al. 2004; Simmonds and Keer, 2007). Understanding, 
assessing and managing JHS is complex due to its multi-dimensional impact. Moreover, 
JHS is not uncommon, reaching a prevalence of 55% of patients attended for 
physiotherapy with musculoskeletal symptoms (Clark and Simmonds, 2011). More 
importantly, JHS is one of the most disabling conditions in musculoskeletal practice, and 
is associated with serious consequences (Scheper et al. 2016). In particular, JHS is 
associated with multiple joint widespread pain and recurrent dislocation (Hakim and 
Grahame, 2003; Grahame, 2009; Castori et al. 2010; Toker et al. 2010). JHS is also 
associated with muscle weakness, fibromyalgia and osteoarthritis (Sahin et al. 2008b; 
Voermans et al. 2009; Mulvey et al. 2013; Scheper et al. 2013). Additionally, 
cardiovascular deterioration, gastrointestinal disturbances, and autonomic nervous 
symptoms have been reported in people with JHS (Gazit, et al. 2003; Yazici et al. 2004; 
Castori et al. 2010). JHS’ negative impact expands from the physical sector to the 
psychological sector, leading to stress, anxiety, and depression (Scheper et al. 2016).  
The serious and disabling impact of JHS provides a significant rationale for being 
intensively explored to optimise diagnostic and management strategies. Grahame (2001, 
p. 486) explained that: 
“There is now abundant evidence from papers published in peer reviewed journals in 
many countries to demonstrate the serious impact that hypermobility can have on 
people’s lives…...it’s not an easy condition to treat. Physiotherapy forms the mainstay of 
treatment but has to be tailored to the need of intrinsically vulnerable tissues, otherwise 
it may aggravate rather than relieve. Analgesics and non-steroidal anti-inflammatory 
drugs are ineffective, and surgery can be counter-productive unless the surgeon is aware 
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of the underlying condition and the need to take additional precautions in handling and 
suturing tissues”  
Scheper et al. (2016, p.12) have concluded, based on recent and comprehensive 
meta-analysis of the JHS literature which analysed both the symptoms and management 
that: 
“The lack of core sets of clinical outcomes, non-identified pathways on which disability 
overlaps, and inadequate diagnostic criteria limit the ability of health care professionals 
to provide adequate care. … Clinicians should be aware that within these disorders, a 
large variability in phenotype exists, and they should take great care in conducting 
comprehensive assessments that include all aspects of the ICF”. 
Although JHS has been acknowledged since the seventies, it is poorly recognised, 
under-studied and not well understood (Scheper et al. 2016). Ultimately, to inform 
appropriate diagnostic, assessment, and management strategies for people with JHS, the 
current investigation has explored the impact of JHS on impairment, activity and 
participation following the International Classification of Functioning, Disability and 
Health (ICF) as explained by Jette (2006). Additionally, the current study has focused on 
the entire joints of the lower limbs for two reasons. First, the lower limb joints might be 
at higher risk of pain and injury in JHS as they accept the body weight, unlike the upper 
limb joints (Hall, 1999). Secondly, the lower limb joints act as a kinematic chain (Hall, 
1999). Therefore, it is more appropriate to study the whole chain of the lower back, 
pelvis, hip, knee, and ankle joints, rather than focusing on one joint, to provide a 
comprehensive understanding of the condition.  
Regarding the impairment domain of the ICF, the current study focuses on 
multiple joint pain as the most dominant complaint in JHS (Hakim and Grahame, 2003; 
Grahame, 2009; Rombaut et al. 2010). Moreover, the components linked to joint stability 
have been explored, including muscle-tendon unit stiffness, muscle strength and joint 
proprioception (Riemann and Lephart, 2002a; Rabita, Couturier and Lambertz, 2008).  
Regarding the activity domain, the gait of people with JHS has been analysed as it is a 
daily task, as well as using the vertical jump test as an advanced physical task. Regarding 
the third domain of ICF, the participation level has been explored using the 12- Item 
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Short Form Health Survey (SF-12), and the Bristol Impact of Hypermobility 
questionnaire (BIoH) (Figure 1.1). 
 
Figure 1.1: The variables explored in the current investigation under the three domains 
of the International Classification of Functioning, Disability and Health (ICF): 
impairment, activity and participation (SF-12; the 12-Item Short Form Health Survey, 
BIoH; Bristol Impact of Hypermobility Questionnaire). It is acknowledged that personal 
and environmental factors could influence the studied variables, yet they have not been 
assessed in the current research. 
 
1.2 Research in context:  
This section aims to put the current research into context, although a detailed 
rationale for exploring each variable, and a critical analysis of the previous literature, 
have been demonstrated and discussed later in Chapter Three, the Literature Review 
chapter. 
Joint pain is chronic, widespread and severe in people with JHS (Hakim and 
Grahame, 2003; Grahame, 2009; Toker et al. 2010). However, the previous literature on 
joint pain in JHS is limited, with pain quantifications mostly generic or limited to one 
joint (Sacheti, et al. 1997; Rombaut et al. 2011; Celletti et al. 2012a; Fatoye et al. 2012; 
De Wandele, et al. 2013; Rombaut et al. 2015). Therefore, the current investigation has 
provided discrete pain quantifications for each joint of the lower-limbs; hip; knee, and 
ankle joints, bilaterally, and has also assessed pain in the lower back. Additionally, as 
pain is the dominant complaint and feature in people with JHS, pain has been correlated 
with walking parameters as an essential daily task involving the lower limb joints.  
Muscle-tendon unit stiffness is vital for regulating energy storage, and for the 
force transmission and release essential for an activity (Wilson, Watson and Lichtwark, 
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2003; Rabita, Couturier and Lambertz, 2008). However, the connective tissues 
responsible for the mechanical rigidity in the muscle-tendon unit could be compromised 
in people with JHS due to the suggested genetic abnormalities and hormonal and 
environmental factors, which could reduce the amount of stiffness required for an activity 
(Malfait et al. 2006; Voermans et al. 2009). However, studies on muscle-tendon unit 
stiffness are limited in quantity and quality, with only two studies available (Rombaut et 
al. 2012a; Nielsen, et al. 2014). Additionally, the available literature has explored the 
stiffness in a ‘single-muscle response level’; Achilles and patellar tendons (Rombaut et 
al. 2012a; Nielsen, et al. 2014).  A ‘single-muscle response level’ means that stiffness 
was studied in one muscle only. However, the current study considers the muscle-tendon 
stiffness by examining the Achilles tendon stiffness as well as stiffness at the ‘entire 
lower limb response level’ by utilising the vertical jump test. The ‘entire lower limb 
response level’ means that stiffness will be studied in the entire structures of the lower 
limb including muscles, tendons, ligaments, cartilage and bone. 
Skeletal muscles are the joint dynamic stabilisers, which could explain joint 
instability and frequent dislocation in people with JHS (Hall, 1999; Castori et al. 2010). 
Additionally, pain associated with JHS could cause muscle inhibition and weakness (Le 
Pera et al. 2001; Hakim and Grahame, 2003; Malfait et al. 2006). Previous studies have 
focused on the knee flexors and extensors (Fatoye et al. 2009; Sahin et al. 2008b; 
Rombaut et al. 2012b; and Scheper et al. 2013), and the literature review indicated that 
there was a complete lack of evidence on exploring the impact of JHS on muscle strength 
in other essential muscle groups in the lower limbs. In particular, plantar flexors strength 
has not been studied previously, despite it being essential for balance and walking 
(Fukagawa et al. 1995; Neptune, Kautz and Zajac, 2001; Lichtwark and Wilson, 2005; 
Ribeiro et al. 2009). Therefore, the current study explores the strength of the plantar 
flexors. 
Joint hypermobility and instability might be related to a failure in joint 
proprioception in people with JHS. In particular, functional joint stability is regulated by 
joint proprioception (Hogervorst and Brand, 1998; Riemann and Lephart, 2002a), yet all 
the previous studies have explored proprioception in a non weight-bearing position (Hall 
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et al.1995; Sahin et al. 2008a; Fatoye et al. 2009; Rombaut et al. 2010). However, the 
weight-bearing position is more accurate for exploring joint proprioception, where it is 
capable of stimulating the entire mechanoreceptors (Marks, Quinney and Wessel, 1993; 
Stillman and McMeeken, 2001; Andersen, Terwilliger and Denegar, 2010). Therefore, 
the current study has explored knee proprioception in a weight-bearing position using the 
squat test.  
Gait components are essential measures for functional capacity, general health, 
and participation, which reflects the integrity of visual, vestibular, proprioceptive, 
neuromusculoskeletal, cognitive and psychological systems (Buchner et al. 1996; Patla, 
1998; Ringsberg et al. 1999; Lemke et al. 2000; Allum and Adkin, 2003; Lelas et al. 
2003; Riskowski et al. 2005; Flansbjer, Downham and Lexell, 2006). However, only two 
studies have explored gait in adults with JHS, although their external validity has been 
risked by the small sample sizes used (Galli et al. 2011; Celletti et al. 2012b). More 
importantly, the previous evidences lack a comprehensive analysis of the gait of people 
with JHS. Therefore, the current study provides a comprehensive analysis, including 
spatiotemporal, kinematic and kinetic parameters including powers and moments. 
Additionally, the current study has challenged the lower limb joints by introducing an 
advanced task, using the vertical jump. This is specifically to make it difficult to employ 
the compensatory strategies often used by people with JHS, which could aid in 
identifying the underlying problems (Schmid et al. 2013). Moreover, JHS has not 
previously been explored using the vertical jump task. 
The symptomatic manifestation in people with JHS could have a negative impact 
on their participation level. In particular, chronic widespread pain, instability and 
frequent injury are common in JHS and have a disabling impact (Gedalia, Press and 
Buskila, 1996; Hakim and Graham, 2003; Grahame, 2009; Castori et al. 2010). However, 
the literature review clearly highlights the limited quantity of previous studies which have 
explored participation in adults with JHS (Rombaut et al. 2010; Albayrak et al. 2015; 
Johannessen et al. 2016). Moreover, to understand the impact of participation, 
correlations have been established to other vital variables related to impairment and 
activity, such as joint pain and walking. 
 7 
Finally, the current study has introduced sonoelastography (SEG) to explore the 
elasticity of the gastrocnemius medius (GM) in people with JHS as an alternative 
diagnostic measure. Specifically, diagnosing JHS is based on questions and clinical 
examination, which were established in 1998 (Hakim and Grahame, 2003; Smits-
Engelsman, Klerks and Kirby, 2010). SEG is able to quantify the elasticity of structures 
by providing colour coded images (Sconfienza et al. 2010; Turan et al. 2013). 
Furthermore, administering SEG may be valuable, as the muscle-tendon structure in 
people with JHS could be hyper-elastic, which may be identified using SEG (Rombaut et 
al. 2012a). Tissue elasticity has not been explored previously in JHS; therefore, the 
current study has focused on the feasibility of using SEG to identify people with JHS. 
The serious and severely disabling impact of JHS, along with the limited quantity 
and quality of JHS research, justifies the need for a more comprehensive explorative 
study. Consequently, the findings of the current research will be for the benefit of people 
with JHS, healthcare professionals in musculoskeletal practice, and researchers. This will 
be achieved by shedding light on areas that have been neglected and are not well 
understood, which could guide assessment and diagnostic strategies to optimise the 
management programs currently being provided. Thus, clinicians can consider the 
discovered abnormalities and problems from this study to help them to manage their 
patients with JHS better. Researchers may be guided concerning what should be 
emphasised in future research to improve patients’ conditions through the uncovering of 
critical areas in the current study. More importantly, the findings of the study could 
strongly recommend randomised controlled/clinical trials. Ultimately, the findings of the 
current research should clarify the impact of JHS, and make it more understandable. 
Therefore, the complaints and needs of people with JHS will be better understood and 
acknowledged; their problems more easily identified; and management programs 
designed to directly target their impairments and problems.  
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1.3 Aims: 
Specified objectives have been detailed at the end of the literature review chapter 
(section 3.11). However, this section presents the general aims of the current study, as 
follows:  
1.3.1 To study the impacts of JHS on impairments including joint pain, Achilles 
tendon stiffness, muscle strength and proprioception in adults through a 
comparison with a control group. 
1.3.2 To study the impacts of JHS on activity, including walking and vertical 
jump in adults, through a comparison with a control group. 
1.3.3 To study the impacts of JHS on participation, measured using the SF-12 
and BIoH, in adults through a comparison with a control group. 
1.3.4 To study the feasibility of using SEG to assess tissue elasticity in GM in 
people with JHS through a comparison with a control group. 
 
1.4 Thesis outline: 
This section has been developed to provide a roadmap for the current thesis by 
detailing the content of each chapter. 
1.4.1 Chapter Two: Background 
This chapter focuses on the background of JHS, including definition, the 
diagnostic criteria and the epidemiology. Additionally, the aetiological presentation is 
discussed. Moreover, the clinical features have been discussed and categorised into 
musculoskeletal and non-musculoskeletal features.   
1.4.2 Chapter Three: Literature Review 
The Literature Review Chapter has discussed each variable under exploration 
separately. Each section has covered a specific variable, such as pain, participation, 
muscle strength, muscle-tendon stiffness and proprioception. Additionally, further 
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sections have covered gait biomechanics, vertical jump biomechanics and SEG. Next, a 
section has been developed to justify performing two intra-rater reliability studies in the 
current research to assess the repeatability of measuring muscle-tendon unit stiffness and 
gait kinematics. In particular, each section starts with a discussion to support the rationale 
for studying each variable, and this is followed by the search strategy and the critical 
literature review for the previous studies, ending with the specified objectives of the 
current study.  
1.4.3 Chapter Four: Methods 
The Methods Chapter has been constructed to describe, discuss and justify the 
methodological procedures used in the current study in detail. The methods chapter starts 
by discussing the research design implemented to achieve the objectives, followed by the 
inclusion/exclusion criteria and sample size determination. Additionally, the assessment 
methods section has been developed to compare the methods and assessment tools used 
with the other available alternatives; next the assessment methods used are described, and 
their psychometric and clinimetric properties demonstrated. The following sections have 
been developed to present the sample recruitment details, ethical considerations, and the 
data collection procedures. Finally, the methods chapter ends with the data processing 
and analysis procedures.  
1.4.4 Chapter Five: Results 
The results chapter starts with an introduction and then details the response rate, 
and details of inclusion and exclusion in the current investigation. The academic critique 
of the clinimetric properties of the assessment methods implemented in the current study 
has informed two intra-rater reliability studies; Achilles tendon stiffness with the 
ultrasound and strain-gauge myometer, as well as measuring gait kinematics. The results 
of these two studies are presented. Then the main demographic data is presented. The 
next section has been organised to cover the results related to each variable separately, 
starting with the results related to the pain variable, then the SF-12 and the BIoH 
questionnaire. Following that, the results related to the Achilles tendon stiffness are 
presented. A section has been developed to cover the results obtained from the Qualisys 
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three-dimensional motion capture system, including proprioception, gait and vertical 
jump analysis. Regarding the gait analysis section, it starts with presenting the variables 
related to kinematics, moments and powers measures, with each section including the 
related curve graphs, and descriptive and interferential statistical comparisons. The next 
section covers the results related to the vertical jump test by presenting the stiffness of the 
lower limbs measured using the jump test, and then the biomechanical analysis of the 
vertical jump task; kinematics, moments and powers through curve graphs, and 
descriptive and interferential comparisons. Finally, the results chapter ends by presenting 
the results of the feasibility of using the SEG to measure the elasticity of the GM muscle.  
1.4.5 Chapter Six: Discussion  
The discussion chapter provides a detailed justification and explanation of the 
results identified, along with establishing possible theories which could explain the 
findings. Each variable has been discussed separately, starting with the pain variable, and 
then the results of the SF-12 and BIoH questionnaire. Next, the results of the Achilles 
tendon stiffness are discussed, followed by stiffness measured using the vertical jump 
test, and the findings of these two parts are compared. Then the discussion focuses on the 
proprioception study, followed by explaining the biomechanical findings for gait. The 
vertical jump biomechanical findings are discussed, as well as the findings from the 
feasibility of SEG study. Ultimately, the discussion chapter ends by discussing the 
limitations of the current research, the clinical implications, followed by a section 
explaining the recommendations for future research.   
1.4.6 Chapter Seven: Conclusion  
This chapter presents an overview of the ICF domains investigated in the current 
study. Additionally, the results of the current research are summed up. Finally, the 
conclusion chapter summarises the overall significance of the research. 
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2. CHAPTER TWO: BACKGROUND 
2.1 Introduction: 
Chapter Two will present the background to JHS. This chapter will start by 
defining JHS and then set out its diagnostic strategies. Moreover, the epidemiology of 
JHS will be explored in both children and adults, and the aetiological presentation of JHS 
will be identified. The clinical features of JHS will be discussed and divided into 
musculoskeletal and non-musculoskeletal features, before ending the chapter with the 
conclusion.   
 
2.2 Definition: 
Joint hypermobility syndrome (JHS) is a heritable connective tissue disorder, in 
which multiple synovial joints demonstrate symptomatic and extraordinary motion, due 
to genetic and pathologic factors in the absence of systemic inflammation (Hakim and 
Grahame, 2003; Hakim et al. 2004; Simmonds and Keer, 2007). JHS is a multi-systemic 
disorder that adversely affects the musculoskeletal, cardiovascular, digestive and 
autonomic nervous systems due to abnormalities in the connective tissues of these 
systems, which adversely changes their physiology (Hakim and Graham, 2003). JHS is 
the most common type of heritable disorder of the connective tissues (Hakim and 
Grahame, 2003). JHS is under-recognised and often poorly managed; consequently, it has 
been called a human physiology enigma (Larsson et al. 1995; Simmonds and Keer, 
2007). 
JHS was first recognised in 1967 due to the association of musculoskeletal 
complaints with joint laxity (Hakim and Grahame, 2003). Exhibiting excessive joint 
motion without experiencing pain is termed “generalised joint laxity” (GJL), and this can 
be utilised in professional athletic performances such as in ballet and gymnastics (Juul-
Kristensen et al. 2007; Simmonds and Keer, 2007). However, if the joint’s hypermobility 
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is associated with chronic multiple joint pain it is referred to as JHS. JHS is also referred 
to as “benign joint hypermobility syndrome”, where the word “benign” reflects the non-
fatal nature of the condition (Hakim and Grahame, 2003). Importantly, there are many 
other heritable connective tissue disorders which involve life threatening signs such as 
heart valves prolapse and blood vessels tearing (Pepin et al. 2000). Yet while JHS has a 
severe and distressing impact on overall quality of life, none of the identified 
consequences of JHS are considered fatal.     
Ehlers-Danlos syndrome (EDS) is a heritable connective tissue disorder, which is 
also associated with symptomatic joint hypermobility (Simmonds and Keer, 2007). EDS 
it is the most frequent heritable connective tissue disorder (Simmonds and Keer, 2007). 
Moreover, EDS includes various groups of heritable connective tissue disorders which 
vary from clinical and genetic perspectives (Simmonds and Keer, 2007; Rombaut et al. 
2011). Additionally, EDS involves a wide range of symptoms mainly due to connective 
tissue fragility within the body’s vital systems. There are six subtypes of EDS, and 90% 
of patients with EDS are of the hypermobility type (Hakim and Grahame, 2003). The 
hypermobility type of EDS, also known as EDS-HT, involves unique clinical 
manifestation of substantially painful joints with hypermobility, joint instability and skin 
hyper-extensibility (Hakim and Grahame, 2003). More importantly, it has been accepted 
than JHS is identical to EDS-HT, where the two are indistinguishable and have the same 
phenotypic identification (Ainsworth and Aulicino, 1993; Hakim and Grahame, 2003; 
Ferrell et al. 2004; Simmonds and Keer, 2007; Tinkle et al. 2009). Other subtypes of 
EDS have been excluded. For the purpose of this thesis EDS-HT has been included under 
the term ‘JHS’. The term ‘JHS’ is used throughout for clarity, except where individual 
authors specifically refer to EDS-HT. 
Joint laxity has been reported in various conditions, such as Marfan syndrome and 
osteogensis imperfecta, but these conditions differ from JHS. Marfan syndrome is 
characterised by marfinoid habitus; long bones and limbs; aortic dilation and ectopia 
lenntis; subluxation of the eye lens, beside joint hypermobility (Grahame, 1999). 
Osteogensis imperfecta mainly presents with bone fragility, blue sclerae, short stature and 
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joint hypermobility (Malfait et al. 2006). Both conditions represent clear alternative 
diagnoses and are not the focus of this thesis.  
 
2.3 Diagnosis: 
The diagnosis of JHS has developed through different stages. Initially, Carter and 
Wilkinson test criteria were used by administering five tests, where three positive tests 
would confirm the diagnosis of GJL (Beighton, Grahame and Bird, 2012). The Carter and 
Wilkinson tests were: thumb apposition to the forearm flexor aspect, finger 
hyperextension to be perpendicular to the forearm extensor aspect, elbow hyperextension 
> 100, knee hyperextension > 100, ankle hyper-dorsiflexion and hyper-eversion 
(Beighton, Grahame and Bird, 2012). The Carter and Wilkinson test criteria were revised 
to the Beighton nine-point scoring system, which was developed in 1973 based on 
performing various manoeuvers (Appendix 1) (Beighton, Solomonand and Soskolne, 
1973; Hakim and Grahame, 2003; Smits-Engelsman, Klerks and Kirby, 2010). A result of 
four or more is used to diagnose the condition of GJL, and it is highly reproducible 
(Remvig, Jensen and Ward, 2007a). However, the Beighton score neglects hypermobility 
in other joints such as the tempo-mandibular, cervical, shoulder, wrist and flat feet. In 
addition, the Beighton score focuses solely on quantifying joint hypermobility in the 
spine, elbow and knee joints bilaterally, thumb apposition to the forearm and fifth finger 
hyper-extension bilaterally (Juul-Kristensen et al., 2007; Remvig, Jensen and Ward, 
2007a; Smits-Engelsman, Klerks and Kirby, 2010). Therefore, the Beighton score does 
not confirm a JHS diagnosis but confirms GJL. Alternatively, the Brighton criteria 
(Appendix 2), was developed in 1998 to confirm a diagnosis of JHS by identifying joint 
hypermobility using the elements of the Beighton score, in addition to considering the 
presence of other symptoms such as joint pain and instability (Hakim and Grahame, 
2003; Simmonds and Keer, 2007; Tinkle et al. 2009). The Brighton criteria demonstrates 
good to excellent reproducibility; kappa coefficient ranges from 0.84 – 0.90 for JHS 
(Juul-Kristensen et al. 2007). In addition, the recommendations of a literature review 
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reflect the high nosographic sensitivity and specificity of the Brighton criterion in 
detecting JHS (Remvig, Jensen and Ward, 2007a).  
Hypermobility may reduce with age, resulting in a negative diagnosis for an 
individual with remarkable hypermobility during childhood when using the Beighton 
score (Castori et al. 2012a). However, the Brighton criteria adds musculoskeletal 
complaints as a major diagnostic criterion besides the hypermobility of the joint, with 
other minor criteria such as joint instability and dislocation, marfanoid habitus and skin 
hyper-extensibility (Tinkle et al. 2009). Moreover, a simple five-point self-report 
questionnaire can also be used for the diagnosis, where answering yes to two or more of 
the questions would confirm the diagnosis.  It is a validated questionnaire and it is 
appropriate for clinical settings, as it shows high sensitivity and specificity; 80% and 90 
% respectively (Hakim and Grahame, 2003). The Five-points self-reported questionnaire 
of Hakim and Grahame (2003) consists of the following questions: 
- Can you now [or could you ever] place your hands flat on the floor 
without bending your knees? 
- Can you now [or could you ever] bend your thumb to touch your forearm? 
- As a child, did you amuse your friends by contorting your body into 
strange shapes or could you do the splits? 
- As a child or teenager, did you kneecap or shoulder dislocate on more than 
one occasion? 
- Do you consider yourself “double-jointed”? 
The Revised Nosology of Villefranche was developed to confirm the diagnosis of 
EDS-HT (Appendix 3) (Brighton et al. 1998). The Nosology provides a clear 
classification to distinguish the hypermobility type of EDS from the other types. It 
considers joint hypermobility, pain, dislocation, skin involvement, and family history 
(Brighton et al. 1998). 
The European Organisation for Rare Diseases has reported that EDS involves the 
longest delay in being diagnosed, reaching consultations with 20 health professionals 
before coming to a diagnosis, which has a substantial impact psychologically and 
financially (Kole and Faurisson, 2009, cited by Castori et al. 2010). In particular, EDS-
HT is the most difficult type of EDS to be diagnosed (Kole and Faurisson, 2009, cited by 
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Castori et al. 2010). As has been shown earlier, the diagnostic methods for JHS/EDS-HT 
are simple and clinically applicable. However, lateness in diagnosing JHS/EDS-HT may 
indicate that this condition is often overlooked and not considered. Ultimately, the 
Brighton criteria are the recommended diagnostic criteria.    
 
2.4 Epidemiology: 
2.4.1 Children with JHS:  
Although adults with JHS form the main scope of the current project, 
understanding the prevalence rate of JHS in children could aid in understanding the 
prevalence rate in adults. Specifically, adults with JHS frequently complain about 
GJL/symptomatic GJL since childhood (Simmonds and Keer, 2007). Moreover, children 
and adolescents with GJL are at a higher risk of developing JHS (Simmonds and Keer, 
2007). Therefore, the prevalence rate of GJL and JHS/symptomatic GJL in children and 
adolescents will be discussed in this section. The literature concerning the prevalence 
rates of GJL and JHS/symptomatic GJL among children and adolescents has been 
reviewed and is summarised in Table 2.1.  
The review indicates that GJL and JHS/symptomatic GJL are widespread among 
children and adolescents with a worldwide distribution across Europe, Asia and the 
United States, reaching 54.1% (Table 2.1). Additionally, the prevalence rate of GJL and 
symptomatic GJL is substantially influenced by gender and age. However, the review 
questions the impact of ethnicity on the prevalence rate. For example, Brazilian children 
recorded the highest GJL prevalence rate of 54.1%, even when administering a high cut-
off point of 6/9 for the Beighon score, while in Southwest England, the prevalence rate 
declines to 4.2% when using a similar Beighton score cut-off point (Clinch et al. 2011; 
Neves et al. 2013). However, the remarkable differences between the two studies may be 
related to the differences in the samples’ ages: children age 5-6 years were examined in 
Brazil, while 14-year-old adolescents were examined in Southwest England. In contrast, 
the prevalence rates of GJL are relatively the same in adolescents from South India 
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(17.2%); Turkey (11.7%); Southwest England (19.2%), and Egypt (16.1%) 
(Subramanyam and Janaki, 1996; El-Garf, Mahmoud and Mahgoub, 1998; Seckin et al. 
2005; Clinch et al. 2011). These similarities in the prevalence rates could be largely 
related to the similarities in the samples’ ages and the Beighton cut-off point of 4/9 used 
in those studies. In contrast, using a Beighton cut-off point of 6/9 reduces the prevalence 
rates of GJL to 4.2% and 7.8% for relatively similar sample ages according to Clinch et 
al. (2011) and Mikkelsson, Salminen and Kautiainen (1996) respectively. Additionally, 
gender has a considerable impact on the prevalence rate of GJL, where girls’ prevalence 
rates are greater than boys. The reported girls-boys prevalence is 18-14.4%, 40.5-12.9%, 
14%-4.8%, and 59.6-49.8% (El-Garf, Mahmoud and Mahgoub, 1998; Qvindesland and 
Jonsson, 1999; Neves et al. 2013). In a like manner, a high percentage of children and 
adolescents with GJL complain of musculoskeletal pain, reaching 55% of those who have 
GJL (Mikkelsson, Salminen and Kautiainen, 1996; El-Garf, Mahmoud and Mahgoub, 
1998; Qvindesland and Jonsson 1999).    
In summary, directly comparing the epidemiological studies on the prevalence of 
GJL, with and without musculoskeletal pain, in children and adolescents is complicated 
due to the dissimilarities in the diagnostic cut-off points used to confirm GJL, as they 
range from four, five and six out of nine points (see Table 2.1). Such differences in 
confirming the diagnosis could have an influence on the overall prevalence rate. 
Additionally, the sample sizes differ, ranging from 264 up to 6022, and this factor 
influences the generalisability of the results (see Table 2.1). More importantly, there are 
discrepancies in the literature with regard to the sample ages, which vary from 5-19 years 
(Table 2.1). However, all the studies reveal that GJL and symptomatic GJL are not 
uncommon in the children and adolescent population, and GJL is more prevalent than 
symptomatic GJL. 
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Table 2.1: The epidemiological studies of generalised joint laxity (GJL) and symptomatic GJL in children and adolescents. 
Study Diagnostic 
criteria 
Population Gender Age 
(Years) 
Ethnicity Sample 
size 
Prevalence 
GJL 
Subramanyam 
and Janaki 
(1996) 
Carter-
Wilkinson 
method ≥ 4/9 
Five schools Boys and 
girls 
(equal 
number) 
6-15 South 
India 
1000 17.2% 
Decoster et al. 
(2007) 
Carter-
Wilkinson 
method ≥ 5/9 
School athletes 150 boys 
114 girls 
Average 
15.5 
- 264 12.9% 
Seckin et al. 
(2005) 
Beighton score 
≥ 4/9 
High school 
students 
excluding athletes 
428 boys 
433 girls 
13-19 Turkey 861 11.7% 
Clinch et al. 
(2011) 
Beighton score 
≥ 4/9 and ≥ 6/9 
 
 
From population-
based cohort 
2961 
boys 
3061 
girls 
14 Southwest 
England 
6022 19.2% with a cutoff of ≥ 4. 
4.2% with a cutoff ≥ 6. 
Neves et al. 
(2013) 
Beighton score 
≥ 6/9 
Kindergarten 
children 
- 
 
5-6 Brazil 366 Overall 54.1%. 
Girls 59.6%. and Boys 49.8%. 
GJL and Symptomatic GJL 
Mikkelsson, 
Salminen and 
Kautiainen 
(1996) 
Beighton score 
≥ 6/9 
Pre-adolescents 
3rd and 5th grades 
- 3rd 
grade 
9.8, 5th 
grade 
11.8 
- 1637 GJL 7.8%. 
Musculoskeletal pain (symptomatic GJL): 
29.9% from GJL cases/ 2.33% from total 
sample in 3rd grade, and 32.3% from GJL/ 
2.51% from total sample in 5th grade. 
El-Garf, 
Mahmoud and 
Mahgoub 
(1998) 
Beighton score 
≥ 4/9 
Schools - 12 Egypt 997 Overall 16.1%; Girls 18%. And Boys 14.4%. 
55% with GJL have pain/ 7.01% of total sample 
have musculoskeletal pain. 
Qvindesland 
and Jonsson 
(1999) 
Beighton score 
≥ 4/9 
Schools and 
health system 
143 girls 
124 boys 
12 years Iceland 267 GJL 40.5% in girls and 12.9% in boys (53% 
girls and 63% boys have history of joint pain). 
Beighton score 
≥ 6/9 
14% in girls and 4.8% in boys. 
55% of GJL. 
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2.4.2 Adults with JHS: 
As people with GJL are at higher risk of developing JHS, the prevalence rate for 
GJL has been reviewed. The prevalence rate of GJL in adults reveals fluctuating 
percentages, which range from 4% to 36.5%; the lowest prevalence rate has been 
recorded in New Zealand for responders to an epidemiologic survey of rheumatic 
diseases, and the highest has been recorded in Korean women from a directory call centre 
(Table 2.2) (Kemp, Williams and Stansfield, 2002; Kwon et al. 2013). The prevalence 
rate of GJL is the lowest in New Zealand, elevated in the Maori population, followed by 
Southeast Asia, the United Kingdom’s adult twin registry, and Kuwait, and finally, the 
highest figure has been recorded in Korea (see Table 2.2).  The fluctuation of the 
prevalence figures suggests an impact from geographical area on the overall prevalence 
figure. However, introducing different sample ages, sizes and diagnostic criteria reduce 
the ability to confirm the influence of geographical location on the prevalence rate. 
Despite that, the changes in the prevalence rate among the geographical areas could be 
due to the environmental or occupational demands in these areas rather than ethnic 
origin; even so, such factors need to be confirmed by future studies. Although the 
prevalence rate fluctuates in different geographical areas, it has reached a figure of 
36.5%, suggesting that GJL is not uncommon (Table 2.2).    
The prevalence of symptomatic GJL and JHS in the general population is difficult 
to determine as most of the available studies have explored the prevalence rate in specific 
populations. The prevalence rate of JHS/symptomatic GJL in adults presents fluctuating 
percentages, as has been observed in child epidemiological studies. The prevalence figure 
varies from 0.0% to 55%; the lowest prevalence rate has been recorded in New Zealand 
from the responders to an epidemiologic survey of rheumatic diseases, and the highest 
has been recorded for patients attending for physiotherapy with musculoskeletal 
symptoms in Oman (Table 2.2) (Klemp, Williams and Stansfield, 2002; Clark and 
Simmonds, 2011). Adult prevalence figures vary according to different geographical 
sectors. The lowest prevalence figure of 0.0% has been obtained from New Zealand 
(European population) for responders to an epidemiologic survey of rheumatic diseases 
(Table 2.2) (Klemp, Williams and Stansfield, 2002). The prevalence figure increases for 
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adults from the Maori population to 8.7% for respondents to an epidemiological survey of 
rheumatic diseases (Klemp, Williams and Stansfield, 2002). The prevalence figure rises 
slightly to reach 9.95% for adults from Northern India referred to a rheumatology clinic, 
followed by undergraduate students from Nigeria who recorded a prevalence figure of 
12.91% (Table 2.2) (Didia and Dapper, 2002: Kumar et al. 2006). A higher prevalence 
rate of 15% has been recorded for adults referred to the rheumatologist in Columbia 
clinics (Bridges, Smith and Reid 1992). Higher figures of 19.5% and 21% have been 
recorded for college students from New York and healthy women from Oman, 
respectively (Clark and Simmonds, 2011; Russek and Errico, 2016). A higher prevalence 
figure of 30% was obtained from patients attended a musculoskeletal triage clinic in 
London (Connelly et al. 2014). Also, much higher prevalence rates of 38.5% and 25.4% 
were recorded for Iraqi women and men, respectively, who were university students with 
musculoskeletal complaints (Al-rawi, Al-Aszawi and Al-Chalabi, 1985). The highest 
prevalence figures of 54% and 55% were obtained from the responders to a joint pain 
survey in Nigeria, and women who attended for physiotherapy in Oman (Birrell et al. 
1993; Clark and Simmonds, 2011). 
Observing the ages of the studies’ groups suggests an influence due to the 
sample’s age on the prevalence rate of JHS and symptomatic GJL. In particular, the 
lowest prevalence figure of 0.0% has been recorded for an older sample age of 46.1 and 
45.5 years for women and men respectively (Klemp, Williams and Stansfield, 2002). The 
prevalence rate increases to 8.7% when the sample age is reduced to 35 years for women 
and 30.4 years for men, and that may explain the elevation in the prevalence rate (Klemp, 
Williams and Stansfield, 2002). Similarly, a prevalence rate of 9.95% was recorded when 
studying a similar age group in Klemp, Williams and Stansfield’s (2002) study, where the 
sample mean age is 30.9 years (Kumar et al. 2006). The prevalence rates increased to 
12.91% and 19.5%, and that could be due to introducing a much younger sample in the 
age ranges 17-30 and 17-26 years (Didia and Dapper, 2002; Russek and Errico, 2016). 
However, a higher prevalence rate of 15% has been recorded for a study of a wider age 
range from 18-83 years (Bridges, Smith and Reid 1992). Greater prevalence figures of 
38.5% for women, and 25.4% for men were recorded for a younger sample age of 20-24 
years by Al-rawi, Al-Aszawi and Al-Chalabi (1985). The highest prevalence rates of 54% 
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and 55% have been reported when a younger age group was included with the older 
group: 6-66 years and 18-50 years (Birrell et al. 1993; Clark and Simmonds, 2011). The 
increase in the prevalence rate with the reduction of the samples’ age groups suggests that 
age has an influence on the prevalence rate. This could make the influence from 
geographical area over the prevalence rate in adults with JHS/symptomatic GJL 
questionable. This needs to be confirmed through a worldwide study that uses similar 
inclusion criteria. Moreover, using different Beighton cut off points does not seem to 
change the prevalence figure, as the lowest prevalence was recorded by the study that 
used the lowest Beigton cut off points of 4/9 (Klemp, Williams and Stansfield, 2002). 
Using a lower Beighton cut off point would lead to a higher inclusion rate for the JHS 
group, and that should lead to a higher prevalence rate, but that does not apply in the 
studies reviewed. 
In summary, the prevalence figures indicate that JHS is not uncommon and is 
widespread. Moreover, JHS is more common in females than males, and in children than 
adults, where the prevalence reduces with age (Remvig, Jensen and Ward, 2007b; 
Simmonds and Keer, 2007). In addition, it can be seen that the prevalence of JHS could 
be influenced by geographical area.  
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Table 2.2: The epidemiological studies of the generalised joint laxity (GJL) and joint hypermobility syndrome (JHS) in studies 
involving adult samples (part 1). 
Study Diagnostic criteria Population Gender Age 
(Years) 
Ethnicity Sample 
size 
Prevalence 
GJL 
Seow, Chow and 
Khong (1999)* 
Carter-Wilkinson 
modified by 
Beighton 
 
Singapore population Men and women 15-39 Southeast Asia 
(Chinese, 
Malays and 
Indians) 
306 17% 
Hakim et al. 
(2004)* 
Five parts joint 
hypermobility 
questionnaire (if 
answered yes to 2 
or more) 
Adult twin registry 
(UK) 
Not specified 20-30, 
60 and 
older 
United 
Kingdom 
483 MZ 
472 DZ 
19.5% MZ 
22.1% DZ 
24% 20-30 years 
18.4% 60 years and 
older 
Kwon et al. 
(2013)* 
Beighton score 
≥ 4/9 
Girls from elementary 
school, and women 
from the directory of a 
call centre. 
Women only Girls (6-
12), women 
24-50. 
Korea 403 50% 
(58.9% girls, 36.5% 
women) 
Al-Jarallah et al. 
(2014)* 
Beighton score ≥ 
4/9 
Undergraduate 
students 
204 men 
186 women 
18-29 Kuwait 390 22.3% 
JHS & GJL (part 1) 
Bridges, Smith 
and Reid 
(1992)** 
Carter-Wilkinson 
modified by 
Beighton 
≥ 5/9 
Patients referred to 
rheumatologist 
97 women 
33 men 
18-83 
Mean 51 
Not specified. 
Patients 
referred to USA 
(Columbia) 
clinic 
130 15% 
(all women). 
Didia, and 
Dapper (2002)** 
Beighton score ≥ 
5/9 
Undergraduate 
students 
250 men 
300 women 
17-30 Nigeria 550 12.91% 
Klemp, 
Williams and 
Stansfield 
(2002)*,** 
Beighton score ≥ 
4/9 for GJL, and 
clinical descriptor 
for JHS. 
From epidemiologic 
survey of rheumatic 
diseases 
256 women 
182 men 
Mean age: 
women 
35.0, and 
men 30.4 
Maori 438 GJL: 6.2% 
JHS: 8.7% of the 
GJL/ 0.53 % of the 
total sample. 
195 women 
159 men 
Mean age: 
women 
46.1 and 
men 45.5 
New Zealand 
(Europeans) 
354 GJL: 4% 
JHS: 0.0% of the 
GJL and total 
sample 
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Table 2.2: The epidemiological studies of the generalised joint laxity (GJL) and joint hypermobility syndrome (JHS) in studies 
involving adult samples (part 2). 
Study Diagnostic criteria Population Gender Age 
(Years) 
Ethnicity Sample 
size 
Prevalence 
JHS & GJL (part 2) 
Kumar et al. 
(2006)*, ** 
Beighton score  ≥ 
5/9, and Brighton 
criteria 
Referred to 
rheumatology clinic 
Women 
Men 
30 ± 9.4 Northen India 2050 20% had GJL. 
9.95% JHS. 
Clark and 
Simmonds 
(2011)*,** 
Beighton score ≥ 
4/9, and Brighton 
score. 
Patients attended 
physiotherapy with 
musculoskeletal 
symptoms. 
Women 18-50 
years. 
Oman 184; 94 
patients 
and 90 
age and 
ethnicity 
match 
controls. 
From the patient 
group 51% have 
GJL and 55% have 
JHS. 
From the control 
group 30% have 
GJL and 21% have 
JHS. 
Connelly et al. 
(2014)*,** 
Beighton score. 
Brighton score. 
Patients attended a 
Musculoskeletal 
Triage Clinic. 
-- -- London 150 GJL: 19%. 
JHS: 30%. 
Russek and 
Errico 
(2016)*,** 
Beighton score ≥ 
5/9. 
Brighton score. 
Healthy college 
students. 
Women and men 17-26 
years. 
Clarkson 
University, 
New York, US. 
267 GJL: 26.2%; 36.7% 
women, 13.7% 
men. 
JHS: 19.5; 24.5% 
women, 13.7% 
men. 
 
Symptomatic GJL 
Al-rawi, Al-
Aszawi and Al-
Chalabi (1985) 
© 
Carter-Wilkinson 
modified by 
Beighton 
≥ 4/9 
University students 
(357 students with 
joint complaints, 
dislocation or 
ligament sprain) 
361 women 
885 men 
20-24 
years. 
Iraq 1774 38.5 % in women. 
25.4 % in men. 
 
Birrell et al. 
(1993) © 
Beighton score ≥ 
4/9 
Positive responders to 
joint pain survey 
57% females 
35% males 
6-66 years. Africa 
(Nigerian) 
204 54% 
Keys: *  Indicates studies for (GJL). ** Indicates studies for (JHS). © Indicates studies for symptomatic GJL. MZ: monozygotic twins. DZ: dizygotic twins. 
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2.5 Aetiological presentation:   
There is more unknown than is known about the genetic basis of JHS. However, 
the aetiological presentation of JHS could be related to hereditary factors as it can be 
genetically determined, and it is an autosomal dominant disease (Narcisi et al. 1994; 
Hakim et al. 2004; Malfait et al. 2006). However, the genetic basis for JHS is not yet 
conclusive, and sometimes contradictory. Collagen is the richest protein in mammal 
tissue including tendons, ligaments, bone, skin, arteries and cartilage, giving these 
structures their mechanical durability, strength and rigidity (Fratzl, 2008). Moreover, 
collagen is the dominant constituent of muscular tendons, making up 65-80% of tendon 
composition (Kannus, 2000). Genetic reports have identified abnormalities in the genes 
encoding collagen as well as the enzymes responsible for collagen modification in people 
with JHS (Narcisi et al. 1994; Malfait et al. 2006). Likewise, a mutation has been found 
in the genes encoding collagen in a family with EDS-HT (Narcisi et al. 1994). A 
molecular defect has been identified in four genes encoding protein in 34 members from 
a three generation family with EDS-HT, where the identified genes are responsible for 
the formation and regulation of collagen (Syx et al. 2015). In contrast, other studies have 
found no deficits or mutations in collagen gene subtypes in people with joint 
hypermobility (Henney et al. 1992). Therefore, such an explanation might not apply to all 
cases.  
The aetiology of JHS may be related to abnormalities in the protein gene 
(tenascin-X: extra-cellular glycoprotein. In particular, 5-10% of females with JHS in the 
study carried out by Zweers et al. (2003) had a mutation in tenascin-X (Malfait et al. 
2006). Indeed, a complete lack of tenascin-X was revealed in a seven year old boy with 
EDS-HT (O’Connell et al. 2010). Tenascin-X is highly presented in musculoskeletal 
tissues and it bridges between the collagen fibres (O’Connell et al. 2010). Additionally, 
tenascin-X also contributes towards collagen formation and regulation (O’Connell et al. 
2010). Therefore, a reduction/absence of tenascin-X could result in the multi-joint 
hypermobility found in people with JHS. Additionally, JHS is an autosomal determined 
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condition with significant concordance in monozygotic twins at 60%, and in dizygotic 
twins at 36% (Hakim et al. 2004).  
A hormonal imbalance could be one of the aetiological elements which might 
explain the presence of JHS. First, three growth hormones have been shown to be 
elevated in women and men with JHS, including insulin, insulin-like growth factor-1 and 
growth hormone (Denko and Boja, 2001). The elevation of growth hormones could 
explain the musculoskeletal complications in people with JHS (Denko and Boja, 2001). 
In particular, the elevation of growth hormone and insulin-like growth factor-1 is 
associated with joint pain and arthralgia in elderly healthy women and athletes (Liu et al. 
2008; Thompson et al. 2009).  
JHS is more common in women than men (Remvig, Jensen and Ward, 2007b; 
Simmonds and Keer, 2007), and this may suggest the dominance of sex hormones in 
explaining the aetiology of JHS. However, this point cannot currently be supported as sex 
hormones have not been investigated previously in people with JHS. However, previous 
studies on other conditions might support this claim. For example, a significant reduction 
in testosterone, 17-β estradiol and progesterone was found in a group of women with 
non-contact ACL injuries when compared to a control group (Stijack et al. 2014). 
Moreover, sex hormones have an influence on activity and general wellbeing (Aloisi and 
Bonifazi, 2006). Aloisi and Bonifazi (2006) suggested, based on a literature review, that 
the pathogenesis of pain differs between women and men, and this difference could be 
related to differences in their sex hormones during the entire stages of their lives.  
Hormonal changes during pregnancy have been identified in conjunction with 
joint laxity in healthy women, where 54% of 35 women developed wrist laxity from the 
first to third trimester (Marnach et al. 2003). In particular, cortisol, estradiol, 
progesterone and relaxin hormones are elevated during pregnancy (Marnach et al. 2003). 
Even so, the fact that JHS starts from childhood eliminates pregnancy hormones from the 
aetiological dilemma of JHS. Pregnancy hormones might worsen the symptoms of JHS 
and further reduce the stability of the joints, but it might not be a dominant factor in 
understanding the aetiology of JHS. In summary, various hormones in the body could 
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have a direct impact on joint stability and pain pathogenesis, but the literature is limited 
in robust evidence to support and understand the hormonal input to JHS’ aetiology. 
The hereditary component of JHS is more conclusive; moreover, JHS is 
substantially dominant in women when compared to men (Hakim et al. 2004; Remvig, 
Jensen and Ward, 2007b; Simmonds and Keer, 2007). This suggests that an inherited sex-
related deficit could be the origin of JHS. However, previous genetic studies have 
focused on genes encoding collagen, but have not explored sex-related genes. The fact 
that JHS is dramatically dominant in women strongly supports exploring inherited sex-
related factors. To partially support this theory, various disorders are more common in 
women compared to men and vice versa (Romano et al. 2016). An interaction between 
genes and sex hormones can be found in various conditions, including Rett, Fragile-X 
and Down’s syndrome (Romano et al. 2016). Rett and Fragile-X syndromes affect mainly 
girls and women, while Down’s syndrome affects mainly boys (Romano et al. 2016). 
However, the interaction between sex hormones and genes has not been studied in people 
with JHS.      
 Environmental factors could be one of the main issues in understanding the 
aetiology of JHS, as suggested by the results from different countries outlined above. 
Linked to that, improper training and excessive stretching could cause micro-trauma to 
the joint surrounding structures including joint’s capsule, ligament, and soft tissues, 
which could cause joint hypermobility and pain (Gedalia and Brewer, 1993; Grahame, 
1999). 
The pathogenesis of JHS runs in a vicious cycle leading to widespread chronic 
pain. The genetic mutations, hormonal and environmental influences in people with JHS 
could compromise the mechanical rigidity and strength of the joint’s supportive 
structures including ligaments, tendons, muscles and meniscus (Gedalia and Brewer, 
1993; Denko and Boja, 2001; Malfait et al. 2006; Grahame, 2009; O’Connell et al. 
2010). This could lead to overall joint laxity and fragility of the connective tissues in the 
joint surrounding structures (Hakim and Grahame, 2003; Grahame, 2009). The reduction 
in the tensile strength of the joint supportive structures compromises their physical 
integrity, making them vulnerable to trauma and over-use injuries (Hakim and Grahame, 
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2003; Grahame, 2009). This leads to soft tissue injuries, which is worsened by improper 
healing processes in people with JHS as the healing may be slow or incomplete 
(Grahame, 2009). Moreover, the scar formation at the injury site is rather poor (Grahame, 
2009). This explains the increased tendency in people with JHS to suffer sprains, 
ligament injuries, muscle tears, traction injuries of the tendon-bone attachment and other 
over-use complications (Grahame, 2009; Verity et al. 2010; Wolf, Kenneth and Owens, 
2011). This cycle of supportive tissue fragility leading to injury and poor healing, could 
lead to chronic pain syndrome in JHS due to pain receptors’ sensitisation, pain signal 
amplification and psychological distress (Hakim and Grahame, 2003; Grahame, 2009).  
 
2.6 Clinical features: 
JHS incapacitates the connective tissues, where the connective tissues maintain 
the mechanical rigidity of various systems in the human body that are essential for 
normal functioning (Kannus, 2000). Although painful articular hypermobility is the 
commonest feature of JHS, the clinical features of JHS are not limited to the 
musculoskeletal system, but further impact upon other systems. Henceforth, the clinical 
features of JHS will be categorised into musculoskeletal and non-musculoskeletal (Figure 
2.1). In this chapter, an overview has been presented of the clinical features of JHS; 
whereas in the literature review chapter, the primary musculoskeletal features and their 
pathophysiological indications have been extensively explained. 
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Figure 2.1: The clinical features of joint hypermobility syndrome categorised into 
musculoskeletal and non-musculoskeletal.  
 
2.6.1 Musculoskeletal clinical features: 
People with JHS present with a variety of musculoskeletal clinical features, and 
multiple joint hypermobility, pain and recurrent joint dislocation are the primary and 
prominent features (Figure 2.2). First, and as has been explained in the aetiological 
identification section, genetic, hormonal or environmental factors could compromise the 
mechanical architecture of the joint’s supportive structures in JHS, leading to multiple 
joint hypermobility (Malfait et al. 2006; Tinkle et al. 2009; O’Connell et al. 2010). 
Multiple joint hypermobility is the commonest clinical feature in JHS and a diagnosis of 
JHS is mainly confirmed by the existence of joint hypermobility in more than four 
articular joints (Hakim and Grahame, 2003). Second, the main reason for people with 
JHS seeking medical help is due to pain/arthralgia, and joint pain is one of the major 
diagnostic measures of JHS (Gedalia, Press and Buskila, 1996; Grahame, 2009; Hakim 
and Grahame, 2003). Multiple joint arthralgia of the limbs, back and neck is a major 
complaint of people with JHS; it is chronic and severe, ranging from localised pain to 
widespread pain (Hakim and Grahame, 2003; Grahame, 2009; Rombaut et al. 2010; 
Toker et al. 2010; Fatoye et al. 2012). Moreover, pain in JHS is recurrent and overlaps 
with central pain processes and psychological factors (Hakim and Grahame, 2003; Toker 
et al. 2010). As has been discussed in the aetiological identification section, it has been 
suggested that joint pain is a result of the fragility of the joint supportive structures, 
which leads to trauma or overuse injuries, and therefore pain (Hakim and Grahame, 2003; 
Grahame, 2009). The third primary clinical feature of JHS is recurrent joint dislocation, 
which is common and affects two thirds of people with JHS (Castori et al. 2010). The 
 29 
 
most frequently dislocated joint is the ankle, followed by the tempo-mandibular, knee, 
elbow, and then the shoulder joint (Castori et al. 2010). 
People with JHS may present with various secondary musculoskeletal clinical 
features.  Firstly, muscle weakness/myalgia has been frequently reported (Fatoye et al. 
2009; Sahin et al. 2008b; Voermans et al. 2009; Scheper et al. 2013). Secondly, 
fibromyalgia is strongly associated with joint hypermobility, as 64.2 % of those who have 
fibromyalgia have joint hypermobility (Ofluoglu et al. 2006). Thirdly, a significant 
association has been identified between joint hypermobility and osteoarthritis, where 
60% of those diagnosed with JHS develop osteoarthritis (Bridges, Smith and Reid, 1992; 
Mulvey et al. 2013). Fourthly, neurophysiological deficits have been identified in people 
with JHS (Rombaut et al. 2010), particularly proprioception, which is significantly 
impaired at the knee and inter-phalangeal joints in JHS (Ferrell and Craske, 1992; Mallik 
et al. 1994; Hall et al. 1995; Fatoye et al. 2009; Sahin et al. 2008a; Rombaut et al. 2010; 
Scheper et al. 2013; Smith et al. 2013). Moreover, one third of people with JHS show 
clinical features of Marfanoid habitus, which refers to long bones and limbs (Grahame, 
1999; Hakim and Grahame, 2003).  
 
 
 
 
 
 
 
Figure 2.2: The musculoskeletal clinical features of Joint hypermobility syndrome.   
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2.6.2 Non-musculoskeletal clinical features: 
People with JHS may complain of other symptoms which are not related to the 
musculoskeletal system but rather related to other systems (Figure 2.3). Cardiac valve 
disease has been reported previously in people with JHS (Castori et al. 2010). However, 
the studies on the cardiovascular system and JHS have conflicting results. Some previous 
literatures state that cardiac problems are not common or significant in people with JHS, 
and others have found a significant correlation between cardiac valve prolapse and JHS 
(Pitcher and Grahame, 1982; Mishra et al. 1996). However, the most recent study 
highlights a significantly greater incidence rate of JHS in patients with mitral valve 
prolapse when compared to a control group: 45.6% vs 12% respectively (Yazici et al. 
2004). This indicates that signs of cardiovascular disorders could serve as a clue to 
diagnosing JHS, but not as primary clinical features. Symptoms related to the 
gastrointestinal (GI) system have been reported too, such as discomfort, gastritis, reflux, 
and irritable bowel syndrome (Hakim and Grahame, 2004; Castori et al. 2010). In 
particular, 49% of patients referred to a neurogastroenterology clinic had signs of joint 
hypermobility (Zarate et al. 2010). GI symptoms are common in people with JHS, the GI 
symptoms increase with the severity of the phenotype of JHS, which further suggests a 
multidisciplinary approach for identifying the clinical features (Hakim, and Grahame, 
2004; Fikree et al. 2014).  
Symptoms of the urogynecological system are generally rare, yet stress urinary 
incontinence is reported in females with JHS and found to be significantly common (Jha, 
Arunkalaivenen and Situnayake, 2007; Castori et al. 2010). Mucocutaneous symptoms 
are also reported, where the most frequent manifestations are smooth skin, easy bruising, 
abnormal skin elasticity and scarring (Hakim, and Sahota, 2006; Castori et al. 2010). 
Furthermore, JHS is associated with higher perceptions of fear, anxiety and depression, 
which may explain the significant association of JHS with the deterioration of the 
physical activity and health-related quality of life (Hakim and Grahame, 2003; Hakim, 
and Grahame, 2004; Rombaut et al. 2010; Smith et al. 2013; Castori et al. 2010). The 
clinical features of JHS extend to the autonomic nervous system, including syncope, pre-
syncope, palpitations, chest discomfort, fatigue and heat intolerance (Gazit et al. 2003). 
 31 
 
In particular, 78% of those with JHS have been reported to have orthostatic hypotension 
or postural orthostatic tachycardia, which supports dysautonomia as a pathophysiological 
indication (Gazit et al. 2003). Fatigue is commonly reported in people with JHS, and 
those who experience fatigue with joint hypermobility have higher psychological distress 
levels (Gedalia, Press and Buskila, 1996; Hakim and Grahame, 2003; Hakim, and 
Grahame, 2004; Voermans et al. 2009; Castori et al. 2010; Voermans et al. 2010). 
 
Figure 2.3: The non-musculoskeletal features of joint hypermobility syndrome.  
Symptoms of JHS vary from minor complaints to having a severely distressing 
impact on various systems. Moreover, there is a spectrum of clinical features of JHS and 
the severity varies from mild to severe (Grahame, 2001). The appreciation of other mild 
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and uncommon features is desirable and will aid in the diagnosis. However, multiple joint 
hypermobility and arthralgia are essential clues to diagnosis.  
 
2.7 Conclusion: 
In summary, the Background Chapter defined JHS and discussed the diagnostic 
criteria and the prevalence rate. Additionally, the aetiological features and the clinical 
manifestations have been explained. The next chapter is the Literature Review Chapter, 
which has been written to provide the rationale for exploring each variable of the current 
study, along with a critical review of relevant previous studies. Finally, it presents the 
specified objectives of the current study.  
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Chapter Three 
“Literature Review” 
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3. CHAPER THREE: LITERATURE REVIEW 
3.1 Introduction: 
JHS will be explored following the framework of the International Classification 
of Functioning, Disability and Health (ICF), which is the international standard for 
describing and measuring health and disability according to the World Health 
Organization framework. Through the ICF framework, the level of functioning and 
disability can be acknowledged, which is the optimal way for planning management.   
“…ICF assists in scientific research by providing a framework or structure for 
interdisciplinary research in disability and for making results of research comparable. 
Traditionally, scientists have measured the outcomes of health conditions by relying on 
mortality data. More recently, the international concern about health care outcomes has 
shifted to the assessment of functioning at the level of the whole human being, in day-to-
day life.” (World Health Organization, 2002, page 7)  
The ICF recommends concentrating on three levels of functioning (Jette, 2006): 
• Body level, which is the ‘impairment’ domain in the bodily function or 
structure. 
• Whole person level, which is the ‘activity’ domain. 
• The whole person in a social life, which is the ‘participation’ domain.    
A multidimensional approach has been followed in the current project because 
JHS has an impact on various aspects of human health. A comprehensive exploration is 
recommended to explore the disabling impact of JHS following the International 
Classification of Functioning, Disability and Health (ICF) (Scheper et al. 2016). The ICF 
considers the impairment, activity and participation domains, and these were explained in 
section 3.1 (Jette, 2006). Similarly, impairment, activity limitation and participation 
restriction have been reported by people with JHS (Palmer et al. 2016). The disabling 
impact of JHS extends from the physical level to the psychological level (Terry et al. 
2015; Scheper et al. 2016). Within the impairment domain pain, proprioception deficit 
and weakness have been reported as being the most prominent features of JHS (Terry et 
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al. 2015; Palmer et al. 2016). Terry et al. (2015) (p. 355) have quoted participants 
regarding their pain and proprioception as follows: 
“...day in day out you’re managing your pain and it’s a lot of pain, it’s a dull ache.” 
(Female G, age 30, FG1). 
“…it’s on your mind the whole time because I am constantly thinking about where my 
hands and feet are.” (Female G, age 48, FG2). 
Walking is the most frequently reported problematic feature in the activity 
domain (Terry et al. 2015; Palmer et al. 2016). People with JHS frequently complain 
about their modifications or restrictions to activities as a way of avoiding recurrent injury 
and pain (Terry et al. 2015). JHS has been poorly understood by health professionals, and 
that has led to lengthy diagnoses, and even when it is diagnosed, many health 
professionals have no experience of managing JHS (Terry et al. 2015). Understanding 
JHS is essential for both patients to self-manage their conditions, and for clinicians to 
provide appropriate advice and management (Terry et al. 2015). JHS has a disabling 
impact on several levels including impairment, activity and participation. Therefore, a 
multidimensional approach has been followed in this research to study the impact of JHS.   
Consequently, the current project has focused on the three levels of functioning: 
impairment, activity and participation (Figure 1.1). Regarding the impairment domain, 
the following variables will be explored: joint pain, plantar flexor strength, Achilles 
tendon stiffness, knee proprioception, entire-leg stiffness, knee proprioception and 
gastrocnemius muscle elasticity. Regarding the activity domain, walking and vertical 
jump biomechanics will be analysed. The SF-12 and BIoH questionnaire will be used to 
determine the participation level. The rationale for exploring each variable will be 
discussed in the following sections, along with a critical literature review of each variable 
after presenting the search strategy, ending with the objectives of the current study. The 
variables in this chapter will be presented following the order of the data collection 
procedures to follow the order of the variables presented in the methods chapters. 
Crombie’s (2010) recommendations for critically appraising the medical literature 
will be utilised in various areas in this chapter. A systematic review will not be carried 
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out, but rather a critical review will be performed, which aims to inform the essential 
research questions by mainly assessing the accuracy and generalisability of the previous 
results (Crombie, 2010). Crombie (2010, p. 6) states: 
“Critical appraisal is not only a fault-finding exercise. It is a process of reviewing a 
paper to identify information in value”. 
Therefore, the literature review chapter will focus on items which reflect the accuracy 
and generalisibility of the findings such as the studied sample and methods (Crombie, 
2010). Specifically, the accuracy of the findings and their generalisability will be 
analysed by assessing the sample in terms of the selection and diagnostic criteria, size, 
and homogeneity. Additionally, the methods conducted will be critically reviewed and 
the impact of methodological flaws on the results will be assessed. 
Previous reports and reviews can be used to inform research questions. However, 
using previous reviews may not provide a detailed and comprehensive exploration of the 
previous studies, which can be only achieved by reviewing the original primary reports 
(Crombie, 2010). Therefore, previous reviews will not be included in the analysis, but the 
review will focus instead on analysing the original studies (Crombie, 2010). Where 
possible, studies focusing on people with JHS/EDS-HT will be reviewed. Where such 
studies were available, it was decided to exclude studies which only included people with 
GJL. Although both JHS/EDS-HT and GJL exhibit joint hypermobility, the symptomatic 
manifestations of JHS/EDS-HT, such as chronic widespread pain, recurrent dislocation, 
and injuries (Hakim and Grahame, 2003), make it distinct from GJL. Moreover, focusing 
the inclusion criteria on JHS/EDS-HT will allow a detailed and in-depth exploration. 
Crombie (2010, p. 2) explains that:  
“Selectivity in reading is essential to ensure that there is time for detailed inspection of 
important papers”. 
However, on some occasions, studies specific to JHS/EDS-HT were unavailable. In those 
cases, it was necessary to include studies which explored people with GJL. Although this 
was recognised as not being ideal, it was felt that some potentially useful information 
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would still be gained due to the shared feature of joint hypermobility. Where literature on 
GJL will be discussed, this will be clearly identified.  
 
3.2 Pain: the impact of JHS on pain in lower limbs joints: 
The pain section is divided into three parts. The first part will provide background 
information on pain in general before discussing pain associated with JHS. The second 
part will present a critical literature review of the studies that have explored the impact of 
JHS on pain. Finally, the third part will outline the objectives of the current study in 
relation to the pain variable. Pain is categorised under the impairment domain following 
the ICF (Figure 1.1).  
3.2.1 Introduction: 
Understanding pain is complex, as pain extends from an unpleasant psychological 
experience to the activation of the biological systems. In general, pain is: 
“an unpleasant sensory and emotional experience associated with actual or potential 
tissue damage, or described in terms of such damage” (Merskey, 1991, p. 153). 
Biologically, pain can be physiological or pathological. Physiological pain is the 
sensation felt due to stimuli, with a level of intensity which threatens to cause tissue 
damage or injury, but does not reach the level of provoking inflammation or damaging 
the nervous system (Woolf, 1989; Woolf, and Latremolierre, 2009). Physiological pain is 
a protective mechanism facilitated by the withdrawal reflex that we experience in daily 
life in response to hot or sharp objects (Woolf, 1989). Conversely, pathological pain is 
experienced as a consequence of tissue inflammation resulting from tissue damage or 
damage to the nervous system (Woolf, 1989; Woolf and Latremolierre, 2009). Clinically, 
pathological pain is spontaneous and comes with all or most of these signs: hyperalgesia, 
allodynia and referred pain (Woolf, 1989; Woolf and Latremolierre, 2009). The 
pathophysiology of pathological pain is triggered by the stimulation of the nociceptors by 
an inflammation or injury, then the nociceptive stimuli ascend in complex pathways to 
 38 
 
the spinal cord and then the brain (Woolf, 1989; Woolf and Latremolierre, 2009). If acute 
pathological pain does not subside, this could cause peripheral sensitisation. Peripheral 
sensitisation is an increase in the nociceptive sensitivity maintained by a local 
inflammatory process, where the pain threshold reduces at the site of injury as well at the 
surrounding area of the injury, making it more sensitive to mechanical stimuli (Woolf, 
1989; Woolf and Latremolierre, 2009). 
Pain pathophysiology is not only local, and may be centrally mediated. 
Understanding pain in JHS is related to understanding the central control mechanism of 
pain through central sensitisation. In particular, JHS is characterised by chronic 
widespread pain as a primary clinical feature and major diagnostic indicator (Figure 3.1) 
(Hakim and Grahame, 2003; Grahame, 2009; Rombaut et al. 2010; Fatoye et al. 2012; 
Johannessen et al. 2016). The chronicity of pain in JHS might induce a modification of 
the central nervous system, consequently, the sensitivity of pain increases due to central 
sensitisation (Woolf, 1989; Woolf and Latremolierre, 2009). Central sensitisation can be 
elicited by high intense repeated injury, which facilitates plasticity in the somatosensory 
nervous system by increasing membrane excitability and synapse efficiency (Woolf and 
Latremolierre, 2009). Similarly, a repeated injury is a major stage in the pathoaetiology 
of JHS, which results from joint hypermobility and instability (Hakim and Grahame, 
2003; Grahame, 2009). Central sensitisation applies new input to the nociceptor 
pathways, and increases the sensitivity of the pathologic area (Woolf and Salter, 2000). 
Moreover, chronic pain causes a deficiency in the physiological pain inhibition areas in 
the brain, where these areas release pain reduction chemicals as norepinephrine (Yunus, 
2007). Similarly, a deficiency in the physiological pain’s inhibitory control could explain 
pain in chronic musculoskeletal conditions (Arendt-Nielsen, Sluka and Nie, 2008). 
Studies of JHS/EDS-HT suggest that widespread pain might be related to the central 
sensitisation phenomena (Rombaut et al. 2015; Di Stefano et al. 2016). Moreover, central 
sensitisation has been found in conditions with widespread pain such as fibromyalgia, 
osteoarthritis and rheumatoid arthritis (Gwilym et al. 2009; Meeus et al. 2012; Girbes, 
Torres-Cueco and Cubas, 2013). These studies may further support the presence of 
central control of pain in JHS. 
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Figure 3.1: An example of a pain chart filled 
in by a patient with JHS indicating the 
widespread nature of the pain. Adapted from 
Johannessen et al. (2016) with permission 
(Appendix 4). 
 
 
Due to the importance and complexity of pain in JHS, a relevant critical literature 
review has been conducted. The following sections explain the strategy of the literature 
review, ending with the objectives of the current study.                                   
3.2.2    Literature review: 
• Introduction: 
Databases have been reviewed up to August 2016, including PUBMED, 
MEDLINE and CINHAL, where the following key words have been used: pain, 
hypermobility, joint hypermobility syndrome and Ehlers-Danlos syndrome. Eight studies 
have been identified that have explored pain in people with JHS/EDS-HT using various 
assessment methods and from different perspectives (Sacheti et al. 1997; Rombaut et al. 
2011; Celletti et al. 2012a; Fatoye et al. 2012; De Wandele et al. 2013; Albayrak et al. 
2015; Rombaut et al. 2015; Palmer et al. 2016). The studies identified have been 
critically reviewed to support the objectives of the current study. 
• Samples: 
All the studies have focused on adults with JHS/EDS-HT except Fatoye et al. 
(2012) who explored pain in children (Table 3.1). Additionally, four studies used a 
within-subject approach, where they have studied only one group of patients, including 
Sacheti et al. (1997), Celletti et al. (2012a), De Wandele et al. (2013), and Palmer et al. 
(2016). Conversely, the other four studies have used a multiple-group approach. 
Specifically, three studies have compared pain in the JHS/EDS-HT group to a healthy 
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matched control group (Fatoye et al. 2012; Albayrak et al. 2015; Rombaut et al. 2015). 
However, Rombaut et al. (2011) compared an EDS-HT group to two groups: a group 
with fibromyalgia and a group with rheumatoid arthritis. A multiple-group approach is 
more appropriate and valuable than a within-subject approach. In particular, a between-
group approach generates a wider range of results by allowing the comparison of single 
or multiple variables (Edmonds and Kennedy, 2013). 
• Pain assessment methods, and the tested areas: 
Each study implemented a different pain assessment method (Table 3.1), except 
for two studies that used the same method of the Multidimensional Pain Inventory, but 
have used a different category from the scale: Rombaut et al. (2011) and De Wandele et 
al. (2013).  
Substantial heterogeneity has been noticed among the available literature in terms 
of the tested area. First, De Wandele et al. (2013) explored pain from the psychological 
perspective (Table 3.1). Secondly, generic quantifications of pain have been observed 
among four studies, where only one measure of pain was reported to reflect all joints and 
body pain (Sacheti et al. 1997; Rombaut et al. 2011; Celletti et al. 2012a; Rombaut et al. 
2015). Third, Celletti et al. (2012a), Fatoye et al. (2012), Albayrak et al. (2015) and 
Palmer et al. (2016) specified their pain measurement for certain area. Although Celletti 
et al. (2012a) provided a generic measure for pain felt in the body, they specifically 
measured the frequency of lower back pain. Moreover, Fatoye et al. (2012) explored the 
knee joint only, while Albayrak et al. (2015) and Palmer et al. (2016) investigated pain in 
various areas of the back, upper and lower extremities. However, Albayrak et al. (2015) 
have not looked at the dominant and non-dominant side, where the dominant side can be 
at higher stress therefore pain due to the dependency on the dominant side (Jacobs et al. 
2005). Albayrak et al. (2015) have not considered the hip joint in their study, and have 
only measured pain from the severity perspective. Similarly, Palmer et al. (2016) 
provided one measure for the dominant and non-dominant side, and focused their study at 
the commonly painful joints by asking:  
“During the past 7 days, have you had pain in any of the following areas?” (p. 4). 
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• Results: 
As different pain assessment methods were used by the previous studies, different 
dimensions of pain have been reported (Table 3.1). Regarding the results related to lower 
back pain, 77.5% of Celletti et al.’s (2012a) cohort, and 89.7% of Palmer et al.’s (2016) 
cohort have lower back pain, while the severity of low back pain was reported by 
Albayrak et al. (2015) to be 32.2%. Only Palmer et al. (2016) provided area-specific 
measurement for the commonly painful joints (Table 3.1). The number of painful 
locations has only been reported by Sacheti et al. (1997) and Palmer et al.  (2016), which 
is equal to 8.9 ± 2.6; mean ± SD, and 8 ± 3; median ± IQR, respectively. Regarding pain 
intensity, only Sacheti et al. (1997) and Fatoye et al. (2012) reported pain intensity. 
However, Sacheti et al. (1997) reported a generic measurement for reflecting pain in all 
the joints, and Fatoye et al. (2012) only examined the knee joint in children, indicating 
that joint-specific measurement for pain intensity in the lower limb joints was not 
explored previously in adults with JHS.  
The severity of pain is the most frequently reported item among the previous 
studies, and all agreed that pain in people with JHS was significantly severe. Rombaut et 
al. (2011) indicated that pain severity is significantly higher in the EDS-HT group when 
compared to the rheumatoid arthritis group, and significantly lower when compared to 
the fibromyalgia group. De Wandele et al. (2013) have presented one score for the mean 
severity of pain which is equal to 41.2%. In contrast, pain severity has been reported for 
seven specified areas by Albayrak et al. (2015) (Table 3.1). Pressure pain threshold has 
only been reported by Romabut et al. (2015), which was significantly lower in the EDS-
HT group when compared to the control group. 
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Table 3.1: Summary of the identified literature that has explored the impact of JHS/EDS-HT on pain (part1). 
 Sample Pain assessment method Assessed area Results 
Sacheti et 
al. (1997) 
N = 28 with EDS-HT, age range 
36.5 ± 12.3ɑ years. 
Interview + McGill-Melzack 
Pain Questionnaire.  
Upper and lower 
limb joints. 
Number of painful locations: 8.9 ± 2.6ɑ. 
Mean pain intensity: 5.3 ± 1.4ɑ. 
Progressive pain 24/28. 
Rombaut et 
al. (2011) 
EHD-HT group: n = 72 aged 
40.1 ± 11.9ɑ years. 
Fibromyalgia group: n = 69, aged 
44.3 ± 9.8ɑ years. 
Rheumatoid arthritis group: n = 
65 aged 54.9 ± 12.1ɑ years. 
Multidimensional Pain 
Inventory. 
Joint pain generic 
Muscle pain. 
Pain severity and pain interfering with life are 
significantly higher in EDS-HT when compared to 
the RA group, but significantly lower when 
compared to the fibromyalgia group. 
Joint pain reported as the most severe symptom in 
EDS-HT group in 67.6%. 
Joint pain frequency 100. 
Muscle pain frequency 26.8. 
Celletti et 
al. (2012a) 
N = 40 with JHS, aged 33.3 ± 
12.9ɑ years. 
Numerical rating scale. Low back pain, and 
generic. 
Frequency of back pain is 31/40 with 77.5% of the 
cohort have back pain. Chronic arthralgia 34/40 
with 85% of the cohort complaining of chronic 
arthralgia. 
Fatoye et 
al. (2012) 
JHS group: n = 29 aged 11.9 ± 
1.8ɑ years. 
Control group: n = 37 aged 11.5 
± 2.6ɑ years. 
Colored Analogue Scale.  Knee joint. Pain intensity is significantly higher in the JHS 
group when compared to the control group. 
De 
Wandele et 
al. (2013) 
EDS_HT: n = 78, aged 40.3 ± 
12.6ɑ years. 
Multidimensional pain 
inventory (first page only). 
Psychosocial 
impact of pain. 
Pain has a substantial impact on the activities of 
daily living. Mean score for pain severity scored 
41.2, pain interference with daily life scored 45.9, 
life control scored 49.8, distress scored 41.5, and 
social support scored 42.2/ all out of 100%.  
Albayrak et 
al. (2015) 
 
JHS group: n = 115, aged 30.1 ± 
7.4ɑ years. 
Control group: n = 114, aged 
31.8 ± 6.8ɑ years. 
Visual Analogue Scale during 
movement in the last week. 
Neck, low back, 
knee, back, ankle, 
wrist, other joints. 
Severity of pain was calculated: 
Neck 20%, low back 32.2%, knee 27.8%, back 
5.2%, ankle 4.3%, wrist 8.7%, and other joints 
1.7%. 
Rombaut et 
al. (2015) 
 
EDS-HT group: n = 23 aged 40 ± 
10.6ɑ years. 
Control group: n = 12 aged 39 ± 
10.0ɑ years. 
Pressure Pain Threshold (PPT), 
Margolis Pain Diagram for the 
pain in the last 4 weeks which 
lasts than more 24 hrs. 
Form about pain type. 
14 locations at the 
body including 
trunk and 
extremities. 
PPT is significantly lower in the patient group when 
compared with the control group in the symptomatic 
and asymptomatic areas, which suggests a sensitised 
central nervous system. 
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Table 3.1: Summary of the identified literature that has explored the impact of JHS/EDS-HT on pain (part2). 
 Sample Pain assessment method Assessed area Results 
Palmer et 
al. (2016) 
Single group design of JHS: n = 
615, aged 39 ± 17Ƅ years. 
A question from the Bristol 
Impact of Hypermobility 
questionnaire, asking about 
pain during the last seven days. 
10 locations at the 
back, upper and 
lower extremities. 
Regarding the results related to the back and lower 
limbs: Back 89.7%, knees 85.8%, hips 83.0%, feet 
72.4%, and ankles 66.3%. 
Keys:  
ɑ: Values are reported in mean ± standard deviation.  
Ƅ: Values are reported in median ± interquartile range. 
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3.2.3 Conclusion and objectives: 
Joint pain in people with JHS/EDS-HT has been explored by various studies 
previously. However, the quantifications of previous studies were either generic or 
specified to one joint. Two studies only; Albayrak et al. (2015) and Palmer et al. (2016) 
assessed pain in specific joints. Albayrak et al. (2015) have only reported the severity of 
the pain, while Palmer et al. (2016) have reported the frequency of pain in specific joints. 
The literature is limited in joint-specific quantification for pain intensity and severity for 
the lower-limb joints. Therefore, the objectives of the current study are: 
• To study the impact of JHS on pain in the lower back and lower limb joints 
bilaterally, in adults, through a comparison to a control group. 
 
3.3 The impact of JHS on physical activity level, general health and 
participation: 
            3.3.1    Introduction: 
The symptomatic manifestation in people with JHS could have a negative impact 
on their physical activity level, general health and, therefore, participation level, which is 
the third domain in the ICF. In particular, people with JHS present with various disabling 
symptoms such as chronic widespread pain, instability and frequent injury (Gedalia, 
Press and Buskila, 1996; Grahame, 2009; Hakim and Grahame, 2003; Castori et al. 
2010). These symptoms could lead to a withdrawal from participating in daily activities, 
which could induce a negative impact on general health and quality of life (Simsek et al. 
2010; McCarberg et al. 2008). Following ICF, the participation level in people with JHS 
has been considered in the present study (Jette, 2006). Therefore, the following section 
contains a detailed relevant literature review to inform the objectives of the current study.   
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           3.3.2   Literature review: 
• Introduction: 
A search strategy was established for studies that have explored the impact of JHS 
on physical activity levels, general health and participation up to August 2016. Databases 
have been reviewed including PUBMED, MEDLINE and CINHAL, using the keywords 
of joint hypermobility syndrome, Ehlers-Danlos syndrome, participation, activity, 
physical activity and function. Due to the limited quantity of relevant adult studies, 
studies on children have been included in the review. Six studies have been found, which 
are Rombaut et al. (2010), Fatoye et al. (2012), Schubert-Hjalmarsson et al. (2012), 
Albayrak et al. (2015), Johannessen et al. (2016) and Palmer et al. (2016) and these have 
been critically reviewed (Table 3.2), including the sample, diagnostic criteria, assessment 
tools and results. This section ends by presenting the objectives of the current study. 
• Sample and diagnostic criteria: 
The objectives of the six studies are relatively similar, as they aimed to explore 
the impact of JHS on general health and participation. However, the samples studied are 
different. Four studies explored adults with JHS/EDS-HT: Rombaut et al. (2010), 
Albayrak et al. (2015), Johannessen et al. (2016) and Palmer et al. (2016). In contrast, 
two studies focused on children with JHS: Fatoye et al. (2012) and Schubert-Hjalmarsson 
et al. (2012). Moreover, the diagnostic criteria are dissimilar among the studies (Table 
3.2). The diagnostic criteria used by Romabut et al. (2010), Albayrak et al. (2015), and 
Fatoye et al. (2012) could be considered appropriate; particularly, Rombaut et al. (2010) 
who used the validated Villefranche criteria to diagnose people with EDS-HT (Brighton 
et al. 1998). Albayrak et al. (2015) used the Beighton criteria initially and then confirmed 
the diagnosis using the Brighton criteria. Moreover, Fatoye et al. (2012), who explored 
children with JHS, appropriately used the Beighton score, as the Brighton score has not 
been validated for children, and they corrected the deficit in the Beighton score by 
considering the association with joint pain to confirm the diagnosis. In contrast, the 
diagnostic criteria might not be appropriate in Schubert-Hjalmarsson et al. (2012), and 
Johannessen et al. (2016), which has risked the studies’ internal validity. Specifically, 
Schubert-Hjalmarsson et al. (2012) used the Del Mar Scale, and its reliability was not 
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tested in children, which risked the study’s internal validity (Greenhalgh, 2011). 
Moreover, Johannessen et al. (2016) and Palmer et al. (2016) could not confirm the 
diagnosis of their cohorts, as the participants self-declared their diagnosis. 
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Table 3.2: Summary of the identified literature that has explored the impact of JHS/EDS-HT on participation (part 1). 
 Rombaut et al. (2010) Fatoye et al.  (2012) Schubert-
Hjalmarsson et al. 
(2012) 
Albayrak et al. 
(2015) 
Johannessen et al. 
(2016) 
Palmer et al. (2016) 
Sample EDS-HT group: n = 32, 
median age 38, range: 
25-67 years. 
Control group: n = 32, 
median age 38, range 
24-66 years. 
JHS group: n = 29, 
aged 11.9 ± 1.8ɑ 
years. 
Control group: n = 
37, aged 11.5 ± 2.6ɑ 
years. 
JHS group: n = 20, 
aged 11.2 ± 1.9ɑ 
years. 
Control group: n = 
24, aged 11.4 ± 2ɑ 
years. 
JHS group: n = 
115, aged 30.1 ± 
7.4ɑ years. 
Control group: n = 
114, aged 31.8 ± 
6.8ɑ years. 
JHS/EDS group: n = 52, 
aged 28.7 ± 12.7ɑ years. 
Control group: n = 29, 
aged 43.2 ± 15ɑ years. 
JHS group: n = 615, 
aged 39 ± 17Ƅ years. 
Diagnostic 
tool 
Villefranche criteria. Beighton score with 
the association of 
joint pain. 
Del Mar Scale 
contains 11 items; 
five driven from 
the Beighton score, 
beside shoulder 
lateral rotation, 
knee flexion and 
extension, patellar 
movement, elbow 
extension, ankle 
dorsiflexion and 
first toe extension. 
First using the 
Beighton criteria, 
then confirming 
using the Brighton 
criteria. 
Records from two 
hospitals as it is a postal 
survey. 
Self-declared as the 
questionnaires were 
sent to members of an 
association for joint 
hypermobility. 
Assessment 
tool 
Daily Physical activity 
and health-related 
quality of life by 
Baecke questionnaire. 
RAND 36-Item Health 
Survey. 
Paediatric Quality of 
Life Inventory. 
Frequency of 
participation used 
to assess daily life 
activities. 
36-item short form. Postal survey using 36-
item Short form.  
Bristol Impact of 
Hypermobility 
questionnaire (BIoH).  
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Table 3.2: Summary of the identified literature that has explored the impact of JHS/EDS-HT on participation (part 2). 
 Rombaut et al. (2010) Fatoye et al.  (2012) Schubert-
Hjalmarsson et al. 
(2012) 
Albayrak et al. 
(2015) 
Johannessen et al. 
(2016) 
Palmer et al. (2016) 
Results EDS-HT group is 
significantly lower in 
sport participation, no 
significant difference at 
leisure time. 
All items of health-
related quality of life 
(RAND-36) were lower 
when compared to the 
control group, including 
physical and social 
functioning, physical 
and mental problems 
causing limitations, 
mental health, vitality, 
bodily pain, general 
health perceptions, and 
health changes.    
Overall quality of 
life score was 
significantly 
reduced in the JHS 
group, which is 
negatively 
correlated with pain. 
All items were 
reduced including 
physical, emotional, 
social, and school 
functioning.  
The activities of 
daily life were 
affected in the JHS 
group mainly for 
the items dealing 
with housework, 
riding bicycle, 
sport and outdoor 
games.  
Significant 
reduction for the 
JHS group in the 
components of 
physical 
functioning, 
physical role, 
bodily pain, 
general health, 
emotional role, and 
mental health. 
JHS/ED-HR group had 
significantly lower 
health-related quality of 
life with a significantly 
lower physical 
component scale 
including physical 
functioning, physical 
role, bodily pain, and 
general health 
perception; also for the 
mental health scores 
including vitality, social 
functioning, and 
emotional role. 
The impact of JHS on 
people lives is 
equivalent to 234 
±81/360Ƅ, where the 
higher the score is the 
more severe the 
condition is. 
Indicating an impact 
on the physical 
activity level as BIoH 
is highly correlated to 
the SF-36 physical 
components score. 
88% and 52% of the 
cohort scored lower 
than the normative 
score for the PCS and 
MCS of the SF-36 
respectively.   
Keys: ɑ: Values are reported in mean ± standard deviation. Ƅ: Values are reported in median ± interquartile range. PCS: physical component score. MCS: 
mental component score. 
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• Assessment tools: 
The internal validity refers to the accuracy degree of the findings which can be 
enhanced by reducing sources of errors and bias (Greenhalgh, 2011). All the reviewed 
studies used valid and reliable assessment tools to enhance the accuracy of their findings, 
which is one indicator of an appropriate internal validity of the reviewed studies 
(Greenhalgh, 2011). Various assessment tools were used, and the 36-item Short Form 
Health survey (SF-36) was used by Rombaut et al. (2010), Albayrak et al. (2015), 
Johannessen et al. (2016) and Palmer et al. (2016) (Table 3.2). All the studies described 
the SF-36 questionnaire well. Moreover, the validity and reliability were well proven for 
the SF-36 (Jenkinson, Wright and Coulter, 1994). Rombaut et al. (2010) used the Baecke 
questionnaire, where its validity and reliability were also demonstrated. Fatoye et al. 
(2012) used the Paediatric Quality of Life Inventory, which was well described and also 
has high validity and reliability (Varni, Seid and Kurtin, 2001). The Frequency of 
Participation was used by Schubert-Hjalmarsson et al. (2012), which was well described, 
justified, and its face validity demonstrated. Finally, Palmer et al. (2016) used a condition 
specific questionnaire for joint hypermobility syndrome; the Bristol Impact of 
Hypermobility questionnaire (BIoH), and they demonstrated its high validity when 
correlated to the physical component score of the SF-36 questionnaire.       
• Results: 
The results of the studies are summarised in Table 3.2. All of the studies reached 
the same conclusion about the significant impact of JHS on physical activity, general 
health and participation. Moreover, the psychological impact of JHS/EDS-HT has been 
also presented, including reduced mental health, vitality, social functioning and 
emotional role (Table 3.2).    
3.3.3 Conclusion and objectives: 
The review indicates that the literature is limited concerning the quantity of 
studies investigating the impact of JHS on participation and physical activity, where only 
four studies explored adults with JHS/EDS-HT. A condition-specific questionnaire 
(BIoH) for JHS was recently developed and implemented only by the same developer 
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researchers (Palmer et al. 2016). The BIoH will be used in the current research as it’s a 
condition-specific questionnaire, which can aid in examining the impact of JHS on 
participation. Moreover, the BIoH questionnaire can aid in making a statement about how 
representative the current study sample is in relation to a much larger sample of 615 
participants with JHS explored by Palmer et al. (2016). The 12-item Short Form Health 
survey (SF-12) was not used previously, and it’s the practical and clinically applicable 
alternative to the SF-36 with high correspondence and correlation levels, which involves 
the items with the best prediction for physical and mental component scores (Gandek et 
al. 1998). Therefore, the current study will explore the impact of JHS on participation 
using the BIoH and SF-12 questionnaires. Moreover, to understand the impact of JHS on 
participation, correlations should be established to other vital variables related to 
impairment such as joint pain. Consequently, the objectives of the current study are: 
• To study the impact of JHS on participation, and physical and mental 
functioning, in adults using a comparison with a control group using the SF-
12 and BIoH questionnaire. 
• To study the relationship between participation, physical and mental 
functioning, and joint pain. 
 
3.4 Muscle strength: the impact of JHS on plantar flexor muscle 
strength: 
            3.4.1 Introduction: 
Muscle strength in people with JHS can be dramatically impaired, which could be 
related to two major factors. First, chronic widespread pain is substantial in JHS (Hakim 
and Grahame, 2003; Grahame, 2009). Additionally, pain inhibits the motor system during 
and after the time of pain (Le Pera et al. 2001). Ultimately, pain associated with JHS 
could cause muscle inhibition and, therefore, weakness. Secondly, the connective tissues 
in people with JHS are fragile and weak, which could be related to genetic mutations 
(Malfait et al. 2006). Therefore, the fragility of the connective tissue could contribute to 
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muscle weakness. Muscle weakness can be categorised under the ICF impairment domain 
(Figure 1.1). The skeletal muscles are the dynamic joint stabilisers, and people with JHS 
often complain of joint instability and dislocation (Castori et al. 2010). Examining 
muscle weaknesses could inform future interventional studies aimed at improving muscle 
strength to improve functional joint stability in JHS. A literature review has been 
conducted to inform the objectives of the current study.  
           3.4.2 Literature review: 
• Introduction: 
A relevant literature review has been conducted up to August 2016 by searching 
PUBMED, MEDLINE and CINHAL using the following keywords: joint hypermobility 
syndrome, Ehlers-Danlos syndrome, strength, force, torque and power. Studies on 
children have been included due to the limitation in the amount of the available literature 
in adults. Five studies were identified including Engelbert et al. (2003), Fatoye et al. 
(2009), Sahin et al. (2008b), Rombaut et al. (2012b), and Scheper et al. (2013). However, 
the full article by Scheper et al. (2013) could not be found as it was submitted to a 
conference, therefore it has been excluded from the review.  
• Sample, sample size calculation, and diagnostic criteria: 
From the four remaining studies, two explored muscle strength in adults with 
JHS/EDS-HT: Sahin et al. (2008b) and Rombaut et al. (2012b), and two studies focused 
on children with JHS: Engelbert et al. (2003) and Fatoye et al. (2009). All the studies 
employed a multiple-group approach by including a healthy matched control group, 
which can aid in determining the impact of JHS/EDS-HT on muscle strength. Including a 
matched control group is a main factor in enhancing the internal validity of the study by 
demonstrating control over some external factors (Greenhalgh, 2011). Including a 
matched control group can ensure that there are no baseline differences between the 
groups in terms of demographic characteristics (Greenhalgh, 2011), which can be 
considered an overall strength among the reviewed studies. 
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Unjustified sample size might threaten the findings to type II error, where the 
study might not be powered to detect true differences between the groups (Biau, Kerneis 
and Procher, 2008; Greenhalgh, 2011). Only Fatoye et al. (2009) demonstrated sample 
size justification and calculation, so their results are the least affected by potential type II 
error in reporting false negative results. However, all the identified studies found 
significant muscular weakness in the JHS group, which eliminate the threat of type II 
error (Table 3.3). An overall strength point was demonstrated by the four studies by 
implementing appropriate diagnostic criteria for the patient group, which can be 
considered a factor in enhancing the studies’ internal validity (Table 3.3). Moreover, 
introducing an appropriate diagnostic criteria can enhance the external validity and the 
generalisability of the study, by ensuring that the patient group is representative of the 
target population (Bailey, 1997; Greenhalgh 2011).  
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Table 3.3: Summary for literature review for the studies who have explored the impact of JHS/EDS-HT on muscle strength.  
   Engelbert et al. (2003) Fatoye et al. (2009) Sahin et al. (2008b) Rombaut et al. (2012b) 
Sample 
 
GJL with musculoskeletal 
complaints group: n = 15, aged 
8.1 ± 2.5ɑ years. 
GJL without musculoskeletal 
complaints group: n = 16, aged 
8.9 ± 0.7ɑ years. 
Control group: n = 79, aged 9.3 ± 
0.7ɑ years. 
JHS group: n = 29, 
aged 11.9 ± 1.8ɑ years. 
Control group: n = 37, 
aged 11.5 ± 2.6ɑ years. 
Sample size was 
calculated. 
JHS group: n = 40 aged 
27.87 ± 8.12ɑ years, 
Control group: n = 45, 
aged 26.72 ± 9.22ɑ 
years. 
No sample size. 
EDS-HT: n = 43 aged 40 
± 10.8ɑ years. 
Control group: n = 43 
aged 40 ± 10.6ɑ years. 
No sample size 
calculation. 
Diagnostic 
criteria 
Bulbena et al., hypermobility 10 
points score. GJL cutout point 
was 5/10 in girls, and 4/10 in 
boys. Described and referenced.  
Beighton score ≥ 6/9 
in the presence of 
joint pain. 
Brighton criteria. Villefranche criteria. 
Tested muscle Total muscle strength was 
presented as a summation of 
shoulder abductors, hand grip, hip 
flexors and foot dorsal extensors. 
Knee flexors and 
extensors. 
Knee flexors and 
extensors. 
Knee flexors and 
extensors. 
Assessment tools Hand-held dynamometer. Digital myometer; 
Standardised and well 
described procedures. 
Biodex isokinetic 
dynamometer. 
Standardised, 
described, but 
clinimetric properties 
not demonstrated. 
Isokinetic dynamometer 
Standardised and 
described, but clinimetric 
properties not 
demonstrated. 
Results The symptomatic GJL group was 
significantly weaker than the 
control group in term of total 
muscle strength. 
Knee flexors and 
extensors’ strength 
significantly lower in 
the JHS group. 
Knee extensors and 
flexors’ strength 
significantly reduced in 
the JHS group. 
Significant reduction in 
strength. 
Keys: ɑ: Values are reported in mean ± standard deviation. 
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• Muscle groups tested, assessment tools and methodological procedures: 
All the studies focused on the same muscle groups- knee flexors and extensors, 
but Engelbert et al. (2003) provided one total muscle score to reflect the strength of 
shoulder abductors, hand grip, hip flexors and foot dorsal extensors. Two studies used the 
isokinetic dynamometer: Sahin et al. (2008b) and Rombaut et al. (2012b). Fatoye et al. 
(2009) used a digital myometer, while Engelbert et al. (2003) used a hand-held 
dynamometer. More importantly, the assessment tools used have good clinimetric 
properties, including both validity and reliability, which has increased the studies’ 
internal validity (Brinkmann, 1994; Drouin et al. 2004; Bohannon, 2012). Moreover, all 
the studies described their standardised methodologies well, and justified their 
procedures, which can be considered an overall strong point. 
• Results: 
The quality of the available studies could be considered moderate, due to using 
homogenous groups, appropriate diagnostic criteria, valid and reliable assessment tools 
and well described and justified methodologies. Only Fatoye et al. (2009) justified their 
sample size, but they have studied children with JHS. The sample sizes of Sahin et al. 
(2008b) and Rombaut et al. (2012b) are larger than Fatoye et al. (2009), which could 
suggest that their sample sizes were sufficient. Therefore, the results of the available 
studies can be generalised, which supports the impact of JHS/EDS-HT on muscle 
strength. However, Engelbert et al. (2003) included unjustified sample size. 
The review indicates that there is a lack of evidence on exploring the impact of 
JHS on muscle strength in other essential muscle groups in the lower limbs. Engelbert et 
al. (2003) is the only one who considered different muscle groups but presented a 
summation for the scores for all the tested areas. In particular, plantar flexor strength is 
essential for balance and walking (Fukagawa et al. 1995; Lichtwark and Wilson, 2005), 
but it has not been explored. Improving the strength of the plantar flexors is associated 
with improvement in balance and functional mobility (Ribeiro et al. 2009). Moreover, the 
plantar flexors provide trunk support, acceleration and deceleration during walking 
(Neptune, Kautz and Zajac, 2001). Additionally, during walking, the ankle flexors 
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transmit energy to the leg and trunk, and aid in leg and trunk support and forward 
progression (Neptune, Kautz and Zajac, 2001). Specifically, impaired balance and 
mobility with increased falling frequency are significant in people with JHS (Rombaut et 
al. 2011).   
3.4.3 Conclusion and objectives: 
Studying muscle strength in JHS is vital, as joint pain could induce muscle 
weakness (Le Pera et al. 2001). The fragility of the connective tissues could negatively 
impact on the mechanical properties of the muscles (Malfait et al. 2006), which could 
cause muscle weakness. Plantar flexor strength is essential for balance and walking 
(Ribeiro et al. 2009), but no study has explored plantar flexor strength in people with JHS 
previously. Consequently, the objective of the current study is: 
• To study the impact of JHS on plantar flexors strength in adults with JHS 
through comparisons with a control group. 
 
3.5 Muscle-tendon unit stiffness: the impact of JHS on Achilles tendon 
stiffness:  
           3.5.1 Introduction and rationale: 
The functioning mechanism of the muscle-tendon unit during activity is complex. 
This is because stiffness and compliance of the muscle-tendon unit are both required to 
produce efficient movement (Rabita, Couturier and Lambertz, 2008). Muscle-tendon 
stiffness refers to the ratio of muscular force changes to changes in muscle-tendon length 
(McNair, Wood and Marshall, 1992). The stiffer the muscle-tendon unit is during the 
loading phase of an activity, the faster and greater is the force transmission and 
generation (Wilson, Watson and Lichtwark, 2003). However, for efficient force 
production, compliance is also required at the muscle-tendon unit for recoil to store 
elastic energy during the unloading phase of an activity (Rabita, Couturier and Lambertz, 
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2008). Neuromuscular strategies are required to balance these two conflicting 
requirements: stiffness during loading response, and compliance during the unloading 
response (Rabita, Couturier and Lambertz, 2008). 
JHS may modify the viscoelastic proprieties of the muscle-tendon unit and its 
capability of storing, transmitting and generating force from the mechanical and 
neuromuscular perspectives. The aetiological presentation in JHS has suggested a 
mutation in the genes encoding the connective tissue matrix, collagen and protein, and 
these genes are responsible for the mechanical proprieties of the muscle-tendon unit 
(Narcisi et al. 1994; Zweers et al. 2003; Malfait et al. 2006; Voermans et al. 2009). 
Consequently, the muscle-tendon unit’s mechanical abnormalities may explain the 
reported joint hypermobility and instability, reduced functional performance, and the 
increased risk of injuries in patients with JHS (Granata, Wilson and Padua, 2002). 
Moreover, muscle force deficiency has been reported in JHS without evidence of muscle 
atrophy (Rombaut et al. 2012a). Thus, muscle force deficiency in JHS could be related to 
an imbalance in the functioning mechanism of the muscle-tendon unit. Optimising the 
management of JHS requires acknowledging the potential sources of force deficiencies. 
Moreover, a deficiency in muscle-tendon unit stiffness can be categorised under the 
impairment domain of the ICF (Figure 1.1). The relevant literature of muscle-tendon unit 
stiffness in people with JHS/EDS-HT has been reviewed to inform the current study 
objectives. The critical review has focused on the objectives, sample, methodological 
considerations and results, which will be discussed in the following sections, ending with 
the conclusion and the objectives of the current study. 
3.5.2 Literature review: 
Databases have been reviewed up to August 2016, including PUBMED, 
MEDLINE and CINHAL, using the following key word: stiffness, mechanical, 
biomechanical, viscoelastic, joint hypermobility and Ehlers-Danlos syndrome. Two 
studies have been identified: Rombaut et al. (2012a) and Nielsen et al. (2014). The two 
studies have been critically reviewed to inform the objectives of the current study, and 
Table 3.4 summarises the main points of the review.  
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• Objectives: 
Rombaut et al. (2012a) studied muscle-tendon stiffness in EDS-HT by 
determining ultra-sonographic tendon elongation of the Achilles tendon whilst measuring 
the plantar flexors’ strength. Similarly, Nielsen et al. (2014) explored muscle-tendon unit 
stiffness in JHS by using ultrasound to measure the patellar tendon deformation whilst 
measuring knee extensor strength. 
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Table 3.4: Summary for the review of the literature examining stiffness in people with JHS/EDS-HT. 
 Rombaut et al. (2012a) Nielsen et al. (2014) 
Objective To explore the mechanical properties of the Achilles tendon 
in EDS-HT.  
To explore biomechanical properties of the patellar 
tendon in JHS. 
Sample Only women.  
EDS-HT group: n = 25, aged 41 ± 10.0ɑ years, control group 
n = 25, aged 41 ± .9.9ɑ years. 
Homogeneous groups in term of demographic characteristics. 
No sample size calculation. 
Men and women. 
Eight patients with JHS age range 31-53 years, and eight 
matched controls age range 23-70 years.   
Homogenous groups in term of age and BMI. 
No sample size calculation. 
Diagnostic 
criteria 
Revised Villefranche criteria, and Beighton score ≥ 5/9. Brighton criteria. 
Examined 
area 
The Achilles tendon. Patellar tendon. 
Method Standardised, well descried and referenced. Dynamometer to 
measure the isometric contraction of the plantar flexors, and 
ultrasound to measure tendon elongation by tracking the 
fascicles and aponeurosis of the gastrocnemius muscle 
following Fukashiro method. 
The ratio of force to tendon elongation determined Achilles 
tendon stiffness. 
Standardised, well explained and referenced.  
Strain gauge was used to measure the isometric force of 
the knee extensors, and ultrasound was used to track 
patellar tendon deformation. 
The ratio of force to tendon elongation determined 
patellar tendon stiffness.    
Statistical 
tests 
Appropriately described and justified. Appropriately described and justified. 
Results Significant reduction in Achilles tendon stiffness in people 
with EDS-HT; 12.3 ± 4.84ɑ N/mm when compared to the 
control group 15.6 ± 4.43ɑ N/mm. 
No significant difference between the two groups in 
patellar tendon stiffness at maximal force; JHS group: 
3935 ± 519Ŝ N/mm, control group: 4602 ± 587Ŝ N/mm. 
No significant difference between the two in patellar 
tendon stiffness at common force; JHS group 3390 ± 
618Ŝ N/m and the control group 3061 ± 309Ŝ N/mm.  
Keys: ɑ: Values are reported in mean ± standard deviation. 
Ŝ
 Values are reported in mean ± standard error of the mean. 
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• Sample: 
The two studies had the same objective of determining the stiffness of the muscle-
tendon unit, yet the sample characteristics of the two studies are different. Rombaut et al. 
(2012a) studied only women, while Nielsen et al. (2014) included both men and women. 
Both studies risked their research results due to type II error, as the sample size was not 
justified. However, Nielsen et al. (2014) might have greater risk of type II error as their 
sample size is small: eight participants in the JHS group and eight participants in the 
control group, as no significant difference has been found between the two groups in 
patellar tendon stiffness. In contrast, the results of Rombaut et al. (2012a) are less at risk 
of type II error, as their sample size is bigger: 25 participants in the EDS-HT group and 
25 participants in the control group. Moreover, Rombaut et al. (2012a) identified 
significant reduction in Achilles tendon stiffness in the JHS group so by default type II 
error is eliminated. On the contrary, the two studies have examined homogenous groups 
in terms of demographic characteristics, which enhances the internal validity of the two 
studies. Moreover, the diagnostic criteria are appropriate and well justified, which can be 
considered a strength point (Table 3.4).  
• Methodological considerations: 
The two studies by Rombaut et al. (2012a) and Nielsen et al. (2014) demonstrated 
standardised, well described and evidence-based methodological procedures, which 
supports the internal validity of the studies by enhancing the accuracy rate of the reported 
results (Greenhalgh, 2011). The two studies employed the same concept of examining 
muscle-tendon stiffness during isometric muscle contraction, while tracking tendon 
elongation using ultrasound. Consequently, they have measured muscle-tendon stiffness 
by calculating the ratio of force to tendon elongation. However, each study has focused 
on different structures. Rombaut et al. (2012a) scanned the elongation of the intersection 
of the fascicles and aponeurosis in the gastrocnemius medius muscle, which reflects 
Achilles tendon elongation. Moreover, the force measure was obtained from the plantar 
flexors’ strength by using a dynamometer (Rombaut et al. 2012a). Similarly, but for the 
patellar tendon, Nielson et al. (2014) tracked the patellar tendon deformation using 
ultrasound, and measured the knee extensors’ force using a strain gauge dynamometer. 
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Additionally, the two studies have used appropriate statistical tests, which have been 
described and justified, which can be considered an overall strength point. 
• Results: 
Despite utilising similar methodologies, the two studies have revealed different 
results. Significantly lower Achilles tendon stiffness was found by Rombaut et al. 
(2012a) for the EDS-HT group. In contrast, no statistical significant difference was found 
in the stiffness of the patellar tendon between the two group in the study by Nielson et al. 
(2014). The contradiction in the results of the two studies could be related to the small 
sample size of Nielson et al. (2014), who included eight participants in each group, 
whereas Rombaut et al. (2012a) used a larger sample size of 25 participants in each 
group. Therefore, the results of Nielson et al. (2014) might be false-negative; however, 
Nielson et al. (2014) have another point of view on the discrepancy between their results 
and Rombaut et al. (2012a). The stiffness of the Achilles tendon might have been 
underestimated by Romabaut et al. (2012a) because they have only tracked the 
elongation of the proximal part the tendon (Nielson et al. 2014). In contrast, the proximal 
and distal parts of the patellar tendon were tracked in Nielson et al.’s (2014) study. Even 
so, this point should be confirmed with a justified sample size study. Specifically, the 
descriptive statistics in Nielson et al.’s (2014) study showed reduced patellar tendon 
stiffness at maximal force in the JHS group when compared to the control group; 3935 ± 
519 N/mm and 4602 ± 587 N/mm, respectively, which could indicate a possible type II 
error in Nielson et al.’s (2014) study.  
• Conclusion: 
The literature review indicates that there is a limitation in the quantity of studies 
that have explored muscle-tendon unit stiffness in people with JHS, as only two studies 
have been identified. Moreover, the sample sizes of the two studies have not been 
justified, which raises the need for a justified sample size study. The methodology of 
Rombaut et al. (2012a) has been well established using a valid and reliable conceptual 
background and instrumentation (Kawakami, Abe and Fukunaga, 1993; Fukashiro et al. 
1995; Mahieu et al. 2004; Vlychou and Teh, 2008). Therefore, the current study will 
follow the same methodology as Rombaut et al (2012a). However, Rombaut et al. 
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(2012a) included an unjustified sample size of 25 subjects and studied stiffness in a 
single-muscle group. 
The proposed study will quantify stiffness on two levels: “single-muscle response 
level” following Rombaut et al. (2012a), and at the “entire-lower-limb response level” 
following Farley and Morgenroth’s (1999) study of healthy participants. Exploring 
muscle-tendon stiffness on these two diverse levels will provide a comprehensive 
understanding of the impacts of JHS. Studying stiffness according to a single-muscle 
response level following the method of Rombaut et al. (2012a) may not reflect muscle 
behaviour during functional activity, which has been addressed by Farley and 
Morgenroth’s (1999) methods. Stiffness at a single-muscle response level will be studied 
by examining the plantar flexor’s force generation and tendon elongation using a 
myometer and ultrasonography, respectively (Rombaut et al. 2012a). Introducing the 
ultrasonography measurement, will aid in understanding and quantifying the intra-
muscular fascicle and aponeurosis behaviour towards force generation. Such a 
methodology involves testing the plantar flexor force generation in a prone positioning to 
allow plantar flexor ultrasound imaging. However, the plantar flexor lifts the entire body 
weight during locomotion, which is greater than the force generated in a prone testing 
position. Therefore, the current study will add the entire-lower-limb response level for 
measuring stiffness, by following Farley and Morgenroth’s (1999) methodology during 
jump tests using a three-dimensional motion analysis system and force platform. Farley 
and Morgenroth (1999) measured stiffness by calculating the ratio of the peak ground 
reaction force to the maximum vertical displacement of the center of mass. Farley and 
Morgenroth’s (1999) methodology will aid in measuring the plantar flexor’s stiffness in 
its original role of lifting the entire body weight. It is worth mentioning that lower-limb 
stiffness using the jump test was not studied previously in people with JHS/EDS-HT. 
The stiffness at the Achilles tendon will be explored in the current study for 
several reasons. First, the Achilles tendon is the longest and strongest tendon in the 
human body; therefore, a deficiency in the Achilles tendon can cause disability (Hall, 
1999). Secondly, energy storage and release at the Achilles tendon is essential during 
walking and higher levels of activity (Komi, Fukashiro and Jarvinen 1992; Ishikawa et al. 
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2005). Moreover, alteration in the mechanical properties of the Achilles tendon is 
associated with deteriorated postural balance (Onambele, Narici and Maganaris, 2006). 
Specifically, impaired balance, history of frequent falling and fear of falling are 
significant in people with JHS (Onambele, Narici and Maganaris, 2006).     
3.5.3 Objectives: 
Ultimately, the objectives of the current study are: 
• To study the impact of JHS on Achilles tendon stiffness in adults through a 
comparison with a control group. 
• To study the impact of JHS on the entire stiffness of the lower-limbs using the 
jump test with adults and a comparison with a control group. 
• To study the relationship between Achilles tendon stiffness and entire stiffness 
of the lower limbs in people with JHS. 
 
3.6 Knee proprioception: the impact of JHS on knee proprioception:  
    3.6.1 Introduction and rationale: 
Proprioception refers to the perception of position and motion in space, where 
both position and motion awareness are associated with each other in daily activities 
(Stillman, 2002; Han et al. 2016). Proprioception is also known as “joint position sense” 
and kinaesthesia, where the first refers to position awareness and the last refers to 
position and movement awareness (Stillman, 2002; Han et al. 2016). Proprioception 
plays a vital role in regulating joint stability through its multiple inputs and unique 
mechanisms. In particular, proprioception involves the afferent signals originating from 
the body’s internal structures mainly for controlling posture and movement and 
stabilising the joints (Hogervorst and Brand, 1998; Riemann and Lephart, 2002a; Han et 
al. 2016). Proprioception also reflects the individual’s ability to detect changes in joint 
angle and to reposition the joint in a predetermined angle while visual feedback is 
minimised (Dover and Powers, 2003). Proprioceptive input is mainly driven by the 
mechanoreceptors in the muscles, ligaments, tendons, capsules and skin (Lephart, 
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Pincivero and Rozzi,1994; Riemann and Lephart, 2002a; Collins et al. 2005). 
Additionally, four types of receptors are located in the tissues of the ligament and tendon: 
Ruffini, Pacinian corpuscles, Golgi tendon organ endings, and free nerve endings 
(Lephart, Pincivero and Rozzi, 1994; Riemann and Lephart, 2002a; Winter, Allen and 
Proske, 2005; Proske and Gandevia 2009). Conversely, muscle tissues are rich with 
different types of mechanoreceptors, called muscle spindles (Lephart, Pincivero and 
Rozzi, 1994; Riemann and Lephart, 2002a; Winter, Allen and Proske, 2005; Proske and 
Gandevia, 2009). 
Joint stability is maintained via a multi-process mechanism, starting with 
stimulation of the mechanoreceptors, followed by neural transmission, then signal 
integration by the central nervous system which causes muscle stimulation, and then 
force production (Lephart, Pincivero and Rozzi, 1994; Hogervorst and Brand, 1998; 
Riemann and Lephart, 2002a). The process of regulating functional joint stability is a 
result of the collaboration between static and dynamic components (Riemann and 
Lephart, 2002a). The static components are joint geometry, ligaments, capsule and 
cartilage, while the dynamic components are the skeletal muscles (Riemann and Lephart, 
2002a).  
Studying the impact of JHS on proprioception is crucial for several reasons.     
Proprioception maintains functional joint stability and coordination, and it relies on the 
biomechanical and physical characteristics of the joint, such as range of motion, and 
muscle strength (Hogervorst and Brand, 1998; Riemann and Lephart, 2002a). However, 
both range of motion and muscle strength are altered in people with JHS (Hakim and 
Grahame, 2003; Sahin et al. 2008b; Scheper et al. 2013). Therefore, excessive joint 
mobility in people with JHS might be related to failure in their joint proprioception and 
functional stability. In addition, joint instability and recurrent dislocation have been 
frequently reported in people with JHS, which could be related to a deficiency in their 
joint proprioception in addition to other factors (Castori et al. 2010). Moreover, soft 
tissue injuries are frequently reported by people with JHS, and injuries can disturb 
proprioceptive mechanoreceptors (Hogervorst and Brand, 1998; Riemann and Lephart, 
2002b). Intact joint proprioception improves motor control, which in turn prevents 
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injuries (Hogervorst and Brand, 1998; Riemann and Lephart, 2002b). Additionally, 
osteoarthritis is also reported in people with JHS, and 60% of those diagnosed with JHS 
develop osteoarthritis (Bridges, Smith and Reid, 1992; Mulvey et al. 2013). Specifically, 
the deficiency in joint proprioception could alter the force distribution at the joint surface, 
which in turn can predispose osteoarthritis. However, the association between JHS and 
osteoarthritis is controversial, where GJL was found to be protective from hand 
osteoarthritis (Karus et al. 2004). Therefore, studying joint proprioception is essential as 
it could explain various features of JHS such as joint hypermobility, instability, recurrent 
dislocation, injuries, as well as osteoarthritis. Ultimately, confirming a proprioceptive 
deficit could inform future research, and proprioception deficit can be categorised under 
the impairment domain of the ICF. Therefore, the relevant literature has been reviewed to 
inform the objectives of the present study. The critical review has focused on the studies’ 
objectives, sample size justification, group homogeneity, diagnostic criteria, 
methodological considerations, and results. Finally, this section ends with the conclusion 
and the study’s objective.     
    3.6.2 Literature review: 
• Introduction: 
Databases have been reviewed up to August 2016, including PUBMED, 
MEDLINE and CINHAL, using the following key words: hypermobility, Ehlers-Danlos, 
proprioception and joint position sense. The search was limited to those studies that have 
explored the lower limb joints. Five studies were identified: Hall et al. (1995), Sahin et 
al. (2008a), Fatoye et al. (2009), Rombaut et al. (2010) and Pacey et al. (2014). 
However, Pacey et al. (2014) was excluded because it was a single group design study 
aimed at comparing proprioceptive acuity in end range of knee extension to initial flexion 
in children. This limits the identification of the impact of JHS on proprioception mainly 
due to the lack of a control group. Therefore, the identified literature has been reduced to 
four studies. Table 3.5 summarises the major points of the review.     
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Table 3.5: Summary of the literature reviewed related to joint proprioception in the lower-limb joints in people with JHS/EDS-HT.  
Study Sample Tested 
joint 
Diagnostic 
criteria 
Instrumentation Limitation Results 
Hall et al. 
(1995) 
Men and women 
JHS group: n = 10 women 
aged 30.3 ± 6.1ɑ years. 
Control group: n = 10 men 
and n = 10 women aged 
29.7±6.4ɑ and 
30±6.2ɑ years, respectively. 
Knee Beighton 
score ≥ 4/9. 
Specially designed rig with an air splint to 
immobilise the tested leg.  Tested in a side 
lying position on the contralateral limb. 
The rig moved the tested knee to an angle 
and the participants used an angled 
handhold to stop the motor at the estimated 
angle.  
Small and 
unjustified sample 
size. 
Validity and 
reliability of the 
used instrument 
was not 
demonstrated. 
Significant 
reduction in knee 
proprioception in 
the JHS group.  
Sahin et 
al. 
(2008a) 
 
 
 
Men and women. 
JHS group: n = 40 aged 26.9 
± 7.1ɑ years. 
Control group: n = 30 aged 
26.3 ± 6.1ɑ years. 
Knee Brighton 
criteria 
Isokinetic dynamometer using angle 
reproduction test at angles from 5
0
-75
0
 in 
sitting position, then absolute error angle 
was calculated. 
Unjustified sample 
size. 
Significant 
reduction in knee 
proprioception in 
the JHS group.  
Fatoye et 
al. (2009) 
Boys and girls 
JHS group: n = 29 children 
aged 11.9 ± 1.8ɑ years. 
Control group: n = 37 
children aged 11.5 ± 2.6ɑ 
years. 
Sample size calculated and 
justified. 
Knee Beighton 
criteria ≥ 
6/9, with the 
association 
with 
multiple 
joint pain. 
Purpose built motor device with validity 
tested and proved. Sitting position using 
absolute error angle test. 
No limitation. Significant 
reduction in knee 
proprioception at 
the two testing 
angles; 10
0
 and 25
0
.  
Rombaut 
et al. 
(2010) 
Women only. 
EDS-HT group n = 32, aged 
39.6 ± 11.61ɑ years. 
Control group: n = 32 aged 
40.2 ± 13.01ɑ years. 
Knee Villefranche 
criteria. 
Isokinetic Biodex dynamometer was used 
in a high sitting position. Validity and 
reliability of the instrument used were 
demonstrated, using angle reproduction 
approach from 90
0
 flexion to 30
0
 and 60
0
 
degrees of flexion. 
Unjustified sample 
size. 
Significantly 
lowered knee 
proprioception in 
EDS-HT group. 
Keys: ɑ: Values are reported in mean ± standard deviation.  
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• The studies’ objectives: 
The objectives of the four studies were mainly to explore knee proprioceptive 
integrity in JHS/EDS-HT through a comparison with a control group. Three studies have 
focused on adults: Hall et al. (1995), Sahin et al. (2008a), and Rombaut et al. (2010). In 
contrast, one study has focused on children with JHS (Fatoye et al. 2009).  
• Sample size justification, group homogeneity and diagnostic criteria: 
An appropriate sample size reduces the risk of reporting false-negative results- 
type II error- therefore the sample sizes of the identified studies have been analysed 
(Biau, Kerneis and Procher, 2008; Greenhalgh, 2011). All the studies, except Fatoye et 
al. (2009), have not demonstrated sample size calculation, which could risk their studies 
to type II error, reduce the studies’ internal validity and reduce the results’ generalisation 
(Greenhalgh, 2011). However, all the previous studies have found significant reduction in 
knee proprioception in the JHS group, which eliminate the risk of type II error as positive 
results were identified (Biau, Kerneis and Procher, 2008; Greenhalgh, 2011). All the 
studies have included homogenous groups in terms of the demographic characteristics, 
which has increased the internal validity of those studies (Greenhalgh, 2011). One study 
has focused on children (Fatoye et al. 2009), while the other three studies have focused 
on adults with JHS/EDS-HT with dissimilarities in the sample ages (Table 3.5). Both 
sexes were included in all the studies, except for Romabut et al. (2010), who included 
only women. 
The diagnostic criteria among the five studies was dissimilar. Hall et al. (1995) 
used the Beigthon criteria to diagnose those with JHS using a cut point of ≥ 4/9. 
However, the Beighton criteria considers hypermobility and discards other essential 
symptoms, which are all considered in the Brighton criteria. However, the Brighton 
criteria was developed in 1998, three years after Hall et al. (1995) published their study. 
However, such an issue should be considered, as the tested sample by Hall et al. (1995) 
might not well represent JHS, which in turn reduces the study external validity and 
generalisation (Greenhalgh, 2011). Sahin et al. (2008a) used the Brighton criteria, which 
is appropriate for diagnosing people with JHS. In contrast, the Brighton criteria has not 
been validated for children with JHS, therefore Fatoye et al. (2009) have appropriately 
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used the Beighton score, and adjusted the limitation in the Beighton score by including 
those with multiple joint pain. The Villefranche criteria was used by Rombaut et al. 
(2010), which is the validated method used to diagnose people with EDS-HT. 
• Methodological considerations: 
All the identified literature on lower limbs has focused at the knee joint, but they 
have used different instrumentation (Table 3.5). Purpose-built devices have been used by 
Hall et al. (1995) and Fatoye et al. (2009). The issue with purpose-built devices is that 
there are clinimetric properties might not be adequately examined, and that might risk the 
results to error, and the risk of not testing the required parameter; hence, a lack of 
validity. However, Fatoye et al. (2009) have proven the validity of their purpose-built 
device, whereas Hall et al. (1995) have not. In contrast, Sahin et al. (2008a) and Rombaut 
et al. (2010) have used an isokinetic dynamometer, which has high validity and reliability 
(Drouin et al. 2004), and this has improved their studies’ internal validity.  
• Results: 
Regardless of the limitations identified in some of the previous studies, all have 
reached the same conclusion: significant reduction in knee proprioception in the JHS 
/EDS-HT group when compared to the control group (Table 3.5). However, generalising 
these results may be questionable. Hall et al. (1995) used a small sample size of 10 
participants in each group, along with the Beighton criteria which only quantifies joint 
hypermobility, and have not demonstrated the clinimetric properties of their specially 
designed rig. Moreover, Fatoye et al. (2009) have examined children, therefore the results 
cannot be generalised to adults.  
Sahin et al. (2008a) and Rombaut et al. (2010) examined adults and their sample 
sizes seem appropriate (Table 3.5). Moreover, they used isokinetic dynamometers, which 
are highly valid and reliable (Drouin et al. 2004). However, they employed a non-weight 
bearing position to examine proprioception, which might not be the optimal position for 
examining proprioception integrity, as it might underestimate proprioceptive awareness. 
In particular, significantly higher proprioception awareness, accuracy and reproducibility 
have been reported in a weight-bearing testing position when compared to a non-weight 
bearing position (Stillman, and McMeeken, 2001; Andersen, Terwilliger and Denegar, 
 68 
 
2010). Additionally, a non-weight bearing position is incapable of fully stimulating the 
mechanoreceptors in the muscles (Marks, Quinney and Wessel, 1993; Stillman, and 
McMeeken, 2001), while a weight-bearing position increases the sensitivity of the muscle 
spindle receptors, and estimates the role of muscular activation and active articular 
displacement in proprioception (Marks, Quinney and Wessel, 1993; Riemann and 
Lephart, 2002a). Moreover, Golgi tendon organ receptors located at the muscle-tendon 
junction are stimulated by active tension rather than passive tension, where the amount of 
stress applied at the joint changes the activity of the articular mechanoreceptors (Riemann 
and Lephart, 2002a). Therefore, a non-weight bearing position might neglect the input of 
articular mechanoreceptors. Furthermore, most daily activities involving the lower limbs 
are performed in a weight-bearing position, and proprioceptive rehabilitation is 
performed in a closed kinetic chain position, which is purely a weight bearing position. 
This suggests that a proprioceptive examination should be in the same position as daily 
activities and therapy to reflect the real problem.  
3.6.3 Conclusion and objective: 
The critical review of the literature indicates that future study is required, with a 
justified sample size and validated diagnostic criteria to confirm the diagnosis of 
JHS/EDS-HT. Moreover, a system with validity, reliability and good accuracy is required 
to measure proprioception. More importantly, a weight-bearing testing position is 
required to accurately estimate proprioceptive integrity in people with JHS. The squat test 
will be used to assess knee proprioception in the present study, along with a three-
dimensional motion analysis system to measure knee absolute error angle. Further details 
and the rationale have been explained in the methods chapter.  
Knee joint proprioception will be explored in the current study for several 
reasons. Knee hyperextension is a major diagnostic feature of JHS (Hakim and Grahame, 
2003). Moreover, the knee joint is a prime weight-bearing joint, and the development of 
torque about the knee joint is mainly due to its position between the two longest bones in 
the body (Hall, 1999). The complexity of the knee joint makes it vulnerable to injury, and 
knee injuries are the most common injuries in musculoskeletal practice (Clayton and 
Court-Brown, 2008; Nabhan et al. 2016; Tenan, 2016). Additionally, a proprioceptive 
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deficit reduces joint stability and increases the risk of injury (Hogervorst and Brand, 
1998; Riemann and Lephart, 2002b). Therefore, knee proprioception will be explored in 
the current study. Ultimately, the objective of the current study is: 
• To study the impact of JHS on knee proprioception using a weight-bearing 
testing position in adults, with a comparison to a control group. 
 
3.7 Gait biomechanics: the impact of JHS on gait spatiotemporal 
parameters, kinematics and kinetics: 
           3.7.1 Introduction and rationale: 
Studying gait is essential in understanding particular disorders, exploring 
deficiencies, and informing specified interventions. Gait can be categorised under the 
activity domain of the ICF. In general, gait is a daily requirement for locomotion and it 
reflects physical ability, independency, and quality of life (Lelas et al. 2003; Simonsen et 
al. 2012). Moreover, gait components can serve as vital measures for functional capacity, 
general health, and participation (Buchner et al. 1996; Ringsberg et al. 1999; Flansbjer, 
Downham and Lexell, 2006). Gait can also be a measure of the underlying physiological 
changes resulting from a condition (Lelas et al. 2003; Fritz and Lusardi, 2009). In 
particular, gait is a product of interconnecting systems and apparatuses, including visual, 
vestibular, proprioceptive, sensory-motor, neuro-musculoskeletal, cognitive and 
psychological systems (Patla, 1998; Lemke et al. 2000; Allum and Adkin, 2003; Lelas et 
al. 2003; Riskowski et al. 2005). 
The gait of people with JHS might involve variations and impairments, which 
could be as a result of different factors. First, people with JHS exhibit multiple joint 
hypermobility due to laxity in the connective tissues of their joints’ supportive structures 
(Hakim and Grahame, 2003; Simmonds and Keer, 2007). Secondly, condition-related 
symptoms such as chronic joint pain and instability, fatigue, muscle weakness, 
proprioceptive deficit, and physical and psychological decline, might have a major 
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impact on the gait of people with JHS (Hakim and Grahame, 2003; Rombaut et al. 2010; 
Toker et al. 2010; Fatoye et al. 2012). All these factors, which have been detailed in the 
background chapter, could support the hypothesis of possible gait impairments in people 
with JHS. Moreover, understating gait parameters and their relation to joint pain in JHS 
could provide an in-depth understanding of JHS, and direct interventions toward specific 
movements and parameters. 
As shown above, gait is an essential measure in understanding the impact of JHS, 
and recommending specified interventions. Therefore, a related literature review has been 
conducted to inform the current study’s objectives. Databases have been reviewed up to 
August 2016, including PUBMED, MEDLINE and CINHAL, using the following key 
words; hypermobility syndrome, Ehlers-Danlos syndrome, 3D, three dimensions, three 
dimensional, analysis system, gait, walking, locomotion, functional, kinetics and 
kinematics. The search strategy raised five studies which have been critically appraised to 
acknowledge their strengths and weaknesses. Ultimately, the current study’s objectives 
have been determined.  
The literature review has been divided into several elements to aid the critical 
analysis, which are: the study’s objective, sample size, diagnostic criteria, group 
homogeneity and instrumentation. Additionally, blinding, intensity of the walking task, 
methodological procedures, statistical tests, and the results, have been reviewed. Finally, 
the gait section ends with the conclusion and proposes the objectives of the current study. 
Table 3.6 summarises the major points identified and analysed in the review. 
3.7.2 Literature review: 
• Studies’ objectives: 
The gait pattern of people with JHS/EDS-HT has been analysed by five previous 
studies using three-dimensional motion analysis systems (Fatoye et al. 2011, Galli et al. 
2011, Celletti et al. 2012b; Rigoldi et al. 2012, Celletti et al. 2013b). Fatoye et al. (2011) 
focused on the gait kinematics of children with JHS to serve as management guidance. In 
contrast, the other four studies focused on adults with JHS/EDS-HT. Celletti et al. 
(2012b), Galli et al. (2011), and Rigoldi et al. (2012) may seem to be three different 
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studies, but it has been concluded from the review that the three studies actually present 
one data set. This is because, first, there are similar author names used for the three 
studies; second, the sample sizes are equivalent; and third, the groups’ demographic 
characteristics concerning age, height and weight, along with means and standard 
deviations, are identical. Galli et al. (2011) analysed gait kinematics and kinetics, while 
Celletti et al. (2012b) correlated fatigue intensity to gait pattern, and Rigoldi et al. (2012) 
compared the EDS-HT group to a Down’s syndrome group. Therefore, only Galli et al. 
(2011) has been included in the literature review, because its aims are directly related to 
the current study, and because Celletti et al. (2012b) and Rigoldi et al. (2012) have 
explored questions beyond the scope of the current study. This has reduced the total 
number of studies identified in the literature review from five to three. Similarly, the last 
study by Celletti et al. (2013b) analysed the gait pattern of people with JHS but computed 
the Gait Profile Score (GPS) as a practical tool for summarising the findings resulting 
from gait analysis. In particular, the main objective of Celletti et al. (2013b) is to explore 
the effectiveness of GPS in measuring functional impairment in people with JHS.   
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Table 3.6: Summary for the literature identified and reviewed for three-dimensional gait analysis for people with joint hypermobility 
syndrome. 
 Fatoye et al. (2011) Galli et al. (2011) Celletti et al. (2013b) 
Instrumentation Vicon 3D motion analysis 
system. 
3D gait analysis system and Kistler force 
platform. 
3D gait analysis system. 
Sample: sex, size and age; (mean ± SD), 
in years 
Boys and girls. 
29 in JHS group (age: 11.9 ± 
1.8ɑ years), 
37 in control group (age: 
11.5 ± 2.6ɑ years). 
Unjustified sample size. 
Men and women. 
12 in JHS group (age: 43.08 ± 6.78ɑ 
years). 
20 in control group (age: 37.23 ± 8.91ɑ 
years). 
Unjustified sample size. 
 
Only women. 
21 in JHS group (age: 36.1 ± 12.7ɑ 
years) and 20 in control group (age: 
37.2 ± 8.91ɑ years). 
Unjustified sample size. 
Diagnostic criteria Beighton ≥ 6/9 with the 
association with pain, 
Brighton was not used 
because it was not validated 
for children. 
The selection criterion is not clear but 
referenced. 
Villefranche and Brighton criteria. 
Variables considered 
and results found in the 
JHS group when 
compared with the 
control group 
Spatio-
temporal 
Speed was explored only. 
No significant difference 
was found. 
Speed, and step width, stance phase 
duration: no significant difference. 
Lower anterior step length. 
Not explored. 
Kinematic Investigation was limited to 
the knee joint in the sagittal 
plane. 
Significantly reduced knee 
flexion at loading response, 
and significantly increased 
knee extension in mid-
stance. 
Mean pelvic tilt, Hip and knee 
kinematics were comparable to the 
control group. 
Ankle showed reduced dorsiflexion 
during stance and swing phases. 
Foot in plantar flexion position at initial 
contact. 
Gait profile score (GPS) was used, the 
higher GPS the lower physiological gait 
is. Higher GPS for the JHS group: 
pelvic obliquity, hip flexion/extension, 
knee flexion/extension, ankle 
dorsi/plantarflexion, and hip 
abduction/adduction. No differences in 
pelvic tilt and foot progression.  
Kinetic Not explored. Ankle moment and power were analysed 
only, and both were reduced during 
terminal stance. 
Not explored. 
Walking intensity Self-selected walking speed. Self-selected walking speed. Self-selected walking speed. 
Keys: ɑ: Values are reported in mean ± standard deviation. 
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• Sample size, diagnostic criteria and groups homogeneities: 
Identifying true results is largely impacted upon by the sample size, where an 
appropriate sample size reduces the risk of reporting false-negative results (type II error), 
therefore the sample sizes have been analysed (Biau, Kerneis and Procher, 2008; 
Greenhalgh, 2011). The sample size of Fatoye et al. (2011) may be appropriate, as 29 
children were included in the JHS group, and 37 healthy matched participants were 
included in the control group. However, sample size justification has not been 
demonstrated in Fatoye et al.’s (2011) study. This might have risked the results to type II 
error and reduced the results’ internal validity, as no significant difference was found 
between the two groups in terms of speed (Biau, Kerneis and Procher, 2008; Greenhalgh, 
2011). However, type II error has not influenced Fatoye et al.’s (2011) kinematic 
findings, as significant reduction in knee flexion and significant increase in knee 
extension have been identified.  In contrast, the sample sizes of the remaining two studies 
with adults are smaller, ranging from 12 to 21 participants in the JHS group, versus 20 
participants in the control group for the two studies (Galli et al. 2011; Celletti et al. 
2013b). Similarly, no sample size justification is reported in these studies, which 
threatened the findings to type II error (Biau, Kerneis and Procher, 2008; Greenhalgh, 
2011). Specifically, Galli et al. (2011) reported no significant differences between the 
two groups in terms of spatiotemporal, kinematic and kinetic parameters, which could be 
false-negative results due to their small and unjustified sample size (Table 3.6). 
The diagnostic criteria and age range differ among the three studies, which makes 
it more difficult to compare their results. Children aged 11.9 ± 1.8 years (mean ± SD) in 
the JHS, and 11.5 ± 2.6 years (mean ± SD) in the control group, were included by Fatoye 
et al.’s (2011), using a cut-point of ≥ 6/9 of the Beighton score, with multiple joint pain 
(Table 3.6). Conversely, adults with JHS were included by Galli et al. (2011) and Celletti 
et al. (2013b). Men and women were included by Galli el al. (2011), aged 43.08 ± 6.78 
(mean ± SD) years in the JHS group and 37.23 ± 8.91 (mean ± SD) in the control group, 
but the diagnostic method was not specified. In contrast, Celletti et al. (2013b) limited 
their inclusion criteria to women, and their JHS cohort was approximately seven years 
younger than that of Galli et al. (2011) (Table 3.6). Moreover, the diagnostic criteria used 
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by Celletti et al. (2013b) was well explained, which increased the internal validity of their 
study, and the Villefranche and Brighton criteria were used to confirm the diagnosis.  
All the studies mentioned have included homogeneous groups for the JHS and 
control group, in terms of the demographic characteristics of age, height and weight, 
which is a strong point and increases the internal validity of these studies. However, the 
height in Galli et al.’s (2011) study was incomparable between the two groups but that 
has been overcome by normalising the stride length to the subjects’ height. 
• Instrumentation, explored variables and blinding: 
The three studies have used three-dimensional motion analysis systems, which is 
considered the gold standard for gait analysis. This point can be considered a strength, as 
three-dimensional motion analysis systems are highly valid, reliable and sensitive for gait 
analysis (Everaert et al. 1999, Windolf, Gotzen and Morlock 2008, Yavuzer et al. 2008). 
Fatoye et al. (2011) utilised the Vicon motion analysis system to measure gait 
kinematics, where gait kinetics were not considered. Galli et al. (2011) and Celletti et al. 
(2013b) have not specified the make of their motion analysis system used for gait 
kinematic analysis, but Galli et al. (2011) also used the Kistler force platform to analyse 
gait kinetics (Table 3.6). In terms of spatiotemporal parameters, Galli et al. (2011) is the 
only study that has looked at certain spatiotemporal parameters in their gait analysis, 
including speed, step length and width, and stance phase duration. Fatoye et al. (2011) 
only measured speed, while Celletti et al. (2013b) have not considered the spatiotemporal 
aspect in their analysis. Regarding the kinematic analysis, although the three studies 
focused on gait kinematics, there was substantial heterogeneity in the explored variables 
(Table 3.6). Only knee kinematics in the sagittal plane were analysed by Fatoye et al. 
(2011), yet Galli et al. (2011) focused on the pelvis, hip, knee, ankle and foot kinematics 
at various planes of motion. In contrast, the results reported by Celletti et al. (2013b) 
cannot be compared to the other studies as the GPS was used, which has summarised the 
overall deviation and given one score for each joint. The higher the GPS score the lower 
the physiological gait is as been explained by Celletti et al. (2013b).  
None of the mentioned studies have blinded the tester, which has risked the 
results to expectation bias (Bailey, 1997; Bowling, 2009). However, blinding the tester 
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might be difficult in studies of gait analysis, which involve complex application of 
procedures and are best performed by the main researcher. 
• Intensity of the walking task: 
All the studies in the reviewed literatures implemented self-selected walking 
speed to conduct their biomechanical analysis. The intensity of self-selected walking 
speed task might be low and unable to challenge the musculoskeletal system, which 
might make it difficult to explore the underlying impairments. Detection of possible 
deficiencies may be easier using a higher intensity task. In particular, Fatoye et al. (2011) 
asked the participants to walk at self-selected walking speed for six trials along a six-
meter walkway, while Galli et al. (2011) and Celletti et al. (2013b) asked the participants 
to walk at self-selected walking speed along a ten-meter walkway for at least six trials.  
• Methodological procedures: 
All the studies discussed demonstrated standardised, reliable and well described 
methodological procedures, which increases their overall strength. This includes 
instrument settings, examination procedures, testing protocol, calibration, marker 
placement methods and data processing techniques. 
• Statistical tests: 
All the reviewed studies have implemented appropriate statistical tests, which is 
an overall strong point and improves the studies’ internal validity. Fatoye et al. (2011) 
justified the statistical tests well and used the Shapiro-Wilk test to assess the data’s 
normal distribution, and the independent t-test and Mann-Whitney U test were 
implemented alternately. Moreover, Galli et al. (2011) and Celletti et al. (2013b) have 
used the Kolomogorov-Smirnov test to assess the normal distribution of their data. As the 
data of Galli et al. (2011) and Celletti et al. (2013b) were not normally distributed, they 
appropriately used the Mann-Whitney U test to compare the results from the two groups 
(Field, 2009). 
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• Results: 
As has been explained earlier, there is substantial heterogeneity among the 
reviewed studies in terms of the explored variables. The spatiotemporal parameters have 
been analysed only by Fatoye et al. (2011) and Galli et al. (2011), yet both focused on 
different parameters and their investigations were limited in the number of variables. 
Fatoye et al. (2011) looked at speed only and found no significant differences between 
the two groups. Similarly, Galli et al. (2011) found no significant differences between the 
two groups in terms of speed. Galli et al. (2011) also measured anterior step length, 
which was significantly lower in the JHS group, and also looked at stance phase duration 
and step width, which were comparable between the two groups.  
Gait kinematics were explored by the three studies, but their perspectives were 
divergent and mostly unconnected. Fatoye et al. (2011) measured knee kinematics only 
from one movement plane- sagittal- and identified significantly reduced knee flexion and 
increased knee extension in the JHS group when compared to the control group. Unlike 
Fatoye et al. (2011), Galli et al. (2011) did not identify any differences in knee 
kinematics for the JHS group. This controversy could be related to the differences in the 
cohorts’ mean ages: 11.9 versus 43.08 years (Table 3.6), and also due to the risk of false-
negative results by Galli et al. (2011) who included a smaller sample size of 12 versus 29 
(Table 3.6). However, Galli et al. (2011) also explored pelvis, hip, ankle and foot 
kinematics. They identified that the JHS group walked with significantly increased pelvis 
tilt and reduced ankle dorsiflexion (Galli et al. 2011). The results showed comparable 
kinematics between the two groups in the pelvis; frontal plane, and hip joint; sagittal 
plane (Galli et al. 2011). Furthermore, Celletti et al. (2013b) analysed gait kinematics at 
all the joints of the lower limbs, but the results were presented using the GPS, which give 
a score for each joint as a physiological indicator. Introducing the GPS by Celletti et al. 
(2013b) could provide a practical and clinically applicable tool to quantify gait analysis, 
but using the GPS has made it hard to form a comparison with the previous studies. 
Celletti et al. (2013b) found that all gait kinematics were significantly higher for the 
patient group, except for pelvic tilt and foot progression, including hip flexion/extension, 
knee flexion/extension, ankle dorsiflexion/planterflexion, hip abduction/adduction, pelvic 
rotation and hip rotation. The GPS summarises the gait deviation in comparison to the 
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control group, where the higher the GPS is, the lower physiological gait is, and that has 
been explained by Celletti et al. (2013b). 
The kinetic aspect of gait analysis was the least considered among the reviewed 
studies. Neither Fatoye et al. (2011) or Celletti et al. (2013b) explored gait kinetics in 
people with JHS. In contrast, Galli et al. (2011) considered gait kinetics but that is limited 
to the ankle joint, moment and power.   
• Conclusion: 
As shown above, there are various strong points among the reviewed studies, 
which has improved their internal validity. First, the groups are homogenous in terms of 
their demographic characteristics, expect for height in Galli et al. (2011), but this was 
overcome by normalising height to stride length. Second, a three-dimensional motion 
analysis system was utilised by the three studies, which is considered the gold-standard 
for gait analysis with high clinimetric properties (Everaert et al. 1999, Windolf, Gotzen 
and Morlock, 2008, Yavuzer et al. 2008). Third, the methodological procedures have 
been standardised, well described and are evidence based. Fourth, the statistical analyses 
methods have been appropriately explained and administrated. However, the critical 
review has highlighted several weak points, which have been considered in generating 
the current study’s objectives and establishing the other considerations; these are: 
- All of the previous studies in the literature have not justified their sample 
sizes, which has risked some of their results to type II error, where no 
significant findings were identified (Table 3.6) (Biau, Kerneis and Procher, 
2008; Greenhalgh, 2011). The highest sample size was for Fatoye et al. (2011) 
(Table 3.6), but this study was performed on children. Therefore, generalising 
the results to adults is not applicable, as children’s musculoskeletal system is 
immature and has cartilaginous growing plates, unlike adults (Spannow et al. 
2010). Moreover, the synovial joints in adults have a more rigid bony 
configuration which contributes to joint stability and knee locking 
mechanisms (Hall, 1999). Therefore, sample size calculation has been 
considered in the present study in establishing the required number of 
participants for the JHS and control groups. 
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- Patient selection criteria differ among the reviewed studies, and is unclear in 
Galli et al.’s (2011) study. As has been demonstrated in the background 
chapter, at the moment, the Brighton criteria is the optimal method used to 
confirm a diagnosis of JHS, and it considers both joint hypermobility and 
other essential symptoms such as joint pain and instability (Hakim and 
Grahame, 2003; Simmonds and Keer, 2007; Tinkle et al. 2009). Therefore, the 
current study has implemented the Brighton score to confirm the diagnosis of 
JHS. 
- The spatiotemporal parameters of adult gait were presented by one study: 
Galli et al. (2011), but they only looked at speed, step length and width, and 
stance phase duration. Other essential spatiotemporal parameters will be 
considered in the current study, besides the previously explored ones. The 
exploration will involve stance and swing times bilaterally, cycle time, double 
support time, and initial and terminal double support times. The 
comprehensive exploration of gait spatiotemporal parameters should give a 
clearer insight for designing interventions.  
- Gait kinematics in adults with JHS have been explored by two studies 
previously: Galli et al. (2011) and Celletti et al. (2013b); yet the results of 
Celletti et al. (2013b) are hard to interpret as they have used the GPS. 
Moreover, the small sample size of Galli et al. (2011), 12 versus. 20 in the 
JHS and control group respectively, have risked their results to type II error, 
where no significant findings were identified for pelvis, hip and knee 
kinematics. Therefore, the present study will comprehensively explore the gait 
kinematics of people with JHS using a justified sample size for certain 
spatiotemporal, kinematic and kinetic parameters (Table 4.1).  
- Previous studies are substantially limited in exploring the gait kinetics of 
people with JHS for both children and adults. The only available study that 
has considered gait kinetics limited the exploration to the ankle joint (Galli et 
al. 2011). Gait kinetic components are moments and power. Moments are a 
result of force in relation to the moment arm being originated from the 
muscles and soft tissues (Hall, 1999). Studying moment can provide an insight 
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into the capacity of the muscular system during activity, which may be 
essential for people with connective tissue disorders such as JHS (Hall, 1999). 
However, studying gait power is also crucial, as power is a predictor of the 
energy being generated and absorbed by the muscles and soft tissues during 
activity (Hall, 1999). Although moment and power in gait mainly reflect 
muscular capability, power further reflects the velocity component (Hall, 
1999). In particular, power reflects both muscle strength and movement speed, 
where the speed is dependent on muscular shortening (Hall, 1999; Sadeghi, 
Allard and Duhaime, 2000). More importantly, high speed walking relies on 
muscle power, where reduced power can result in the inability to perform 
speed-related tasks (Hall, 1999). Additionally, gait power is an indicator of 
gait propulsion and control, and therefore it is responsible for gait asymmetry 
(Sadeghi, Allard and Duhaime, 2000). Thus, the current study will analyse the 
gait of people with JHS by exploring both moments and powers for the lower 
limb joints. 
- As has been illustrated, there is no detailed investigation available on the gait 
of adults with JHS, including spatiotemporal, kinematic and kinetic 
parameters combined in the same cohort. Gait kinematics identifies joint 
angular changes and movement sequences in respect to time, while gait 
kinetics explains the kinematic results in relation to the acting forces (Hall, 
1999). Examining the three major sectors of gait in the same cohort could 
provide an explanation for the findings. For example, differences in gait 
kinematics could be explained by moment and power variables.  
- None of the studies mentioned have correlated gait parameters to joint pain, 
which is the major complaint of people with JHS, and that will be addressed 
in the present study. 
- All the reviewed studies tested walking at self-selected speed. Although self-
selected walking speed is vital, it could be a task with low intensity. This 
reason might explain the insignificant findings between the JHS group and the 
control group regarding speed, some spatiotemporal parameters, and knee and 
hip kinematics in Galli et al. (2011). Specifically, the knee joint is one of the 
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most affected joints in people with JHS (Beighton, Grahame and Bird, 2012), 
and knee kinematics were comparable to the control group by Galli et al. 
(2011). Moreover, the significantly shorter step length and greater stance 
phase duration highlighted by Galli et al. (2011) might be a compensatory 
mechanism used to avoid knee hyperextension with longer step length and a 
shorter stance phase period. Specifically, the JHS group was able to walk at a 
comparable speed when compared to the control group. Therefore, the 
unchallenged walking task of self-selected walking speed might provide a 
chance for people with JHS to employ compensatory mechanisms. However, 
it has been hypothesised that introducing a challenging task might reveal the 
underling deficiencies. These deficiencies, if identified, can help in tailoring 
rehabilitation and management programs. The high intensity task will be 
discussed in section 3.8. 
 
           3.7.3 The study’s objectives: 
In the light of the literature review, the following objective has been determined 
for the current study, which is: 
• To study the impact of JHS on gait spatiotemporal, kinematic and kinetic 
parameters of the lower limb joints: pelvis, hip, knee and ankle joints in 
adults, through a comparison with a control group. 
• To study the relationship between pain and gait spatiotemporal and kinematics 
parameters.  
 
3.8 Vertical jump biomechanics: the impact of JHS on vertical jump 
kinematics and kinetics: 
3.8.1 Introduction and rationale: 
It might be hard to identify biomechanical deficiencies in low intensity tasks, as 
compensatory mechanisms can easily be employed. As has been explained in the gait 
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section (3.7.2), people with JHS may adopt compensatory mechanisms during low 
intensity tasks such as self-selected walking speed. Various flaws have been identified in 
the literature concerning analysing the gait of people with JHS (section 3.7.2), for 
example small sample sizes; therefore, generalising the results might be questionable. 
  The claim of adopting compensatory mechanisms by people with joint 
hypermobility at low intensity tasks is well supported by electromyographic studies. In 
particular, the internal validity of the electromyographic studies on people with JHS is 
superior to the biomechanical studies, with larger sample sizes and well explained and 
justified methodologies (Jensen et al. 2013; Schmid et al. 2013; Luder et al. 2015). 
Specifically, significant alterations have been reported in the strategies of muscle 
activation in people with joint hypermobility, such as increased muscular activation in 
certain muscle groups or decreased muscular activation in other muscle groups 
(Greenwood et al. 2011; Jensen et al. 2013; Schmid et al. 2013; Luder et al. 2015). These 
muscular changes are mostly aimed at controlling joint laxity and improving joint 
stability (Brunner and Romkes, 2008; Greenwood et al. 2011; Jensen et al. 2013; Schmid 
et al. 2013; Luder et al. 2015). However, these changes have been reported during low 
intensity tasks such as standing for 30 seconds, one leg standing, self-selected walking 
speed and stair climbing (Greenwood et al. 2011; Jensen et al. 2013; Schmid et al. 2013; 
Luder et al. 2015). Significant increases in semitendenosis activation and rectus femoris 
co-contraction were reported in people with GJL during standing and one leg standing 
(Greenwood et al. 2011). These electromyographic changes could be adopted to stablise 
the joints and overcome joints’ ligamentous laxity (Greenwood et al. 2011). However, 
muscular hyperactivity for joint stabilisation could cause early fatigue, injuries, and 
predispose osteoarthritis (Castori et al. 2012b; Celletti et al. 2012b and 2013a). Similarly, 
greater activity of the vastus medialis, vastus lateralis and gastrocnemius muscles has 
been noticed during self-selected walking speed (Schmid et al. 2013). Therefore, it has 
been hypothesised that low intensity tasks might result in compensatory mechanisms 
instead of actual condition-related deficiencies. Therefore, introducing a high intensity 
task could reveal underlying problems. 
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Revealing biomechanical impairments through a high intensity task could identify 
the mechanisms behind joint injury in people with JHS; provided that joint instability is 
an intrinsic factor for predisposing injuries, and as people with JHS commonly get soft 
tissues injuries (Hertel, 2002; Castori et al. 2010). Moreover, injuries might predispose 
joint osteoarthritis, which is also reported in people with JHS (Bridges, Smith and Reid, 
1992; Roos, 2005; Mulvey et al. 2013). The mechanisms of joint injury in people with 
JHS and its relation to joint laxity is not yet understood, which is mainly due to the 
limitations of the available biomechanical studies. Consequently, a high intensity task 
will be introduced in the present study.  
Vertical jump will be employed by the present study as a high intensity task to 
possibly explore biomechanical impairments in people with JHS, and it can be 
categorised under the activity domain of the ICF. The vertical jump test has been chosen 
because it requires a great amount of force generation as an indirect method for 
measuring the power of the lower limbs (Aragon-Vargas, 2000; Darmiento, Galpin and 
Brown, 2012; Fox et al. 2016). Moreover, vertical jump is a simple, quick, and practical 
test with excellent reliability and validity; the intra-rater reliability correlation coefficient 
is 0.994, reliability coefficient of determination is 0.987, and validity coefficient of ˃ 
0.95 (Aragon-Vargas, 2000). Additionally, the vertical jump test is able to challenge the 
entire musculoskeletal system of the lower limbs, including muscles, ligaments and 
tendons (Farley, and Morgenorth, 1999). Based on two systematic reviews, the jump test 
can be used in the early and later stages of ligamentous injuries, and it is valid for 
predicting injury risk (Chua et al. 2016; Fox et al. 2016). Moreover, the jump test is a 
measure of the power of the lower limbs, and is also a strong predictor of bone strength 
(Munukka et al. 2014). Additionally, vertical jump is influenced by muscle-tendon 
stiffness of the plantar flexors, which will be explored in the proposed study (Kubo et al. 
2002). Therefore, the relationship between the vertical jump test and the muscle-tendon 
stiffness of gastrocnemius muscle will be explored to provide an in-depth understanding 
of the effect of JHS. 
The overall stiffness of the musculoskeletal system of the lower limbs can be 
measured through a jump test (Farley and Morgenorth, 1999; Bulter et al. 2003). This 
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reason adds an extra advantage to the jump test to be implemented in the current study. In 
particular, to examine the correlation between stiffness measured with the jump test, with 
the stiffness measured with ultrasonography (section 3.5). Examining such a correlation 
might provide a better understanding of the condition.  
3.8.2 Literature review: 
Databases have been reviewed up to August 2016, including Pubmed, medline 
and Cinhal, using the key words jump, hypermobility and Ehlers-Danlos syndrome. The 
search identified two studies: Juul-Kristensen et al. (2012), and Junge et al. (2015), but 
neither of them can be directly related to the scope of the present study for important 
reasons. First, the two studies have examined people with GJL not JHS (Juul-Kristensen 
et al. 2012; Junge et al. 2015), and GJL differs from JHS as the latter involves various 
symptoms such as chronic widespread pain, joint dislocations and injuries (Juul-
Kristensen et al. 2007; Simmonds and Keer, 2007). Moreover, Junge et al. (2015) have 
included children, whereas only adults are the scope of the present study, and Juul-
Kristensen et al. (2012), who included adult and children groups, limited their analysis of 
the jump test to two parameters: vertical jump displacement and rate of force 
development. These two measures explored by Juul-Kristensen et al. (2012) might not be 
sufficient for comprehensively identifying specified impairments in the lower limb joints. 
Despite the major discrepancies between the available literature and the scope of the 
present study, the two identified studies have been critically reviewed to aid in informing 
the current study’s objectives. Table 3.7 summarises the main points of the review. 
• Sample sizes, group homogeneity and selection criteria: 
Both studies focused on children with GJL and compared them with a control 
group (Juul-Kristensen et al. 2012; Junge et al. 2015). Juul-Kristensen et al. (2012) 
examined 19 children age 10.1 ± 0.5 (mean ± SD) years, and compared them to 20 
controls age 10.2 ± 0.4 (mean ± SD) years. Similarly, Junge et al. (2015) examined 25 
children with GJL age 11.5 ± 1.3 (mean with 95% CI) years, and compared them to 29 
controls age 11.6 ± 1.1 years (mean with 95% CI) (Table 3.7). Juul-Kristensen et al. 
(2012) also included two adult groups- a GJL group of 18 participants age 40.1 ± 5.8 
(mean ± SD) years, and a matched control group of 18 participants age 40.3 ± 4.1 (mean 
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± SD) years (Table 3.7). The internal validity was improved in the two studies by 
examining homogenous groups in terms of demographic characteristics, and by using an 
appropriate selection criterion- a Beighton score of ≥ 5/9. A Beighton score of ≥ 4/9 was 
used by Juul-Kristensen et al. (2012) for the adult group. However, a major weak point 
has been found in the study by Juul-Kristensen et al. (2012) due to not specifying the 
selection criteria whereby both asymptomatic and symptomatic individuals were included 
in the GJL group. This has resulted in 11 adults and three children in the GJL, and three 
children met the Brighton criteria, which confirms the diagnosis of JHS. Therefore, the 
exploratory group does not purely present GJL or JHS, which has risked the study’s 
external validity therefore limiting generalising the results as the sample might not be 
well representative of the target population. Additionally, the studies are at risk of type II 
error because they have not justified their sample sizes (Biau, Kerneis and Procher, 2008; 
Greenhalgh, 2011). Specially, the results showed comparable vertical jump displacement 
and rate of force development between the two groups by Juul-Kristensen et al. (2012), 
and no significant difference between the two groups was illustrated in hop distance by 
Junge et al. (2015). The insignificant findings could be false negative results where the 
studies might not be powered to detect true differences by including unjustified sample 
sizes. 
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Table 3.7: Summary for the literature who have looked at generalised joint hypermobility and jump test. 
 Juul-Kristensen et al. (2012) Junge et al. (2015) 
Sample size,  
age (years) 
Children: control group n = 20 and aged 10.2 ± 0.4ɑ 
years, GJL group n = 19 and aged 10.1 ± 0.5ɑ years. 
Adult: control group n = 18 and age 40.3 ±4.1ɑ 
years, GJL n = 18 and aged 40.1 ± 5.8ɑ years. 
Groups were homogenous in terms of demographic 
data. 
Children: control group n = 29 and aged 11.6 ± 1.1Ŝ years, GJL group 
n = 25 and aged 11.5 ± 1.3Ŝ years. 
Groups were homogenous in term of demographic data. 
Selection criteria Beighton score: ≥ 5/9 for children, and ≥ 4/9 for the 
adult group. 
Beighton score ≥ 5/9. Excluded participants with current pain in the 
back or lower limbs. 
Test  
specification  
and 
instrumentation 
Force platform. 
Three maximal vertical jumps: standing, dropping 
down, jumping to highest possible height, then 
landing. 
Single hop for distance jump. Jumped forward to a new place. 
The distance was measured in cm from the toe at the starting position 
to the back of the heel at the landing position; no other details given 
regarding the way of measuring the distance. 
Surface electromyography for knee flexors and extensors during 
landing. 
Variables 
considered  
Peak vertical jump displacement and rate of force 
development. 
Single leg hop distance. 
Major flaws No sample size justification. 
Eleven adults with GJL and three children from the 
control group have fulfilled the Brighton criteria.  
No sample size justification. 
Results Children with GJL demonstrated greater peak 
vertical jump displacement than the control group. 
Adults with GJL had comparable peak vertical 
jump displacement to the control group. 
No significant differences between the two groups 
in peak rate of force development. 
No significant difference between the two groups in single leg hop 
distance.  
Before landing: 33% significantly reduced semitendinosus activity, 
32% significantly higher gastrocnemius medius activity, and 39% 
significantly higher coactivation index, which is defined as a 
simultaneous activation of two muscles; quadriceps and 
gastrocnemius. 
After landing: 36% significantly lower semitendinosus activity. 
Keys: ɑ: Values are reported in mean ± standard deviation. 
Ŝ
: Values are reported in mean with 95% confidence interval. 
 86 
 
• Test specification and instrumentation: 
Although the two studies by Juul-Kristensen et al. (2012) and Junge et al. (2015) 
both employed the jump task, they are totally dissimilar with regard to the 
instrumentation used and variables considered. Juul-Kristensen et al. (2012) used a force 
platform to measure vertical displacement and rate of force development for the vertical 
jump. In contrast, Junge et al. (2015) used electromyography to assess the activity of the 
knee flexors and extensors, and measured the jumping distance in centimeters (Table 
3.7). Moreover, Junge et al. (2015) used jumping for a distance task, and it differs from 
vertical jumping. Jumping for a distance is more challenging and might not be safe for 
patients with musculoskeletal problems as it requires them to land in a different spot, 
while vertical jumping is safer as the patient only needs to jump and land in the same 
spot. The jumped distance in Junge et al.’s (2015) study was measured in cm from the toe 
at the starting position to the back of the heel at the landing position. However, the 
validity of this measurement was not demonstrated, which can risk the internal validity of 
Junge et al.’s (2015) study. 
• Results: 
The results of the two studies are summarised in Table 3.7. However, they cannot 
be compared to each other as different variables have been explored. Moreover, the 
results are related to GJL, so they might not directly inform a study of JHS.  
• Conclusion: 
The literature review indicates that there is no study available in the literature that 
has examined people with JHS using a vertical jump as a high intensity task. Two studies 
have been reviewed, but they cannot directly inform the current study’s objectives. 
However, the critique of the biomechanical studies as well as the electromyography 
studies supports the need to study JHS using a high intensity task (section 3.7.2 and 
3.8.1). 
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           3.8.3 Objectives: 
Accordingly, the objectives of the current study are: 
• To study the impact of JHS on vertical jump height, kinematics and kinetics of 
the lower limb joints: pelvis, hip, knee and ankle joints in adults, through a 
comparison with a control group. 
• To study the impact of JHS on leg stiffness measured with vertical jump in 
adults, through a comparison with a control group. 
 
3.9 The impact of JHS on the elasticity of gastrocnemius medius and 
the feasibility of using the sonoelastography in examining people 
with JHS: 
 
           3.9.1 Introduction and rationale: 
Identifying people with JHS/EDS-HT is based on questions and a clinical 
examination using the Beighton, Brighton or Villefranche criteria, which have been 
detailed in the background chapter (Hakim and Grahame, 2003; Smits-Engelsman, Klerks 
and Kirby, 2010). Despite the high psychometric properties of the criteria, they encounter 
various issues. First, the last update of these criteria was in 1998, and various studies 
have since been published concerning JHS, and various technologies in diagnostic 
medicine have been developed. Second, the nature of the available diagnostic criteria 
might depend on the examiner’s experience, and the memory of the patient. Therefore, 
diagnostic error might arise from an inexperienced examiner or the inability to recall 
memories by the patient. Third, Scheper et al. (2016) also raised the need for new 
identification measures based on meta-analysis:  
‘…Both diagnosis of HMS and EDS-HT are characterised by a large variability within 
the phenotype and in the last decade it has become clear that neither the current 
classification nor the distinction between HMS and EDS-HT are sufficient’  
Various advances have led to developments over the last twenty years in the 
imaging and ultrasound field, which could help people with JHS. In particular, an 
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ultrasound based system, sonoelastography (SEG), is able to quantify the elasticity of 
structures by providing coloured images, where each colour indicates a different elasticity 
degree (Sconfienza et al. 2010; Turan et al. 2013). SEG measures the perpendicular strain 
in the tissue in response to the examiner’s external mild compressions using a SEG 
probe, where the SEG converts tissue displacement into colour-coded images (Sconfienza 
et al. 2010; Turan et al. 2013; Klauser et al. 2014). Further details about the SEG have 
been explained in the methods chapter. However, administering SEG should be valuable, 
as the muscle-tendon structure in people with JHS could be hyper-extensible, which may 
be identified using the SEG. In particular, multiple joint hypermobility and the weakness 
of the connective tissues in people with JHS could support this hypothesis (Malfait et al. 
2006). The genetic mutations identified in people with JHS could weaken the 
musculoskeletal system and reduce its rigidity (Malfait et al. 2006; Grahame, 2009; 
O’Connell et al. 2010). Consequently, this could induce overall joint laxity and fragility 
of the connective tissues, which shows the multiple joint hypermobility feature (Hakim 
and Grahame, 2003; Grahame, 2009). Possibly, SEG could show distinct features and aid 
in diagnosing people with JHS, as well as being a tool for monitoring progression. 
Therefore, a relevant literature review has been conducted to inform the objectives of the 
current study.       
3.9.2 Literature review and objectives: 
PUBMED, MEDLINE and CINHAL databases have been reviewed up to August 
2016 using the following key words: joint hypermobility syndrome, Ehlers-Danlos 
syndrome, and sonoelastography. One study was identified, which is a case study of a 10-
year-old boy diagnosed with GJL (Kocyigit et al. 2015). Although GJL is different to 
JHS/EDS-HT, it shares the hypermobility features, and the lack of other studies on 
JHS/EDS-HT means that this study has been reviewed to inform the objectives of the 
present study. 
The study is a case report of a 10-year-old boy with GJL and a Beighton score of 
8/9. SEG has been used to measure the elasticity of the Achilles tendon, using a well 
described methodology. The results indicated that the SEG image was mostly green and 
red, where previous studies on healthy participants were used as a reference, which 
 89 
 
indicated that the healthy Achilles tendon is mostly green and blue in a SEG image (red: 
soft, green: intermittent, and blue: hard tissue). Despite the originality of this case report, 
there are various weaknesses, and these will be addressed in the present study. First, as 
this study is a one case report, the results cannot be generalised, are at risk of selection 
bias, and are not representative of the wider population (Zainal, 2007). Second, 
comparing the data to previously published findings might not be appropriate, as 
differences might arise due to differences in the examination procedures, examiner, and 
demographic characteristics between the two groups. Third, as SEG has not yet been 
studied in JHS patients, examining its feasibility is essential. Additionally, as the 
gastrocnemius-Achilles tendon complex will be explored at various levels in the current 
study for its essential role in functional balance and mobility, the elasticity of the 
gastrocnemius muscle will be explored by the current study using the SEG. Ultimately, 
the objectives of the current study are: 
• To study the impact of JHS on the elasticity of gastrocnemius muscle in 
adults, using a comparison with a control group. 
• To study the feasibility of using sonoelastography in examining the 
gastrocnemius muscle in people with JHS. 
 
3.10 The intra-rater reliability of measuring Achilles tendon unit 
stiffness, and gait kinematics: 
 
The clinimetric properties of the assessment methods used in the current study 
have been critically reviewed in the methods chapter. However, the review has informed 
two intra-rater reliability studies, which will be performed in the current study to ensure 
the repeatability of the measurement. The first intra-rater reliability study has been 
informed after reviewing the clinimetric properties of the diagnostic ultrasound and 
digital strain-gauge myometer in determining Achilles tendon stiffness. The review has 
been presented in the methods chapter (section 4.5.4: the active method and 
ultrasonography). The second intra-rater reliability study has been informed after 
reviewing the clinimetric properties of the Qualisys motion capture system for kinematics 
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gait analysis. The review has been presented in the methods chapter (section 4.5.5: the 
advantages of three-dimensional motion analysis system). Ultimately, the objectives of 
the two intra-rater reliability studies are:     
• To study the repeatability of measuring Achilles tendon stiffness by using the 
ultrasound and strain-gauge myometer. 
• To study the repeatability of measuring gait kinematics by the Qualisys 
motion capture system through markers reapplication. 
 
3.11 The objectives of this PhD project: 
In summary the objectives of the current project which were identified in this 
chapter are: 
• To study the impact of JHS on pain in the lower back and lower limb joints 
bilaterally, in adults, using a comparison with a control group. 
• To study the impact of JHS on participation, and physical and psychological 
functioning, in adults, using a comparison with a control group. 
• To study the relationship between participation, physical and mental 
functioning, and joint pain.  
• To study the impacts of JHS on plantar flexor strength in adults with JHS 
through comparisons with a control group. 
• To study the impact of JHS on Achilles tendon stiffness in adults through a 
comparison with a control group. 
• To study the impact of JHS on the entire stiffness of the lower-limbs using the 
jump test with adults, and a comparison with a control group. 
• To study the relationship between Achilles tendon stiffness and entire stiffness 
of the lower limbs in people with JHS, using a comparison with a control 
group. 
• To study the impact of JHS on knee proprioception using a weight-bearing 
testing position in adults, with a comparison with a control group. 
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• To study the impact of JHS on gait spatiotemporal, kinematic and kinetic 
parameters of the lower limb joints: pelvis, hip, knee and ankle joints in 
adults, through a comparison with a control group. 
• To study the relationship between pain and gait spatiotemporal and kinematic 
parameters.  
• To study the impact of JHS on vertical jump height, kinematics and kinetics of 
the lower limb joints: pelvis, hip, knee and ankle joints in adults, through a 
comparison with a control group. 
• To study the impact of JHS on leg stiffness measured with a vertical jump in 
adults, using a comparison with a control group. 
• To study the impact of JHS on the elasticity of gastrocnemius muscle in 
adults, using a comparison with a control group. 
• To study the feasibility of using sonoelastography in examining the 
gastrocnemius muscle in people with JHS. 
• To study the repeatability of measuring Achilles tendon stiffness by using the 
ultrasound and strain-gauge myometer. 
• To study the repeatability of measuring gait kinematics by the Qualisys 
motion capture system through markers reapplication. 
 
3.12  Conclusion:  
 
This chapter has critically reviewed the previous studies to identify the knowledge 
gap and support the objectives of the current study. The next chapter, Chapter Four, the 
methods chapter, will be discussed the methods used to achieve the objectives of the 
current project. 
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“Methods” 
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4. CHAPTER FOUR: METHODS 
4.1 Introduction: 
The method chapter will explain and discuss the methodological aspects required 
to achieve the aims and objectives of the current PhD project. In particular, this chapter 
will start by explaining the study design, inclusion and exclusion criteria, then the sample 
size. Details related to the assessment methods will be covered by providing a general 
overview of the possible alternatives to justify the assessment methods choice in the 
current investigation. Furthermore, the psychometric and clinimetric properties of the 
used assessment methods will be reviewed and discussed. Additionally, details related to 
the recruitment sites and strategy, ethical considerations, and the input of the Patient 
Research Partner in the current research will be presented. The data collection procedures 
will be discussed and explained in chronological order as conducted in this research on 
the day of the examination. Finally, data processing and analysis procedures will be 
detailed, ending this chapter with a conclusion. Figure 4.1 summarises the sequence of 
the examination procedures in chronological order as performed in the current 
investigation. 
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Figure 4.1: The study flow summary. 
       (*)Stages for assessing the intra-rater reliability. Ten participants from each group 
were involved in reliability study I, and ten participants from the control group were 
involved in reliability study II. 
      (**) Stage conducted at the Radiography diagnostic facilities. Ten participants from 
each group were involved in this stage.  
SF-12: The 12-item Short Form Health Survey. BIoH: Bristol Impact of Hypermobility 
questionnaire. 
Recruitment  
JHS group 
(Target n = 30) 
 
n 
  
Control group 
(Target n = 30) 
 
n 
  
Explanation and consenting 
Confirming inclusion eligibility using Brighton/Villefranche criteria 
Answering biographic, visual analogue scale, SF-12 and BIoH questionnaires  
Measuring Achilles tendon stiffness with ultrasound and myometer and 
measuring plantar flexor strength 
Applying Qualisys motion capture system markers 
Measuring proprioception using the Qualisys system through the squat test 
Gait biomechanical analysis using the Qualisys motion capture system: 
spatiotemporal, kinematics and kinetics analysis.  
*Reliability study II: Reapplying the Qualisys markers then repeating gait 
biomechanics analysis; reassessing gait kinematics 
*Reliability study I: Repeating “measuring Achilles tendon stiffness” 
Vertical jump biomechanical analysis using the Qualisys motion capture 
system. Through the same test lower limb stiffness was measured 
**Feasibility study: Measuring the elasticity of the gastrocnemius muscle 
using the sonolestography 
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4.2 Study design: 
4.2.1 Cross-sectional design: 
A quantitative observational cross-sectional research design was employed to 
achieve the research objectives. Specifically, this design was used to attain those 
objectives aiming to compare the JHS group against a control group. This is because the 
study's variables were measurable and the main aim was generalisation of the results 
following a positivist perspective (Bailey, 1997). Studying JHS in a cross-sectional 
design study is the most appropriate design nowadays. In particular, the literature review 
illustrated that JHS was poorly recognised and studied, and there was a limitation in the 
quantity and the quality of studies that support the diagnosis and management of JHS 
(Scheper et al. 2013; Smith et al. 2013). This meant that exploring JHS in a cross-
sectional design study will enable studying a wide range of variables in a short period of 
time, which would inform a higher level of research as a cohort or randomised 
clinical/control design study (Hennekens and Buring, 1987; Heiman, 2002; Mann, 2003). 
A cross-sectional design is practical, cheap, easy and quick for studying a large number 
of variables at one point of time (Mann, 2003). It is not possible to distinguish between 
the cause, effects and the sequence of events, but it is the best method for identifying 
prevalence and between factor associations to recommend a higher level of research by 
helping in generating hypotheses (Hennekens and Buring, 1987; Heiman, 2002; Mann, 
2003). More importantly, establishing relationships may highlight the burden of JHS and 
flag up the need for certain health resources. Moreover, this cross-sectional study design 
is ethically acceptable as it does not expose the participants to any kind of treatment or 
manipulation (Mann, 2003). A cross-sectional design study is descriptive and analytical 
and both domains will be utilised in the current study (Hennekens and Buring, 1987; 
Heiman, 2002).   
4.2.2 Correlational design: 
A correlational design has been also employed in the present investigation to 
establish the strength and direction of the relationships between the variables whether 
they are positively, negatively or not correlated (Mann, 2003; Greenhalgh, 2011). 
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4.2.3 Reliability design: 
A reliability design has been used to evaluate the intra-rater reliability for: 
• Measuring Achilles tendon stiffness using the ultrasound and the digital 
myometer. 
• Analysing gait kinematics by reapplying the markers of the Qualisys motion 
capture system and repeating the walk test.  
In particular, the reliability design could identify whether the collected data are free from 
rater error, where Walter, Eliasziw and Donner (1998, p. 101) have stated that: 
“reliability studies are often used to evaluate the measurement properties of human 
observers.”  
The main issue in the reliability study was the careful consideration of the number 
of test repetitions to avoid fatigue, learning effects and to replicate within the 
participants’ tolerance (Walter, Eliasziw and Donner, 1998). All of these factors were 
considered by providing rest periods, and test familiarisation, an appropriate number of 
trials, and asking the participants to stop during any test if it exceeded their tolerance. 
4.2.4 Feasibility design: 
Sonoelastography is a new technology in musculoskeletal practice used to 
quantify the elasticity of tissue (Sconfienza et al. 2010; Turan et al. 2013; Klauser et al. 
2014). Tissue elasticity has not been studied previously in the JHS population. Therefore, 
the success or failure of sonoelastography was assessed in the current study following a 
feasibility design (Bailey, 1997). Studying tissue elasticity in a feasibility study could 
help future research in assessing sample size, protocol integrity, acceptability to 
participants, recruitment rate, time needed to collect and analyse the data, as well as the 
usefulness of the data (Lancaster, Dodd and Williamson, 2004). 
4.2.5 Matching pairs design: 
To ensure between group homogeneity in term of age and gender, a matching 
pairs design was used in the current study. This design was the only way to ensure groups 
equivalency if randomisation has not been performed (Bowling, 2009). The matching 
pairs design has been described by Robson (2011, p. 105) as:  
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"In its simplest form, the matched pairs design, matching involves testing participants on 
some variables which is known to be related to the dependent variable on which 
observations are being collected in experiment…..creating matched age pairs allow us to 
carry out a relatively sensitive test without the conclusions being restricted to a 
particular and narrow age range." 
It is relatively difficult to find a match for each participant, and it is a time-
consuming method (Bowling, 2009; Robson, 2011). However, the match pairs design is 
commonly used in research to eliminate the effects of original differences between the 
participants such as gender and age, to observe actual condition-related differences 
without applying huge restriction and control on the research environment (Robson, 
2011). Additionally, controlling some variables by using the matching pairs design 
increases the sensitivity of the conducted tests, especially if the controlled variables are 
highly correlated to the dependent variables (Robson, 2011). Specifically, gender and 
age; the matched variables in the current study, are highly correlated to most of the study 
variables in the current study such as strength, stiffness, tissue elasticity, gait and jump 
performance (Lindle et al. 1997; Granata, Padua and Wilson, 2002; Steffen, Hacker and 
Mollinger, 2002; Kubo, Kanehisa and Fukunaga, 2003; Arai and Asmara, 2012). 
There are two ways for matching; “precision control” and “frequency distribution 
control” (Bowling, 2009). The precision control works by matching each patient member 
to each control member with the same entire characteristics of the matched variables; 
such as age and gender by conducting participant by participant matching, which results 
in pairs of participants sharing certain characteristics (Bowling, 2009). However, it is 
difficult to find the required matched participant by following the precision control, and 
that increases the exclusion rates which in turn reduces the external validity of the study 
and the results generalisation (Bowling, 2009). In contrast, the frequency distribution 
control matching is not an individual matching but group by group matching, where a 
group is matched to another group who shares certain characteristics (Bowling, 2009). 
Therefore, it is easier to find the matched participant following the frequency distribution 
control way of matching (Bowling, 2009). Therefore, that reduces the exclusion rates, 
which in turn increases the study’s external validity and generalisation (Bowling, 2009). 
Therefore, the frequency distribution control has been followed in the current study. In 
addition, there are only two matching variables; age and gender, which makes it 
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relatively less difficult in finding the match and that increases the study's external 
validity. 
The matched variables; such as age and gender in the current study, cannot be 
statistically analysed to assess the relationship between that matched variables and the 
condition, and the inability to analyse the matched variables reduces the power and 
increases the cost of the study (Robson, 2011). However, ensuring groups homogeneity is 
superior to assessing this relationship. Particularly, assessing the relationships of age and 
gender to JHS is not the scope of this study. 
Matching techniques violate one of the main assumption to operate the statistical 
tests, which is the independent samples (Bowling, 2009). However, Bowling (2009) has 
stated based on Blalock’s (1972, p. 276) argument: 
"That is an important assumption underlying statistical tests, although statisticians may 
argue that there is no simple way to make use of a statistical test which is efficient and 
which does not involve questionable assumptions."   
 
4.3 Inclusion and exclusion criterion: 
This section will detail the inclusion and exclusion criterion followed in the current 
study for both the JHS and the control group. 
4.3.1 Participants were included in the JHS/healthy group if they meet all 
of the following: 
• Women or men participants. 
• Age equal or over 18 years. 
• The ability to fill in questionnaires in English language. 
• The ability to understand English verbal commands to perform the physical 
tasks. 
• The ability to walk for 10 m for ten times with rest periods. 
• The ability to mini squat to 200 – 300 of knee flexion, while holding a walking 
frame for assistance. 
• The ability to perform a vertical jump test three times: take off from the floor 
to the level of ability, and land on both feet.  
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4.3.2 Participants were included in the JHS group if they met any of the 
following: 
• Met the Brighton score for JHS diagnosis (Appendix 2). 
• Met the Revised Nosology of Villefranche to confirm EDS-HT (Appendix 3). 
4.3.3 Participants were excluded from the JHS/healthy group if the met any 
of the following: 
• Had recent injury of the lower back or lower limbs, during the last three 
months. The injured site would be at the repair stage for a maximum of two 
months to transfer the scar into flexible tissues, and performing the physical 
tests at the repair stage could interrupt the healing process at the injury site 
(Connell et al. 2004).  
• Had recent surgery of the lower limbs during the last 12 months, where 
performing the vertical jump test might be risky for those with recent lower 
limb surgery.  
• Had recent fracture of the lower limbs during the last year. Fractures of the 
lower limbs can cause gait abnormalities and affect walking speed and 
balance (Ingemarsson et al. 2003; Jansen et al. 2013). 
• Pregnancy (Rombaut et al. 2012a). 
• Women who gave birth during the last year due to postpartum ligament laxity 
(Rombaut et al. 2012a). 
• Cardiac problems. 
4.3.4 Participants have been excluded from the control group if they meet 
any of the following: 
• Had generalised joint laxity; ≥ 4/9 in the Beighton score. 
• Recent pain; within the last three months, in the lower back or lower limb 
joints. 
• Had a connective tissue disorder. 
• Conditions which cause weakness to the lower limbs. 
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4.3.5 Healthy matched participants were included in the control group 
based on gender and age.  
 
4.4 Sample size determination: 
Sample sizes were determined for the variables under exploration. The sample 
sizes were calculated using Becker's online calculator; University of Colorado Springs 
(www.uccs.edu/lbecker/), by entering the means and standard deviations. Further details 
were specified in the following sections. 
4.4.1 Muscle-tendon unit stiffness: 
Sample size calculation was initially based on the only available study that 
examined JHS’s muscle-tendon stiffness (Rombaut et al. 2012a). It should be 
acknowledged that although the mean and the standard deviation of 3.3±0.41 N/mm 
difference was statistically significant, it might not be clinically significant (Rombaut et 
al. 2012a). Specifically, to calculate the clinical significance pre-test and post-test scores 
are required for the same group, and that is not available in Rombaut et al.'s (2012a) 
study (Hsu, 1999; Peterson, 2008). Therefore, sample size calculation was based instead 
on Morse et al.'s (2008) study involving healthy participants, in which muscle-tendon 
stiffness of the gastrocnemius-Achilles tendon was assessed using a similar method to the 
current study; ultrasound, before and after stretching. To calculate the clinical 
significance, the Reliability Change Index (RCI) could be used based on Jacobson-Truax 
method (Jacobson and Truax, 1991; Hsu, 1999; Peterson, 2008). However, Kazdin (1999) 
p. 12, has stated that: 
"A number of measures of clinical significance are available, but researchers do not have 
a clear idea of the meaning of results that are clinically significant (i.e., beyond meeting 
the criteria for the operational definition). Also, it is still quite possible that multiple 
clients meet the operational definitions of clinically significant change but, in fact, are 
not functioning much better, do not feel better, or nor seen as improved by significant 
others." 
Clinical significance measures; as RCI, quantify the true changes in the score 
rather than treatment efficacy (Hsu, 1999). Despite that, the statistically significant 
reduction in muscle-tendon stiffness post intervention in Morse et al.’s (2008) study can 
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be considered clinically meaningful and effective because this improvement occurs in 
conjunction with a 17% increase in range of motion, 47% reduction in passive stiffness, 
and 56% reduction in active stiffness (Morse et al. 2008). Therefore, Morse, et al.’s 
(2008) study was used for sample size calculation. An appropriate sample size was 
determined to be at least 23 participants per group at () 0.05, and with a power (1- ß) of 
80% (Bowling, 2009). The effect size was 0.85 where the mean (standard deviation) of 
active stiffness before conditioning stretches was 38.8 (8.4) Nm/cm and after 
conditioning stretches was 17.2 (3.5) Nm/cm.  
4.4.2 Plantar flexor strength: 
Plantar flexor strength for people with JHS has not been reported previously. 
Therefore, the sample size calculation for the plantar flexor strength variable was based 
on Holme et al.’s (1999) study, which investigated plantar flexor strength in people with 
ankle ligament sprains through a comparison with a non-injured group. People with ankle 
ligament sprains share several symptoms with the people of JHS such as severe ankle 
pain and ligamentous laxity (Denegar, Hertel and Fonseca 2002; Collins, Teyes and 
Vicenzine, 2004). Consequently, sample size calculation was based on Holme et al.’s 
(1999) study. An appropriate sample size of 30 participants per group was determined at 
() 0.05, and with a power (1- ß) of 80%. The effect size was 0.66 where the means 
(standard deviations) of an ankle sprain injury and non-injured group were 5.9 (4.6) and 
51.6 (3.7) Nm (Holme et al. 1999).  
4.4.3 Knee proprioception: 
A study by Sahin et al. (2008a) was used to calculate the required sample size for 
studying knee proprioception. Sahin et al. (2008a) explored knee proprioception in a JHS 
group through a comparison with a control group. An appropriate sample size of 29 
participants per group was determined at () 0.05, and with a power (1- ß) of 80%. The 
calculation was based on the effect size of 0.67 where the means (standard deviations) for 
the proprioceptive absolute angular error in Sahin et al.’s (2008a) study were 2.40 (0.8)0 
and 1.250 (0.41)0 for the JHS and healthy group, respectively.  
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4.4.4 Spatiotemporal parameters: 
Galli et al.’s (2011) study was used to calculate the sample size required to study 
the spatiotemporal parameters. This study was chosen because it was the only available 
study where the spatiotemporal parameters were reported for adults with JHS. In 
addition, Galli et al. (2011) found a significant reduction in anterior step length in the 
JHS group when compared with the control group, where anterior step length was the 
only spatiotemporal parameter explored and found statistically significant in JHS 
previous studies. An appropriate sample size was determined to be at least 19 participants 
per group at () 0.05, and with a power (1- ß) of 80%. The calculation was performed 
using the effect size of 0.84 where the means (standard deviations) of the JHS group and 
control group were 0.34 (0.12) and 0.88 (0.21) m, respectively. 
4.4.5 Kinematic variable: 
Celletti et al. (2013b) was the only available study which explored the all gait 
kinematics of the lower limb joints; pelvis, hip, knee and ankle, for adults with JHS. 
Based on Celletti et al.’s (2013b) study an appropriate sample size was estimated to be at 
least 24 participants per group at () 0.05, with a power (1- ß) of 80%. Sample size 
determination was calculated using the effect size of 0.74 where the means (standard 
deviations) of the reported overall measure for the kinematic data were 8.9 (2.6) and 4.6 
(0.9) for JHS and the control group, respectively (no unit of measurement is known for 
values obtained from the Gait Profile Score used by Celletti et al. (2013b)). However, the 
kinematics results in Celletti et al.’s. (2013b) study was reported using Gait Profile Score 
(GPS), which is a software designed to summarise the overall differences in gait 
kinematics compared to a control group. Therefore, as the GPS will not be used in the 
current investigation, the sample size was recalculated. Therefore, the study by Rigoldi et 
al. (2012) was used to recalculate the sample size required to study the kinematic 
variables. Rigoldi et al. (2012) studied a JHS group compared to a control group, and the 
only reported significant difference in the kinematic data was ankle dorsiflexion. An 
appropriate sample was determined to be 24 participants per group at () 0.05, with a 
power (1- ß) of 80%. The used effect size was 0.74, where the means (standard 
deviations) were 10.660 (4.16)0 and 21.040 (5.16)0 for the JHS and control group, 
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respectively. A similar sample size of 24 participants was determined using both Celletti 
et al. (2013b) and Rigoldi et al. (2012). 
4.4.6 Kinetic variable: 
The only clearly reported kinetic variable in the available literature was plantar 
flexor moment during the terminal stance phase by Galli et al. (2011). A sufficient 
sample size was estimated to be 26 participants per group at () 0.05, with a power (1- ß) 
of 80%. Sample size was determined using the effect size of 0.7, where the means 
(standard deviations) were 1.17 (0.16) and 1.51 (0.18) Nm/Kg for the JHS and control 
group, respectively. 
4.4.7 Intra-rater reliability: 
Sample size estimation for the intra-rater reliability examinations was determined 
based on Walter, Eliasziw and Donner (1998). The number of participants required, using 
the intra-class correlation coefficient (ICC) was estimated to be 10 participants per group, 
for which at least 0.8 intra-rater reliability would be acceptable, and the specific 
underlying value of ICC under the hypothesis was 0.9 at α = 0.05 with a power (1- ß) of 
80% for repeating the measurement twice (Walter, Eliasziw and Donner, 1998). 
Therefore, ten participants from each group, the JHS and control group, were required to 
examine the intra-rater reliability for measuring muscle-tendon unit stiffness and 
Qualisys marker application. 
4.4.8 The feasibility sonoelastography study for measuring the elasticity of 
the gastrocnemius muscle: 
Measuring tissue elasticity using sonoelastography was considered as a feasibility 
pilot study projecting from the main study. The rule of thumb for pilot studies’ sample 
size is 12 participants per group (Julious, 2005). However, based on an audit of the 
studies registered in the United Kingdom, ten participants per group was reported as the 
minimum sample size for feasibility studies (Billingham, Whitehead, and Julious, 2013). 
Therefore, ten participants from each group; JHS and control group, have been included 
in this study. 
From the previous sample size justifications, the required sample size ranges from 
10 participants to 30 participants per group (Table 4.1). Therefore, the largest estimated 
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sample size of 30 participants per group has been considered to ensure that the study is 
strong enough for the entire variables under exploration. Although ten participants per 
group were included for the reliability and feasibility studies.  
Table 4.1: The required sample sizes for the tested variables in the current study based 
on sample size calculations and justifications. 
Tested variable Sample size required (per group) 
Muscle-tendon unit stiffness 23 
Plantar flexor strength 30 
Knee proprioception 29 
Spatiotemporal (anterior step length) 19 
Kinematics: 
• Kinematics data score 
• Ankle dorsiflexion during stance phase 
 
24 
24 
Kinetics: 
• Plantar flexor moment 
 
26 
Intra-rater reliability 10 
Tissue elasticity (sonoelastography) 10 
 
4.5 Assessment methods: 
The methodology of the present study has been justified in this section by 
discussing issues related to alternative assessment methods, conceptual, and assessment 
procedures. More importantly, the clinimetric properties of the assessment methods may 
affect the results’ accuracy and could be an error source (Crombie, 2010). Therefore, this 
section has discussed the clinimetric properties of the instruments and methods used. 
4.5.1 Pain measurement using Visual Analogue Scale (VAS): 
Various methods are available for measuring pain. Some of the pain measurement 
methods are purely non self-reported, where brain activities are monitored in response to 
externally induced noxious stimuli (Tracey et al. 2000). Some of the measurement 
methods are semi self-reported, where the patient has the chance to express in response to 
artificially induced stimuli (Garcia-Fernandez et al. 2006). However, most of the pain 
scales are self-reported, where the patient is asked to answer several questions. Pain is a 
subjective multidimensional phenomenon, which is influenced by motivation and 
cognitive inputs besides the pathological causes (Melzack, 1975; Bruce et al. 2004). 
Therefore, it might be more appropriate to measure pain using a self-reported method. In 
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particular, self-reported methods give the patient the chance to report and express their 
pain (Melzack, Katz and Turk, 2001). Thus, in this section various examples of of pain 
assessment methods will be presented to justify using the Visual Analogue Scale by the 
current study 
Functional magnetic resonance imaging (fMRI) is a non self-reported pain 
assessment method. Using fMRI requires stimulating the pain at the time of the 
examination (Tracey et al. 2000; Dunckley et al. 2005), so fMRI may not be appropriate 
for tracking chronic pain in JHS. More importantly, JHS causes pain in several joints for 
the same patient, which makes it difficult to distinguish the relationship between each 
joint pain and brain-related activities. The dolorimeter is semi self-reported scale, which 
is a tenderness assessment device, which works by following the principle of pressure 
application (Langley et al. 1983). The examiner applies pressure using the dolorimeter at 
a specific area until the patient reports tenderness, while patient response can be scaled 
on a 10 level scale (Langley et al. 1983). The manual dolorimeter is portable, inexpensive 
and involves high reliability, validity, and responsiveness for assessing healthy 
individuals and patients with chronic pain (Levoska, Keinanen-Kiukaanniemi and Bloigu, 
1993; Garcia-Fernandez et al. 2006). However, the dolorimeter measures only tenderness 
in response to pressure application, and the current study focused on pain intensity during 
rest and movement, which is more correlated to activities performed in the current study 
such as walking and vertical jump.  
Pain Quality Assessment Scale (PQAS) is a self-reported method for measuring 
pain by using a scale for quantifying the quality of pain (Jensen et al. 2006; Victor et al. 
2008). PQAS is highly valid for describing the quality of pain, and it demonstrates high 
sensitivity when studying the effect of pain-relieving treatment (Jensen et al. 2006). 
However, PQAS is lengthy and not practical for the current study, where the current 
study focused on studying pain in multiple areas involving the lower back area, hip, knee 
and ankle joints, bilaterally. Numerical Rating Scale (NRS) is a graphically or verbally 
administered scale, where the numbers 0 - 10, used to quantify pain intensity (Williamson 
and Hoggart, 2005). NRS is an appropriate and valid tool for assessing pain intensity in a 
clinical setting (Williamson and Hoggart, 2005). However, there is no published data 
regarding the magnitude of error from using NRS (Williamson and Hoggart, 2005). 
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Moreover, poor repeatability has been found by using the NRS (Van Tubergen et al. 
2002). Therefore, NRS has not been used in the current study. McGill Pain Questionnaire 
(MPQ) is a self-reported scale designed to measure the pain experience following a 
multidimensional approach (Melzack, 1975; Melzack, Katz and Turk, 2001). MPQ is 
appropriate for clinical and research purposes with high validity, reliability and 
consistency for assessing pain (Melzack, Katz and Turk, 2001). However, MPQ involves 
various sections to assess the quality of pain, which is out of the scope of the current 
study. Therefore, the MPQ was not used. Verbal rating scale (VRS) uses words to 
describe the pain intensity. For example, one of the response options is from 0-3, where 
zero indicates no pain, one indicates mild pain, two indicates moderate pain, and three 
indicates severe pain (Williamson and Hoggart, 2005). VRS is simple, practical, reliable 
and valid, but the Visual Analogue Scale is more robust when compared to the VRS in 
terms of reliability and validity (Williamson and Hoggart, 2005). Therefore, the VRS has 
not been used in the current study. 
 The current study implemented the Visual Analogue Scale (VAS) to assess 
average pain intensity experienced over the last week; during rest and movement. That is, 
by using 14 VASs to measure the pain intensity in the lower back area and at the entire 
joints of the lower limbs; hip, knee and ankle joints, bilaterally (Appendix 5). The 
questions are limited to pain during the past week to eliminate errors arising from recall. 
Moreover, the questions have been asked about pain during rest and movement to provide 
some explanation or possible correlation with the activities being assessed in the current 
study. 
VAS is simple for measuring pain intensity by précising 101 pain levels 
(Williamson, and Hoggart, 2005). It is a 100 mm length line with two descriptors at the 
beginning and at the end: "no pain" and "worst possible pain”. VAS is highly reliable and 
valid when correlated to noxious stimuli (Price et al. 1983; Bijur, Silver and Gallagher, 
2001; Lara-Munoz et al. 2004; Williamson and Hoggart, 2005). The test-retest reliability 
of the VAS is high where the ICC ranges from 0.97-0.99 (Roiser, Iadarola and Coghill, 
2002). Williamson and Hoggart (2005) have stated in their critical review that the VAS is 
the most robust assessment tool when compared to the VRS and NRS in terms of validity, 
reliability and sensitivity. Therefore, the VAS has been used in the current study. 
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            4.5.2 The 12-item Short Form Health Survey (SF-12) for measuring physical 
activity level, general health and participation: 
 There are many questionnaires available for measuring physical activity level, 
general health and participation, however, the SF-12 is the most appropriate 
questionnaire for the current study and it was used in the current study. First, the Patient 
Health Questionnaire 9 (PHQ9) is sensitive, valid and reliable, but focuses only at the 
psychological domain (Lowe et al. 2004). Therefore, PHQ9 was not used in the current 
study as it does not consider the physical aspect of general health. Second, The General 
Health Questionnaire measures overall wellbeing, chronic inflammation, nutrition, 
lifestyle, toxin exposure, immune system and hormonal imbalance (Goldberg and Hiller, 
2009). However, it involves various limitations: long, neglects the physical activity 
domain, and some questions require medical tests. Third, the Global Physical Activity 
Questionnaire measures the physical activity level in relation to work, travel and 
recreation (Armstrong and Bull, 2006). It is a valid and reliable in quantifying the 
physical activity levels. However, it does not provide information regarding the 
psychological condition. Therefore, the SF-12 (Appendix 6) has been used in the current 
study as it provides a quantitative result for both the physical and mental domains in 
relation to participation and general health level (Ware, Kosinski and Keller, 1996; Hurst, 
Ruta and Kind, 1998). 
The SF-12 involves high psychometric properties, which further support using it 
in the current investigation. The SF-12 is practical and a shorter alternative to the SF-36 
with high correspondence and correlation levels, which involves the items with the best 
prediction for physical and mental component scales (Gandek et al. 1998). The physical 
and mental components of the SF-12 have shown high reliability, validity and 
responsiveness for assessing the health status of patients with musculoskeletal conditions 
(Ware, Kosinski and Keller, 1996; Hurst, Ruta and Kind, 1998). The physical component 
scale shows good validity; median ICC is 0.67, and excellent validity for the mental 
component scales; median ICC is 0.97, when compared to the 36-Item Short-Form Health 
Survey (SF-36) (Ware, Kosinski and Keller, 1996).  
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           4.5.3 The Bristol Impact of Hypermobility Questionnaire (BIoH):  
The BIoH questionnaire was used as it is the first condition-specific questionnaire 
designed to assess the impact of JHS/EDS-HT on people’s lives in the domains of 
impairment, activity, and participation (Palmer et al. 2016). This questionnaire was 
developed in close collaboration with people with JHS/EDS-HT. It passed through three 
stages of a mixed method study which consisted of focus groups and interviews with 
patients, researchers, and clinicians, followed by think aloud interviews with patients, and 
finally, the responses to the questionnaire were analysed quantitively (Palmer et al. 
2016). It consists of 55 items used to evaluate several essential components, such as joint 
pain (average pain and in relation to rest and activity), fatigue and joint instability 
(Palmer et al. 2016). Additionally, the impact of JHS on various daily activities involving 
the upper and lower-limbs were considered (Palmer et al. 2016). The three Bristol 
Rheumatoid Arthritis Fatigue Numerical Rating Scales (BRAF-NRS) were implemented 
in the BIoH questionnaire to assess fatigue in terms of intensity, effect, and coping 
(Hewlett, Dures and Almeida, 2011; Palmer et al. 2016). The BIoH questionnaire 
demonstrated excellent test-retest reliability; ICC 0.922, and has undergone extensive 
qualitative validation with patients and physiotherapists where it was evaluated positively 
in terms of its appropriateness, validity, acceptability, and feasibility (Manns et al. 2017; 
Palmer et al. 2017). This new questionnaire correlates highly against the physical 
component score of the SF-36 (r = 0.722) (Palmer et al. 2016). Although a range of 
psychometric properties of the questionnaire are yet to be established, this is the first 
condition-specific outcome measure for JHS. Inclusion in this study will allow a 
comparison of the included cohort against an existing database of n = 615 adult members 
of the Hypermobility Syndromes Association (HMSA).  
           4.5.4 Muscle-tendon unit stiffness: 
• Introduction: 
The mechanical behaviour and elastic properties of the muscle-tendon complex 
can be studied by measuring muscle-tendon unit stiffness (MTUS) (Rugg et al. 1990; 
McNair, Wood and Marshall, 1992). MTUS is the ratio of muscular force to changes in 
muscle-tendon length (Rugg et al. 1990; McNair, Wood and Marshall, 1992; Fukashiro et 
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al. 1995; Rombaut et al. 2012a). Yet, there is heterogeneity in the terminologies used to 
describe the relationship between force and length at the muscle-tendon unit within the 
previous literature. Some of the terminologies are: viscoelastic properties, Young’s 
modulus and load-elongation characteristics. In the current study, the term muscle-tendon 
unit stiffness (MTUS)/Achilles tendon stiffness has been used to refer to the relationship 
between muscle force and muscle-tendon elongation. 
Previous studies which have measured MTUS have been critically reviewed to 
inform the method of the present investigation. Ultimately, two methods were identified 
for measuring MTUS; invasive and non-invasive. Moreover, the non-invasive methods 
have been categorised into active and passive. The following sections have explained 
each method to justify using a non-invasive active method in the current study. 
• Invasive methods for measuring MTUS: 
 Since the seventies, the mechanical characteristics of the muscle-tendon complex 
have been studied invasively in mammals (Morgan, 1977; Rack and Westbury, 1984; 
Bennett et al. 1986; Fukashiro, Noda and Shibayama, 2001). Invasive methods on 
mammals have been divided into the alpha, spindle-null, free-vibration and tensile testing 
methods (Morgan, 1977; Rack and Westbury, 1984; Bennett et al. 1986; Fukashiro, Noda 
and Shibayama, 2001). However, the invasive methods were designed to support 
scientific theories related to the mechanical properties of the muscle-tendon complex 
(Morgan 1977; Rack and Westbury, 1984; Bennett et al. 1986; Fukashiro, Noda and 
Shibayama, 2001). The invasive methods provide the most accurate measurements for 
muscle-tendon elongation through allowing direct measurement. Additionally, invasive 
methods allow direct observations for the site of elongation; muscle or tendon part. 
However, transferring invasive methods to humans is not ethical or acceptable. 
Therefore, none of the invasive methods for measuring MTUS have been considered for 
use in the current study. 
• Non-invasive methods for measuring MTUS: 
The non-invasive methods have been divided into passive and active methods. 
The passive method measures MTUS in a relaxed muscle condition, while the active 
method measures MTUS during muscle contraction (Fukashiro et al. 1995; Hoang et al. 
2005). Both techniques are well established (Fukashiro et al.’s, 1995; Hoang et al. 2005; 
 110 
 
2007b; 2009, Rombaut et al. 2012a). However, the active method has been used by the 
current study for several reasons, which have been discussed in the following sections: 
 
- The Passive method by Hoang for measuring MTUS; concept 
and improvements: 
One of the main methods for evaluating MTUS is the passive method, where the 
participant is passive during the procedure, and electromyographic activities are 
monitored to ensure muscular inactivity (Hoang et al. 2005; Nordez et al. 2010). Hoang 
et al. (2005) were the first to introduce the passive method in humans by measuring the 
passive MTUS of the medial gastrocnemius muscle. Particularly, the method consists of 
measuring the passive ankle torque through the entire ankle range, and at eight knee 
positions from 00 to 1000, where the ankle torque presents tension, and the ankle/knee 
angles presents medial GM length. Consequently, MTUS is estimated from the torque-
angle data. A specially designed board controls the ankle and knee angles, while the 
participant is relaxed in prone or kneeling positions. A force transducer is attached to the 
foot plate to measure the ankle torque, while two potentiometers are used to record the 
ankle and knee angles. Then, MTUS can be calculated using the collected force and angle 
data through multiple complex mathematical equations, and by estimating nine 
parameters using the non-linear and quasi-Newton algorithm (Hoang et al. 2005). 
Hoang’s passive method for measuring MTUS has gone through various 
improvements. First, to simplify Hoang's mathematical equations, the parameters have 
been reduced from nine to two: the stiffness index and the slack length of the 
gastrocnemius muscle (Nordez et al. 2010). However, simplifying the mathematical 
equations of Hoang et al. (2005) showed poor test-retest reliability for some of the 
measures (0.49 ICC), and it underestimates the force when compared to the original 
methods (Nordez et al. 2005). Secondly, the biodex dynamometer has been used to 
measure the force at the ankle joint instead of the force plate used by Hoang et al. 
(Nordez et al. 2005). Thirdly, ultrasound technology was added to Hoang et al.'s original 
method by Hoang et al. (2007) to measure the slack length of the fascicles and tendon 
lengthening. 
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- The active method: 
The second main method used for measuring MTUS is the active method, where 
MTUS is measured during muscle activity (Fukashiro et al. 1995). The concept of the 
active method relies on tracking and measuring muscle-tendon elongation through real-
time ultrasonography during the maximal isometric contraction of a certain muscle 
(Fukashiro et al. 1995; Maganaris and Paul, 2000; Rombaut et al. 2012a). At the same 
time, muscular force is measured to calculate MTUS from the ratio of length changes to 
the ratio of force (Fukashiro et al. 1995; Maganaris and Paul, 2000; Rombaut et al. 
2012a). There are several ways of measuring muscle force, such as with an isokinetic 
dynamometer, digital myometer or specially designed dynamometer (Maganaris and 
Paul, 2000; Kubo, Kanehisa and Fukunage, 2001). Kubo, Kanehisa and Fukunage (2001) 
measured MTUS of the GM by tracking one muscle fascicle before and after contraction 
using ultrasonography. Kubo, Kanehisa and Fukunage (2001) considered the tendon part 
by tracking the deep aponeurosis as it has a similar line of action to the Achilles tendon. 
Kubo, Kanehisa and Fukunage's (2001) method consisted of measuring the intersection 
between one muscle fascicle and the deep aponeurosis (identified as position one (P1)). 
Then P1 is tracked during isometric contraction as it moves proximally to position two 
(P2). The distance between P1 and P2 is the measure of muscle-tendon unit elongation. 
- Reasons for following the active method in the current study: 
1. Reliability and sensitivity: 
The active method is more reliable when compared to the passive method. The 
reliability of Hoang et al.'s (2005) passive method varies from high to low. Test-retest 
reliability is high when the tests are repeated on the same day; ICCs ranges from 0.80 – 
0.97, but some of the measures are not reliable when the tests are repeated after one 
week, where the ICC drops to 0.19 (Hoang et al. 2005). A potential source of error could 
be related to the inability to fix the foot at the force plate, and the inability of maintaining 
the knee angle when a rapid force is applied at the ankle joint at the end of dorsiflexion 
(Hoang et al. 2005). In contrast, the active method demonstrates high test-retest 
reliability for plantar flexor stiffness measurements when performed on two separate 
days; ICC 0.89 (Kubo, Kanehisa and Fukunage, 2001). Therefore, this is one of the 
reasons for following the active method in the current study.  
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The sensitivity of Hoang's passive method is questionable. The passive method is 
highly sensitive for measuring GM MTUS (Hoang, Herbert and Gandevia, 2007). 
Specifically, the effect of one hour of eccentric exercise, backward treadmill walking, 
was assessed on four occasions: at one, 24, 48 hours, and one week after exercise 
(Hoang, Herbert and Gandevia, 2007). The eccentric exercise significantly increased 
MTUS at GM at one and 24 hours post exercise, and the stiffness reduced then returned 
to its original level after 48 hours and one week after exercise, respectively (Hoang, 
Herbert and Gandevia, 2007). However, reviewing the results from previous studies 
which have used the passive method may indicate the insensitivity of the passive method. 
That is, an insignificant difference in MTUS has been found in people with multiple 
sclerosis and stroke when compared to control groups by using the ultrasound version of 
Hoang’s method (Hoang et al. 2009; Kwah et al. 2012). The findings of these studies 
contradict the expected results, as multiple sclerosis and stroke have an impact on muscle 
tone, therefore stiffness. Consequently, one of the main reasons for not using the passive 
method in the current study is its questionable sensitivity.  
2. Estimation error: 
The passive method relies on complex mathematical equations, which require 
various estimations for several parameters, and that could be a source of error. Nine 
parameters are estimated using the non-linear and quasi-Newton algorithm, while the 
moment arm is estimated using data from cadaver studies (Hoang et al. 2005). In 
addition, the GM length is estimated from the knee and ankle angles (Herbert and Diong, 
2012). More importantly, MTUS measures could differ substantially if true non-estimated 
data is used (Herbert and Diong, 2012). In contrast, the active method relies on actual 
real-time measurements with the ultrasound and the dynamometer, so there is no source 
of error arising from variable estimations. Therefore, the active method has been used in 
the current study.  
3. The passive method is neurological conditions relevant, while the active method is 
musculoskeletal conditions relevant: 
The examination procedures following the passive method runs in a slow pattern 
to prevent provoking involuntary muscle contraction and reflexes (Hoang et al. 2005). 
Therefore, the passive technique has been used to study patients suffering from strokes 
 113 
 
and multiple sclerosis (Hoang et al. 2009; Kwah et al. 2012). However, such a 
consideration is not essential for studying the musculoskeletal condition, as with JHS, 
where pathological reflexes and involuntary muscular contractions are not expected. 
Therefore, this is one of the reasons for not using the passive method in the current study. 
4. Standardisation and practical issues: 
The passive method examines torque through the entire range of ankle and knee 
motion, reaching the maximum available range (Hoang et al. 2005). However, people 
with JHS/EDS-HT exhibit a significantly greater maximal range of motion (Brighton et 
al. 1998), which makes standardising the examination angle between the JHS group and 
the control group difficult. Therefore, following the active method could be more 
appropriate for studying JHS, as the examination angle is fixed at a neutral position 
throughout the examination procedure. Moreover, the active method minimises any errors 
which might arise from the inaccuracy of fixing the testing angle. Additionally, some 
practical issues have been reported during the passive method. For example, EMG is 
required to ensure muscle inactivity, but the electrodes interfere with the ultrasound 
examination (Hoang et al. 2005; 2009). 
5. Active method’s potential in relation to activity and participation: 
Studying MTUS during activity could be more related to the other variables of the 
current study which present both activity and participation. In particular, stiffness 
depends on force production in relation to the deformation at the musculotendinous 
structures during activity, and quantifying such dynamic behaviour may be invalid if 
assessed during passive muscle-tendon status, as performed by Hoang et al. (Serpell et al. 
2012). Additionally, there was only one study which measured MTUS in JHS, and this 
study followed the active method (Rombaut et al. 2012a). Following Rombaut et al.’s 
(2012a) active method can build up knowledge and create comparisons for a better 
understanding of the effects of JHS. 
6. The active method and ultrasonography: 
The active method depends on ultrasound to measure lengthening at the muscle-
tendon unit, and depending on ultrasound is one of the strengths of following the active 
method for measuring MTUS. The literature review indicated that ultrasound involves 
high clinimetric properties. Particularly, ultrasound is highly valid for measuring the 
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metric dimensions of the muscle-tendon structure, with high accuracy rate when 
compared to magnetic reasonance imaging, where the ICC ranges 0.97 – 0.99 
(Kawakami, Abe and Fukunaga, 1993; Mahieu et al. 2004; Reeves, Maganaris and 
Narici, 2004; Vlychou and Teh, 2008). Additionally, the ultrasound shows high accuracy 
for assessing the muscle-tendon structure statically and dynamically, with high resolution 
and precision, low cost and minimal radiation hazards (Kawakami, Abe and Fukunaga, 
1993; Mahieu et al. 2004; Vlychou and Teh, 2008). Additionally, ultrasound showes high 
test-retest reliability for measuring muscle-tendon structure, where ICC ranges from 0.98-
0.99 for quantifying the volume, cross sectional area and length of the gastrocnemius 
muscles (Reeves, Maganaris and Narici, 2004; Barber, Barrett and Lichtwark, 2009). 
Similarly, high test-retest reliability was demonstrated by ultrasound in measuring 
Achilles tendon elongation during isometric plantar flexion (ICC ranged 0.92-0.94) 
(Kubo, Kanehisa and Fukunaga, 2001). Although high validity and reliability of 
ultrasound has been demonstrated by previous literature, an error might occur from the 
examiner in the current investigation. Therefore, the intra-rater reliability for assessing 
MTUS using the ultrasound was studied in the current study to examine the consistency 
of the measurements. The methodological procedures related to this intra-rater reliability 
study are explained in section 4.9.4. 
7. The active method and strength measurement: 
The active method of assessing MTUS depends on accurate muscle strength 
measurements, and using a digital strain gauge myometer in the current study can be 
considered one of the advantages. Manual muscle testing involves some elements of 
subjectivity and it is insensitive for quantifying slight differences in strength (Cuthbert 
and Goodheart, 2007). The isokinetic dynamometer is the gold standard for muscle 
strength measurement but is expensive and might not be practical due to the prolonged 
operating and training time (Drouin et al. 2004). The hand-held dynamometer is valid, 
reliable, practical, and requires less time for training and operating than the isokinetic 
dynamometer, but it depends on the examiner’s strength in counteracting the participant’s 
strength (Andrews, Thomas and Bohannon, 1996; Cathy et al. 2010). However, the 
digital strain gauge myometer is a good alternative to the hand-held dynamometer and it 
does not depend on the examiner’s strength (Brinkmann, 1994; Bohannon, 2012). The 
 115 
 
digital strain-gauge myometer is objective, requires less time for training and operation, 
and is highly reliable for assessing lower limb strength (Brinkmann, 1994; Scott et al. 
2004; Tung-We et al. 2008; Bohannon, 2012). Therefore, the digital strain gauge 
myometer has been used in the current study. 
           4.5.5 Measuring gait biomechanics: 
• Introduction: 
Various systems and apparatuses are available for studying gait, and they have 
different operational concepts, and clinimetric properties. Some systems are designed to 
measure spatiotemporal parameters, such as the instrumented walkway, while some 
systems focus on gait kinematics, such as electrogoniometers (Barker et al. 2006). Other 
gait measurement methods are designed to study gait kinetics, such as the Kistler force 
plate (Simonsen et al. 2012). However, to comprehensively analyse the gait of people 
with JHS/EDS-HT, the spatiotemporal, kinematic and kinetic parameters need to be 
explored by the current study. However, there are a variety of advantages and 
disadvantages with different gait measuring methods. The following sections discuss 
details related to the available systems and apparatuses, which can be used for studying 
gait to justify the method utilised in this study; combined kinematics and kinetics system 
using the Qualisys three-dimensional motion capture system with Kistler force plate.  
A range of different gait assessment methods were considered such as visual gait 
analysis, gait assessment, video examination, footswitches and instrumental walkway, in 
addition to electrogoniometers, gyroscopes and accelerometers. However, these 
assessment methods were excluded due to several factors. Visual gait analysis is 
commonly used in clinical practice for its accessibility and ease (Whittle, 1991; Maathuis 
et al. 2005). However, visual gait analysis may not be suitable for scientific research due 
to its inability for assessing basic gait parameters and analyse high speed activities as it 
depends on the human eye and skills (Whittle, 1991; Maathuis et al. 2005). Gait 
assessment and video examination are also subjective and highly dependable on the 
observer’s skills and experience (Whittle, 1991; Eastlack et al. 1991; Lord, Halligan and 
Wade, 1998; Brunnekreef et al. 2005). Footswitches and instrumented walkway are 
designed to study the spatiotemporal parameters of the gait cycle (Whittle, 1991; 
Hausdorff, Ladin and Wei, 1995; Cutlip et al.  2000). Due to the footswitches direct 
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placement on the feet, they are placed under high pressure, which can risk their accuracy 
level and durability but the footswitches produce high test-retest reliability: ICC 0.82-
0.92 (Whittle, 1991; Menz et al. 2004). Similarly, an excellent agreement has been found 
between the instrumented walkway when compared to a three-dimensional gait analysis 
system for measuring spatiotemporal timing; 0.994 ICC (Barker et al. 2006). However, 
poor agreement has been found when measuring the distance related variables using 
instrumented walkway; 0.24 ICC (Barker et al. 2006). Both the footswitches and the 
instrumented walkway involve sources of inaccuracy, for example unreliable contact of 
the switches, so the events might not be recorded or might be recorded late (Whittle, 
1991; Menz et al. 2004; Barker et al. 2006).  
Electrogoniometers are designed to measure joint angles in respect to time as a 
way to assess gait kinematics (Sutherland, 2002; Zheng, Black and Harris, 2005). 
However, electrogoniometers are not practical, track skin rather than bone motion, and 
involve high amount of inaccuracy (Sutherland, 2002; Zheng, Black and Harris, 2005; 
Piriyaprasarth et al. 2008). Therefore, electrogoniometers were not used in the current 
study. Gyroscopes and accelerometers are wearable inertia-dependent sensors, which can 
be placed over the limbs to provide a wide range of gait measurements (Mayagoitia, 
Nene and Veltink, 2002; Fong and Chan, 2010). The gyroscope, which rotates in 
response to the pull of gravity, utilises the earth’s gravity to measure the segment’s 
angular orientation and position, where joint angles can be estimated (Tong and Granat, 
1999; Mayagoitia, Nene and Veltink, 2002). In contrast, accelerometers have been 
designed to measure non-gravity related acceleration (Mayagoitia, Nene and Veltink, 
2002; Fong and Chan, 2010). The accelerometers can provide joint kinematic 
measurements by placing eight accelerometers on the lower limbs (Mayagoitia, Nene and 
Veltink, 2002; Fong and Chan, 2010). However, the accelerometer provides two-
dimensional analysis only and the data obtained from the gyroscopes and accelerometers 
involves severe noise, signal drifting, and distortion errors (Tong and Granat, 1999; Fong 
and Chan 2010). The following section will justify employing the three-dimensional 
motion analysis system in the current study. Furthermore, details related to the current 
research method have been discussed. 
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• Three-dimensional (3D) motion capture system: 
- Introduction: 
Three-dimensional (3D) motion analysis is the gold standard for biomechanical 
motion analysis, and it has been employed in the current study for gait and vertical jump 
biomechanical analysis.  A Qualisys motion capture system for motion analysis. The 
following sections will go through the hardware and software of the Qualisys system, and 
the principles behind kinematic and kinetic measurements. Then, the advantages and 
disadvantages of the Qualisys system will be discussed to justify using this system in the 
current investigation.  
- The Qualisys motion capture system: 
The Qualisys system (Qualisys, Gothenburg, Sweden) is a computer aided 
system, which measures movement kinematics through infrared cameras (Oqus 3+), 
where the cameras emit infrared light onto reflective markers attached to the human 
body. Consequently, the position, orientation and local coordinate system of each body 
segment can be defined by redirecting the light from the markers to the camera’s optical 
array sensors (Figure 4.2 and 4.3) (Stolze et al. 1997; Richards, 1999; Hamill, Selbie and 
Kepple, 2014). Additionally, a Kistler force platform (Multicomponent force plate type 
9281E, Kistler Group, Eulachstrasse, Switzerland) is synchronised with the Qualisys 
system for kinetic measurement (Figure 4.2 and 4.4) (Whittle, 1991; Simonsen et al. 
2012; Robertson et al. 2014). For accuracy, a special calibration kit (wand and frame) is 
used to calibrate the system before each session to identify the laboratory coordinate 
system (Figure 4.5) (Hamill, Selbie and Kepple, 2014). 
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Figure 4.2: a) The ten infrared cameras (highlighted by ten small circles) of the Qualisys 
system in the Human Analysis Laboratory in the University of the West of England, 
Bristol. The arrow is directed toward the Kistler force plate. The large circle highlights 
the computer which has been used to operate the Qualisys system. b) A closer view of the 
Qualisys operation computer. c) A closer view of one of the infra-red cameras (Oqus 
3+). 
 
 
a
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Figure 4.3: a) Markers and marker clusters applied on the lower-limbs by the examiner 
for kinematics analysis. b) Closer view to one marker cluster. c) Closer view to one 
marker. 
 
 
 
 
 
 
 
 
 
 
Figure 4.4: The Kistler force plate placed at the center of the walkway to identify the 
kinetic variables of the gait cycle.  
 
 
 
 
 
 
 
 
a
) 
b
) 
c
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Figure 4.5: The calibration wand (a) and frame (b) which have been used for calibration 
for defining the laboratory coordinate system. 
 
The Qualisys system is controlled via a computer with downloaded Qualisys 
Track Manager software (QTM) (Figure 4.6). The QTM’s 3D view window displays the 
calibrated 3D volume, where the data is collected and the walking task is recorded. The 
trajectories of markers, are displayed by QTM to identify their six degrees of freedom; x, 
y and z positions, so QTM is used to track and record markers trajectory and force plate 
data. Additionally, for every research project a folder is created in QTM, and this folder 
contains the files, scripts, and the information needed for QTM to process the research 
data. Moreover, a label list is downloaded in QTM to identify and name the markers, 
which have been applied on the body segments. Moreover, the QTM is equipped with the 
Automatic Identification Model (AIM), which can label the markers automatically.  
 
Figure 4.6: The operational computer of the Qualisys system with Qualisys Track 
Manager software (QTM). 
 
 
 
b
) 
a
) 
 121 
 
- The principles of kinematic analysis:               
Kinematics is the measurement of joint motion and pattern with respect to time 
(Whittle, 1991; Vaughan, Davis and O'Connor, 1992; Hall, 1999). Three-dimensional 
kinematics of the lower limb joints can be attained by tracking the motion of reflective 
markers by the infra-red emitting cameras (Stolze et al. 1997; Richards, 1999; Hamill, 
Selbie and Kepple, 2014). The Qualisys system is equipped with ten cameras. Each 
camera has its field of view to identify the two dimensional position of each marker with 
high spatial and resolution rates (Stolze et al. 1997; Richards, 1999; Hamill, Selbie and 
Kepple, 2014). The third dimension of each marker is computed from the ten cameras’ 
two dimensional coordinates using the Direct Linear Transformation (DLT) method 
(Hamill, Selbie and Kepple, 2014). 
Three coordinate systems are required for three-dimensional kinematics analysis: 
the global/laboratory coordinate system (GCS), local/segment coordinate system (LCS), 
and force platform coordinate system (FCS) (Hamill, Selbie and Kepple, 2014). The GCS 
presents the fixed capturing volume of the laboratory, in which the 3D space is presented 
for recording motion and where the data is resolved (Hamill, Selbie and Kepple, 2014). 
The LCS defines the position and kinematics of each body segment by applying the 
assumption of rigidity (Hamill, Selbie and Kepple, 2014). The position of the body 
segment is known according to its positions in the GCS or LCS, where the 
"transformation" of a body segment in these two coordinate systems describes the 
movement (Hamill, Selbie and Kepple, 2014). The third coordinate system (FCS) is 
defined from the force platform position to locate the force platform in the GCS (Hamill, 
Selbie and Kepple, 2014). 
For defining the LCS for the lower limbs segments, three non-collinear 
points/markers are used; the points are not in a straight line, for the pelvis, thigh, shank 
and foot (Hamill, Selbie and Kepple, 2014). A static standing trial is captured to identify 
the LCS of each segment by providing information for estimating the joint centre by 
identifying the reflective markers on the body segments (Figure 4.17) (Hamill, Selbie and 
Kepple, 2014). During this procedure, calibration markers and tracking markers are both 
applied, and the calibration markers are removed after capturing the static standing trial 
(Table 4.2). The pelvis LCS is defined from the markers applied at the right anterior 
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superior iliac spine (RASIS), left anterior superior iliac spine (LASIS), right posterior 
superior iliac spine (RPSIS) and left posterior superior iliac spine (LPSIS). The LCS 
origin for the pelvic is in the midway between the RASIS and LASIS (Hamill, Selbie and 
Kepple, 2014). The thigh LCS is defined from a virtual position of the hip joint using the 
medial and lateral femoral epicondyle markers, where the hip joint centre is estimated 
from regression equations from the pelvic LCS, and the hip centre is calculated from the 
RASIS and LASIS. (Hamill, Selbie and Kepple, 2014). The shank LCS is defined from 
the medial and lateral femoral epicondyle markers, and the medial and lateral malleoli 
markers, where the shank LCS defines the knee and ankle angles (Hamill, Selbie and 
Kepple, 2014). The foot LCS is defined by the markers of the medial and lateral malleoli, 
first and fifth metatarsal heads, second metatarsal base and calcaneus (Hamill, Selbie and 
Kepple, 2014).  
 
Table 4.2: The calibration and tracking markers placement positions on the anatomical 
bony landmarks to identify the local coordinate system (LCS) of each body segment of 
the lower limbs; pelvis, thigh, shank and foot. 
Calibration markers; bilateral 
(attached during the static trial only) 
Tracking markers; bilateral (attached 
during the static and dynamic trials) 
• Greater trochanter 
• Medial femoral epicondyle 
• Lateral femoral epicondyle 
• Medial malleoli 
• Lateral malleoli 
• Anterior superior iliac spine  
• Posterior superior iliac spine  
• Thigh marker cluster  
• Shank marker cluster  
• Calcaneus, 
• 1st metatarsal head 
• 2nd metatarsal base 
• 5th metatarsal head  
 
Two marker application methods are available for defining the LCSs of the body 
segments. The first method works by placing two markers directly on the bony landmarks 
at each joint, so the position and the orientation of each joint is relative to a straight line 
drawn between the two markers (Stolze et al. 1997; Richards, 1999). The second method 
works by mounting three markers or more on each limb so the relative position of each 
joint can be mathematically calculated, as with the Calibrated Anatomical System 
Technique (CAST) used in the current study (Sinclair et al. 2012a; 2012b). CAST is the 
gold standard for marker application because CAST allows six degrees of freedom 
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modelling for each segment of the body (figure 4.17) (Sinclair et al. 2012b). CAST is a 
method for defining the position and orientation of body segments by constructing 
surface marker trajectories through the implementation of algorithms (Cappozzo et al. 
1997). That is, by identifying the segments' anatomical coordinate systems through 
palpating and identifying the anatomical bony landmarks (Figure 4.7) (Sinclair et al. 
2012a; 2012b). Then the anatomical landmarks are calibrated in respect to tracking 
clusters (Sinclair et al. 2012a; 2012b). CAST uses marker clusters to compensate for 
errors arising from skin artefacts (Cappozzo et al. 1997). Specifically, Cappozzo et al. 
(1997) have indicated that a cluster made up of four markers is effective for error 
compensation, as used in the current study. Additionally, The CAST method is more 
accurate than the first method of calibration as it is less affected by the skin artefact when 
compared to the first method (Sinclair et al. 2012a; 2012b). CAST reduces soft tissue 
artefact because the markers are distributed over a big area (Cappozzo et al. 1997). 
Additionally, there is no restriction for applying the 
tracking markers with the CAST as they can be placed 
over an area with less skin artefact such as the distal 
part of the thigh or shank (Cappozzo et al. 1997).  
 
 
 Figure 4.7: The anatomical coordinate systems 
orientation for the Foot (F), Shank (S), Thigh (T), and 
Pelvic (P), at the six degrees of freedom; X, Y, and Z, 
through using the Calibrated Anatomical Systems 
Technique (CAST). Image adapted from Sinclair et al. 
(2012b) with permission (Appendix 8). 
 
 
The position and orientation (pose) of rigid segments is estimated using three 
algorithms: direct method, segment optimisation and global optimisation (Hamill, Selbie 
and Kepple, 2014). Six variables are needed for pose estimation; three for the position of 
the segment origin, and three for the orientation (Hamill, Selbie and Kepple, 2014). To 
fully describe the pose of a segment, three non-collinear markers are required to identify 
its six degrees of freedom (Hamill, Selbie and Kepple, 2014). The direct method’s 
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algorithm for pose estimation computes the LCS of the segment during the static and 
dynamic trial in the same fashion; however, this method is limited due to lack of marker 
redundancy and the lack of marker position leniency (Hamill, Selbie and Kepple, 2014). 
Moreover, applying this method requires precise marker application and all the markers 
should be obvious at all the frames (Hamill, Selbie and Kepple, 2014). Therefore, the 
direct method has not been used in the current study. In contrast, pose estimation using 
segment optimisation has been utilised in the current study. It also known as the six 
degrees of freedom method, where each segment is presented with at least three tracking 
markers and mathematical algorithms are used for optimisation using CAST (Hamill, 
Selbie and Kepple, 2014).  In this method, the joints are considered to have six degrees of 
freedom, and each segment is independent and not linked to the other segments (Hamill, 
Selbie and Kepple, 2014). This method uses the same marker application used in the 
direct method, but additional markers are also applied, with at least three markers being 
applied to each segment following the CAST (detailed in the previous paragraph). 
Moreover, the segment optimisation method does not constrain the segment endpoints, 
and that reflects reality, as each joint has more than one axis of rotation (Cappozzo et al. 
1997; Hamill, Selbie and Kepple, 2014). Therefore, pose estimation using segment 
optimisation through CAST has been utilised in the current study.  
The third method of pose estimation using global optimisation based on Lu and 
O'Connor (1999) adds the physical constraints for the joints to enhance the accuracy and 
reduce the soft tissue artefact. It is also known as the inverse kinematic method (Lu and 
O'Connor, 1999). This method searches for the best optimal pose at each frame, where 
the error can be distributed and it provides a mechanism for error compensation (Hamill, 
Selbie and Kepple, 2014). This method is preferred when compared to the pose 
estimation using segment optimisation because the global optimisation reduces the 
artefact by applying joint constraints to the model (Hamill, Selbie and Kepple, 2014). 
However, using global optimisation for pose estimation may lead to describing the joint 
in a way that hides the damage effect when patients are assessed (Hamill, Selbie and 
Kepple, 2014). Therefore, this method was not followed in the current study. 
 
 
 125 
 
- The principles of kinetic analysis: 
For the kinetic analysis, a Kistler force platform was synchronised with the 
Qualisys system to measure the three-dimensional ground reaction force (anter-posterior, 
medio-lateral and vertical), and the centre of pressure (Figure 4.2 and 4.4) (Whittle, 1991; 
Simonsen et al. 2012; Robertson et al. 2014). The Kistler force plate is a rectangular rigid 
plate 40cm in length, 60cm wide, and 10cm deep, which is levelled with the laboratory 
floor (Figure 4.2 and 4.4) (Whittle, 1991; Mickelborough et al. 2000). The Kistler force 
plate has 12 piezoelectric sensors distributed at its four corners (Robertson et al. 2014). 
Two types of transducers are commonly used: the strain gauge type and the piezoelectric 
crystal type (Robertson et al. 2014). The strain gauge type is cheap but it has low 
sensitivity, but the piezoelectric crystal type involves high frequency response, and the 
latter has been used in the current study (Robertson et al. 2014).  
The force platform output is transmitted through eight channels from four vertical 
signal transducers at the four corners of the force plate (Whittle, 1991; Simonsen et al. 
2012). The output is transmitted to a computer through an analogue-digital converter, 
then to QTM and sampled at a frequency of 100 Hz (Whittle, 1991).  
Signal is the quantity of time or space variation presented in waveform data, 
which involves both the required information and noise (Derrick, 2014). During gait 
analysis, signals are presented at all times, therefore these signals have been called 
continuous or analogue signals (Derrick, 2014). Software is used to convert the analogue 
signals into digital signals using analogue to digital convertors to gain a series of actual 
values (Derrick, 2014). The signals have four characteristics: frequency, amplitude, phase 
angle and offset (Derrick, 2014). The frequency refers to the speed of signals' oscillations 
in Hz. The amplitude is the signals' oscillation magnitude. The offset is the signal average 
magnitude. The phase angle is the magnitude of the signal delay (Derrick, 2014). A 
sampling frequency of 100 Hz indicates that 100 signals per second are registered, and 
the sampling interval is the reverse of the sampling frequency to be 1/100 (0.01), 
indicating that every 0.01 second a signal has been registered (Derrick, 2014). A signal 
should be processed at a sampling frequency twice as high as the signal itself or equal to 
the highest available signal frequency (Derrick, 2014). Human motion is equivalent to a 
frequency of 10 Hz, so 20 Hz is satisfactory as a sampling frequency (Derrick, 2014). 
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However, to ensure a high accuracy rate to record peak value, a sampling rate of 50-100 
Hz is usually used (Derrick, 2014). Therefore, a sampling rate of 100 Hz was used in the 
current study.   
Measuring signals involves several factors, which leads to noise being added to 
the actual signals (Sinclair, Taylor and Hobbs, 2013; Derrick, 2014). These factors are 
skin motion, electrical and digital errors (Derrick, 2014). The noise appears within the 
waveform data with different frequencies and amplitudes when compared to the signal 
itself (Sinclair, Taylor and Hobbs, 2013; Derrick, 2014). However, the noise can be 
removed, and that is called data smoothing (Sinclair, Taylor and Hobbs, 2013; Derik, 
2014). A low-pass filter was used to remove the noise without affecting the true signals 
(Sinclair, Taylor and Hobbs, 2013; Derrick, 2014).  
Nine parameters are used to describe a force vector: three orthogonal components; 
FX, FY, and FZ, three coordinates to identify the location of the force vector in relation to 
the force plate reference; X, Y and Z, which are commonly known as the centre of 
pressure (COP), and three orthogonal moments (MX, MY and MZ) (Robertson et al. 
2014). In human studies, six components are focused on: three GRF components; Rx, Ry, 
and Rz, the location of COP in the GCS; x and y, and the free moment (Simonsen et al. 
2012; Robertson et al. 2014). To compute these six parameters, each platform has its own 
unique equations according to the manufacturer (Robertson et al. 2014). 
- The advantages of three-dimensional motion analysis system:  
According to Whittle (1991), three terms are used to describe the data obtained 
from three-dimensional motion capture systems: resolution, precision, and accuracy. 
Resolution is the system’s ability to detect tiny motion, precision is the amount of noise 
from the variability of one frame, while accuracy is the difference between the marker’s 
actual position, and the position estimation by the camera system (Whittle, 1991).  
With accurate setting and application, the Qualisys system is able to provide a 
powerful biomechanical analysis with high resolution, precision and accuracy levels. In 
terms of resolution, the Qualisys system demonstrates a high resolution level as it is 
highly valid for defining precise events such as foot contact and balancing movements, 
when compared to kinetic data and a balance platform (Mickelborough et al. 2000). The 
Qualisys motion capture system is highly valid for quantifying small to large movements 
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(Richards, 1999; Mickelborough et al. 2000; Kejonen and Kauranen, 2002; Laroche et al. 
2011). Moreover, the Qualisys measurement is strongly correlated to the Good balance 
platform for measuring balancing movement, with a Spearman Correlation Coefficient of 
0.72 (Kejonen and Kauranen, 2002). In terms of precision, the Qualisys system shows 
high precision rate for angle measurement (0.860 ± 1.55% of the angles), where the 
difference between the actual angle and the measured angle is less than 10 (Everaert et al. 
1999; Laroche et al. 2011). In terms of accuracy, the Qualisys system demonstrates a 
high accuracy rate with the ability to detect small differences of 0.171 and 0.109 mm, 
mean error of 0.034 mm and mean absolute error of 0.094 mm (Everaert et al. 1999; 
Laroche et al. 2011). Moreover, the Qualisys’ relationship shows high accuracy rate for 
distance measurement, where the maximum error rates are 0.189 - 1.276 cm (Richards, 
1999). The Qualisys system is highly valid for assessing healthy groups, as well as 
patients with chronic musculoskeletal disorders, where it has been used to assess the 
spine, trunk and lower limbs (Richards, 1999; Mickelborough et al. 2000; Kejonen and 
Kauranen, 2002; Laroche et al. 2011). 
The literature review illustrated the high reliability of the Qualisys system in 
analysing human motion. In particular, its inter-rater reliability is high for defining foot 
contact events; ICC ranges from 0.993-0.999 (Mickelborough et al. 2000). Moreover, the 
intra-rater reliability is high for assessing simple and complex movements such as 
standing balance, walking, hop test and running; ICC ranges from 0.75-0.999 for 
kinematic parameters (Mickelborough et al. 2000; Kejonen and Kauranen, 2002; 
Augustsson et al. 2006; Sinclair et al. 2012b; Laroche et al. 2011). The Qualisys system 
demonstrates high reliability in assessing symptomatic individuals, where the ICC ranged 
from 0.82-0.99 (Yavuzer et al. 2008). Although the literatures have supported the high 
clinimetric properties of the Qualisys system, error may arise from markers application 
by the researcher. Therefore, the intra-rater reliability for marker application was studied 
in the current investigation by re-applying the markers and re-assessing the walking test. 
Methodological procedures related to the intra-rater reliability study have been explained 
in section 4.9.9.  
Inaccuracy in distance measurement may arise from using systems which work 
without calibration (Whittle, 1991). However, the Qualisys system was calibrated before 
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each session, which ensures a high accuracy rate. Moreover, the accuracy rate depends on 
the field of view of the cameras and this was checked before each session by ensuring 
that markers were visible for all the cameras.  
- The disadvantages of three-dimensional motion analysis system: 
For kinematic analysis, the markers were applied over the skin to represent the 
bony land marks underneath. Yet, marker application over the skin can be compromised 
by “soft tissue artefact” which causes mal-representation of the required point (Schwartz, 
Trost and Wervey, 2004; Peters et al. 2010). Soft tissue artefact could result from the skin 
and subcutaneous soft tissue movement and deformation, muscle contraction, the 
physical characteristics of the examined individual, and the intensity of the examined 
motion (Schwartz, Trost and Wervey. 2004; Peters et al. 2010). Although, a systematic 
review indicated that “soft tissue artefact” was minimal such experimental error should 
be considered (Peters et al. 2010).  
The error magnitude is high when biomechanical analysis is performed by 
multiple examiners in separate sessions (Schwartz, Trost and Wervey, 2004). Conversely, 
employing the same examiner to conduct the examination within the same session 
reduces the error rate (Schwartz, Trost and Wervey, 2004). Therefore, experimental error 
can be greatly eliminated by avoiding multi-session and multi-examiner evaluation 
(Schwartz, Trost and Wervey, 2004). Consequently, one examiner conducted the 
biomechanical analysis within the same day in the current study. Unstandardised walking 
speed could be a source of experimental error in gait analysis. Walking speed has an 
influence on the resultant angle; magnitude; timing, and pattern (Schwartz, Trost and 
Wervey, 2004). Some researchers have used photocells to unify the walking speed, but 
such methods could result in an artificial gait pattern. In contrast, some techniques can be 
used to eliminate such sources of error, and these techniques have been considered in the 
current study. First, the instructions can be standardised by asking the participants to 
walk at their normal walking speed. Secondly, the “inconsistent gait velocity” factor can 
be considered during data analysis and interpretation for possible exclusion of outliers 
(Schwartz, Trost and Wervey, 2004). 
Although the force plate provides comprehensive kinetic data, its narrow 
diameters can cause some practical difficulties. Specifically, for recording the kinetic 
 129 
 
data a full clear contact of each foot with the force plate should be attained without 
asking the subject to do so. For example, asking the participant to step over the force 
contaminates the walking data with the targeting factor. Particularly, the targeting factor 
is the artificial changing of the step length to step on the force plate during walking, 
which changes the individual’s walking pattern (Whittle, 1991). However, the walk 
starting position can be adjusted to overcome this problem. Even so, such a strategy 
might not solve the problem entirely, and gaining kinetic data might be impossible, 
especially with people with an inconsistent gait pattern (Whittle, 1991). 
- Conclusion: 
Analysing the gait of people with JHS is in the preliminary stage as been 
indicated in the literature review chapter. Moreover, vertical jump was not studied 
previously in people with JHS, as an advanced physical task. Therefore, a 
comprehensive, highly accurate, valid and reliable motion analysis method needs to be 
employed to study JHS. Qualisys 3D motion capture system has been used in the current 
investigation to study gait and vertical jump task in people with JHS. 
          4.5.6 The Qualisys motion capture system for knee proprioception 
measurement: 
Knee proprioception is usually examined in a non-weight bearing position. 
Commonly, proprioception is tested in a sitting, supine, or prone position by using the 
“angle reproduction test”. In particular, the knee is moved into a specified angle; the 
“target angle”, and then the participant is asked to replicate the target angle as the 
“estimated angle” (Petrella. Lattanzio and Nelson, 1997; Pincivero, Bachmeier and 
Coelho, 2000; Birmigham et al. 2001). The difference between the target and estimated 
angles is the absolute angular error, which reflects joint proprioception (Pincivero, 
Bachmeier and Coelho, 2000; Birmigham et al. 2001). Knee movement is either 
performed manually or by using an isokinetic dynamometer (Pincivero, Bachmeier and 
Coelho, 2000; Birmigham et al. 2001). Often, electrogoniometers are used to measure the 
target and estimated angles to attain the difference (Petrella, Lattanzio and Nelson, 1997). 
However, the critical literature review indicated that a weight-bearing testing position is 
required to accurately estimate proprioceptive integrity in people with JHS (Marks, 
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Quinney and Wessel, 1993; Riemann and Lephart, 2002a; Andersen, Terwilliger and 
Denegar, 2010). Therefore, the squat test has been employed in the current study as a 
weight-bearing position to test proprioception through applying the angle reproduction 
test (Marks, Quinney and Wessel, 1993, Hopper et al. 2003; Kasten et al. 2009). 
Importantly, the literature review highlighted that a system with high validity and 
reliability, and a good accuracy rate is required to measure proprioception. The Qualisys 
motion capture system has been used to measure knee joint angle. 
It has been highlighted in the gait section that the Qualisys system provides highly 
valid, reliable and accurate angular measurement (Richards, 1999; Mickelborough et al. 
2000; Kejonen and Kauranen, 2002; Laroche et al. 2011). Therefore, the Qualisys system 
is appropriate for conducting the “angle reproduction test” to assess proprioception 
integrity. Moreover, the angle reproduction test shows high intra-session reliability for 
assessing knee proprioception reaching an ICC of 0.93 (Arvin, et al. 2015). Moreover, 
the squat test showed high inter-rater reliability when used to assess proprioception, 
where the ICC ranges from 0.57 – 0.80 (Piriyaprasarth et al. 2008). Similarly, high intra-
rater reliability of 0.87- 0.88 ICC was illustrated by employing the weight-bearing squat 
test for proprioception examination (Petrella, Lattanzio and Nelson, 1997; Piriyaprasarth 
et al. 2008). Ultimately, the current investigation has explored knee proprioception 
integrity using the squat test as a weight-bearing position utilising the Qualisys system.  
           4.5.7 Sonoelastography (SEG): 
 Tissue elasticity can be assessed through various methods, where each method 
relies on different concepts. Commonly, the palpation method is used in clinical practice 
as a way to sense the hardness/elasticity of any tissue using the pressure receptors within 
the examiner’s hands who applies manual downward tissue displacement pressure (Garra, 
2007). However, this method is subjective. B mode ultrasound provides deep visual 
observation by noticing the behaviour of the tissue when compressed with an ultrasound 
probe, where elastic tissues show a high amount of movement and hard tissues show a 
low amount of movement (Garra, 2007). But this method is also subjective and highly 
dependable on the examiner’s skills and experience. In contrast, several methods are 
available to objectively measure tissue elasticity. In the elastography method, radio 
waves are used to estimate the tissue elasticity by comparing the radio wave frequencies, 
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before and after applying compression, through the ultrasound probe (Garra, 2007). The 
difference between the wave frequencies before and after the compression indicates the 
elasticity level by displaying elastograms (Garra, 2007). However, to be able to read the 
elastogram of any area, the adjacent areas need to be examined too, in order to compare 
the elastograms and notice any remarkable elasticity difference within the examined area 
(Garra, 2007). Such an operational concept may be unreliable if the applied pressure to 
the multiple areas is not similar, and different elastograms could be related to different 
amounts of compression application rather than a real difference in tissue elasticity.  
Magnetic Reasonance Elastography is also used for measuring tissue elasticity by 
providing direct visualisation of the tissues using strain waves to enhance the sensitivity 
of breast cancer detection, where tumors demonstrate reduction in elasticity (Manduca et 
al. 2001; Garra, 2007). 
For the current study, compression sonoleastography (SEG) was used to assess 
the elasticity of the gastrocnemius medius muscle. SEG is an ultrasonography based 
system, which assess tissues’ perpendicular displacement and strain in response to the 
examiner’s external mild compressions using a sonoelastography probe (Sconfienza et al. 
2010; Turan et al. 2013; Klauser et al. 2014). Consequently, tissue displacement is 
calculated then converted in real time into colour-coded images, where each colour 
presents a different elasticity degree (Figure 4.8) (Turan et al. 2013; Klauser et al. 2014). 
SEG calculates the Young modulus, which is the ratio of stress to strain by following the 
principle of compressing tissue results in strain (Klauser et al. 2014). SEG estimates the 
strain by comparing the radiofrequency signals produced before and after compression 
(Wu et al. 2012). 
SEG is quick, practical, and provides high quality data for examining skeletal 
muscle elasticity (Hoyt et al. 2008; Turan et al. 2013). Additionally, SEG is equipped 
with a visual indicator to show the amount of compression applied by the examiner 
(Klauser et al. 2014). However, this indicator is only visual, and the exact amount of 
pressure application used by the examiner is unknown. Yet, this limitation was 
proportionally controlled by providing sufficient training to the examiner to apply similar 
compressions, and the whole tests have been performed by the same examiner, which 
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eliminates between-examiners error. Additionally, SEG might be unreliable for 
examining tissues embedded in hard incompressible structures, which harden inducing 
strain at the soft tissues and that limits the generation of a strain image (Klauser et al. 
2014). However, the gastrocnemius medius examined in this study is embedded with in 
soft muscular layers.     
    
Figure 4.8: A sonoelastography image taken from a healthy participant for the medial 
gastrocnemius muscle. (S.A: Superficial aponeurosis, D.A: Deep aponeurosis, GM: 
Gastrocnemius medius). Red refers to soft tissues, green refers to moderate elasticity, 
and blue refers to hard tissues. 
 
4.6  Recruitment sites and strategy: 
Patients with JHS were recruited from four sources: 
• Hypermobility Syndromes Association (HMSA). 
• Royal National Hospital for Rheumatic Diseases (RNHRD). 
• North Bristol NHS Trust (NBT). 
• University of the West of England; staff and students with JHS. 
Healthy participants were recruited from: 
• University of the West of England; staff and students. 
• Friends and relatives of UWE staff and students. 
• Friends and relatives of the JHS group, as long as they did not have JHS.  
Regarding the JHS group, recruitment packs were prepared and sent to the 
principal investigator in the HMSA, who addressed the envelopes and sent them to adult 
participants with JHS/EDS-HT. Participants from RNHRD and NBT were identified by 
the chief investigator using the RNHRD and NBT electronic data base. Then the chief 
investigator addressed the recruitment packs and sent them to the participants. The 
S.A 
D.A 
GM 
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recruitment packs involved the invitation letter, participant information sheet, and the 
reply slip (Appendix 9, 10 and 11). Participants willing to participate in the study have 
completed and sent the reply slip to the chief investigator. The participant information 
sheet involved the five points questionnaire so the participant can self-check and confirm 
the diagnosis of JHS. The chief investigator contacted the participant via telephone once 
she received the reply slip, to answer questions, check the inclusion/exclusion criteria, 
and arrange an appointment for the participant to attend the Human Analysis Laboratory 
(HAL). An email then was sent to the participant which included the examination date 
and time, directions and maps to reach the HAL, and dressing requirements. 
Regarding the control group, an advert email was sent to UWE staff and students, 
and the email involved the eligibility criteria to take part in the study (Appendix 12). 
Participants willing to take part in the study sent an email to the chief investigator to 
arrange an appointment to attend to the HAL. Participants in the JHS group were 
recruited first to identify their demographic characteristics in order to include sex and age 
matched participants in the control group.   
 
4.7 Ethical considerations: 
The research was conducted with the approval of the Research Ethics Committee 
(REC) of East Midlands, Leicester (Reference number: 14/EM/1008). In addition, Site 
Specific Assessments (SSA) of NBT and RNHRD and their Research and Innovation 
Departments’ approvals were secured in accordance with the Research Governance 
Framework for Health and Social Care and Good Clinical Practice (Appendix 13-17).  
According to established principles of Good Clinical Practice (GCP), a full 
informed consent form was completed for each participant. The Chief Investigator was 
responsible for informed consent and she has received full Good Clinical Practice (GCP) 
training. If fully informed consent was not obtained, that was considered as an exclusion 
criterion (Appendix 18). 
Voluntary participation was clearly explained in the participant information sheet 
(Appendix 10) and was explained verbally to reassure the patients that their participation 
was voluntary and their received care would not be adversely affected by any means. 
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Confidentiality concerning participants’ personal information and data was maintained at 
all times to prevent any possible identification of the participants. Patient privacy and 
dignity were maintained at all times during the data collection period (Appendix 19). 
 
4.8 Patient research partner: 
4.8.1 Input plan: 
A participant from the JHS group volunteered to be a patient research partner 
(PRP) to support the current research. She is a 60-year-old woman diagnosed with JHS > 
30 years ago, and will be referred to as PRP_J. She was approached after completing the 
whole examination for the current study as a participant in the JHS group. Although 
engaging a patient research partner would have been more informative and constructive 
in the design planning stage, this weak point in the current study has been addressed by 
gaining the patient research partner’s input during the other stages of the research. The 
input of the patient research partner has been divided into two stages: 
a) Comment on the data collection procedures: An email was sent to PRP_J to 
gain her feedback on the established design regarding: 1) appropriateness 
level, 2) hardness level, and 3) relevance to JHS. Specifically, PRP_J was 
asked to comment on the SF-12, BIoH, VAS, ultrasound scanning, strength 
testing, marker application, squat test, walk test, jump test, and the 
sonoelastography examination. She was advised to take her time in answering 
the questions, and to contact the researcher for further explanation. A face to 
face meeting was offered to PRP_J to go through the questions, but she 
preferred to reply via email.  
b) Comment on the results interpretations: A lay summary of the results 
interpretation was emailed to the PRP_J to obtain her opinion, by: 1) agreeing, 
2) disagreeing or 3) adding a different perspective. A face to face meeting and 
a phone call were offered to document the research partner’s feedback. 
Contact was lost with PRP_J for unknown reasons. Therefore, a PRP was 
contacted to volunteer to obtain her feedback regarding the results 
interpretation. She was a participant in the JHS group, and she will be referred 
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to as PRP_S; she is 58 years, and was diagnosed with JHS five years ago. An 
email was sent to PRP_S to gain her feedback on the results interpretation, by: 
1) agreeing, 2) disagreeing, or 3) adding a different perspective.   
4.8.2 Actual input: 
PRP_J was invited to this collaboration after undergoing the whole examination 
as a participant in the JHS group. The comments from the Patient Research Partner are as 
follows: 
• The SF-12 and BIoH questionnaires are relevant to JHS; however, the 
questions regarding pain during the last week were a little difficult as pain 
varies from day to day. 
• Strength and ultrasound measurements are appropriate, 
• In general, the input on the whole procedures is as follows: 
“Level of appropriateness: it was not an inconvenience and would be appropriate 
if it allowed you to measure all the results you felt were required for your project. 
Hardness level: there was nothing too hard or invasive to do, so I would say it was an 
easy task for the patient to undertake. Relevant to JHS: I would say all the tasks are 
relevant to JHS if it provides bench marks for setting out criteria for the analysis of JHS”  
PRP_J’s response was via email. Although a face to face meeting might have 
provided more detailed feedback, PRP_J preferred to respond through email. The 
response of PRP_S will be presented in the discussion chapter.  
 
4.9 Data collection procedures:    
 All the data collection procedures were conducted at the Human Analysis 
Laboratory (HAL) in the University of the West of England, Bristol (UWE). With tissue 
elasticity measured in the Radiography facilities in UWE. Tissue elasticity measurement 
was considered a feasibility pilot study projecting from the original study. Therefore, 
only ten participants from each group were asked to attend the radiography facilities. 
Moreover, only ten participants from each group were asked to repeat muscle-tendon 
stiffness measurement, markers reapplication and walking test repetition to assess intra-
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rater reliability. The original study lasted for a maximum of 60 minutes, the intra-rater 
reliability tests required a maximum of 30 minutes, and tissue elasticity measurement 
required a further maximum of 10 minutes. The following sections explain the data 
collection procedures in chronological order. 
4.9.1 Consenting and confirming eligibility: 
The study started by explaining the study and answering the participant’s 
questions. If the participants confirmed their willingness to take part in the study, they 
were asked to sign the consent form (Appendix 18). In addition, participants’ rights were 
explained regarding the right to stop at any time, ask for extra rest, and reserving their 
privacy and dignity at all times. The “Participant information sheet” (Appendix 10), 
which was sent in advance for the participants, includes the 5-point hypermobility 
questionnaire developed by Hakim and Grahame (2003). These questions ensured the 
participants’ eligibility to take part in the study before attending the research site. 
However, participants’ eligibility was reconfirmed using the Brighton and Villefranche 
criteria on the data collection day (Appendix 2 and 3). 
4.9.2 Answering the Questionnaires: 
Participants in the JHS group were asked to complete the biographic, visual 
analogue scales, SF-12, and BIoH questionnaires (Appendix 20, 5, 6 and 7). The 
researcher secured a license to use the SF-12 questionnaire (license number QM024590, 
QualityMetric Incorporated, part of Optumlnsight, United States). Participants in the 
healthy group were asked to complete all previously mentioned questionnaires except the 
BIoH questionnaire because it was not relevant to the healthy group. At that stage, the 
participants’ height and weight were measured. All procedures lasted for a maximum of 
ten minutes. 
4.9.3 Achilles tendon stiffness measurement: 
Achilles tendon stiffness was measured by calculating muscle-tendon elongation 
using diagnostic ultrasound technology (SonoSite MicroMaxx, SonoSite, USA), 
following Fukashiro et al.’s (1995) and Kubo, Kanehisa and Fukunage's (2001) method, 
while the plantar flexor strength was measured with a digital strain gauge myometer 
(MIE Medical Research Ltd, Leeds, UK) (Figure 4.9). The ratio of muscle strength to 
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changes in the muscle-tendon length was calculated as Achilles tendon stiffness (McNair, 
Wood and Marshall, 1992).  
A Manfrotto Magic Arm (Manfrotto Co Spa. Company, Cassola, Italy, owned by 
The Vitec Group, UK) was used to maintain the ultrasound probe position, and to ensure 
that the ultrasound probe did not move during the examination (L38e/10-5MHz Sonosite 
probe, US) (in 3.8 depth) (Figure 4.9 and 4.10). Moreover, the Manfrotto Magic Arm 
freed the examiner’s hands to have more control of the other aspects of the test. 
  
 
Figure 4.9: Instrument setup for measuring Achilles tendon stiffness, using portable 
diagnostic ultrasound, and the digital strain gauge myometer while the ultrasound probe 
is held by the Manfrotto Magic arm. 
 
 
 
 
 
 
 
 
 
 
 
Ultrasound system 
Digital myometer 
Examination plinth 
Manfrotto Magic Arm 
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Figure 4.10: Closer image of the super clamp connected to the Manfrotto Magic arm, 
which was used to stabilise the ultrasound probe during the examination process for 
Achilles tendon stiffness. A soft cover was wrapped around the ultrasound probe to 
protect the probe from the super clamp’s sharp edges. (a: side image, b: superior image). 
 
The digital strain-gauge myometer’s transducer was positioned between two 
strain gauges; one gauge was strapped to a stationary point on the plinth, while the other 
strap was attached to ankle joint pad (Figure 4.11). The third strap was used to support 
the transducer (Figure 4.11) (Brinkmann, 1994). The calibration of the digital strain-
gauge myometer was checked and confirmed by Avon Dynamic Company (Appendix 
21).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a
) 
b
) 
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Figure 4.11: a) Strain gauge digital myometer setup at the examination plinth with three 
straps: one strap across the plinth to support the transducer (highlighted with round 
shape.) b) Closer image: inferior image for the transducer. c) Side image for the 
transducer. The second strap connected the transducer to a stationary arm from the 
plinth. The third strap connected the transducer to the ankle pad (highlighted with 
rectangular shape), which resisted the participant’s force. 
 
Participants were positioned in a prone position, while the dominant ankle joint 
was maintained in a neutral position with the ankle pad (Figure 4.12). The dominant leg 
was determined by asking the participant to define the leg which is used to kick a ball 
(Tanaka et al. 1996). The knee joint was maintained in full extension. An electronic 
ultrasound probe with linear array was placed at 30% GM length to obtain a longitudinal 
image, where a measuring tape was used to measure the distance from a midpoint of the 
popliteal fossa to midpoint between the ankle malleoli to determine the proximal 30% of 
the GM length (Figure 4.13) (Kubo, Kanehisa and Fukunaga, 2003; Rombaut et al. 
2012a). A marker was used as a reference and to ensure that the ultrasound probe did not 
move during the examination. P1 was identified during muscle rest; intersection between 
a
) 
b
) 
c
) 
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one muscle fascicle and the deep aponeurosis. P2 was identified during a maximal 
isometric plantar flexor contraction by tracking P1 proximal transition. The difference 
between P2 to P1 distances indicated muscle-tendon lengthening (Figure 4.15) 
(Fukashiro et al. 1995; Kubo, Kanehisa and Fukunage, 2001). Three trials were measured 
and the mean value was used as muscle-tendon elongation (Fukashiro et al. 1995). 
Simultaneously, plantar flexor strength was measured using a digital strain-gauge 
myometer. Three submaximal plantar flexor contractions were performed as test 
familiarisation. Then participants were asked to build a maximal plantar flexion 
contraction, at a fixed neutral ankle position, for five seconds for three trials with 30 
seconds rest between trials (Rombaut et al. 2012a). The test was repeated if angular 
motion was observed at the ankle joint to ensure that the data presented isometric muscle 
work at a standardised testing angle.  
 
 
 
Figure 4.12: A participant positioned for Achilles tendon stiffness measurement in a 
prone position. The ultrasound probe has been stabilised with the Manfrotto Magic Arm, 
and the ankle pad connected to the stain gauge digital myometer, has been placed over 
the metatarsal area to counteract the isometric contraction of the plantar flexors (a: 
superior view, b: lateral view). 
 
 
 
 
 
 
 
 
a
) 
b
) 
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Figure 4.13: a) Achilles tendon stiffness measurement and the examiner position while 
scanning the GM muscle. b) a measuring tape was used to identify 30% of the GM length 
where the area was marked with a hypoallergenic marker. 
 
 
Figure 4.14: Ultrasound image for measuring Achilles tendon lengthening. The 
Superficial aponeurosis (S.A) was identified as a straight white line covering the 
gastrocnemius medius (GM) from the superior aspect, and the deep aponeurosis (D.A) 
was the white straight line which covered the inferior side of the GM. The parallel 
diagonal lines between the S.A and D.A are the GM muscle fascicles. a) was captured 
during muscular resting status to identify one intersection between one muscle fascicle 
and the D.A as position 1 (P1) (highlighted with small red circle). b) was captured 
during isometric plantar flexion to track P1 moving proximally during contraction as P2. 
The distance between P1 to P2 was the muscle-tendon unit elongation. The ultrasound 
provided the measurement in cm, which was later converted to mm to measure Achilles 
tendon stiffness in N/mm.   
 
S.A 
D.A 
GM 
Isometric contraction Resting muscle status 
a
) 
b
b 
a
) 
b
) 
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4.9.4 Reliability study I; identifying the intra-rater reliability of measuring 
Achilles tendon stiffens: 
This procedure was performed to assess the intra-rater reliability of the previous 
procedure (section 4.9.3). Therefore, the previous procedure was repeated after five 
minutes rest to avoid any fatigue effect. Ten participants from each group (JHS and 
control) were re-assessed to examine Achilles tendon stiffness. The participants from the 
main groups were asked to participant in the intra-rater reliability study, and those who 
have time to stay longer for the examination were included.  
           4.9.5    Qualisys system preparation and markers application: 
Two minutes rest was provided after the last procedure. Instrument settings (Table 
4.3), and calibration were performed and the system was checked in advance 
approximately half an hour before participant attendance according to the manufacturer 
guidelines (Table 4.3). Before each session the cameras' fields of view were checked by 
placing the frame; with four markers attached to it, on the force plate, then checking the 
field of view of each camera to ensure that each camera was capturing the four markers. 
This process also helped to remove any reflective objects from the cameras’ fields of 
view. The next step was the calibration. First, the force plate coordinate system was 
identified and calibrated by placing four markers on the force plate corners, which was 
recorded by the QTM. Then the LCS was calibrated and identified by using two 
calibration devices: wand “2 points” and reference frame “4 points” (Figure 4.5). The 
wand was moved into the cameras’ capturing space to define the laboratory’s coordinate 
system. The Qualisys Track Manager software was used to confirm the integrity of the 
calibration and if the calibration was passed, where the residuals should be ≤ 3 mm 
according to the manufacturer guidelines.  
 
Table 4.3: The settings which were checked for the Qualisys motion capture system.  
Settings  Option 
Capture rate 100 
Analog acquisition Enabled 
Marker type Passive 
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The segmental coordinate systems of the lower limbs were identified following 
the calibrated anatomical system technique (CAST) (Cappozzo et al. 1995). Infrared 
retro-reflective markers, spherical and 14mm diameter, and four marker clusters were 
used (Figure 4.15). Markers were placed over the participants’ lower limbs following the 
CAST (Figure 4.16 and 4.17) (Cappozzo et al. 1995). Markers were placed over anterior 
and posterior superior iliac spines and greater trochanters, medial and lateral femoral 
condyles, medial and lateral malleoli, bilaterally. Moreover, markers have been placed 
over the first and fifth metatarsal heads, second metatarsal base and mid-calcaneus, 
bilaterally. Additionally, four marker clusters have been placed on the thigh and shank, 
bilaterally (Figure 4.18). After marker application, a static standing trial was recorded 
with the full set of markers being applied to define the segmental coordinate system of 
the lower limbs. After recording the static trial, the markers’ visibility was checked in 
real time in QTM, then the following markers were removed to prepare for dynamic 
testing: bilateral greater trochanters, bilateral medial and lateral femoral condyles and 
bilateral medial and lateral malleoli following CAST (Cappozzo et al. 1995). 
The Qualisys motion capture system was used to measure: 
a) Knee joint proprioception. 
b) Gait biomechanics. 
c) Vertical jump biomechanics. 
 
 
 
 
 
 144 
 
 
Figure 4.15: Twenty two markers and four marker clusters were used to identify the 
segmental coordinate systems of the lower limbs. The single markers were prepared with 
double-sided tape, while self adhesive straps were used to attch the four marker clusters. 
 
 
 
Figure 4.16: Markers application procedure performed in a standing position with the 
examiner in a kneeling position to identify the required landmarks.  
 
 
 
 
 
 
 
Single markers 
Marker clusters 
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Figure 4.17: Calibrated anatomical system technique (CAST) which was used for marker 
application.  
 
 
            4.9.6 Knee Proprioception test: 
Knee proprioception was examined by implementing the following procedures 
(Marks, Quinney and Wessel, 1993, Hopper et al. 2003; Kasten et al. 2009): 
• The participant was asked to stand barefoot while holding a walking frame. 
The legs were kept slightly apart to avoid skin contact and possible tactile 
Anterior view Posterior view 
Lateral view 
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clues. Participant’s eyes were blindfolded to eliminate visual feedback using 
an eye mask (Figure 4.18).  
• The examination started with three trials for test familiarisation. The test 
consisted of two parts: the ‘examiner holding’ part and the ‘participant 
holding’ part, using standardised verbal instructions. A goniometer was used 
to know when the participant reached the target testing angles: 200, 250, 300for 
the first, second and third trial, respectively (Figure 4.18). Different testing 
angles were used for each trial to avoid any learning effect. In the ‘examiner 
holding’ part, the examiner asked the participant to squat by flexing the knees 
down to the target testing angle, and then the examiner asked the participant to 
hold for five seconds. Next, the participant was asked to straighten up and 
hold for ten seconds. This was followed by the ‘participant holding’ part 
where the participant was asked to mini-squat to the angle which she/he 
thought was similar to the target angle attained in the ‘examiner holding’ part. 
The reproduced angle by the participant was considered the ‘estimated angle’. 
The difference between the target and estimated angle is the absolute error 
which indicates knee proprioception. 
 
Figure 4.18: a) Knee 
proprioception testing; 
the participant was 
holding the walking 
frame, and the eyes were 
blind folded to eliminate 
visual input. The examiner held the trigger of the 
Qualisys system to start recording while using a 
goniometer to measure the knee target angle.  
b) The goniometer used to measure the target 
angle. (consent was obtained from the participant 
to use this photograph). 
 
 
 
 
 
a
) 
b
) 
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           4.9.7 Walking test: 
Gait biomechanics were examined during self-selected walking speed. The test 
started with three trials of test familiarisation. The participant was asked to walk along 
the walkway over the force platform (Figure 4.2 and 4.4). Five trials of each limb were 
recorded with clear full foot contact with the force plate, as five trials are sufficient to 
obtain a good reliability level; ICC > 0.7 (Laroche et al. 2011). Each foot should have a 
clear full contact with the force plate to obtain kinetic measurement. Full clear contact 
with the force plate was achieved by adjusting the walk starting position, and by 
changing the leg to start with. Twenty seconds rest was provided between trials to 
eliminate any fatigue effect, and chairs were provided at the two ends of the walkway. 
           4.9.8 Vertical jump test: 
Joint biomechanics were examined during vertical jump test as an advanced 
physical task. Moreover, the same test was used to calculate the entire stiffness of the 
lower limb following Farley and Morgenroth’s (1999) methodology by calculating the 
ratio of the peak ground reaction force to the maximum vertical displacement of the 
center of mass. The jump test started with three trials of test familiarisation. Initially, 
participants were asked to maintain an upright posture with the feet slightly apart. 
Minimal trunk movement was allowed to minimise momentum generation from the upper 
body (Leard et al. 2007). Hands were placed on the waist to eliminate momentum 
generation from the upper limbs (Feltner, Bishop and Perez, 2004; Lees, Vanrenterghem 
and Clercq, 2004). The participants were asked to perform a mini-squat then jump to their 
preferred height, and landing on the force platform to obtain the kinetic data (figure 4.4) 
(Leard et al. 2007). 20 seconds rest was provided between trials to eliminate fatigue 
effect. The test was repeated three times to obtain the mean value. The jump test was 
divided into two phases: the compression phase and the push phase. Figure 4.19 details 
the division of the jump test.  
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Figure 4.19: A drawing illustrating the jump test phases: compression and push phase. 
The compression phase is the phase between still standing to the lowest reached distance 
before the jump. The push phase is the phase between the first frame after the lowest 
reached distance to the maximum height reached. A pelvis marker; the red dot, was used 
to measure vertical displacement and jump height. VD stands for vertical displacement, 
and VGRF stands for the vertical ground reaction force. Lower limb stiffness was 
calculated by dividing VGRF over the VD. JH stands for jump height. 
 
            4.9.9 Reliability study II: markers reapplication and repeating the walk test: 
This procedure was conducted to assess the intra-rater reliability of measuring gait 
kinematics by re-applying the markers and repeating the walk test. The participants from 
the control groups were asked to participant in this intra-rater reliability study, and those 
who had time to stay longer for the examination were included. Ten participants from the 
control group have participated in the reliability study II. At this stage, all the markers 
were removed and five minutes rest was given after the last procedure. After the rest, 
Qualisys markers were re-applied following CAST (Figure 4.17) (Cappozzo et al. 1995). 
A static standing trial was recorded, and then the calibration markers were removed to 
prepare the participant for the walking test. The walking test was repeated, as mentioned 
in section 4.9.7. 
            4.9.10 Tissue elasticity measurement: 
Tissue elasticity was measured using the SEG (Toshiba Apolio XG and Pegasus 
Imaging corporation, Florida, USA) (Figure 4.20). However, the SEG is a large device 
and it was hard to be brought to the HAL. The SEG was available in the Radiography 
 
  
 
  
 
   
Compression phase Push phase 
VD 
JH 
VGRF 
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facilities in UWE, in another part of the campus. Switching the examination area 
increased the burden on participants as well as the researcher. Moreover, switching the 
examination area risked the participants' willingness to take part in the study as well as 
their adherence to the entire examination procedures. Therefore, only ten participants 
from each group were asked to undergo this procedure. Participants were informed in the 
participant information sheet that they would be asked if they willing to further 
collaborate in measuring tissue elasticity. Agreed participants were asked to rest for five 
minutes after reaching the SEG site; transfer time was 3-4 minutes. Measuring tissue 
elasticity lasted for a maximum of five minutes.  
 
Figure 4.20: The sonoelastography device used to assess gastrocnemius medius 
elasticity. 
 
The participant was positioned in a prone position and relax his/her leg, then the 
examiner placed the sonoelastography probe (PLT-1204BT) on the medial gastrocnemius 
muscle (Park and Kwon, 2012). The ultrasound probe was placed at 30% GM length to 
obtain a longitudinal image. A measuring tape was used to measure the distance from a 
midpoint of the popliteal fossa to midpoint between the ankle two malleoli to determine 
the proximal 30% of the GM length (Kubo, Kanehisa, and Fukunaga, 2003). After 
determining the area of interest, the examiner applied perpendicular mild compressions to 
that area four times (Park and Kwon, 2012). A coloured image appeared on the 
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sonoelastography screen and then it was saved for analysis (Park and Kwon, 2012). This 
procedure was repeated three times and the three images were used for analysis. The 
visual indicator of the SEG was used to ensure similar compression magnitudes. If the 
curves were not similar in amplitude the test was repeated.  
 
4.10 Data processing and analysis: 
            Statistical Package for the Social Science (SPSS) was used for data analysis. 
However, several software packages were used to process the data before entering the 
results into SPSS:  
              4.10.1 Visual Analogue Scale (VAS): 
              VAS is a 10 cm length line and the participant indicated at that line her/his pain 
intensity from 0-10, where 0 was no pain, and 10 was worst possible pain. By using the 
ruler, the researcher measured the participants pain intensity using the line ticked by the 
participants on the VAS line. 
          4.10.2 The Bristol Impact of Hypermobility Questionnaire (BIoH): 
         The BIoH questionnaire consists of 55 items, which provide a single composite 
score of 360. The higher the score, the more severe the impact of JHS (Palmer et al. 
2016). 
          4.10.3 The Quality Metric Health Outcomes TM Scoring software (4.5.1):  
          The Quality Metric Health Outcomes TM Scoring software (4.5.1) was used to 
process the results from the SF-12 Questionnaire. The software was provided with the 
SF-12 license. The responses of each participant were entered, and the software 
calculated the scores for each participant; 0-100, for the following eight categories: 
physical functioning, physical role, bodily pain, general health, vitality, social 
functioning, emotional role, and mental health. Moreover, the composite physical 
component score and mental component score were provided. A high score reflects better 
physical and mental health. Particularly, scores range from zero: worst level, to 100: best 
level. The scores were entered into SPSS for analysis. 
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           4.10.4 The Qualisys Track Manager: 
The Qualisys Track Manager (QTM) is a processing software, which is also 
designed for real time 2D and 3D data visualization and processing. QTM was used to 
process the squat, walk and jump tests. Each trial of those tests was checked, markers 
were identified, and the events were labeled through QTM. For the squat test performed 
for proprioception assessment, the events were reduced mainly to identify the knee 
flexion angle during the five seconds hold phase of the squat test during the target and 
estimated angle. These events were identified and confirmed through the trajectory 
analysis option in the QTM. For the walk test, the markers for each trial were labeled, 
and the following events were identified: for a right side walk trial, right heel strike, left 
heel strike, right off, and right heel strike. Similarly, for a left side walk trial, the 
following events were identified: left heel strike, right heel strike, left off, and left heel 
strike. The events were confirmed using the trajectory analysis option. The jump task, 
was divided into compression and push phase by specifying the following events in QTM 
(Figure 4.19): 
a. Upright standing position. At this event the vertical position (z axis) of the right 
PSIS marker was recorded as position one to attain the vertical displacement 
needed to calculate the lower limb stiffness. 
b. Maximum knee flexion during the compression phase before the jump. The 
trajectory analysis option was used to confirm the exact time of this events. At 
this event the vertical position of the right PSIS marker was recorded as position 
two to attain the vertical displacement required to measure lower limb stiffness. 
This event was also used to measure the peak ground reaction force to calculate 
the entire stiffness of the lower limbs. The compression phase refers to (a) and 
(b) events. 
c. The first frame after maximum knee flexion.  
d. Maximum reached height after initiating the jump. The trajectory analysis was 
used to confirm the exact timing of this event. The push phase refers to (c) and 
(d) events.  
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Specifically, to measure the entire stiffness of the lower limbs during the jump 
test, the maximum ground reaction force during the compression phase was divided over 
the vertical displacement of the right PSIS marker (Farley and Morgenroth, 1999). 
           4.10.5 Visual 3D and Excel software: 
V3D was used to build a gait model for the lower body by loading a standing trial 
and creating segments. After processing each event through the QTM, trials were 
converted to C3D files and were transferred and processed in the Visual 3D software, to 
produce the spatiotemporal, kinematic and kinetic report and kinematic and kinetic curve 
graphs for lower limb joints during the walking and jump tests. Data normalised to the 
measurement cycle was exported in ASCii format, which can be opened in Microsoft 
Excel. Visual 3D provided the spatiotemporal gait parameters. Kinematic and kinetic; 
moments and powers, were extracted from Excel. For the gait task, joint angle at initial 
contact, minimum and maximum kinematics for the swing and stance phases were 
extracted for the pelvis, hip, knee and ankle joints, bilaterally. Initial contact, maximum 
and minimum moments were also calculated in Excel, as well as maximum and minimum 
powers for the hip, knee and ankle joints, bilaterally. For the jump test, Excel was used to 
extract mean, maximum and minimum kinematics during the compression and push 
phase, as well as mean and maximum moments and powers for the hip, knee and ankle 
joints, bilaterally during the compression and jump phase. Regarding the squat test, the 
knee flexion angle; target and estimated angles; bilaterally, were extracted from Excel 
(further details will be explained in section 4.10.5). Ultimately, the data extracted from 
Excel has been entered into SPSS for analysis. 
            4.10.6 Processing proprioception test: 
Three softwares were used to process the proprioception/squat test. The Qualisys 
Track Manager software (QTM) was used to minimise the squat to the five seconds 
steady-state holding phase; the phase of the target and estimated angle, by using 
trajectory analysis. Specifically, during the examination procedures, participants were 
asked to stay still for five seconds when they attained the target and estimated angles. 
Therefore, the squats were minimsed to that five seconds holding phase. In QTM, the 
markers were labelled, then the file was exported to C3D format to be processed in V3D. 
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In V3D, four scripts were used to process the squat to be exported to Microsoft Excel. In 
Excel, the mean knee angle; for both the target and estimated angles, during the holding 
phase was calculated for the dominant and non-dominant sides. The absolute error was 
calculated by subtracting the estimated angle from the target angle (Hopper et al. 2003; 
Kasten et al. 2009). 
           4.10.7 IMAGE-J software for SEG image analysis: 
Image-J software (a Java-based image processing tool) was used to analyse the 
SEG images. The GM of each participant was scanned three times and the three images 
were used for the analysis. Through Image-J the area of interest; GM muscle, was 
highlighted using the crop option and through the cropping procedure the superior fat 
layers and inferior soleus muscle were eliminated from the analysis (Figure 4.21). Then 
the outside area was cleared from the image using the ‘clear outside’ option. Then the 
analysis was performed using a plugin which was downloaded to Image-J; colour pixel 
counter (Pichette, 2010). The colour pixel counter plugin counted the pixels for each 
colour; red, green and blue (Pichette, 2010). However, as the cross sectional area of the 
GM muscle varied from participant to participant, considering the pixel mean was not 
appropriate, where participants with bigger muscle cross sectional area had greater mean 
pixel numbers of each color. Therefore, the percentage of each color was calculated using 
the following formulae (Richardson et al. 2007): 
Total pixels = Mean pixels (red) + Mean pixels (green) + Mean pixels (blue) 
Red % = Mean pixels (red) / total pixels * 100 
Green % = Mean pixels (green) / total pixels * 100 
Blue % = Mean pixels (blue) / total pixels * 100 
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Figure 4.21: SEG image analysis. a) Shows the SEG image when opened in Image-J 
software. b) Shows the yellow lines which were used to outline the area of interest; 
medial gastrocnemius muscle, where the superior fat layers and inferior soleus muscle 
were eliminated from the analysis. c) Shows the curves displayed beneath each SEG 
image as an indication of the compressions magnitude applied by the examiner. 
 
           4.10.8 Statistical Package for Social Sciences: 
Statistical Package for the Social Science (SPSS) was used for statistical analysis. 
Descriptive statistics including the mean (standard deviation)/median (interquartile range) 
were used to describe the demographic data and the study variables. Histograms and 
Shapiro-Wilk tests were used to assess the normal distribution of the data (Field, 2009). If 
the data were normally distributed a parametric independent t-test was used to analyse the 
differences between mean scores of the two groups (Field, 2009). Levene’s test 
assumption was checked before operating the independent sample t-test for the equality 
of variances (Pallant, 2010). Levene’s test significance value should be more than 0.05 to 
operate the independent t-test (Pallant, 2010). If the data were not normally distributed, a 
nonparametric Mann-Whitney U test was the non-parametric alternative for the 
independent t-test (Pallant, 2010). 
 The relationship between the studied variables were assessed initially by 
displaying scatterplots (Pallant, 2010). Pearson Product-moment correlation coefficients 
were used to assess the strength and direction of the relationship between the studied 
variables. Specific assumptions were checked prior to operating the Pearson Product-
moment correlation coefficient as a parametric test (Pallant, 2010): 
• Continuous measurement scale.  
a
) 
b
) 
c
) 
 155 
 
• Independent examination to ensure that each measurement was not influenced 
by the other measurement. 
• Data's normal distribution, which were checked with histograms. 
• Linearity, which was assessed with scatterplots to ensure that the scores are in 
a straight line. 
• Homoscedasticity, which was checked with scatterplots, to ensure similar 
variability between the measurements. 
In contrast, if the histograms indicated that the data were not normally distributed, 
a nonparametric Spearman’s test was used to assess the correlation between the study 
variables (Field, 2009). Intra-class correlation coefficient (ICC) was used to assess the 
repeatability of measuring muscle-tendon unit stiffness and gait kinematics (Pallant, 
2010). The operated statistical test was specified in the results chapter for each 
comparison and correlation.   
           4.10.9 Standardised mean difference: 
Standardised mean difference (SMD) was reported with 95% confidence interval 
(CI) for the study’s outcome measures. SMD is an efficient method to suggest clinically 
important difference between two groups (Samsa et al. 1999; Walker, 2007).  SMD is not 
influenced by the sample size of the study and it can help in determining if the statistical 
significant difference between the two groups are clinically significant too (Samsa et al. 
1999; Walker, 2007). Additionally, SMD provides acceptable indicators to determine the 
size of the difference, where 0.2 indicates a small clinically important difference, 0.5 
indicates medium clinically important difference, and 0.8 indicates large clinically 
important difference (Cohen, 1988; Walker, 2007). SMD can be attained from the 
difference between two means divided by the average standard deviation (Samsa et al. 
1999; Walker, 2007). However, an online calculator has been used from Durham 
University Centre for Evaluation and Monitoring to calculate the SMD and its 95% CI for 
the present research. 
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4.11 Conclusion:  
 A cross-sectional research design was employed as it is the optimal design to 
achieve the main objectives of the current investigation by comparing the JHS group with 
a matched control group. The internal validity of the current investigation was enhanced 
by justifying the sample size and the inclusion/exclusion criteria. Additionally, 
assessment tools and methods used and followed in the current study were based on a 
critical analysis of the alternatives, which has further enhanced the internal validity of the 
current study. Moreover, this chapter provides detailed and justified explanation for the 
data collection procedures, ending with the data processing and analysis methods. 
The next chapter, Chapter Five (Results Chapter), provides the results related to 
the main objectives of the current study. However, the Results Chapter starts with the 
intra-rater reliability studies of measuring muscle-tendon stiffness and marker 
reapplication to assess the consistency of the kinematic measures.  
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Chapter Five 
“Results” 
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5. CHAPTER FIVE: RESULTS 
5.1 Introduction: 
The results chapter has been divided into several sections. It starts by detailing the 
response rate, and the number of participants included and excluded from the JHS and the 
control group. Results related to the intra-rater reliability studies will be presented first as 
an important element of the internal validity of the study as a whole. Then, the main 
demographic characteristics of the studied samples are presented. The other sections 
present the results of each study separately, where the order of the presented results is 
following the order of the tests performed in the data collection session: 
• Pain quantification with visual analogue scales. 
• General health and participation level assessment with the 12-item Short Form 
Health Survey (SF-12) questionnaire. 
• Assessing the impact of JHS on the physical activity level with the Bristol 
Impact of Hypermobility questionnaire (BIoH). 
• Plantar flexors strength and Achilles tendon stiffness. 
• Knee proprioception. 
• Three-dimensional gait analysis; studying the spatiotemporal parameters, 
lower limb joints kinematics, and kinetics. 
• The vertical jump test: measuring lower limbs stiffness, and three-dimensional 
jump analysis; studying jump kinematics, and kinetics. 
• The feasibility of sonoelastography to study the gastrocnemius medius muscle 
elasticity. 
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To compare the mean scores of the two groups (JHS and control), two statistical 
tests were operated alternatively: independent samples t-test and Mann-Whitney U test. 
Justifications for the statistical tests and checking their assumptions were explained in the 
methods chapter (section 4.10.7). Histograms were produced to check the normal 
distribution of the data, however, Shapiro-Wilk tests were also used to provide a 
quantitative indication for the data’s normal distribution (Field, 2009). The Levene’s tests 
for the equality of variance are also checked (Field, 2009; Pallant, 2010). SMD was 
calculated to assess clinically important difference between the two group (section 
4.10.8). Additionally, two tests were used to assess between-variables correlation: 
Pearson Product Moment Correlation Coefficient and Spearman Rank Order Correlation 
as the non-parametric alternative (section 4.10.7) (Pallant, 2010).  
 
5.2  Response rate, inclusion and exclusion details: 
 Various sources were used to recruit participants to the JHS and control groups. 
Figure 5.1 and 5.2 specify details related to the number of included and excluded 
participants from each source. Regarding the JHS group, after receiving reply slips the 
participants were contacted via telephone to check the inclusion/exclusion criteria and to 
arrange an appointment. All the excluded cases from the JHS group were excluded at the 
telephone conversation stage. The reasons for exclusions were as follows: 
• Fractures at the hip an/ or ankle joints during the last 12 months. 
• Osteotomies and other operations during the last 12 months. 
•  Cardiac problems. 
• Some of the cases counted in the excluded number, could not attend the data 
collection site in Bristol as it was too far away. 
• Some cases provided the wrong contact details, or missed writing the contact 
details altogether. 
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Only one participant from the control group was excluded due to having a 
migraine headache as this condition may cause weakness to the lower limbs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1: Details related to the number of participants in the JHS group recruited from 
the Hypermobility Syndromes Association (HMSA), Royal National Hospital for 
Rheumatic Diseases (RNHRD), North Bristol Trust (NBT) and University of West of 
England (UWE) staff and students diagnosed with JHS. The diagram details the number 
of participants invited, responded to the invitation, were excluded, included and not 
examined. Not examined refers to the number of participants that were on a waiting list 
but were not required. Through telephone conversations, 13 participants from HMSA and 
3 participants from RNHRD were excluded. Participants from UWE self-checked their 
eligibility to take part in the JHS group through an advert email inclusion/exclusion 
criteria checklist. Due to initially having a low response rate from men, only men patients 
were invited from NBT. All included participants took part in the study. The required 
number of participants was achieved and 16 volunteers were not examined from HMSA. 
The response rate from the HMSA was 19.14%, 57.89% from the RNHRD, 0.0% from 
men with JHS from NBT, and unknown from UWE.    
 
 
 
 
 
 
JHS Group 
HMSA RNHRD NBT UWE 
Invited 
n = 256 
Invited 
n = 19 
Invited 
n = 7 men 
Invited (advert 
email) n unknown 
n unkown  
 
responded 
n = 49 
responded 
n = 11 
responded 
n = 0 
responded 
n = 3 
excluded 
n = 13 
not examined 
n = 16 
included 
n = 20 
excluded 
n = 3 
not examined 
n = 0 
included 
n = 8 
excluded 
n = 0 
not examined 
n = 0 
included 
n = 3 
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Figure 5.2: Details related to the number of participants included and excluded from the 
control group. Participants self-checked their eligibility criteria through an advert email 
inclusion and exclusion check list (a similar advert email was sent to the relatives and 
friends of UWE staff and student when identified). 
 
5.3  Reliability results: 
5.3.1 Introduction: 
This section presents the results of the two intra-rater reliability studies that have 
been performed in the current investigation to ensure the repeatability of two 
measurements. Therefore, this section is divided into two parts. The first part presents the 
results of the intra-rater reliability study, which was performed to ensure the repeatability 
of measuring the stiffness of the Achilles tendon using ultrasound with the strain-gauge 
myometer. The second part presents the results of the intra-rater reliability study, which 
was conducted to ensure the reproducibility of the kinematic parameters by re-applying 
the Qualisys markers and repeating the walk test. 
To assess the consistency of the measurement for the intra-rater reliability studies 
Intra-class correlation coefficients (ICC) were used (Pallant, 2010). Moreover, one-way 
repeated measure ANOVA was used to compare scores. Justification for the statistical 
tests and checking their assumptions were explained in the methods chapter (section 
4.10.7) 
Control Group 
UWE staff and 
students (n = 
unknown) 
 
Relatives and friends of 
UWE staff and students 
(n = unknown) 
Excluded 
n = 1 
Excluded 
n = 0 
Included 
n = 27 
Included 
n = 4 
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5.3.2 The Results of the intra-rater reliability study of measuring the 
stiffness of the Achilles tendon with the ultrasound and the strain-
gauge myometer: 
Twenty women participated in this study; 10 women from the JHS group and 10 
women from the control group. Table 5.1 illustrates the demographic characteristics of 
the participants. Intra-class correlation coefficients (ICC) were calculated to assess the 
consistency of the measurements. One-way repeated measure ANOVA was used to 
compare the results attained at trial one with trial two. Comparing the demographic 
characteristics of the participants who completed this intra-rater reliability study with the 
demographic characteristics of the main JHS and control groups, illustrated that the 
participants of the intra-rater reliability study were representative of the main groups in 
terms of BMI, height, and weight (Table 5.1 and 5.7). Particularly, similarities were 
observed in term of BMI, height and weight between those who participated in the intra-
rater reliability study and those who participated in the main study (Table 5.1 and 5.7). 
However, differences were noticed in term of age. The JHS group in this intra-rater 
reliability was slightly older than the those in the main JHS group; 40.40 (14.02) versus 
38.52 (14.14) years, respectively. More difference in age has been noticed in the control 
group of this intra-rater reliability study when compared with the main control group; 
35.30 (11.00) versus 39.06 (12.43) years, respectively.   
Table 5.1: The demographic characteristics of the participants for measuring Achilles 
tendon stiffness intra-rater reliability for the JHS and the control groups. 
Demographic 
characteristics 
JHS group  
n =10 
Control group  
n = 10 
Mean SD Mean SD 
Age (years) 40.40 14.02 35.30 11.00 
BMI 27.42 6.35 25.34 2.79 
Height (cm)  165.90 7.79 162.97 6.70 
Weight (kg) 75.63 18.77 67.18 8.38 
Beighton score 6.60 1.50 1.40 0.84 
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The results indicated excellent intra-rater reliability for assessing plantar flexor 
strength and muscle-tendon unit stiffness, ICC ranging from 0.981 - 0.999, for the JHS 
and the control group (Table 5.2 and 5.3). Additionally, the results showed that there 
were no significant differences between the measurements at trial 1 compared to trial 2; p 
≥ 0.05, for the plantar flexors strength and Achilles tendon stiffness. However, a 
significant difference was noticed at Achilles tendon stiffness when measuring the JHS 
group at trial one when compared to trial two; p = 0.03. This difference was not reported 
when measuring the Achilles tendon stiffness in the control group; p = 0.59. 
Table 5.2: Plantar flexors strength and Achilles tendon stiffness measured at trial 1, and 
trial 2 for the intra-rater reliability study: means (standard deviations) (SD), 
comparisons and ICCs for assessing ten participants from the JHS group. * indicates 
excellent correlation. 
 Mean ± SD 
(trial 1) 
Mean ± SD 
(trial 2) 
Mean 
difference 
p-
value 
ICC 
Plantar flexors 
strength (N) 
193.16 ± 73.83 192.49 ± 71.39 0.67 ± 2.44 0.82 0.996* 
Achilles tendon 
stiffness (N/mm) 
17.48 ± 6.36 16.10 ± 6.40 1.38 ± 0.04 0.03 0.981* 
 
Table 5.3: Plantar flexors strength and Achilles tendon stiffness measured at trial 1, and 
trial 2 for the intra-rater reliability study: means (standard deviations)/(SD), 
comparisons and ICCs for assessing ten participants from the control group. * indicates 
excellent correlation.  
 Mean ± SD 
(trial 1) 
Mean ± SD 
(trial 2) 
Mean 
difference 
p-
value 
ICC 
Plantar flexors 
strength (N) 
246.23 ± 127.26 248.99 ± 130.30 2.76 ± 3.04  0.29 0.999* 
Achilles tendon 
stiffness (N/mm) 
21.02 ± 6.30 20.62 ± 7.18 0.4 ± 0.88 0.59 0.984* 
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5.3.3 The Results of the intra-rater reliability study of measuring gait 
kinematics by re-applying the Qualisys markers and repeating the 
walking test: 
Ten women from the control group participated in this intra-rater reliability study 
to assess the consistency of joint kinematics measured during walking with the Qualisys 
system. Table 5.4 presents the demographic characteristics of the participants in this 
intra-rater reliability study. Intra-class correlation coefficients (ICC) were operated to 
assess the consistency of the data including maximum and minimum kinematics 
throughout the gait cycle: stance and swing phases. Paired sample t-tests were used to 
compare the kinematic parameters measured at test one with test two. The results 
illustrated good to excellent intra-rater reliability for assessing the gait kinematics; pelvis, 
hip, knee and ankle joints, and in the three planes of movement: sagittal, frontal and 
transverse planes, ICCs ranging from 0.625 - 0.996 (Table 5.4). Table 5.4 presents and 
summarises the range of values from Table 5.5 and 5.6. Table 5.5 and 5.6 compared the 
participants’ performance at trial 1 with trial 2, indicating that there were no significant 
differences between gait kinematics measured at trial one and trial two; p ≥ 0.05. 
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Table 5.4: The demographic characteristics and intra-rater reliability for assessing the 
three-dimensional gait kinematics for ten women from the control group. 
Demographic characteristics Mean ± standard deviation 
Age (years) 36.6 ± 10.6 
BMI 24.60 ± 2.06 
Height (cm) 162.41 ± 8.00 
Weight (kg) 64.77 ± 7.15 
Kinematic parameter Intra-rater reliability 
Pelvic tilt 0.976 - 0.993 
Pelvic obliquity 0.778 - 0.924 
Pelvic rotation 0.713 - 0.897 
Hip flexion/extension 0.773 - 0.961 
Hip abduction/add 0.855 - 0.996 
Hip internal/ external rotation 0.845 - 0.940 
Knee flexion/extension 0.691 - 0.853 
Knee valgus/valgus 0.625 - 0.954 
Ankle dorsi/planter flexion 0.692 - 0.954 
Foot progression 0.692 - 0.920 
Ankle internal/external rotation 0.671 - 0.889 
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Table 5.5: Gait kinematics parameters for the right side measured at trial 1, and 2; 
means, standard deviation (SD), comparisons and intra-class correlation coefficients for 
10 participants from the control group during the stance phase. 
Kinematics parameters Mean ± SD (trial 1) Mean ± SD (trial 2) P-value ICC 
Maximum kinematics during stance phase 
Pelvic tilt 4.20 ± 4.28 4.31 ± 4.16 0.62 0.993 
Pelvic obliquity  3.10 ± 1.08 3.27 ± 1.05 0.50 0.853 
Pelvic rotation 7.22 ± 2.58 7.34 ± 2.55 0.50 0.736 
Hip flexion/extension 26.54 ± 4.18 26.84 ± 4.47 0.55 0.773 
Hip abduction/adduction 10.56 ± 4.06 10.57 ± 4.08 0.90 0.958 
Hip internal/external rotation 8.66 ± 6.95 7.26 ± 6.20 0.25 0.919 
Knee flexion/extension 35.10 ± 6.48 35.05 ± 5.70 0.45 0.853 
Knee valgus/varus 5.11 ± 3.20 5.67 ± 3.62 0.32 0.935 
Ankle dorsi/plantar flexion 8.35 ± 2.39 9.03 ± 4.34 0.38 0.692 
Foot progression 9.63 ± 4.22 8.52 ± 4.23 0.16 0.920 
Ankle internal/external rotation 9.72 ± 4.03 9.56 ± 4.53 0.85 0.671 
Minimum kinematics during stance phase 
Pelvic tilt 1.76 ± 4.10 1.68 ± 3.94 0.77 0.988 
Pelvic obliquity -5.66 ± 1.71 -5.69 ± 1.90 0.94 0.917 
Pelvic rotation -7.38 ± 1.96 -7.44 ± 1.81 0.52 0.787 
Hip flexion/extension -14.81 ± 5.83 -14.29 ± 6.10 0.54 0.951 
Hip abduction/adduction -2.08 ± 2.58 -2.40 ± 2.83 0.45 0.939 
Hip internal/external rotation -5.40 ± 4.63 -6.36 ± 4.69 0.40 0.845 
Knee flexion/extension 0.23 ± 3.61 0.05 ± 4.48 0.36 0.752 
Knee valgus/varus -0.31 ± 2.69 0.26 ± 3.07 0.17 0.954 
Ankle dorsi/plantar flexion -15.79 ± 5.49 -17.07 ± 6.59 0.17 0.945 
Foot progression -5.63 ± 1.89 -6.99 ± 2.57 0.72 0.692 
Ankle internal/external rotation -5.09 ± 1.90 -4.87 ± 2.22 0.72 0.702 
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Table 5.6: Gait kinematics parameters measured at trial 1, and 2; means ± standard 
deviation (SD), comparisons and intra-class correlation coefficients for ten participants 
from the control group during the swing phase.  
Kinematics parameters Mean ± SD (trial 1) Mean ± SD (trial 2) p-value ICC 
Maximum kinematics during swing phase 
Pelvic tilt 4.30 ± 4.10 4.24 ± 2.74 0.83 0.989 
Pelvic obliquity  4.76 ± 1.15 4.92 ± .87 0.70 0.778 
Pelvic rotation 7.57 ± 1.40 6.86 ± 2.09 0.13 0.713 
Hip flexion/extension 26.59 ± 4.14 26.33 ± 4.30 0.33 0.860 
Hip abduction/adduction 5.01 ± 3.40 4.38 ± 3.41 0.08 0.996 
Hip internal/external rotation 3.52 ± 5.23 1.10 ± 5.91 0.07 0.940 
Knee flexion/extension 60.29 ± 5.31 59.78 ± 4.93 0.13 0.769 
Knee valgus/varus 9.11 ± 2.71 9.53 ± 2.22 0.47 0.625 
Ankle dorsi/plantar flexion 1.46 ± 3.17 .82 ± 4.53 0.20 0.825 
Foot progression 11.15 ± 4.82 9.81 ± 4.70 0.17 0.902 
Ankle internal/external rotation 9.99 ± 4.94 9.57 ± 5.02 0.27 0.724 
Minimum kinematics during swing phase 
Pelvic tilt 2.03 ± 3.83 1.96 ± 3.41 0.83 0.976 
Pelvic obliquity -1.88 ± 1.32 -1.27 ± 1.27 0.09 0.924 
Pelvic rotation -5.14 ± 2.09 -5.03 ± 1.66 0.76 0.897 
Hip flexion/extension -6.17 ± 5.55 -6.13 ± 5.30 0.95 0.961 
Hip abduction/adduction -4.73 ± 2.09 -4.79 ± 2.33 0.90 0.855 
Hip internal/external rotation -7.72 ± 5.81 -8.73 ± 5.38 0.42 0.871 
Knee flexion/extension -3.37 ± 2.71 -3.64 ± 4.60 0.56 0.691 
Knee valgus/varus -.47 ± 2.84 .27 ± 2.71 0.07 0.951 
Ankle dorsi/plantar flexion -20.40 ± 7.03 -20.98± 8.17 0.58 0.954 
Foot progression 2.78 ± 4.55 2.1 ± 4.99 0.50 0.897 
Ankle internal/external rotation -2.94 ± 2.51 -3.39 ± 2.59 0.40 0.889 
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5.3.4 Conclusion: 
In general, this section has indicated that the intra-rater reliabilities of measuring 
the stiffness of the Achilles tendon and the plantar flexors strength are high. However, a 
significant difference has been noticed when assessing Achilles tendon stiffness in the 
JHS group in trial one when compared to trial two. This observation should be considered 
when interpreting the related findings from the primary comparison study. Participants 
from the intra-rater reliability study for measuring Achilles tendon stiffness were 
representative of the general cohort in the current study in terms of BMI, height and 
weight. However, they might not be representative of the general cohort in the current 
study in terms of age. Therefore, this issue should also be considered when interpreting 
the major related findings. Moreover, this section illustrated that the intra-rater reliability 
for assessing walking kinematics is good to excellent, with no significant differences 
between the measurements obtained in trial one when compared to trial two. 
  
5.4 Demographic data:  
The main demographic characteristics of the studied population will be explained 
in this section, which applies to the results related to VAS, SF-12, BIoH, plantar flexor 
strength and Achilles tendon stiffness (Figure 5.3). The other sections will have different 
demographic characteristics due to exclusion and the different required number of 
participants (Figure 5.3). Further details will be explained in the relevant sections. 
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Figure 5.3: Flow diagram for the number of participants of each stage at the research 
project. Reliability study I refers to re-examining muscle-tendon unit stiffness. Reliability 
study II refers to re-analysing gait kinematics. The data of two participants from the JHS 
group were excluded from the second part of the research: proprioception, gait and jump 
analysis, due to having Qualisys marker application error. The data from one participant 
from the control group were excluded due to having abnormal traces in the gait graphs, 
which has been referred to an old history of ankle fracture. Therefore, 62 participants 
were recruited instead of 60. Although the excluded number of participants were three, 
but only two extra participants were recruited because the largest sample size required 
for the second part of the study is 29 participants.   
 
Total number of 
participants (n = 62) 
VAS, SF-12, BIoH, 
strength, stiffness  
n = 62 
JHS Group 
n = 31 
Control group 
n = 31 
Excluded 
n = 2 
Reliability study I 
n = 10 
Excluded 
n = 1 
Reliability study I 
n = 10 
Proprioception, gait, 
and jump analysis 
n = 59 
JHS group 
n = 29 
Control group 
n = 30 
Feasibility 
sonoelastography 
n = 10 
Feasibility 
sonoelastography 
n = 10 
Reliability study II 
n = 10 
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The two groups, JHS and control group, included 62 participants; 31 participants 
in the JHS group and 31 participants in the control group. Nine participants from the JHS 
group were diagnosed with EDS-HT, and 22 participants were diagnosed with JHS. 
There were no significant differences between the two groups in terms of sex, age, body 
mass index (BMI), height and weight (Table 5.7). In contrast, significant difference was 
found in the Beighton score between the two groups (Table 5.7). As explained in section 
5.4 and Figure 5.3, the demographic characteristics in table 5.7 are related to the results 
of VAS, SF-12, BIoH, plantar flexor strength and Achilles tendon stiffness.  
Table 5.7: The demographic characteristics of studied population at the JHS and the 
control group; sex, age, BMI, height and weight.  
Demographic 
characteristics 
JHS group  
n = 31 
Control group  
n = 31 
p-
value 
Sex 29 women 2 men 29 women 2 men 1.00 
 Mean SD Mean SD  
Age (years) 38.52 14.14 39.06 12.43 0.87 
BMI 27.76 6.51 25.44 3.03 0.07 
Height (cm)  164.00 7.72 163.10 8.19 0.65 
Weight (kg) 74.80 18.44 67.72 10.31 0.27 
Beighton score 6.32 1.55 1.06 0.77 0.001* 
Keys: SD: standard deviation. BMI: body mass index. * indicates statistical significant difference.  
 
5.5  Pain quantification with Visual Analogue Scales: 
Pain intensities during rest and movement in the lower back, bilateral hips, knees 
and ankles were assessed using Visual Analogue Scales (VAS). A standard centimetre 
calibrated ruler was used to measure pain intensity from the VAS, which was then 
entered onto the SPSS sheet following the appointment. From the descriptive statistics, 
the greatest pain intensity was experienced in the lower back and hip joints by the JHS 
group. Similar pain intensities were experienced in the knee and ankle joints (Table 5.8). 
Pain intensities experienced by the JHS group during movement were higher when 
compared to pain intensity experienced during rest. Independent samples t-tests were 
used to compare the results between the two groups as the assumptions to operate the 
parametric t-test were met. The results showed that the JHS group had significantly 
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greater pain intensity during rest and movement in the back, bilateral hips, knees and 
ankles when compared to the control group p < 0.001 (Table 5.8). The SMDs were 
greater than 0.8, which suggested a large difference between the groups and that might be 
indicative of large clinically important difference (Cohen, 1988; Walker, 2007). One-
sample t-tests were used to compare pain intensity during rest and movement, indicating 
a significant higher pain intensity during movement when compared to pain during rest 
for all the rested regions: p < 0.001. 
Table 5.8: Comparisons of the pain intensities during rest and movement experienced 
during the last week in the JHS and the control group. Pain intensity was measured on 
a scale from 0-10; 0 = no pain, and 10 = worst possible pain. 
Pain site 
 
JHS group 
n = 31 
Control group 
n = 31 
P value < SMD 95% CI 
Mean SD Mean SD 
During rest 
Lower back 4.15 2.58 0.45 1.32 0.001* 1.81 1.19, 2.37 
Right hip 3.54 2.85 0.06 0.32 0.001* 1.72 1.11, 2.27 
Left hip 3.36 2.82 0.00 0.03 0.001* 1.68 1.09, 2.24 
Right knee 2.62 2.51 0.09 0.38 0.001* 1.41 0.84, 1.95 
Left knee 2.48 2.37 0.06 0.32 0.001* 1.43 0.86, 1.97 
Right ankle 2.07 2.38 0.00 0.00 0.001* 1.23 0.67, 1.76 
Left ankle 1.84 2.10 0.00 0.00 0.001* 1.24 0.68, 1.77 
During movement 
Lower back 4.52 2.70 0.39 0.92 0.001* 2.05 1.41, 2.63 
Right hip 3.97 2.97 0.05 0.20 0.001* 1.86 1.25, 2.43 
Left hip 3.96 2.62 0.03 0.18 0.001* 1.97 1.34, 2.55 
Right knee 3.27 2.73 0.05 0.22 0.001* 1.66 1.07, 2.22 
Left knee 2.98 2.47 0.13 0.48 0.001* 1.60 1.01, 2.15 
Right ankle 2.89 2.61 0.00 0.00 0.001* 1.57 0.98, 2.11 
Left ankle 2.41 2.25 0.00 0.00 0.001* 1.51 0.93, 2.06 
Keys: SD: standard deviation, SMD: standardised mean difference, CI: confidence interval.  
* Indicates statistically significant difference. SMD of 0.2 and higher are highlighted in bold indicating 
clinically important differences. SMD of 0.2 suggests small clinically important difference, 0.5 suggests 
medium clinically important difference, and 0.8 suggests large clinically important difference (Cohen, 
1988). 
 
Sub-analysis was performed for pain intensity to identify the most commonly 
painful joint in the JHS group regarding the lower back and lower limb joints. The results 
showed that the lower back, the left hip during movement and the left knee during rest 
were the most commonly painful area in the JHS group (Table 5.9). It has been 
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demonstrated that 77.41% of the participants in the JHS group have pain in all the tested 
regions. The results of correlating pain with the gait parameters; spatiotemporal, 
kinematics and kinetics, will be presented in the gait sections 5.9.4 and 5.9.6. 
Table 5.9: A sub-analysis for the most common painful joint in the JHS group (n = 31) 
during rest and movement. Points of VAS were added up for each joint to identify pain 
frequency.    
Joint Commonly painful 
Rest Movement 
Lower back 93.54% 93.54% 
Right hip 83.87% 90.32% 
Left hip 83.87% 93.54% 
Right knee 90.32% 87.09% 
Left knee 93.54% 90.32% 
Right ankle 77.41% 90.32% 
Left ankle 80.64% 90.32% 
 
5.6 SF-12 for general health, physical activity level and participation: 
The Mann-Whitney U test was used for comparison as the Levene's test indicated 
that there was a significant difference for equality of variance between the two groups 
(Pallant, 2010). As shown in Table 5.10 the lowest score for the JHS group was for 
vitality and physical function out of the physical components. Mental health and social 
function were similarly the lowest scores from the psychological components. The JHS 
group scored significantly lower than the control group for the combined Physical 
Component Score (PCS), combined Mental Component Score (MCS) and for all the 
components; p < 0.05 (Table 5.10). The SMDs were greater than 0.8, which suggested a 
large difference between the groups and this might be indicative of large clinically 
important difference (Cohen, 1988; Walker, 2007).    
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Table 5.10: Comparisons for the SF-12 questionnaire scores for the JHS and the control 
groups. 
SF-12 
components 
JHS group  
n = 31 
Control group 
n = 31 
P value 
< 
SMD 95% CI 
Median IQR Median IQR 
Physical Component Score 
Physical function 37.09 27.28 97.58 7.51 0.001* -3.02 -3.71, - 2.26 
Role physical 41.12 24.62 97.17 6.21 0.001* -3.12 -3.82, -2.35 
Bodily pain 43.54 30.25 95.96 9.34 0.001* -2.33 -2.96, -0.1.67 
General health 53.70 31.41 85.64 11.95 0.001* -1.34 -1.88, -0.78 
Vitality  27.41 25.29 66.93 14.98 0.001* -1.90 -2.48, -1.28 
Physical 
Component Score 
(PCS) 
37.86 9.54 58.30 2.68 0.001* -2.92 -3.59, -2.17 
Mental Component Score 
Social function 53.22 29.39 91.93 14.98 0.001* -1.66 -2.21, 1.06 
Role emotional  67.74 27.72 89.91 15.94 0.001* -0.98 -1.49, -0.44 
Mental health 51.61 24.94 72.98 14.10 0.001* -1.05 -1.57, -0.51 
Mental 
Component Score 
(MCS) 
44.07 11.39 51.14 6.43 0.001* -0.76 -1.27, -0.24 
Keys: IQR: interquartile range, SMD: standardised mean difference, CI: confidence interval. 
* Indicates statistically significant difference. SMD of 0.2 and higher are highlighted in bold indicating clinically 
important differences. SMD of 0.2 suggests small clinically important difference, 0.5 suggests medium clinically 
important difference, and 0.8 suggests large clinically important difference (Cohen, 1988). 
 
The physical Component Score of SF-12 was correlated across both groups to 
pain at low-back, hip, knee and ankle joint experienced during rest and movement. The 
results indicated moderate to strong negative correlations between the Physical 
Component Score and pain during rest and movement, where the Pearson correlation 
coefficient ranged from r = -0.522 to -0.725 (Table 5.11) (Evans, 1996). The lowest 
correlation was reported for the hip joint and the highest correlation was reported for the 
knee joint (Table 5.11). Moreover, very weak to moderate negative correlations were 
identified between the Mental Component Score of the SF-12 questionnaire and pain at 
the low back and lower limb joints during rest and movement; r = -0.188 to -0.510 (Table 
5.11) (Evans, 1996). The lowest correlation was reported for the ankle joint and the 
highest correlation was reported for the low back (Table 5.11).  
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Table 5.11: The correlation between Physical and Mental Component Score of the SF-
12 with pain experienced during rest and movement at the lower back, hip, knee, and 
ankle joint (pain experienced at the right lower limb was used for analysis). 
Pain during rest 
Tested joint Correlation coefficient with 
Physical Component Score 
Correlation coefficient with Mental 
Component Score  
Low back -0.604* -0.467* 
Hip -0.522* -0.431* 
Knee -0.606* -0.286 
Ankle -0.572* -0.188 
Pain during movement 
Low back -0.683* -0.510* 
Hip -0.628* -0.432* 
Knee -0.725* -0.238 
Ankle -0.528* -0.311 
Keys: * Indicates moderate, strong or very strong correlation; r = 0.00-0.19 indicates very weak 
correlation, r = 0.2-0.39 indicates weak correlation, r = 0.40-0.59 indicates moderate correlation, r = 
0.6-0.79 indicates strong correlation, and r = 0.8-1.0 indicates very strong correlation (Evans, 1996). 
 
5.7 Bristol Impact of Hypermobility Questionnaire: 
From the JHS group, all 31 participants answered the BIoH questionnaire 
resulting in a score of 211.51 ± 39.28 (mean ± standard deviation). A high score equates 
to a higher impact of the condition, where the highest score that can be attained using this 
questionnaire is 360. In addition, the BIoH showed moderate to strong correlations to all 
components from the SF-12 questionnaire (Table 5.12). Large correlation was found 
between BIoH and the Physical Component Score (PCS) of the SF-12 questionnaire.  
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Table 5.12: The correlation of the Short Form health care questionnaire (SF-12) 
components with Bristol Impact of Hypermobility questionnaire (BIoH). 
BIOH SF-12 R 
Physical function -0.748* 
Role physical -0.615* 
Bodily pain -0.570* 
General health -0.346 
Vitality  -0.413* 
Physical Component Score (PCS) -0.658* 
Social function -0.622* 
Role emotional -0.344 
Mental health -0.315 
Mental Component Score (MCS) -0.260 
Keys: * Indicates moderate, strong or very strong correlation; r = 0.00-0.19 indicates very weak 
correlation, r = 0.2-0.39 indicates weak correlation, r = 0.40-0.59 indicates moderate correlation, r = 
0.6-0.79 indicates strong correlation, and r = 0.8-1.0 indicates very strong correlation (Evans, 1996). 
 
5.8 Plantar flexor strength and Achilles tendon stiffness: 
Mann-Whitney U tests were used to compare the plantar flexor strength and 
Achilles tendon stiffness between the two groups, as the data were not normally 
distributed. Independent sample t-test was used to compare muscle lengthening between 
the two groups as the assumptions to operate the parametric test were met (Field, 2009; 
Pallant, 2010). 
The results showed that plantar flexor strength was significantly weaker in the 
JHS group compared to the control group; p < 0.05, and the SMD was greater than 0.5, 
which suggested medium difference between the groups and that could be indicative of 
medium clinically important difference (Table 5.13) (Cohen, 1988; Walker, 2007). No 
significant difference was found in the muscle lengthening between the two groups; p > 
0.05. Achilles tendon stiffness was attained by dividing the plantar flexor strength (N) by 
muscle lengthening (mm) (Fukashiro et al. 1995; Rombaut et al. 2012). Achilles tendon 
stiffness was significantly lower in the JHS compared with the control group; p < 0.05, 
with small difference between the groups; SMD of - 0.32, which suggested small 
clinically important difference (Table 5.13). 
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Table 5.13: Comparisons of the plantar flexor strength, muscle lengthening and Achilles tendon 
stiffness measured for both the JHS and control groups. 
 JHS group 
n = 31 
Control group 
n = 31 
p-value SMD 95% CI 
Plantar flexor 
strength (N) 
143.33 (128.33) 210.33 (126.00) 0.01* ϻ -0.53 -1.03, - 0.01 
Muscle 
lengthening 
(mm) 
9.92 (3.68) 11.60 (3.38) 0.06 Ϯ -0.48 0.97, 0.04 
Achilles tendon 
Stiffness (N/mm) 
15.43 (9.45) 18.51 (9.75) 0.03* ϻ -0.32 -0.82, -.032 
Keys: Ϯ Values reported in mean (standard deviation) by independent t-test. ϻ Values reported in median 
(interquartile range) by Mann-Whitney U test. * Indicates Statistically significant difference. 
SMD: standardised mean difference, CI: confidence interval. SMD of 0.2 and higher are highlighted in bold 
indicating clinically important differences. SMD of 0.2 suggests small clinically important difference, 0.5 suggests 
medium clinically important difference, and 0.8 suggests large clinically important difference (Cohen, 1988). 
 
5.9 Three-dimensional analysis: 
5.9.1 Demographic characteristics: 
For this project, 62 participants were recruited and attended the laboratory for 
testing; however, the data from three participants were excluded from the three-
dimensional motion analysis studies; including squat/proprioception test, gait and jump. 
Two participants from the JHS group and one participant from the control group were 
excluded due to the following reasons: 
• Labelling of the medial femoral epicondyles markers, right and left, was 
compromised, as they were fused when visualised in the static calibration trial 
in QTM. This error made it impossible to analyse the dynamic data (n = 2 JHS 
group). 
• A participant from the control group had a history of a left ankle fracture more 
than one year ago, and although the study criteria excluded people with a 
fracture in the past one year or less, after assessing this participant’s gait 
graphs, an abnormal gait pattern was obvious on the side of the fracture (n = 1 
control group).  
 177 
 
Fifty-nine participants were included in the squat/proprioception, three-
dimensional gait analysis, jump analysis study and lower-limb stiffness measured with 
the jump test; 29 patients diagnosed with JHS/EDS-HT, and 30 healthy sex and age 
matched controls. There were no significant differences between the two groups in terms 
of sex, age, body mass index (BMI), height and weight (Table 5.14). In contrast, 
significant difference was found in the Beighton score between the two groups. Table 
5.14 reports the demographic characteristics. 
Table 5.14: The demographic characteristics of the JHS and the control group who 
participated in the gait analysis, measuring lower limb stiffness and vertical jump 
analysis studies. 
Demographic 
characteristics 
JHS group  
n = 29 
Control group  
n = 30 
p-value 
Sex 27 women 2 men 28 women 2 men 0.94 
 Mean SD Mean SD p- value 
Age (years) 37.57 13.77 39.27 12.59 0.62 
BMI 27.27 6.12 25.45 3.08 0.15 
Height (cm)  164.45 7.89 162.73 8.07 0.41 
Weight (kg) 73.84 17.44 67.44 10.36 0.29 
Beighton score 6.24 1.57 1.10 0.75 0.001* 
Keys: SD: standard deviation. BMI: body mass index. * Indicates statistical significant difference. 
 
5.9.2 Proprioception test: 
Proprioception integrity was examined at three knee flexion angles: 200, 250 and 
300, bilaterally. The mean absolute error of the three angles together was calculated and 
compared at the dominant and non-dominant knee. The results demonstrated that there 
were no significant differences between the JHS and the control group in the dominant 
knee proprioception measured at target angle 1 (200 of knee flexion); target angle 2 (250 
of knee flexion), and target angle 3 (300 of knee flexion) p ≥ 0.05 (Table 5.15). 
Additionally, there were no significant differences in the mean combined absolute error 
at the dominant knee.  
For the non-dominant knee proprioception, no significant difference was found at 
target angle 1. In contrast, a significantly greater absolute error was revealed in the non-
dominant knee at target angles 2 and 3, with medium difference between the groups 
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which might be indicative of medium clinically important difference; SMDs > 0.5 (see 
Table 5.16). There were no significant differences in the mean combined absolute error at 
the non-dominant knee.  
Table 5.15: The proprioception test scores for the dominant knee for the JHS and control 
group. Absolute error refers to the proprioception integrity attained by subtracting the 
estimated angle from the target angle. (target angle 1; smallest angle ≈ 200 of knee flexion, 
target angle 2; intermittent angle ≈ 250 of knee flexion, target angle 3; largest angle ≈ 300 of 
knee flexion).  
Absolute error JHS group 
n = 29 
Control group 
n = 30 
p-
value 
SMD 95% CI 
Median IQR Median IQR 
Target angle 1  2.320 3.670 1.940 4.360 0.85 0.09 -0.42, 0.60 
Target angle 2  2.240 3.200 1.480 2.590 0.38 0.26 -0.25, 0.77 
Target angle 3 3.630 4.590 3.150 3.630 0.60 0.12 -0.40, 0.63 
Mean absolute error 2.840 3.180 2.640 4.370 0.57 0.05 -0.46, 0.56 
Keys: IQR: interquartile range, SMD: standardised mean difference, CI: confidence interval. 
* Indicates statistically significant difference. SMD of 0.2 and higher are highlighted in bold indicating clinically 
important differences. SMD of 0.2 indicates small clinically important difference, 0.5 indicates medium clinically 
important difference, and 0.8 indicates large clinically important difference (Cohen, 1988). 
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Table 5.16: The proprioception test scores of the non-dominant knee for the JHS and control 
group. Absolute error refers to the proprioception integrity attained by subtracting the 
estimated angle from the target angle. (target angle 1; smallest angle ≈ 200 of knee flexion, 
target angle 2; intermittent angle ≈ 250 of knee flexion, target angle 3; largest angle ≈ 300 of 
knee flexion). 
Absolute error JHS group 
n = 29 
Control group 
n = 30 
p-
value 
SMD 95% CI 
Median IQR Median IQR 
Target angle 1 1.560 3.980 2.250 3.560 0.35 -0.18 -0.69, 0.33 
Target angle 2 2.820 2.400 1.260 2.420 0.00* 0.65 0.12, 1.16 
Target angle 3 3.590 3.620 1.610 2.760 0.01* 0.62 0.09, 1.13 
Mean absolute 
error 
2.700 2.500 2.420 1.660 0.052 0.13 -0.38, 0.64 
Keys: IQR: interquartile range, SMD: standardised mean difference, CI: confidence interval. * Indicates 
statistically significant difference. SMD of 0.2 and higher are highlighted in bold indicating clinically important 
differences. SMD of 0.2 suggests small clinically important difference, 0.5 suggests medium clinically important 
difference, and 0.8 suggests large clinically important difference (Cohen, 1988). 
 
           5.9.3 Gait spatiotemporal parameters: 
Independent sample t-tests and Mann-Whitney U tests were used according to the 
met assumptions, which were confirmed using Levene’s and Shapiro-Wilk tests (Field, 
2009; Pallant, 2010). The results revealed that the JHS group walked with a significantly 
reduced speed when compared to the control group; p ≤ 0.05, and the SMD was greater 
than 0.8 and this suggested a large clinically important difference (Cohen, 1988; Walker, 
2007) (Table 5.17). In terms of spatial parameters, the results indicated that the JHS 
group had significantly shorter stride length, and step length bilaterally when compared 
to the control group; p ≤ 0.05, with medium to large SMD; ranged from –0.52 to -1.01 
(Table 5.17). Regarding the temporal parameters, the results evidenced that the 
percentage of stance time duration was significantly longer, bilateral stance times were 
significantly longer in the JHS group when compared to the control group; p ≤ 0.05, and 
the SMDs ranged from -0.22 to 0.64 and this suggested small to medium clinically 
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important differences (Table 5.17). The percentage of double support time, the 
percentage of right initial double support time, and right terminal double support time 
showed significantly greater values in the JHS group when compared with the control 
group; p ≤ 0.05, and the SMDs ranged from -0.22 to 0.80 and this suggested small to 
large clinically important differences (Table 5.17). In contrast, comparable values were 
displayed for the cycle time, and right and left swing times between the two groups. 
Table 5.17 shows the values of the spatiotemporal parameters for the JHS and control 
groups. 
Table 5.17: The descriptive statistics and comparisons of gait spatiotemporal parameters of the 
JHS and the control group. 
Spatiotemporal 
Parameters 
JHS group 
n = 29 
Control group 
n = 30 
p-value SMD 95% CI 
Speed (m/s) 1.14 (0.23) 1.33 (0.16) 0.001*Ϯ -0.96 -1.49, -0.41 
Spatial parameters 
Stride length (m) 1.22 (0.22) 1.32 (0.16) 0.000*ϻ -0.52 -1.03, 0.00 
Right step length (m) 0.616 (0.07) 0.673 (0.06) 0.004*Ϯ -0.88 -1.40, -0.33 
Left step length (m) 0.610 (0.07) 0.671 (0.05) 0.001*Ϯ -1.01 -1.53, -0.45 
Temporal parameters 
Cycle time (s) 1.06 (0.10) 1.03 (0.11) 0.101ϻ 0.29 -0.23, 0.79 
Stance time duration % 60.30 (2.88) 58.71 (2.03)  0.018*Ϯ 0.64 -0.11, 1.15 
Right stance time (s) 0.64 (0.08) 0.60 (0.07)  0.007*ϻ 0.53 0.01, 1.04 
Left stance time (s) 0.64 (0.08) 0.60 (0.06)  0.003*ϻ 0.57 0.04, 1.08 
Right swing time (s) 0.42 (0.04) 0.43 (0.05)  0.975ϻ -0.22 -0.73, 0.29 
Left swing time (s) 0.42 (0.05) 0.43 (0.04)  0.554ϻ -0.22 -0.73, 0.29 
Double support time % 20.49 (3.26) 18.09 (4.97)  0.034*Ϯ -0.22 -0.73, 0.29 
Right initial double 
support time % 
10.64 (3.29) 8.55 (1.63)  0.001*ϻ 0.56 -0.07, 0.29 
Right terminal double 
limb support time % 
10.16 (2.61) 8.43(1.69)  0.002*ϻ 0.80 0.27, 1.33 
Keys: Ϯ Values reported in mean (standard deviation) by independent t-test. ϻ Values reported in median 
(interquartile range) by Mann-Whitney U test. * Indicates statistically significant difference. 
SMD: standardised mean difference, CI: confidence interval. SMD of 0.2 and higher are highlighted in bold 
indicating clinically important differences. SMD of 0.2 suggests small clinically important difference, 0.5 suggests 
medium clinically important difference, and 0.8 suggests large clinically important difference (Cohen, 1988). 
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5.9.4 Gait spatiotemporal parameters’ correlation to pain and power 
measures: 
The spatiotemporal parameters were correlated to pain measured using VAS, and 
power generation and absorption during walking. These correlations were examined to 
possibly justify the significant differences highlighted by the JHS group’s spatiotemporal 
parameters. Pearson Product Correlation Coefficient was used for the analysis, as the 
assumptions for operating this test were met. The results showed moderate to strong 
correlations between walking speed and power generation in the hip, knee and ankle 
joints (Table 5.18). Moderate correlations were highlighted between walking speed and 
power absorption in the knee joint (Table 5.18). Very weak to weak correlations were 
identified between the stride length, pain and power generation and absorption (Table 
5.18). Moderate correlations were illustrated between the percentage of stance duration 
and pain in the hip and ankle joints (Table 5.18). In contrast, no significant correlations 
were found between the percentage of double support time (DST) with pain and power 
absorption and generation in the hip, knee, and ankle joints bilaterally. Therefore, these 
correlations have not been displayed in Table 5.18. Thirteen spatiotemporal parameters 
were explored in the current study, therefore correlating all the spatiotemporal parameters 
to pain measures (seven variables); power generation (six variables), and power 
absorption (six measures) was lengthy. Thus, the basic spatiotemporal parameters were 
only used to establish their correlations to pain and power measures. In addition, the 
observed stride length very weak to weak correlations to pain and power could be applied 
to the other spatial data. Similarly, the moderate correlation between the percentage of 
stance duration with pain could explain the differences in other temporal data such as 
bilateral swing and stance times. No correlation was found between the percentage of 
DST with pain and power measures, which could also support the right initial and 
terminal double support time and percentages 
 
 
 
 182 
 
Table 5.18: Correlation of gait spatiotemporal parameters with pain measured using 
visual analogue scales during the last week during movement, and gait power generation 
and absorption. 
Spatiotemporal 
parameter 
Correlation 
with pain 
Results Correlation with 
power generation 
Results 
Right Left Right Left 
Speed Low back -0.336 Hip 0.608* 0.482* 
Hip -0.335 -0.275 Knee 0.464* 0.462* 
Knee -0.362 -0.167 Ankle 0.548* 0.475* 
Ankle -0.239 -0.166 Correlation with power absorption 
Hip -0.255 -0.291 
Knee -0.513* -0.459* 
Ankle 0.045 0.252 
Stride length Low back 
 
-0.368 Correlation with power generation 
Hip 0.272 0.071 
Hip -0.333 -0.315 Knee 0.290 0.208 
Knee -0.371 -0.339 Ankle 0.360 0.355 
Ankle -0.295 -0.285 Correlation with power absorption 
Hip -0.065 -0.142 
Knee 0.235 -0.279 
Ankle 0.113 -0.261 
Stance duration 
percentage 
Low back 0.293 Correlation with power generation 
Hip 0.436* 0.301 Hip 0.259 -0.138 
Knee 0.283 0.180 Knee -0.174 -0.174 
Ankle 0.446* 0.311 Ankle -0.250 -0.317 
Correlation with power absorption 
Hip 0.211 0.192 
Knee 0.130 0.036 
Ankle -0.126 -0.029 
Keys: * Indicates moderate, strong or very strong correlation; r = 0.00-0.19 indicates very weak correlation, 
r = 0.2-0.39 indicates weak correlation, r = 0.40-0.59 indicates moderate correlation, r = 0.6-0.79 indicates 
strong correlation, and r = 0.8-1.0 indicates very strong correlation (Evans, 1996).  
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5.9.5 Three-dimensional kinematic gait analysis: 
• Introduction: 
 The gait kinematics of the JHS group compared to the control group was analysed 
and viewed from two perspectives. First, curve graphs were constructed for specified 
visual inspection of kinematic features throughout the gait cycle to compare the JHS 
group with the control group. The kinematic data of 29 patients with JHS and 30 sex and 
age matched controls were used to build the curve graphs. Kinematic curve graphs for the 
pelvis, hip, knee and ankle joints bilaterally were observed and analysed. Various 
differences were identified between the two groups and have been presented for each 
joint separately (Figure 5.4, 5.5, 5.6 and 5.7). Second, the descriptive statistics (means 
and standard deviations/ medians and interquartile ranges) and statistical comparisons 
were contemplated to confirm the kinematic features in the JHS group’s gait patterns. 
Specifically, the curve graphs provide visual indications of the kinematic features in the 
JHS group’s gait. However, in order to quantify the features identified, descriptive 
statistics and interferential analysis were also used. In the following sections, maximum 
and minimum gait kinematics were calculated for the JHS group and the control group 
during stance and swing phases, as well as at initial contact for each joint separately. The 
curve graphs were constructed using means and standard deviations. A difference ≥ 20 
between the two groups in gait kinematics was considered as a trend, where a difference 
of < 20 could be due to intra-session variability for the three planes of movement (Bates, 
McGregor and Alexander, 2016b). Finally, gait ground reaction force was analysed using 
a curve graph and statistical analysis.  
• Pelvis gait kinematics; curve graphs, descriptive statistics and interferential 
analysis:  
Various differences can be noticed in the pelvis curve graphs of the JHS group 
when compared to the control group. Figure 5.4 highlights the observed differences. 
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Pelvis kinematics during gait cycle 
 JHS group (n = 29) 
 (blue:  right side, red:  left side) 
Control group (n = 30) 
Sagittal plane 
 
  
Frontal plane 
  
Transverse plane 
  
Figure 5.4: Curve graphs showing the kinematics of the pelvis during the gait cycle in sagittal, frontal 
and transverse planes for the JHS and control groups. The solid line displays the mean and the semi-
transparent line displays the standard deviation. Observed differences were highlighted with red 
circles/ovals. In the sagittal plane, the curve was higher throughout the gait cycle, indicating 
increased anterior pelvis tilt in the JHS group. In the frontal plane, the first peak during the initial to 
mid-stance phase was reduced in the JHS group, indicating decreased upward pelvis obliquity in the 
JHS group. In the same sagittal plane, a smaller peak was also observed in the JHS group at initial to 
mid-swing phase, indicating reduced pelvis downward obliquity in the JHS group. In the transverse 
plane, the curve was reduced in the mid-stance in the JHS group, indicating reduced pelvis internal 
rotation in the JHS group. A slightly smaller curve was also observed in terminal stance phase in the 
JHS group, illustrating a reduced pelvis external rotation when compared to the control group. 
 
The pelvis gait graphs show that the JHS group walked with increased anterior 
pelvis tilt throughout the gait cycle (Figure 5.4). Similarly, the descriptive statistics show 
an increase in anterior pelvis tilt during the stance, swing and initial contact phases in the 
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JHS group when compared to the control group (Table 5.19). Although there is a trend 
towards increased anterior pelvis tilt, the difference between the two groups is < 20, 
which is not statistically significant, and the SMD suggests only a small difference; SMD 
≥ 0.2 and < 0.5 (Table 5.19) (Cohen, 1988).  
The curve graphs show that the JHS group walked with reduced pelvis upward 
obliquity during the stance phase and reduced pelvis downward obliquity during the 
swing phase (Figure 5.4). Statistical significant reduction in pelvis obliquity was found in 
the JHS group when compared to the control group during the swing phase, and the SMD 
suggests a medium clinically important difference between the groups; SMD ≥ 0.5 and < 
0.8 (Table 5.19) (Cohen, 1988). Table 5.19 shows that pelvis upward obliquity; 
maximum kinematics (stance phase), was reduced in the JHS group, but this observation 
was neither statistically significant, nor a clear trend; difference < 20, and SMD suggests 
a small difference; SMD ≥ 0.2 and < 0.5 (Cohen, 1988).  
The pelvis curve graphs highlight reductions in the internal and external rotation 
of the pelvis during the stance phase (Figure 5.4). Similarly, Table 5.19 shows a trend 
toward a reduction in internal pelvis rotation in the JHS group during the stance phase; 
difference ≥ 20 and the SMD suggests a small clinically important difference; SMD ≥ 0.2 
and < 0.5 (Cohen, 1988). Minimal difference has been noted between the two groups in 
pelvis external rotation; minimal kinematics (stance phase) (Table 5.19).   
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• Hip gait kinematics; curve graphs, descriptive statistics and 
interferential analysis:  
Various differences have been highlighted in the hip curve graphs of the JHS 
group when compared to the control group. Figure 5.5 illustrates the differences 
observed. 
 
 
Table 5.19: Gait kinematics for the pelvis during the stance, swing and initial contact (IC) 
phases for the JHS and control group. 
Kinematic 
parameters 
(degrees) 
JHS group 
n= 29 
Control 
group 
n = 30 
p-value SMD 95% CI 
Maximum kinematics (Stance phase) 
Pelvic tilt 8.46 (5.45) 6.97 (5.53) 0.30Ϯ 0.27 -0.24, 0.78 
Pelvic obliquity  2.92 (2.04) 3.52 (2.02) 0.26Ϯ -0.30 -0.80, 0.22 
Pelvic rotation 5.11 (5.42) 7.53 (4.81) 0.37ϻ** -0.47 -0.98, 0.05 
Maximum kinematics (Swing phase) 
Pelvic tilt 8.14 (4.98) 6.97 (5.39) 0.39Ϯ 0.23 -0.29, 0.73 
Pelvic obliquity 3.62 (2.28) 4.88 (2.13) 0.03Ϯ* -0.57 -1.08, -0.04 
Pelvic rotation 5.42 (6.64) 7.02 (3.76) 0.28ϻ -0.3 -.08, 0.22 
Minimum Kinematics (Stance phase) 
Pelvic tilt 4.88 (5.16) 4.15 (5.12) 0.59Ϯ 0.14 -0.37, 0.65 
Pelvic obliquity -3.96 (2.27) -4.99 (2.01) 0.07Ϯ 0.48 -0.04, 0.99 
Pelvic rotation -6.48 (2.68) -6.78 (3.23) 0.70Ϯ 0.10 -0.41, 0.61 
Minimum kinematics (swing phase) 
Pelvic tilt 5.20 (4.93) 4.26 (5.10) 0.47Ϯ 0.19 -0.33, 0.70 
Pelvic obliquity -1.98 (1.60) -1.77 (1.95) 0.65Ϯ -0.12 -0.63, 0.39 
Pelvic rotation -4.59 (2.79) -4.61 (3.02) 0.98Ϯ 0.01 -0.50, 0.52 
Kinematics (IC) 
Pelvic tilt 6.72 (5.21) 5.86 (5.44) 0.53Ϯ 0.16 -0.35, 0.67 
Pelvic obliquity -0.69 (1.71) -0.04 (1.85) 0.17Ϯ -0.36 -0.87, 0.15 
Pelvic rotation 5.76 (4.51) 6.79 (3.42) 0.32Ϯ -0.26 -0.77, 0.26 
Keys: Ϯ Values reported in mean (standard deviation) by independent t-test. ϻ Values reported in median 
(interquartile range) by Mann-Whitney U test. * Indicates statistically significant difference. ** Indicates 
trend; difference ≥ 20. SMD: standardised mean difference, CI: confidence interval. SMD of 0.2 and higher 
are highlighted in bold suggesting clinically important differences. SMD of 0.2 suggests small clinically 
important difference, 0.5 suggests medium clinically important difference, and 0.8 suggests large clinically 
important difference (Cohen, 1988). 
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Hip kinematics during gait cycle 
 JHS group (n = 29) 
 (blue: right side, red: left side) 
Control group (n = 30) 
Sagittal 
plane 
  
Frontal 
plane 
  
Transverse 
plane 
  
Figure 5.5: Curve graphs showing the kinematics of the hip joint during the gait cycle at 
sagittal, frontal and transverse planes for the JHS and control groups. The solid line 
displays the mean and the semi-transparent line displays the standard deviation. Observed 
differences were highlighted with red circles/ovals. In the sagittal plane the peak observed 
during the terminal stance phase was reduced in the JHS group when compared with the 
control group, pointing out a reduced hip extension in the JHS group during the terminal 
stance phase. In the frontal plane, at initial contact the JHS group showed higher hip 
adduction than the control group. Additionally, the JHS group demonstrated differences 
between the right and left hips from the mid to terminal stance phase, where the left hip was 
more abducted than the right hip. In the same plane of movement, the JHS group illustrated 
reduced hip abduction at the initial swing phase when compared with the control group. In 
the transverse plane, the peak during the terminal stance phase was lower and flatter in the 
JHS group, illustrating a reduced hip internal rotation in the JHS group when compared to 
the control group. Additionally, the curve was higher in the JHS group during the mid to 
terminal-swing phase, revealing a reduced hip external rotation for the JHS group when 
compared to the control group.     
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Graphically, the JHS group walked with a reduction in hip extension, abduction, 
internal and external rotation at specific phases of the gait cycle, while hip adduction was 
increased at initial contact (Figure 5.5). Statistically, the data also reveals a trend toward 
reduced hip extension bilaterally during the stance phase; difference ≥ 20, for the JHS 
group, and the SMD suggests a small clinically important difference between the groups; 
SMD ≥ 0.2 and < 0.5 (Table 5.20) (Cohen, 1988). These trends can be observed during 
terminal stance, as shown in the gait graphs (Figure 5.5). Additionally, the descriptive 
statistics of maximum kinematics show a reduction in hip flexion bilaterally for the JHS 
group, but the right hip shows a trend toward reduction; difference ≥ 20, and the SMD 
suggests a small clinically important difference; SMD ≥ 0.2 and < 0.5 (Table 5.20) 
(Cohen, 1988). The descriptive statistics of minimum kinematics during the swing phase 
show that the JHS group walked with reduced hip extension bilaterally and the right hip 
showed a trend toward reduction; difference ≥ 20, and the SMS suggests a small clinically 
important difference; SMD ≥ 0.2 and < 0.5 (Table 5.20) (Cohen, 1988). 
 The curve graphs for the JHS group show an increase in hip adduction at initial 
contact, and this increase has been found to be statistically significant in the left hip with 
medium clinically important difference; SMD ≥ 0.5 and < 0.8 (Table 5.20) (Cohen, 
1988). The descriptive statistics of right hip adduction is also increased and the SMD 
suggests a small clinically important difference; SMD ≥ 0.2 and < 0.5 (Table 5.20) 
(Cohen, 1988). The curve graphs indicate that the JHS group walked with reduced hip 
abduction during the swing phase (Figure 5.5). Similarly, a statistically significant 
reduction has been identified in right hip abduction during the swing phase in the JHS 
group, and the SMD suggests a medium clinically important difference; SMD ≥ 0.5 and < 
0.8 (Figure 5.5, Table 5.20) (Cohen, 1988). Similarly, left hip abduction in the JHS group 
showed a trend toward reduction during the swing phase, and the SMD suggests a 
medium clinically important difference; SMD ≥ 0.5 and < 0.8 (Figure 5.5, Table 5.20) 
(Cohen, 1988). The JHS group showed a trend toward reduced left hip internal rotation 
during the stance phase, and the SMD suggests a small clinically important difference; 
SMD ≥ 0.2 and < 0.5 (Table 5.20) (Cohen, 1988). This trend can be observed in the 
kinematic gait graph for terminal stance (Figure 5.5). The graphical observation of 
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reduced hip external rotation in the JHS group during mid to terminal swing is not 
evidenced in Table 5.20. 
Table 5.20: Gait kinematics for the hip joint during the stance, swing and initial contact phases for 
the JHS and control group. (R: right, L: Left). 
Kinematic parameters 
(degrees) 
JHS group 
n= 29 
Control 
group 
n = 30 
p-value SM
D 
95% CI 
Maximum kinematics (stance phase) 
R hip flexion/extension 26.41 (6.83) 28.46 (6.45) 0.24Ϯ** -0.31 -0.82, 0.21 
R hip abduction/adduction 9.81 (3.88) 10.15 (3.67) 0.73Ϯ -0.09 -0.60, 0.42 
R hip internal/external rotation 6.75 (9.54) 6.92 (9.88) 0.52ϻ -0.02 -0.53, 0.49 
L hip flexion/extension 26.92 (6.96) 27.30 (7.80) 0.84Ϯ -0.05 -0.56, 0.46 
L hip abduction/adduction 9.18 (2.72) 9.54 (3.13) 0.64Ϯ -0.12 -0.63, 0.39 
L hip internal/external rotation 4.27 (6.35) 7.29 (5.99) 0.06Ϯ** -0.49 -1.00, 0.03 
Maximum kinematics (swing phase) 
R hip flexion/extension 27.42 (6.59) 28.77 (6.58) 0.43Ϯ -0.21 -0.71, 0.31 
R hip abduction/adduction 5.37 (4.71) 3.70 (3.23) 0.26ϻ 0.41 -0.11, 0.92 
R hip internal/external rotation 1.20 (6.81) 2.78 (5.25) 0.32Ϯ -0.26 -0.77, 0.26 
L hip flexion/extension 28.30 (6.97) 27.80 (8.24) 0.80Ϯ 0.07 -0.45, 0.58 
L hip abduction/adduction 5.04 (3.21) 4.35 (2.87) 0.38Ϯ 0.23 -0.29, 0.74 
L hip internal/external rotation 0.16 (5.57) 1.48 (6.93) 0.42Ϯ -0.21 -0.72, 0.31 
Minimum kinematics (stance phase) 
R hip flexion/extension -8.54 (7.91) -11.89 (7.81) 0.10Ϯ** 0.43 -0.10, 0.94 
R hip abduction/adduction -0.58 (3.81) -2.09 (3.42) 0.11Ϯ 0.42 -0.10, 0.93 
R hip internal/external rotation -6.86 (11.18) -7.74 (8.52) 0.98ϻ 0.09 -0.42, 0.60 
L hip flexion/extension -8.84 (8.06) -11.30 (6.72) 0.20Ϯ** 0.33 -0.19, 0.84 
L hip abduction/adduction -1.21 (3.26) -2.61 (2.58) 0.07Ϯ 0.48 -0.05, 0.99 
L hip internal/external rotation -7.45 (7.33) -7.11 (5.70) 0.84Ϯ -0.05 -0.56, 0.46 
Minimum kinematics (swing phase) 
R hip flexion/extension -1.71 (8.12) -4.61 (7.03) 0.14Ϯ** 0.38 -0.14, 0.89 
R hip abduction/adduction -2.91 (3.49) -4.73 (2.71) 0.02Ϯ* 0.58 0.06, 1.10 
R hip internal/external rotation -8.38 (7.09) -8.25 (5.66) 0.93Ϯ -0.02 -0.53, 0.49 
L hip flexion/extension  -2.25 (8.18) -4.23 (6.92) 0.31Ϯ 0.26 -0.25, 0.77 
L hip abduction/adduction -3.53 (5.79) -5.84 (2.77) 0.06ϻ** 0.51 -0.01, 1.02 
L hip internal/external rotation -9.71 (7.27) -9.03 (6.37) 0.70Ϯ -0.10 -0.61, 0.41 
Kinematics (IC) 
R hip flexion/extension 25.64 (6.84) 27.03 (7.12) 0.44Ϯ -0.20 -0.71, 0.32 
R hip abduction/adduction 2.81 (4.08) 1.45 (3.70) 0.18Ϯ 0.35 -0.17, 0.86 
R hip internal/external rotation -4.52 (10.48) -4.87 (9.22) 0.96ϻ 0.04 -0.48, 0.55 
L hip flexion/extension 24.86 (11.93) 26.74 (11.66) 0.58ϻ -0.22 -0.73, 0.29 
L hip abduction/adduction  3.10 (2.97) 1.37 (3.36) 0.04Ϯ* 0.54 0.02, 1.06 
L hip internal/external rotation  -5.14 (7.45) -5.40 (5.88) 0.88Ϯ 0.04 -0.47, 0.55 
Keys: Ϯ Values reported in mean (standard deviation) by independent t-test. ϻ Values reported in median (interquartile 
range) by Mann-Whitney U test. * Indicates statistically significant difference. ** Indicates trend; difference ≥ 20. 
SMD: standardised mean difference, CI: confidence interval. SMD of 0.2 and higher are highlighted in bold 
suggesting clinically important differences. SMD of 0.2 suggests small clinically important difference, 0.5 suggests 
medium clinically important difference, and 0.8 suggests large clinically important difference (Cohen, 1988). 
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• Knee gait kinematics; curve graphs, descriptive statistics and 
interferential analysis:  
Many observations can be noticed from the knee gait curve graphs of the JHS 
group when compared to the control group. Figure 5.6 summarises the differences 
observed. Knee kinematic in the transverse plane was not presented in the current study 
as its not clinically important variable and involves poor reliability (Stief et al. 2013; 
Pinzone et al. 2014). 
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Knee kinematics during gait cycle 
 JHS group (n = 29) 
 (blue: right side, red: left side) 
Control group (n = 30) 
Sagittal 
plane 
  
Frontal 
plane 
  
Figure 5.6: Curve graphs showing the kinematics of the knee joint during the gait cycle in 
sagittal and frontal planes for the JHS and control groups. The solid line displays the mean and 
the semi-transparent line displays the standard deviation. Differences were highlighted with red 
circles/ovals. In the sagittal plane, the first curve at loading response was lowered in the JHS 
group, indicating reduced knee flexion when compared with the control group. The second peak 
at the mid-stance phase was flatter and reduced in the JHS group, indicating reduced knee 
extension at mid-stance in the JHS group. The peak during the mid-swing phase was lower in 
the JHS group, indicating a reduction at knee flexion. In the frontal plane, knee valgus at initial 
contact was greater in the JHS group, and knee valgus curve remained higher in the JHS group 
throughout the gait cycle when compared to the control group. Additionally, for the same plane; 
frontal, the JHS group graphs exhibited asymmetrical curves between the right and left knee 
graphs at the initial to mid-swing phase, where the left knee curve is higher than the right knee 
curve, evidencing that the left knee was in a more valgus position than the right knee. 
 
The knee kinematic curve graphs illustrate various differences between the JHS 
and control group, yet no statistically significant differences have been identified between 
the two groups (Figure 5.6, Table 5.21). However, various observational differences, 
trends and clinically important differences have been raised. The kinematic curve graphs 
show that the JHS group walked with reduced knee flexion and extension during specific 
phases of the gait cycle (Figure 5.6). Similarly, the descriptive statistics for maximum 
kinematics during the swing phase illustrate that the knee flexion of the JHS group was 
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reduced bilaterally, and the SMD suggests a small clinically important difference 
bilaterally; SMD ≥ 0.2 and < 0.5 (Table 5.21) (Cohen, 1988). In particular, left knee 
flexion was trending toward a reduction in the JHS group during the swing phase; 
difference ≥ 20, and the SMD suggested small difference (Table 5.21). The descriptive 
statistics of minimum kinematics show that knee extension was also reduced in the JHS 
group during the stance phase, bilaterally, and the SMD for the right knee suggests a 
small clinically important difference (Table 5.21). The kinematics curve graphs showed 
that the JHS group walked with increased knee valgus throughout the gait cycle (Figure 
5.6). Similarly, the descriptive statistics on maximum kinematics during the stance phase 
show that the JHS group walked with increased knee valgus bilaterally, and the SMD 
suggests a small clinically important difference; SMD ≥ 0.2 and < 0.5 (Table 5.21) 
(Cohen, 1988). During the swing phase, the descriptive statistics of the maximum 
kinematics illustrate an increase in knee valgus, and the SMD of the left knee suggests a 
small clinically important difference (Table 5.21).  
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Table 5.21: Gait kinematics for the knee joint during the stance, swing and initial contact 
phases for the JHS and control group. (R: right, L: Left). 
Knee kinematic 
parameters 
(degrees) 
JHS group 
n = 29 
Control 
group 
n = 30 
p-value SMD 95% CI 
Maximum kinematics (stance phase) 
R knee flexion/extension 34.27 (7.76) 34.73 (7.04) 0.81Ϯ -0.06 -0.57, 0.45 
R knee valgus/varus 6.77 (3.73) 5.59 (3.17) 0.19Ϯ 0.34 -0.18, 0.85 
L knee flexion/extension 34.47 (6.88) 34.31 (6.40) 0.92Ϯ 0.02 -0.49, 0.53 
L knee valgus/varus 7.74 (7.22) 5.80 (4.12) 0.15ϻ 0.33 -0.19, 0.84 
Maximum kinematics (swing phase) 
R knee flexion/extension 56.42 (11.95) 58.29 (6.45) 0.05ϻ -0.20 -0.70, 0.32 
R knee valgus/varus 8.51 (3.23) 8.08 (3.30) 0.62Ϯ 0.13 -0.38, 0.64 
L knee flexion/extension 56.62 (8.52) 58.62 (9.79) 0.23ϻ** -0.22 -0.73, 0.30 
L knee valgus/varus 9.82 (3.12) 8.90 (4.11) 0.33Ϯ 0.25 -0.26, 0.76 
Minimum kinematics (stance phase) 
R knee flexion/extension 1.32 (4.34) 0.49 (3.62) 0.42Ϯ 0.21 -0.31, 0.72 
R knee valgus/varus 0.71 (3.70) 0.25 (3.05) 0.60Ϯ 0.14 -0.38, 0.15 
L knee flexion/extension 1.26 (5.76) 0.81 (6.10) 0.72ϻ 0.08 -0.44, 0.59 
L knee valgus/varus 1.53 (3.19) 0.02 (3.60) 0.09Ϯ 0.44 -0.08, 0.95 
Minimum kinematics (swing phase) 
R knee flexion/extension -1.94 (5.10) -2.62 (5.04) 0.60Ϯ 0.13 -0.38, 0.64 
R knee valgus/varus -0.71 (6.57) -0.48 (3.46) 0.86ϻ -0.04 -0.55, 0.47 
L knee flexion/extension -2.45 (4.97) -3.26 (5.49) 0.55Ϯ 0.15 -0.36, 0.66 
L knee valgus/varus 0.23 (3.15) -0.15 (4.19) 0.69Ϯ 0.10 -0.41, 0.61 
Kinematics (IC) 
R knee flexion/extension 3.77 (6.98) 3.60 (4.93) 0.90ϻ 0.03 -0.48, 0.54 
R knee valgus/varus 5.16 (4.17) 3.96 (3.21) 0.22Ϯ 0.32 -0.19, 0.83 
L knee flexion/extension 4.32 (5.08) 2.94 (4.52) 0.82ϻ 0.29 -0.23, 0.80 
L knee valgus/varus 5.50 (3.83) 4.48 (3.13) 0.27Ϯ 0.29 -0.22, 0.80 
Keys: Ϯ Values reported in mean (standard deviation) by independent t-test. ϻ Values reported in median 
(interquartile range) by Mann-Whitney U test. * Indicates statistically significant difference. ** Indicates trend; 
difference ≥ 20. SMD: standardised mean difference, CI: confidence interval. SMD of 0.2 and higher are 
highlighted in bold suggesting clinically important differences. SMD of 0.2 suggests small clinically important 
difference, 0.5 suggests medium clinically important difference, and 0.8 suggests large clinically important 
difference (Cohen, 1988). 
 
• Ankle gait kinematic; curve graphs, descriptive statistics and 
interferential analysis: 
Several differences can be noticed in the ankle curve graphs of the JHS group 
when compared to the control group. Figure 5.7 summarises the differences observed. 
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Visual 3D software was not programmed to produce frontal plane ankle curve graphs, so 
frontal plane curve graphs are not displayed.  
Ankle kinematics during gait cycle 
 JHS group (n = 29) 
 (blue: right side, red: left side) 
Control group (n = 30) 
Sagittal plane 
  
Transverse 
plane 
  
Figure 5.7: Curve graphs showing the kinematics of the ankle joint during the gait cycle in 
sagittal and transverse planes for the JHS and control groups. The solid lines display the mean 
and semi-transparent line displays the standard deviation. Differences were highlighted with 
red circles. In the sagittal plane, the peak curve at the initial swing phase was reduced in the 
JHS group, indicating a reduced ankle plantar flexion when compared with the control group. 
In the transverse plane, the right and left foot progression curves in the JHS group were 
asymmetrical during terminal stance to initial swing phase, indicating higher left foot internal 
progression. 
 
The ankle curve graphs show reduced ankle plantar flexion during the swing 
phase in the JHS group (Figure 5.7). The descriptive statistics for minimum kinematics 
during the swing phase illustrate a slight reduction in the JHS group’s ankle dorsiflexion, 
but this observation is not statistically significant or a trend; difference < 20, and SMD 
suggests no clinically important differences between the two groups (Table 5.22). The 
SMD suggests small clinically important differences between the two groups at certain 
kinematics during the swing and initial contact phase; SMD ≥ 0.2 and < 0.5 (Table 5.22). 
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Yet, no statistical differences or trends have been highlighted for ankle kinematics during 
walking (Table 5.22).  
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Table 5.22: Gait kinematics for the ankle joint during the stance, swing and initial contact phases for 
the JHS and control group. (R: right, L: Left). 
Ankle kinematic parameters 
(degrees) 
JHS group 
n = 29 
Control 
group 
n = 30 
p-value SMD 95% CI 
Maximum kinematics (stance phase) 
R ankle dorsi/plantar flexion 7.71 (5.92) 8.03 (4.20) 0.68ϻ -0.06 -0.57, 0.45 
R foot progression 8.23 (6.34) 7.58 (5.02) 0.66Ϯ 0.11 -0.40, 0.62 
R ankle internal/external rotation 9.00 (6.45) 9.52 (4.63) 0.72Ϯ -0.09 -0.60, 0.42 
L ankle dorsi/plantar flexion 8.93 (4.45) 9.32 (5.40) 0.64ϻ -0.08 -0.59, 0.43 
L foot progression 6.32 (2.81) 6.22 (3.51) 0.90Ϯ 0.03 -0.48, 0.54 
L ankle internal/external rotation 6.30 (4.03) 5.82 (4.35) 0.77ϻ 0.11 -0.40, 0.62 
Maximum kinematics (swing phase) 
R ankle dorsi/plantar flexion 1.62 (6.63) 1.04 (5.69) 0.44ϻ 0.09 -0.42, 0.60 
R foot progression 0.77 (6.68) 0.27 (5.38) 0.51Ϯ -0.17 -0.68, 0.34 
R ankle internal/external rotation 3.21 (5.23) 3.31 (4.69) 0.94Ϯ 0.02 -0.49, 0.53 
L ankle dorsi/plantar flexion 2.08 (5.90) 1.77 (3.66) 0.43ϻ 0.06 -0.45, 0.57 
L foot progression 2.21 (4.47) 1.27 (4.88) 0.44Ϯ 0.20 -0.31, 0.71 
L ankle internal/external rotation 4.13 (4.70) 3.15 (5.72) 0.50ϻ 0.19 -0.33, 0.70 
Minimum kinematics (stance phase) 
R ankle dorsi/plantar flexion -17.15 (8.62) -18.32 (8.13) 0.80ϻ 0.14 -0.37, 0.65 
R foot progression -6.49 (6.97) -5.42 (3.76) 0.71ϻ -0.19 -0.70, 0.32 
R ankle internal/external rotation -5.89 (5.51) -5.48 (4.15) 0.95ϻ -0.08 -0.59, 0.43 
L ankle dorsi/plantar flexion -15.87 (6.47) -16.18 (5.03) 0.83Ϯ 0.05 -0.46, 0.56 
L foot progression -6.44 (4.65) -6.98 (4.30) 0.64Ϯ 0.12 -0.39, 0.63 
L ankle internal/ external rotation -8.03 (4.93) -8.74 (9.96) 0.49ϻ 0.09 -0.42, 0.60 
Minimum kinematics (swing phase) 
R ankle dorsi/plantar flexion -22.34 (9.25) -22.67 (9.84) 0.90ϻ 0.03 -0.48, 0.54 
R foot progression -8.25 (5.95) -8.66 (5.24) 0.78Ϯ -0.07 -0.58, 0.44 
R ankle internal/external rotation -9.02 (5.63) -10.51 (6.28) 0.34Ϯ -0.25 -0.76, 0.27 
L ankle dorsi/plantar flexion -19.72 (5.76) -20.99 (9.68) 0.78ϻ 0.16 -0.35, 0.67 
L foot progression -7.05 (4.61) -6.88 (5.35) 0.89Ϯ -0.03 -0.54, 0.48 
L ankle internal/external rotation -9.21 (6.97) -9.93 (9.42) 0.70ϻ 0.09 -0.43, 0.60 
Kinematics (IC) 
R ankle dorsi/plantar flexion -4.43 (5.84) -3.17 (3.74) 0.25ϻ -0.26 -0.77, 0.26 
R foot progression -4.31 (5.46) -4.28 (5.21) 0.98Ϯ 0.01 -0.50, 0.52 
R ankle internal/external rotation -0.12 (4.68) 0.25 (3.58) 0.72Ϯ -0.09 -0.60, 0.42 
L ankle dorsi/plantar flexion -3.83 (7.21) -3.25 (4.02) 0.72ϻ -0.10 -0.61, 0.41 
L foot progression -3.01 (4.56) -3.34 (4.75) 0.78Ϯ 0.07 -0.44, 0.58 
L ankle internal/external rotation 0.94 (3.33) -0.55 (4.11) 0.13Ϯ 0.40 -0.12, 0.91 
Keys: Ϯ Values reported in mean (standard deviation) by independent t-test. ϻ Values reported in median (interquartile 
range) by Mann-Whitney U test. * Indicates statistically significant difference. ** Indicates trend; difference is ≥ 20. SMD: 
standardised mean difference, CI: confidence interval. SMD of 0.2 and higher are highlighted in bold suggesting clinically 
important differences. SMD of 0.2 suggests small clinically important difference, 0.5 suggests medium clinically important 
difference, and 0.8 suggests large clinically important difference (Cohen, 1988). 
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• Conclusion: 
In summary, the curve graphs indicate that gait kinematics were mostly reduced 
in the JHS group when compared to the control group. During the stance phase, the 
reductions are obvious in the following areas: 
- Pelvic upward obliquity at initial to mid-stance phase. 
- Knee flexion during loading response phase. 
- Pelvic internal rotation, and knee extension during mid-stance phase. 
- Pelvic external rotation, and hip extension and internal rotation during 
terminal stance phase. 
Similarly, during the swing phase, the following kinematic reductions were 
observed in the curve graphs of the JHS group: 
- Hip abduction and ankle plantar flexion during the initial swing phase. 
- Pelvic upward obliquity, hip external rotation and knee flexion during the 
mid-swing phase. 
-  Reduced hip external rotation during the terminal swing phase. 
In contrast, some kinematic parameters were increased, as shown in the JHS 
group’s curve gait graphs, including: 
- Pelvic anterior tilt throughout the gait cycle. 
- Hip adduction and knee valgus at initial contact. 
- Hip abduction at initial swing phase. 
- Knee valgus throughout the gait cycle. 
Statistically, the data from the JHS group indicate a statistically significant 
reduction in upward pelvis obliquity during the swing phase; p ≤ 0.05, and the SMD 
suggests a medium clinically important difference between the two groups. A statistically 
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significant reduction in the JHS group’s right hip abduction during the swing phase has 
been highlighted; p ≤ 0.05, and the SMD suggests a medium clinically important 
difference. At initial contact, a statistically significant increase in left hip adduction has 
been found for the JHS group; p ≤ 0.05, and the SMD suggests a medium clinically 
important difference. No other statistically significant differences have been revealed 
between the two groups. However, various trends have been noticed and supported by the 
SMD, where the SMDs suggest small to medium differences between the groups; SMDs 
ranged from -0.22 to 0.55 (Table 5.19, 5.20 and 5.21). A trend toward reductions in the 
JHS group gait kinematics during the stance phase has been highlighted for pelvic 
internal rotation, right hip flexion, left hip internal rotation and bilateral hip extension 
(Table 5.19, 5.20 and 5.21). A trend toward reductions in the JHS group’s gait kinematics 
during the swing phase has been identified for right hip extension, left hip abduction, and 
left knee flexion (Table 5.20 and 5.21).  
5.9.6 Pain correlation with gait kinematics: 
The results indicate that there were very weak to weak correlations between pain 
intensity experienced during movement and gait kinematics, which ranged from r = -
0.005 - 0.281 (Evans, 1996). 
5.9.7 Three-dimensional moment gait analysis: 
• Introduction: 
Gait moments acting at the hip, knee and ankle joints were analysed from two 
perspectives to provide a comprehensive analysis. First, moment gait graphs were 
produced to observe the differences between the two groups. The moment curve graphs 
have been analysed for the hip, knee and ankle joints (Figure 5.8, 5.9 and 5.10). Second, 
statistical analysis has been performed to explore the maximum and minimum moments 
(Table 5.23, 5.24 and 5.25). Various differences have been revealed between the two 
groups and will be discussed for each joint separately. A difference > 0.18 Nm/kg in 
moment data was considered as a trend, as the minimal detectable change in moment is ≤ 
0.18 Nm/kg (Fernandes et al. 2015). 
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▪ Hip moments; curve graphs, descriptive statistics and interferential 
analysis: 
The differences identified by the hip moment curve graphs for the JHS group 
when compared to the control group are illustrated in Figure 5.8 for the sagittal and 
frontal plane. A moment curve graph for the transverse plane has not been presented 
because the V3D software was not programmed to generate this graph. 
Hip moment during gait cycle 
 JHS group (n = 29) 
 (blue: right side, red: left side) 
Control group (n = 30) 
Sagittal plane 
  
Frontal plane 
  
Figure 5.8: Curve graphs showing the moments acting at the hip joint during the gait cycle in frontal 
and sagittal planes for the JHS and control group. The solid line illustrates the mean and the semi-
transparent line illustrates the standard deviation. Red ovals highlighted the differences between the 
two groups. In the sagittal plane, the first curve at the initial stance phase was reduced and flattened 
in the JHS group, indicating reduced hip flexors moment in the JHS group. Moreover, the flexors 
moment curve at the terminal stance phase was decreased in the JHS group when compared with the 
control group. In the frontal plane, hip adductors moment at the mid-stance phase was lower in the 
JHS group when compared to the control group.  
 
Figure 5.8 illustrates reductions in hip flexors’ and adductors’ moments in the 
JHS group. The statistical analysis of maximum moments indicates significant reductions 
in hip extensors’ moments bilaterally in the JHS group, and the SMD suggests a medium 
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clinically important difference between the groups; SMD ≥ 0.5 and < 0.8 (Table 5.23) 
(Cohen, 1988). The statistical analysis of the minimum moments highlights significant 
reductions in left hip flexors’ and adductors’ moments, as highlighted in Figure 6.8, and 
the SMD suggests a medium clinically important difference; SMD ≥ 0.5 and < 0.8 (Table 
5.23) (Cohen, 1988). A significant reduction in hip external rotators’ moment was 
identified in the JHS group and the SMD suggests a medium clinically important 
difference; SMD ≥ 0.5 and < 0.8 (Table 5.23). All the other descriptive statistics for the 
JHS group point toward reductions in hip moments, and the SMD suggests a small 
clinically important difference for the left hip abductors’ and internal rotators’ moments 
and right hip flexors’ moments (Table 5.23). However, none of these observations can be 
considered to be a trend.  
Table 5.23: Gait moment acting at the hip joint in the JHS and control group. (R: right, L: left). 
Moments parameters 
(Nm/kg) 
JHS group 
n = 29 
Control group 
n = 30 
p- 
value 
SMD 95% CI 
Maximum moment 
R hip flexion/extension 0.50 (0.20) 0.65 (0.22) 0.01Ϯ* -0.71 -1.23, -0.18 
R hip abduction/adduction 0.93 (0.30) 0.94 (0.18) 0.42ϻ -0.04 -0.55, 0.47 
R hip internal/external rotation 0.06 (0.05) 0.07 (0.07) 0.07ϻ -0.16 -0.67, 0.35 
L hip flexion/extension 0.52 (0.18) 0.68 (0.28) 0.00ϻ* -0.68 -1.19, -0.14 
L hip abduction/adduction 0.87 (0.29) 0.96 (0.20) 0.18ϻ -0.36 -0.87, 0.16 
L hip internal/external rotation 0.14 (0.15) 0.18 (0.14) 0.94ϻ -0.28 -0.78, 0.24 
Minimum moment 
R hip flexion/extension -0.57 (0.23) -0.66 (0.16) 0.09Ϯ 0.46 -0.07, 0.97 
R hip abduction/adduction -0.12 (0.11) -0.12 (0.07) 0.66ϻ 0.00 -0.51, 0.51 
R hip internal to external 
rotation 
-0.17 (0.17) -0.18 (0.15) 0.80ϻ 0.06 -0.45, 0.57 
L hip flexion/extension -0.57 (0.22) -0.70 (0.19) 0.01Ϯ* 0.63 0.10, 1.15 
L hip abduction/adduction -0.09 (0.09) -0.14 (0.06) 0.01ϻ* 0.66 0.12, 1.17 
L hip internal/external rotation -0.05 (0.04) -0.09 (0.06) 0.01ϻ* 0.78 0.24, 1.30 
Keys: Ϯ Values reported in mean (standard deviation) by independent t-test. ϻ Values reported in median (interquartile 
range) by Mann-Whitney U test. * Indicates statistically significant difference. ** Indicates trend; difference > 0.18 
Nm/kg. SMD: standardised mean difference, CI: confidence interval. SMD of 0.2 and higher are highlighted in bold 
suggesting clinically important differences. SMD of 0.2 suggests small clinically important difference, 0.5 suggests 
medium clinically important difference, and 0.8 suggests large clinically important difference (Cohen, 1988). 
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▪ Knee moment; curve graphs, descriptive statistics and interferential 
analysis: 
Several differences have been illustrated in the knee moment curve graphs for the 
JHS group when compared to the control group. Figure 5.9 summarises the differences 
observed. A transverse plane curve graph has not been displayed as V3D was not 
programmed to produce this graph. 
Knee moment during gait cycle 
 JHS group (n = 29) 
 (blue: right side, red:  left side) 
Control group (n = 30) 
Sagittal plane 
 
 
  
Frontal plane 
  
Figure 5.9: Curve graphs showing the moments acting at the knee joint during the gait cycle in frontal 
and sagittal planes for the JHS and control group. The solid line illustrates the mean and the semi-
transparent line illustrates the standard deviation. Red circles/ovals highlighted the differences 
between the two groups. In the sagittal plane, the extensors moment during initial stance phase was 
reduced in the JHS group when compared to the control group. During mid-stance knee flexors 
moment was reduced in the JHS group. An increase was observed at knee extensors moment in the 
JHS group during terminal stance. In the frontal plane, the two peaks of knee adductors/varus moment 
were lowered during loading response and terminal stance phases in the JHS group when compared 
with the control group.    
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Moment curve graphs for the JHS group point toward reductions in knee 
extensors’, flexors’ and adductors’ moments (Figure 5.9). Conversely, an increase in 
knee extensors’ moment can be noticed during terminal stance in the JHS group (Figure 
5.9). Statistically, maximum moment analysis indicates significant reductions in right 
knee extensors and internal rotators’ moments, and left knee adductors/varus moment in 
the JHS group, and the SMD suggests a medium clinically important difference; SMD ≥ 
0.5 and < 0.8 (Figure 5.24) (Cohen, 1988). The statistical analysis of minimum moments 
has identified significant reductions in knee external rotators’ moment bilaterally and the 
SMD suggests a medium to large clinically important difference; SMD ≤ 0.5 (Table 5.24) 
(Cohen, 1988). Regardless of the statistically significant findings, the other descriptive 
statistics for the JHS group are mostly reduced, and the SMD suggests a small to large 
clinically important difference (Table 5.24). Bilateral knee abductor/valgus moments 
seem comparable to the control group, and the SMD suggests no clinically important 
differences between the two groups (Table 5.24). However, none of these observations 
can be considered to be a trend. 
Table 5.24: Gait moment acting at the knee joint in the JHS and control group. (R: right, L: left). 
Knee moments parameters 
(Nm/kg) 
JHS group 
n = 29 
Control group 
n = 30 
p- 
value 
SMD 95% CI 
Maximum moment 
R knee flexion/extension 0.41 (0.15) 0.51 (0.22) 0.04Ϯ* -0.53 -1.04, 0.00 
R knee valgus/varus 0.26 (0.15) 0.32 (0.12) 0.07ϻ 0.44 -0.08, 0.95 
R knee internal/external rotation 0.09 (0.05) 0.12 (0.04) 0.02Ϯ* -0.66 -1.18, -0.13 
L knee flexion/extension 0.46 (0.22) 0.56 (0.23) 0.11Ϯ -0.44 -0.95, 0.08 
L knee valgus/varus 0.27 (0.11) 0.33 (0.12) 0.04Ϯ* 0.52 0.00, 1.03 
L knee internal/external rotation 0.09 (0.04) 0.11 (0.04) 0.06Ϯ -0.50 -1.01, 0.02 
Minimum moment 
R knee flexion/extension -0.20 (0.21) -0.36 (0.15) 0.06ϻ 0.88 0.33, 1.40 
R knee valgus/varus -0.11 (0.09) 0.10 (0.05) 0.56ϻ 0.14 -0.37, 0.65 
R knee internal/external rotation -0.10 (0.04) -0.12 (0.04) 0.04Ϯ* 0.50 -0.02, 1.01 
L knee flexion/extension -0.27 (0.26) -0.35 (0.19) 0.08ϻ 0.35 -0.17, 0.86 
L knee valgus/varus -0.09 (0.08) 0.10 (0.07) 0.37ϻ -0.13 -0.64, 0.38 
L knee internal/external rotation -0.08 (0.04) -0.12 (0.03) 0.00Ϯ* 1.13 0.57, 1.67 
Keys: Ϯ Values reported in mean (standard deviation) by independent t-test. ϻ Values reported in median (interquartile 
range) by Mann-Whitney U test. * Indicates statistically significant difference. ** Indicates trend; difference > 0.18 Nm/kg. 
SMD: standardised mean difference, CI: confidence interval. SMD of 0.2 and higher are highlighted in bold suggesting 
clinically important differences. SMD of 0.2 suggests small clinically important difference, 0.5 suggests medium clinically 
important difference, and 0.8 suggests large clinically important difference (Cohen, 1988). 
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▪ Ankle moment; curve graphs, descriptive statistics and interferential 
analysis: 
Figure 5.10 summarises the differences observed in the ankle moment curve 
graphs for the JHS group when compared to the control group. V3D software was not 
programmed to produce frontal and transverse plane ankle moment curve graphs. 
Ankle moment during gait cycle 
 JHS group (n = 29) 
 (blue: right side, red:  left side) 
Control group (n = 30) 
Sagittal plane 
  
Figure 5.10: Curve graphs showing the moments acting at the ankle joint during the gait cycle in the 
sagittal plane for the JHS and control group. The solid line illustrated the mean and the semi-
transparent line illustrated the standard deviation. The graphs revealed comparable dorsi-plantar 
flexors moments between the two groups throughout the gait cycle. 
 
No differences between the two groups can be found in the ankle moment curve 
graph for the sagittal plane (Figure 5.10). Similarly, the statistical analysis of ankle 
moment indicates no significant differences between the two groups in the three planes of 
movement (Table 5.25). However, the descriptive statistics show that the JHS group 
walked with reduced bilateral ankle plantar flexors’ moment, and the SMD suggests a 
small clinically important difference (Table 5.25).  Additionally, the descriptive statistics 
for bilateral ankle dorsiflexion moments are lower, and the SMD suggests a small 
clinically important difference for the right ankle (Table 5.25). However, none of these 
observations can be considered to be a trend. 
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Table 5.25: Gait moment acting at the ankle joint in the JHS and control group. (R: right, L: left). 
Moments parameters 
(Nm/kg) 
JHS group 
n = 29 
Control group 
n = 30 
p- 
value 
SMD 95% CI 
Maximum moment 
R ankle dorsi/plantar flexion 1.26 (0.23) 1.33 (0.14) 0.052ϻ -0.37 -0.88, 0.15 
R foot progression 0.25 (0.19) 0.22 (0.13) 0.36ϻ 0.18 -0.33, 0.69 
R ankle internal/external rotation 0.02 (0.01) 0.02 (0.03) 0.51ϻ 0.00 -0.51, 0.51 
L ankle dorsi/plantar flexion 1.25 (0.18) 1.32 (0.14) 0.14Ϯ -0.44 -0.95, 0.09 
L foot progression 0.04 (0.07) 0.04 (0.08) 0.97ϻ 0.00 -0.51, 0.51 
L ankle internal/external rotation 0.10 (0.06) 0.12 (0.07) 0.13ϻ -0.31 -0.82, 0.21 
Minimum moment 
R ankle dorsi/plantar flexion -0.11 (0.05) -0.13 (0.03) 0.17Ϯ 0.49 -0.04, 1.00 
R foot progression -0.04 (0.05) -0.04 (0.04) 0.39ϻ 0.00 -0.51, 0.51 
R ankle internal/external rotation -0.09 (0.08) -0.11 (0.07) 0.10ϻ 0.27 -0.25, 0.78 
L ankle dorsi/plantar flexion -0.13 (0.10) -0.14 (0.07) 0.37ϻ 0.12 -0.40, 0.63 
L foot progression -0.23 (0.12) -0.23 (0.08) 0.88Ϯ 0.00 -0.51, 0.51 
L ankle internal/external rotation  -0.02 (0.02) -0.02 (0.01) 0.92ϻ 0.00 -0.51, 0.51 
Keys: Ϯ Values reported in mean (standard deviation) by independent t-test. ϻ Values reported in median (interquartile 
range) by Mann-Whitney U test. * Indicates statistically significant difference. ** Indicates trend; difference > 0.18 Nm/kg. 
SMD: standardised mean difference, CI: confidence interval. SMD of 0.2 and higher are highlighted in bold suggesting 
clinically important differences. SMD of 0.2 suggests small clinically important difference, 0.5 suggests medium clinically 
important difference, and 0.8 suggests large clinically important difference (Cohen, 1988). 
 
• Conclusion: 
Most of the graphical observations suggest that gait moments were reduced in the 
JHS group when compared to the control group. Specifically, hip flexors and adductors’ 
moments and knee extensors, flexors and adductors’ moments were reduced in the JHS 
group. The ankle moment curve graph for the JHS group is comparable to the control 
group. In contrast, the curve graph highlights an increase in knee extensor moment in the 
JHS group during terminal stance. Statistically, significant reductions have been 
highlighted in the JHS group’s gait moments in bilateral hip extensors and left hip 
flexors, adductors and external rotators. In addition, significant reductions in knee 
moments have been identified in right knee extensors and internal rotators, bilateral knee 
external rotators, and left knee adductors. The SMDs of all the significant findings 
suggest medium clinically important differences between the two groups. 
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5.9.8 Three-dimensional power gait analysis: 
• Introduction: 
This section has analysed the gait of the two groups in terms of power at the hip, 
knee and ankle joints. Power gait graphs have been presented to illustrate the differences 
between the two groups. Additionally, maximum and minimum powers acting at the hip, 
knee and ankle joints have been statistically analysed. A difference > 0.19 Watts/kg has 
been considered to be a trend for power data, as the minimal detectable change in power 
is 0.19 Watts/kg (Wilken et al. 2012).   
• Hip powers; curve graphs, descriptive statistics and interferential analysis: 
Gait curve graphs have been displayed to analyse the hip powers for the JHS and 
control group. Various differences have been identified and summarised in Figure 5.11 
for the sagittal and frontal planes, where V3D software was not programmed to generate 
transverse plane graphs.    
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Hip power during gait cycle 
 JHS group 
n = 29 
 (blue: right side, red:  left side) 
Control group 
n = 30 
Sagittal plane 
  
Frontal plane 
  
Figure 5.11: Curve graphs showing the generated and absorbed power at the hip joint in the JHS and 
control groups. The solid line illustrates the mean and the semi-transparent line illustrates the 
standard deviation. Red/ovals circles highlighted the differences between the two groups. In the 
sagittal plane, the curve during loading response was reduced in the JHS group, indicating reduction 
at hip power generation. The curve during terminal stance was reduced in the JHS group, highlighting 
reduced power absorption when compared to the control group. Similarly, the peak was smaller during 
pre-swing to initial swing in the JHS group, pointing to a reduction in power generation when 
compared with the control group. In the frontal plane, the peak during loading response was reduced 
in the JHS group, indicating reduced power absorption when compared to the control group. The 
peaks during mid and terminal stance were also reduced in the JHS group, revealing reductions in the 
power generation when compared to the control group. 
 
The curve graphs for hip powers point toward a reduction in power generation 
during loading response, mid to terminal stance and pre-swing phases, while power 
absorption was reduced during loading response and the terminal stance phase (Figure 
5.11). The statistical analysis of hip powers has identified significant reductions in left 
hip power absorption in the sagittal and transverse planes, and the SMD suggests a 
medium clinically important difference between the two group; SMD ≥ 0.5 and < 0.8 
(Table 5.26) (Cohen, 1988). Regardless of the significant findings, most of the other 
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descriptive statistics are reduced for the JHS group when compared to the control group, 
and the SMD suggests a small to medium clinically important difference; SMD ≤ 0.2 and 
< 0.8 (Table 5.26) (Cohen, 1988). Even so, comparable results between the groups were 
noticed in hip power generation in the transverse plane, and right hip power absorption in 
the frontal plane, and the SMD suggests no clinically important difference between the 
two groups (Table 5.26). A trend toward reduction in hip power absorption in the JHS 
group has been found in the sagittal plane/hip flexion and extension, and the SMD 
suggests a medium clinically important difference (Table 5.26).  
Table 5.26: Power generated and absorbed at the hip joint during the gait cycle at the frontal, sagittal 
and transverse planes. (R: right, L:  left) 
Power parameters 
(Watts/Kg) 
JHS group 
n = 29 
Control group 
n = 30 
p-value SMD 95% CI 
Maximum power generation 
R hip flexion/extension 0.70 (0.30) 0.84 (0.28) 0.08Ϯ -0.48 -0.99, 0.04 
R hip abduction/adduction 0.55 (0.31) 0.70 (0.16) 0.06ϻ -0.61 -1.12, -0.08 
R hip internal/external 
rotation 
0.09 (0.18) 0.08 (0.08) 0.66ϻ 0.07 -0.44, 0.58 
L hip flexion/extension 0.71 (0.26) 0.84 (0.27) 0.07Ϯ -0.49 -1.00, 0.03 
L hip abduction/adduction 0.54 (0.29) 0.61 (0.39) 0.16ϻ -0.20 -0.71, 0.31 
L hip internal/external 
rotation 
0.06 (0.12) 0.10 (0.11) 0.50ϻ -0.35 -0.86, 0.17 
Minimum power absorption 
R hip flexion/extension -0.35 (0.48) -0.56 (0.30) 0.23ϻ** 0.53 0.00, 1.04 
R hip abduction/adduction -0.52 (0.41) -0.49 (0.27) 0.66ϻ -0.09 -0.60, 0.43 
R hip internal/external 
rotation 
-0.18 (0.25) -0.29 (0.67) 0.12ϻ 0.22 -0.30, 0.73 
L hip flexion/extension -0.35 (0.39) -0.60 (0.22) 0.03ϻ* 0.79 0.25, 1.31 
L hip abduction/adduction -0.37 (0.33) -0.47 (0.33) 0.15ϻ 0.30 -0.21, 0.81 
L hip internal/external 
rotation 
-0.23 (0.11) -0.35 (0.28) 0.04ϻ* 0.56 0.03, 1.07 
Keys: Ϯ Values reported in mean (standard deviation) by independent t-test. ϻ Values reported in median (interquartile 
range) by Mann-Whitney U test. * Indicates statistically significant difference. ** Indicates trend; difference > 0.19 
Watts/kg. SMD: standardised mean difference, CI: confidence interval. SMD of 0.2 and higher are highlighted in bold 
suggesting clinically important differences. SMD of 0.2 suggests small clinically important difference, 0.5 suggests 
medium clinically important difference, and 0.8 suggests large clinically important difference (Cohen, 1988). 
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• Knee powers; curve graphs, descriptive statistics and interferential analysis: 
Various differences have been identified in the knee power curve graphs in the 
sagittal plane between the two groups, which are illustrated in Figure 5.12. V3D software 
was not programed to produce frontal and transverse plane knee power graphs. 
Knee power during gait cycle 
 JHS group (n = 29) 
 (blue: right side, red:  left side) 
Control group (n = 30) 
Sagittal plane 
`   
Figure 5.12: Curve graphs showing the generated and absorbed power at the knee joint in the JHS 
and control groups. The solid line illustrated the mean and the semi-transparent line illustrated the 
standard deviation. Red circles/ovals highlighted the differences between the two groups. During the 
stance phase, the first curve at heel strike was lowered in the JHS group, demonstrating a reduction in 
knee power absorption when compared with the control group. During loading response, the curve 
was smaller in the JHS group, confirming a reduction in knee power generation. Similarly, reduced 
power absorption was noticed during mid-stance in the JHS group, where the curve was smaller when 
compared to the control group. The second peak during terminal stance was also reduced in the JHS 
group, indicating a reduction in knee generated power. During the swing phase, the peak during 
terminal swing was smaller in the JHS group, evidencing a reduction in the absorbed power when 
compared with the control group. Additionally, the peak during second heel strike during terminal 
swing was reduced in the JHS group, indicating a reduction in knee power generation.   
 
The curve graph of the JHS group illustrates reductions in knee power generation 
and absorption during various stages of the gait cycle (Figure 5.12). Similarly, statistical 
significant reductions were found for the JHS group’s knee power generation in the 
sagittal plane, bilaterally, and in left knee frontal plane, and the SMD suggests a small 
clinically important difference between the groups; SMD ≥ 0.2 and < 0.5 (Table 5.27) 
(Cohen, 1988). Statistically significant reductions have also been identified in knee 
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power generation in the JHS group in the transverse plane bilaterally, and the SMDs 
suggested medium to large clinically important differences; SMD ≥ 0.5 and > 0.8 (Table 
5.27) (Cohen, 1988). Regardless of the significant reductions, the descriptive statistics for 
power generations have been found to be mostly reduced in the JHS group (Table 5.27). 
However, none of these observations can be considered to be a trend. 
Table 5.27: Power generated and absorbed at the knee joint during the gait cycle at the frontal, 
sagittal and transverse planes. (R: right, L:  left) 
Power parameters 
(Watts/Kg) 
JHS group 
n = 29 
Control 
group 
n = 30 
p-value SMD 95% CI 
Maximum power generation 
R knee flexion/extension 0.48 (0.38) 0.63 (0.42) 0.01ϻ* -0.37 -0.88, 0.15 
R knee valgus/varus 0.07 (0.07) 0.08 (0.12) 0.32ϻ -0.10 -0.61, 0.41 
R knee internal/external rotation 0.09 (0.05) 0.09 (0.06) 0.45ϻ 0.00 -0.51, 0.51 
L knee flexion/extension 0.51 (0.35) 0.62 (0.57) 0.01ϻ* -0.23 -0.74, 0.28 
L knee valgus/varus 0.08 (0.06) 0.11 (0.07) 0.00ϻ* -0.46 -0.97, 0.06 
L knee internal/external rotation 0.07 (0.03) 0.08 (0.05) 0.54Ϯ -0.24 -0.75, 0.27 
Minimum power absorption 
R knee flexion/extension -0.77 (0.39) -0.95 (0.48) 0.11Ϯ 0.41 -0.11, 0.92 
R knee valgus/varus -0.12 (0.07) -0.13 (0.09) 0.62ϻ 0.12 -0.39, 0.63 
R knee internal/external rotation -0.10 (0.04) -0.14 (0.05) 0.00Ϯ* 0.88 0.34, 1.40 
L knee flexion/extension -0.78 (0.63) -0.93 (0.78) 0.18ϻ 0.21 -0.30, 0.72 
L knee valgus/varus -0.12 (0.11) -0.13 (0.12) 0.37ϻ 0.09 -0.42, 0.60 
L knee internal/external rotation -0.10 (0.06) -0.14 (0.05) 0.00Ϯ* 0.73 0.19, 1.24 
Keys: Ϯ Values reported in mean (standard deviation) by independent t-test. ϻ Values reported in median (interquartile 
range) by Mann-Whitney U test. * Indicates statistically significant difference. ** Indicates trend; difference > 0.19 
Watts/kg. SMD: standardised mean difference, CI: confidence interval. SMD of 0.2 and higher are highlighted in bold 
suggesting clinically important differences. SMD of 0.2 suggests small clinically important difference, 0.5 suggests medium 
clinically important difference, and 0.8 suggests large clinically important difference (Cohen, 1988). 
 
▪ Ankle powers; curve graphs, descriptive statistics and interferential 
analysis: 
A curve graph has been displayed to illustrate the differences between the two 
groups in terms of ankle power generation and absorption in the sagittal plane (Figure 
5.13). V3D software was not programmed to produce frontal and transverse plane ankle 
power graphs. 
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Ankle power during gait cycle 
 JHS group (n = 29) 
 (blue: right side, red: left side) 
Control group (n = 30) 
Sagittal plane 
  
Figure 5.13: Curve graphs showing the generated and absorbed power at the ankle joint in the JHS 
and control groups. The solid line illustrates the mean and the semi-transparent line illustrates the 
standard deviation. Red ovals highlighted the differences between the two groups. The curve during 
terminal stance in the JHS group was lowered, indicating a reduction in ankle generated power when 
compared with the control group. 
 
The curve graph illustrates a reduction in ankle power generation in the JHS 
group during terminal stance in the sagittal plane (Figure 5.13). Similarly, a trend toward 
reduced ankle power generation in the sagittal plane bilaterally has been illustrated, and 
the SMD suggests a small clinically important difference; SMD ≥ 0.2 and < 0.5 (Table 
5.28). Statistically, a significant reduction in left ankle power absorption was found in the 
JHS group in the transverse plane, and the SMD suggests a small clinically important 
difference; SMD ≥ 0.2 and < 0.5 (Table 5.28). The descriptive statistics for the right 
ankle power absorption in the transverse plane are reduced in the JHS group and the 
SMD suggests a small clinically important difference (Table 5.28). Additionally, the 
SMD suggests small clinically important differences in ankle power generation and 
absorption in the right ankle in the frontal plane (Table 5.28). However, no trends can be 
identified from Table 5.28. 
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Table 5.28: Power generated and absorbed at the ankle joint during the gait cycle at the frontal, 
sagittal and transverse planes. (R: right, L:  left) 
Power parameters 
(Watts/Kg) 
JHS group 
n = 29 
Control 
group 
n = 30 
p-value SMD 95% CI 
Maximum power generation 
R ankle dorsi/plantar flexion 2.68 (0.86) 3.08 (0.82) 0.08Ϯ -0.48 -0.99, 0.05 
R foot progression 0.28 (0.42) 0.19 (0.29) 0.13ϻ 0.25 -0.27, 0.76 
R ankle internal/external rotation 0.03 (0.03) 0.03 (0.02) 0.27ϻ 0.00 -0.51, 0.51 
L ankle dorsi/plantar flexion 2.64 (0.86) 2.93 (0.89) 0.22Ϯ -0.33 -0.84, 0.19 
L foot progression 0.22 (0.27) 0.19 (0.20) 0.40ϻ 0.13 -0.39, 0.64 
L ankle internal/external rotation 0.03 (0.04) 0.03 (0.03) 0.90ϻ 0.00 -0.51, 0.51 
Minimum power absorption 
R ankle dorsi/plantar flexion -0.65 (0.33) -0.65 (0.30) 0.64ϻ 0.00 -0.51, 0.51 
R foot progression -0.16 (0.14) -0.12 (0.10) 0.58ϻ -0.33 -0.84, 0.19 
R ankle internal/external rotation -0.09 (0.07) -0.12 (0.08) 0.06ϻ 0.40 -0.12, 0.91 
L ankle dorsi/plantar flexion -0.65 (0.55) -0.64 (0.37) 0.19ϻ -0.02 -0.53, 0.49 
L foot progression -0.11 (0.12) -0.13 (0.12) 0.23ϻ 0.17 -0.35, 0.68 
L ankle internal/external rotation -0.08 (0.07) -0.10 (0.06) 0.04ϻ* 0.31 -0.21, 0.82 
Keys: Ϯ Values reported in mean (standard deviation) by independent t-test. ϻ Values reported in median (interquartile 
range) by Mann-Whitney U test. * Indicates statistically significant difference. ** Indicates trend; difference > 0.19 
Watts/kg. SMD: standardised mean difference, CI: confidence interval. SMD of 0.2 and higher are highlighted in bold 
suggesting clinically important differences. SMD of 0.2 suggests small clinically important difference, 0.5 suggests 
medium clinically important difference, and 0.8 suggests large clinically important difference (Cohen, 1988). 
  
• Conclusion: 
As has been illustrated in the power curve graphs, power generation and 
absorption was lower in the JHS group when compared to the control group, for the hip, 
knee and ankle joints. Statistically, power generation was significantly reduced in the 
JHS group in the knee joint in the sagittal plane; bilaterally, and in the frontal plane, and 
for the left knee, and the SMD suggests a small clinically important difference between 
the groups. Power absorption of the JHS group was significantly lower in the left hip in 
the sagittal and transverse planes, bilateral knees in the transverse plane, and left ankle in 
the transverse plane when compared with the control group, and the SMD suggests a 
small to large clinically important difference between the two groups.  
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5.9.9 Gait ground reaction force: 
The gait ground reaction force (GRF) of the JHS group increased at 50% of the 
gait cycle (Figure 5.14). However,  there are no statistically significant differences 
between the two groups in GRF at the frontal, sagittal and transverse plane (Table 5.29). 
Yet, the SMD suggest small difference between the groups in the GRF in the frontal and 
sagittal planes (Table 5.29). 
Ground reaction force during gait cycle 
 JHS group (n = 29) 
 (blue: right side, red:  left side) 
Control group (n = 30) 
GRF (N/ms) 
  
Figure 5.14: Curve graphs showing the ground reaction force (GRF) in the JHS and control groups. 
The solid line illustrates the mean and the semi-transparent line illustrates the standard deviation. 
Two horizontal lines were drawn across the two graphs to ease the comparison. Red ovals 
highlighted the difference between the two groups. The second inverted curve at 50% of the gait 
cycle was higher in the JHS group, indicating an increase in the GRF when compared with the 
control group.  
  
Table 5.29: Peak ground reaction force (PGRF) (N/ms) generated during the gait cycle for the JHS 
and control groups. PGRF was normalised to body weight.  
PGRF 
Plane JHS group 
n = 29 
Control group 
n = 30 
p-value SMD 95% CI 
Mean SD Mean SD 
Frontal plane 131.49 49.19 149.02 42.30 0.08 -0.38 -0.89, 0.14 
Sagittal plane 32.03 13.68 35.46 13.36 0.33 -0.25 -0.76, 0.26 
Transverse plane 783.44 202.13 772.47 134.21 0.89 0.06 -0.45, 0.57 
Keys: SD: standard deviation. * Indicates statistically significant difference. SMD: standardised mean difference, CI: 
confidence interval. SMD of 0.2 and higher are highlighted in bold suggesting clinically important differences. SMD of 
0.2 suggests small clinically important difference, 0.5 suggests medium clinically important difference, and 0.8 suggests 
large clinically important difference (Cohen, 1988). 
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5.9.10 Studying the vertical jump; lower limb stiffness and three-
dimensional analysis. 
5.9.10.1 Introduction: 
The vertical jump was employed to study lower limb stiffness, as well as 
kinematics and kinetics in the lower limbs in the JHS group, through a comparison with 
the control group. The demographic characteristics of the population studied for this 
study have been presented in section 5.9.1, evidencing the homogenous characteristics 
between the two groups in term of sex, age, BMI, height and weight; p ≥ 0.05 (Table 
5.14). The following subsections include analyses of the jump of 29 patients diagnosed 
with JHS, and 30 healthy sex and age matched controls. Firstly, the jump test has been 
studied to measure lower limb stiffness. Secondly, the jump test has been analysed in 
term of kinematics and kinetics. 
5.9.10.2 Studying lower limb stiffness; measured with the vertical jump 
test and correlated to Achilles tendon stiffness: 
Stiffness was calculated using the vertical components of the compression phase. 
No differences were identified in the mean and maximum stiffness of the lower limbs 
between the two groups, and the SMD suggests no difference between the groups (Table 
5.30). Similarly, the results reveal a comparable vertical ground reaction force; GRFz, 
and vertical displacement of the right sacral marker; displacementZ, and the SMD 
suggest no differences between the groups (Table 5.30). Independent sample t-tests and 
Mann-Whitney U tests were used alternatively to run the comparisons. Additionally, no 
correlation has been found between Achilles tendon stiffness measured using the 
ultrasound and the strain-gauge myometer, and the entire stiffness of the lower-limb 
measured through the vertical jump test.  
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Table 5.30: Mean and maximum lower limbs stiffness measured with the vertical jump test, The ratio 
of vertical ground reaction force (GFRz) to vertical displacement of the right sacral marker 
(displacementZ) was used to measure the stiffness at the lower limbs; mean and maximum. 
 JHS group 
n = 29 
Control group 
n = 30 
P SMD 95% CI 
GRF z (N) 1113.64 (289.38) 1113.41 (255.82) 0.99Ϯ 0.00 -0.51, 0.51 
Displacement Z (mm) 120.51 (63.13) 118.40 (37.13) 0.91ϻ 0.04 -0.47, 0.55 
Jump stiffness maximum 
(N/mm) 
11.79 (4.86) 11.12 (4.43) 0.57Ϯ 0.14 -0.37, 0.65 
Jump stiffness mean (N/mm) 10.49 (4.46) 9.71 (3.56) 0.46Ϯ 0.19 -0.32, 0.70 
Keys: Ϯ Values reported in mean (standard deviation) by independent t-test. ϻ Values reported in median (interquartile 
range) by Mann-Whitney U test. * Indicates statistically significant difference. SMD: standardised mean difference, CI: 
confidence interval. SMD of 0.2 and higher are highlighted in bold suggesting clinically important differences. SMD of 0.2 
suggests small clinically important difference, 0.5 suggests medium clinically important difference, and 0.8 suggests large 
clinically important difference (Cohen, 1988).  
  
The parameters related to the jump performance, including the jump height and knee 
flexion angle attained to initiate the jump, have been explored. The results highlight 
comparable values between the two groups (Table 5.31). The SMD suggests a small 
difference between the groups in the knee flexion angle (Table 5.31). 
Table 5.31: Parameters related to jump performance including jump height and maximum reached 
knee flexion angle. 
 JHS group 
n = 29 
Control group 
n = 30 
p-
value 
SMD 95% CI 
Mean SD Mean SD 
Jump height (mm) 316.25 70.88 328.45 60.42 0.47 -0.19 -0.69, 0.33 
Jump knee flexion angle 
(degrees) 
64.23 9.22 66.31 9.16 0.38 -0.23 -0.74, 0.29 
Keys: SD: standard deviation, SMD: standardised mean difference, CI: confidence interval. SMD of 0.2 and higher are 
highlighted in bold suggesting clinically important differences. SMD of 0.2 suggests small clinically important difference, 
0.5 suggests medium clinically important difference, and 0.8 suggests large clinically important difference (Cohen, 1988). 
 
            5.9.10.3 Three-dimensional kinematic jump analysis: 
• Introduction: 
Vertical jump has been explored from two perspectives: curve graphs and 
statistical analysis. The curve graphs have been built to identify differences at each phase 
of the activity cycle in the pelvis, hip, knee and ankle joints, considering both jump 
kinematics and kinetics. The jump curve graphs have been built using the data from the 
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JHS group, 29 patients diagnosed with JHS, and 30 healthy sex and age matched 
controls. In addition, the differences highlighted by the curve graphs have been checked 
objectively using statistical analysis methods. Moreover, statistical analysis has been 
performed to objectively identify the differences between the two groups.  
The vertical jump task was divided into two phases: compression and push phase, 
as described in Figure 4.19. The kinematics of the compression phase have been analysed 
by exploring the mean and maximum values. The minimum value has not been 
considered because the compression phase presents the flexion movement of the lower 
limbs, which is best looked at using the maximum value. In contrast, the push phase has 
been analysed by exploring the mean and minimum values, as this phase presents the 
extension of the lower limb joints. Therefore, maximum kinematics were not calculated 
for the push phase. The right side has been analysed, as proposed by previous studies 
exploring the jump task (Chappell et al. 2002; Urabe et al. 2005; Yu, Lin and Garrett, 
2006).  A difference ≥ 20 between the two groups in jump kinematics was considered as a 
trend, where a difference < 20 could be an intra-session variability (Bates, McGregor and 
Alexander, 2016b). 
• Pelvis jump kinematics; curve graphs, descriptive statistics and 
interferential analysis: 
Some differences have been found between the two groups in pelvis jump 
kinematics. Figure 5.15 summarises the differences. Pelvis jump kinematics in the frontal 
and transverse planes have been excluded after analysis due to involving high variability 
which made it hard to interpret. 
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Pelvis jump kinematics 
 JHS group (n = 29) Control group (n = 30) 
Sagittal plane 
  
Figure 5.15: Curve graphs showing the kinematics of the pelvis joint during the jump test in the sagittal 
plane for the JHS and the control group. The solid line illustrates the mean and the semi-transparent 
line illustrates the standard deviation. Red ovals highlighted the differences between the two groups. 
The vertical line separated between the compression phase; left side and push phase; right side. The 
anterior pelvis tilt curve was higher in the JHS group during the terminal compression phase when 
compared with the control group. 
 
The pelvis curve graphs for jump kinematics illustrate an increase in anterior tilt, 
in the JHS group (Figure 5.15). Similarly, Table 5.32 illustrates an increase in anterior 
pelvis tilt in the JHS group, but this is not statistically significant, not a trend, and the 
SMD suggests no clinically important difference between the groups. 
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Table 5.32: Jump kinematics of the pelvis joint for the JHS and the control groups during the 
compression; mean and maximum kinematics, and push phases; mean and minimum kinematics. 
Kinematics parameters 
(degrees) 
JHS group 
n = 29 
Control group 
n = 30 
p-value SMD 95% CI 
Compression phase 
Mean kinematics 
Pelvic tilt 0.48 (1.14) 0.36 (1.12) 0.26ϻ 0.11 -0.41, 0.62 
Maximum kinematics 
Pelvic tilt 2.25 (2.63) 1.98 (2.11) 0.44ϻ 0.11 -0.40, 0.62 
Push phase 
Mean kinematics 
Pelvic tilt 0.62 (1.73) 0.49 (1.55) 0.45ϻ 0.08 -0.43, 0.59 
Minimum kinematics 
Pelvic tilt -0.94 (1.76) -1.16 (1.66) 0.37ϻ 0.13 -0.38, 0.64 
Keys: Ϯ Values reported in mean (standard deviation) by independent t-test. ϻ Values reported in median (interquartile 
range) by Mann-Whitney U test. * Indicates statistically significant difference. ** Indicates a trend; difference ≥ 20. 
SMD: standardised mean difference, CI: confidence interval. SMD of 0.2 and higher are highlighted in bold suggesting 
clinically important differences. SMD of 0.2 suggests small clinically important difference, 0.5 suggests medium clinically 
important difference, and 0.8 suggests large clinically important difference (Cohen, 1988). 
 
• Hip jump kinematics; curve graphs, descriptive statistics and interferential 
analysis: 
Figure 5.16 demonstrates the difference between the two groups for hip 
kinematics during the jump test.  
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 Hip jump kinematics 
 JHS group (n = 29) Control group (n = 30) 
Sagittal plane 
  
Frontal plane 
  
Transverse plane 
  
Figure 5.16: Curve graphs showing the kinematics of the hip joint during the jump test at frontal, 
sagittal and transverse planes for the JHS and the control groups. The solid line illustrates the mean 
and the semi-transparent line illustrates the standard deviation. Red ovals highlighted the differences 
between the two groups. The vertical line separated between the compression phase; left side and 
push phase; right side. In the sagittal and frontal planes, no differences were noticed. In the 
transverse plane, the external rotation curve was lowered during initial-mid compression phase in the 
JHS group, indicating an increase in hip external rotation when compared with the control group. 
 
Figure 5.16 shows that the JHS group jumped with comparable hip kinematics to 
the control group in the sagittal and transverse planes, while hip external rotation was 
increased in the JHS group. Statistically, no significant differences have been found 
between the two groups, but the SMD suggests small clinically important differences in 
some kinematics data; SMD ≥ 0.2 and < 0.5 (Table 5.33) (Cohen, 1988). A trend toward 
an increase in hip external rotation in the JHS group has been shown in mean kinematics 
in the compression phase, and the SMD suggests a small clinically important difference 
(Table 5.33). A trend toward reduced maximum hip flexion during the compression phase 
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in the JHS group has been highlighted; difference ≥ 20, and the SMD suggests a small 
clinically important difference (Table 5.33). Trends toward reduced mean and minimum 
hip extension during the push phase have been revealed in the JHS group; differences ≥ 
20, and the SMD suggests a small clinically important difference for minimum kinematics 
(Table 5.33).     
Table 5.33: Jump kinematics of the hip joint for the JHS and the control groups during the 
compression; mean and maximum kinematics, and push phases; mean and minimum kinematics. 
Kinematics parameters 
(degrees) 
JHS group 
n = 29 
Control group 
n = 30 
p-value SMD 95% CI 
Compression phase 
Mean kinematics 
Hip flexion/extension 32.25 (11.14) 32.52 (10.85) 0.92Ϯ -0.02 -0.53, 0.49 
Hip abduction/adduction 3.51 (4.55) 2.96 (4.14) 0.63Ϯ 0.13 -0.39, 0.64 
Hip internal/external rotation -4.63 (7.86) -2.60 (5.93) 0.26Ϯ** -0.29 -0.80, 0.22 
Maximum kinematics 
Hip flexion/extension 53.81 (12.48) 56.96 (12.25) 0.33Ϯ** -0.25 -0.76, 0.26 
Hip abduction/adduction 6.73 (4.87) 6.21 (4.72) 0.67Ϯ 0.11 -0.40, 0.62 
Hip internal/external rotation 0.32 (6.95) 1.84 (6.24) 0.38Ϯ -0.23 -0.74, 0.28 
Push phase 
Mean kinematics 
Hip flexion/extension 28.47 (11.19) 26.46 (10.68) 0.16ϻ** 0.18 -0.33, 0.69 
Hip abduction/adduction 2.47 (4.48) 1.34 (3.79) 0.30Ϯ 0.27 -0.24, 0.78 
Hip internal/external rotation -6.87 (7.76) -5.88 (5.53) 0.57Ϯ -0.15 -0.66, 0.37 
Minimum kinematics 
Hip flexion/extension 12.27 (12.54) 9.15 (7.84) 0.18ϻ** 0.30 -0.22, 0.81 
Hip abduction/adduction -0.87 (4.22) -1.54 (4.33) 0.55Ϯ 0.16 -0.36, 0.67 
Hip internal/external rotation -11.06 (8.28) -9.95 (5.61) 0.54Ϯ -0.16 -0.67, 0.36 
Keys: Ϯ Values reported in mean (standard deviation) by independent t-test. ϻ Values reported in median (interquartile 
range) by Mann-Whitney U test. * Indicates statistically significant difference. ** Indicates a trend; difference ≥ 20. 
SMD: standardised mean difference, CI: confidence interval. SMD of 0.2 and higher are highlighted in bold suggesting 
clinically important differences. SMD of 0.2 suggests small clinically important difference, 0.5 suggests medium clinically 
important difference, and 0.8 suggests large clinically important difference (Cohen, 1988). 
 
• Knee jump kinematics; curve graphs, descriptive statistics and interferential 
analysis: 
Figure 5.17 shows the differences between the two groups in knee jump 
kinematics.  
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 Knee jump kinematics  
 JHS group (n = 29) Control group (n = 30) 
Sagittal plane 
  
Frontal plane 
  
Transverse plane 
  
Figure 5.17: Curve graphs showing the kinematics of the knee joint during the jump test at frontal, 
sagittal and transverse planes for the JHS and the control groups. The solid line illustrated the mean 
and the semi-transparent line illustrated the standard deviation. Red ovals highlighted the differences 
between the two groups. The vertical line separated between the compression phase; left side and push 
phase; right side. In the sagittal plane, no differences were noticed between the JHS and control group 
graphs. In the frontal plane, the valgus curve was higher in the JHS group during initial-mid 
compression phase, pointing to an increase in knee valgus in the JHS group. In the transverse plane: 
the external rotation curve was higher in the JHS group in the initial push phase, demonstrating a 
reduction in knee external rotation in the JHS group, when compared with the control group. 
 
The curve graphs illustrate an increase in knee valgus and reduction in the knee 
external rotation in the JHS group (Figure 5.17). Similarly, trends toward increased knee 
valgus during the compression phase; mean and maximum kinematics, and a trend 
toward reduced knee external rotation during the push phase; and minimum kinematics 
have been highlighted in the JHS group, and the SMD suggests a small clinically 
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important difference (Table 5.34). Trends toward reduce knee flexion during the 
compression phase; maximum kinematics, and reduced knee extension during the push 
phase; and mean kinematics, have been highlighted, and the SMD suggests small 
clinically important differences (Table 5.34). However, no statistically significant 
differences have been found between the two groups in knee jump kinematics. 
Table 5.34: Jump kinematics of the knee joint for the JHS and the control groups during the 
compression; mean and maximum kinematics, and push phases; mean and minimum kinematics. 
Kinematics parameters 
(degrees) 
JHS group 
n = 29 
Control group 
n = 30 
p-value SMD 95% CI 
Compression phase 
Mean kinematics 
Knee flexion/extension 36.62 (9.83) 34.96 (7.26) 0.46Ϯ 0.19 -0.32, 0.70 
Knee valgus/varus 7.15 (8.01) 4.44 (6.14) 0.31ϻ** 0.38 -0.14, 0.89 
Knee internal/external rotation 0.96 (5.88) -0.51(5.08) 0.30Ϯ 0.27 -0.25, 0.78 
Maximum kinematics 
Knee flexion/extension 63.09 (10.11) 67.17 (8.32) 0.09Ϯ** -0.44 -0.95, 0.08 
Knee valgus/varus 11.79 (8.86) 8.84 (7.16) 0.17ϻ** 0.37 -0.15, 0.88 
Knee internal/external rotation 5.48 (5.40) 4.52 (5.07) 0.48Ϯ 0.18 -0.33, 0.69 
Push phase 
Mean kinematics 
Knee flexion/extension 27.93 (6.90) 24.83 (6.13) 0.07Ϯ** 0.48 -0.05, 0.99 
Knee valgus/varus 6.58 (4.37) 5.66 (3.50) 0.37Ϯ 0.23 -0.28, 0.74 
Knee internal/external rotation 2.04 (5.77) 0.92 (5.09) 0.43Ϯ 0.21 -0.31, 0.72 
Minimum kinematics 
Knee flexion/extension -1.03 (7.53) -1.68 (5.05) 0.35ϻ 0.10 -0.41, 0.61 
Knee valgus/varus 1.73 (7.26) 2.23 (4.47) 0.57ϻ -0.08 -0.59, 0.43 
Knee internal/external rotation -3.56 (9.16) -7.29 (8.22) 0.13ϻ** 0.43 -0.09, 0.94 
Keys: Ϯ Values reported in mean (standard deviation) by independent t-test. ϻ Values reported in median (interquartile 
range) by Mann-Whitney U test. * Indicates statistically significant difference. ** Indicates a trend; difference ≥ 20. 
SMD: standardised mean difference, CI: confidence interval. SMD of 0.2 and higher are highlighted in bold suggesting 
clinically important differences. SMD of 0.2 suggests small clinically important difference, 0.5 suggests medium clinically 
important difference, and 0.8 suggests large clinically important difference (Cohen, 1988). 
 
• Ankle jump kinematics; curve graphs, descriptive statistics and 
interferential analysis: 
Figure 5.18 compares the ankle jump kinematics of the JHS group with the 
control group. V3D software was not programmed to produce frontal plane ankle 
kinematics. 
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Ankle jump kinematics 
 JHS group (n = 29) Control group (n = 30) 
Sagittal plane 
  
Transverse plane 
 
  
Figure 5.18: Curve graphs showing the kinematics of the ankle joint during the jump test at the frontal 
and sagittal planes for the JHS and the control groups. The solid line illustrated the mean and the 
semi-transparent line illustrated the standard deviation. Red ovals highlighted the differences between 
the two groups. The vertical line separated between the compression phase; left side and push phase; 
right side. In the sagittal and transverse plane, no differences were noticed. 
  
No differences were noticed in the curve graphs for ankle jump kinematics 
between the two groups (Figure 5.18). Similarly, no statistically significant findings have 
been found between the two groups for ankle jump kinematics (Table 5.35). One trend 
has been illustrated from an increase in minimum ankle plantar flexion during the push 
phase in the JHS group, and the SMD suggests a small clinically important difference 
(Table 5.35). 
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Table 5.35: Jump kinematics of the ankle joint for the JHS and the control groups during the 
compression; mean and maximum kinematics, and push phases; mean and minimum kinematics. 
Kinematics parameters 
(degrees) 
JHS group 
n = 29 
Control group 
n = 30 
p-value SMD 95% CI 
Compression phase 
Mean kinematics 
Ankle dorsi/plantar flexion 14.94 (8.13) 14.64 (4.96) 0.42ϻ 0.04 -0.47, 0.55 
Foot progression -0.27 (7.04) 0.06 (4.77) 0.64ϻ -0.06 -0.56, 0.46 
Ankle internal/external rotation -3.57 (6.39) -3.95 (3.93) 0.80ϻ 0.07 -0.44, 0.58 
Maximum kinematics 
Ankle dorsi/plantar flexion 24.76 (9.53) 25.17 (7.06) 0.44ϻ -0.05 -0.56, 0.46 
Foot progression 3.35 (7.40) 2.81 (5.03) 0.66ϻ 0.09 -0.43, 0.60 
Ankle internal/external rotation 0.17 (6.23) -0.61 (4.97) 0.44ϻ 0.14 -0.37, 0.65 
Push phase 
Mean kinematics 
Ankle dorsi/plantar flexion -9.74 (12.79) -11.41 (7.70) 0.56ϻ 0.16 -0.35, 0.67 
Foot progression 3.39 (8.35) 4.84 (6.45) 0.69ϻ -0.19 -0.70, 0.32 
Ankle internal/external rotation 1.42 (5.73) 1.48 (4.32) 0.68ϻ -0.01 -0.52, 0.50 
Minimum kinematics 
Ankle dorsi/plantar flexion -43.96 (15.50) -40.83 (8.84) 0.15ϻ** -0.25 -0.76, 0.27 
Foot progression -2.90 (6.88) -1.11 (6.24) 0.61ϻ -0.27 -0.78, 0.24 
Ankle internal/external rotation -7.69 (7.59) -7.09 (4.05) 0.86ϻ -0.10 -0.61, 0.41 
Keys: Ϯ Values reported in mean (standard deviation) by independent t-test. ϻ Values reported in median (interquartile 
range) by Mann-Whitney U test. * Indicates statistically significant difference. ** Indicates a trend; difference ≥ 20. 
SMD: standardised mean difference, CI: confidence interval. SMD of 0.2 and higher are highlighted in bold suggesting 
clinically important differences. SMD of 0.2 suggests small clinically important difference, 0.5 suggests medium clinically 
important difference, and 0.8 suggests large clinically important difference (Cohen, 1988). 
 
• Conclusion: 
 As shown above, people with JHS performed the vertical jump task with 
increased anterior pelvis tilt during the terminal compression phase, and hip external 
rotation and knee valgus during the initial to mid-compression phase. In contrast, knee 
external rotation during the initial push phase has been found to be reduced in the JHS 
group when compared to the control group’s curve: 
Some kinematic trends have been noticed during the jump compression phase of 
the JHS group when compared to the control group. Trends toward reduced kinematics 
have been illustrated in maximum hip flexion and maximum knee flexion, and the SMD 
suggests a small clinically important difference between the groups (Table 5.32, 5.33 and 
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5.34). In contrast, some trends are greater in the JHS group when compared to the control 
group, including mean hip external rotation and mean and maximum knee valgus, and the 
SMD suggests small clinically important differences between the groups (Table 5.33 and 
5.34). However, the results of the jump kinematics analysis have revealed no significant 
differences between the two groups in terms of the mean and maximum kinematics 
during the compression phase.  
Some trends have been found in the JHS group’s jump kinematics during the push 
phase. Kinematic reductions were demonstrated in mean and minimum hip extension, 
mean knee extension and minimum knee external rotation, and the SMD suggests small 
clinically important differences (Table 5.32, 5.33 and 5.34). Conversely, a trend has been 
found to be elevated in the JHS group when compared to the control group in minimum 
ankle plantar flexion, and the SMD suggests small clinically important difference (Table 
5.35). However, no statistically significant differences have been identified between the 
two groups when considering the mean and minimum jump kinematics during the push 
phase.  
           5.9.10.4 Three-dimensional moment jump analysis: 
• Introduction: 
Jump moments have been analysed using curve graphs and the statistical analysis 
of 29 patients with JHS and 30 healthy sex and age matched individuals in a control 
group. The following sections present the jump moment analysis for each joint 
separately. A difference > 0.18 Nm/kg in moment data is considered to be a trend, as the 
minimal detectable change in moment is ≤ 0.18 Nm/kg (Fernandes et al. 2015).  
• Hip jump moment; curve graphs, descriptive statistics and interferential 
analysis: 
Hip moment curve graphs have been constructed to compare the JHS group with 
the control group. Some differences have been observed and are highlighted in Figure 
5.19. V3D software was not programmed to produce transverse plane hip moment 
graphs. 
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Hip moment during jump 
 JHS group (n = 29) Control group (n = 30) 
Sagittal plane 
  
Frontal plane 
  
Figure 5.19: Curve graphs showing the moment of the hip joint during the jump test at the frontal 
and sagittal planes for the JHS and the control groups. The solid line illustrates the mean and the 
semi-transparent line illustrates the standard deviation. Red ovals highlighted the differences 
between the two groups. The vertical line separated between the compression phase; left side and 
push phase; right side. In the sagittal plane, a lower extension curve was noticed at the terminal 
compression and initial push phase, indicating a reduction in the hip extensors moment in the JHS 
group, when compared with the control group. In the frontal plane, a lower hip abduction curve was 
noticed throughout the compression and push phases, revealing a reduction in the hip abductors’ 
moment in the JHS group. 
 
Figure 5.19 illustrates reductions in hip extensors’ and abductors’ moments in the 
JHS group. Similarly, trends toward reductions have been illustrated for the JHS group in 
hip extensors’ and abductors’ moments, and the SMD suggests small clinically important 
differences during both the compression and push phases (Table 5.36). Statistically, no 
significant differences have been identified between the two groups (table 5.36). 
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Table 5.36: Jump moment acting on the hip joint during the compression and push phases for the JHS 
and control group. 
Moments parameters (Nm/kg) JHS group 
n = 29 
Control group 
n = 30 
p-value SMD 95% CI 
Compression phase 
Mean moment 
Hip flexion/extension -0.01 (0.19) 0.11 (0.32) 0.13Ϯ -0.45 -0.96, 0.07 
Hip abduction/adduction 0.31 (0.50) 0.55 (0.54) 0.24Ϯ** -0.46 -0.97, 0.06 
Hip internal/external rotation -0.09 (0.17) -0.16 (0.19) 0.07Ϯ 0.39 -0.13, 0.90 
Maximum moment 
Hip flexion/extension 0.26 (0.46) 0.57 (1.03) 0.051Ϯ** -0.39 -0.90, 0.13 
Hip abduction/adduction 0.56 (0.69) 0.80 (0.89) 0.08Ϯ** -0.30 -0.81, 0.22 
Hip internal/external rotation -0.02 (0.09) -0.03 (0.10) 0.08Ϯ 0.11 -0.41, 0.61 
Push phase 
Mean moment 
Hip flexion/extension 0.05 (0.29) 0.13 (0.42) 0.19ϻ -0.22 -0.73, 0.29 
Hip abduction/adduction 0.30 (0.54) 0.50 (0.47) 0.37ϻ** -0.40 -0.91, 0.12 
Hip internal/external rotation -0.12 (0.13) -0.19 (0.15) 0.06Ϯ 0.50 -0.03, 1.01 
Maximum moment 
Hip flexion/extension 0.34 (0.72) 0.63 (1.19) 0.48ϻ** -0.29 -0.80, 0.22 
Hip abduction/adduction 0.91 (0.67) 1.12 (0.75) 0.26Ϯ** -0.30 -0.80, 0.22 
Hip internal/external rotation 0.04 (0.02) 0.03 (0.03) 0.95ϻ 0.39 -0.13, 0.90 
Keys: Ϯ Values reported in mean (standard deviation) by independent t-test. ϻ Values reported in median (interquartile 
range) by Mann-Whitney U test. * Indicates statistically significant difference. ** Indicates a trend; difference > 0.18 
Nm/kg. SMD: standardised mean difference, CI: confidence interval. SMD of 0.2 and higher are highlighted in bold 
suggesting clinically important differences. SMD of 0.2 suggests small clinically important difference, 0.5 suggests medium 
clinically important difference, and 0.8 suggests large clinically important difference (Cohen, 1988). 
 
• Knee jump moment; curve graphs, descriptive statistics and interferential 
analysis: 
Figure 5.20 summarises the differences between the two groups in terms of knee 
jump moment in the sagittal plane. V3D software was not programmed to produce frontal 
and transverse planes knee moment graphs. 
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Knee jump moment 
 JHS group (n = 29) Control group (n = 30) 
Sagittal plane 
  
Figure 5.20: Curve graphs showing the moment of the knee joint during the jump test in the sagittal 
plane for the JHS and the control groups. The solid line illustrates the mean and the semi-transparent 
line illustrates the standard deviation. Red ovals highlighted the differences between the two groups. 
The vertical line separated between the compression phase; left side and push phase; right side. Knee 
extension moment was lowered in the JHS group during mid-terminal compression and initial-mid 
push phase, illustrating a reduction in knee extensors moment when compared with the control group.  
 
Figure 5.20 illustrates a reduction in knee extensors’ moment in the JHS group 
when compared to the control group. Similarly, and during the compression phase, 
statistically significant reductions in maximum knee extensors’ and internal rotators’ 
moments have been identified in the JHS group, and the SMD suggests small to medium 
clinically important differences between the two groups (Table 5.37). Trends toward 
reductions in mean knee extensors and adductors moments have been highlighted in the 
JHS group during the compression phase, and the SMD suggests small clinically 
important differences (Table 5.37). No significant findings or trends have been revealed 
for during the push phase. However, the SMD suggests small clinically important 
differences between the two groups during the push phase (Table 5.37). 
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Table 5.37: Jump moment acting on the knee joint during the compression and push phases for the 
JHS and control group. 
Moment parameters (Nm/kg) JHS group 
n = 29 
Control group 
n = 30 
p-value SMD 95% CI 
Compression phase 
Mean moment 
Knee flexion/extension 0.25 (0.56) 0.43 (0.59) 0.15Ϯ** -0.31 -0.82, 0.20 
Knee valgus/varus -0.21 (0.34) -0.33 (0.34) 0.19Ϯ** 0.35 -0.17, 0.86 
Knee internal/external rotation 0.06 (0.17) 0.11 (0.18) 0.19Ϯ -0.29 -0.79, 0.23 
Maximum moment 
Knee flexion/extension 0.70 (1.14) 1.13 (1.56) 0.03Ϯ* -0.31 -0.82, 0.20 
Knee valgus/varus -0.09 (0.17) -0.12 (0.30) 0.39Ϯ 0.12 -0.39, 0.63 
Knee internal/external rotation 0.21 (0.36) 0.43 (0.50) 0.04Ϯ* -0.50 -1.02, 0.02 
Push phase 
Mean moment 
Knee flexion/extension 0.29 (0.54) 0.46 (0.60) 0.25ϻ -0.30 -0.81, 0.22 
Knee valgus/varus -0.19 (0.27) -0.25 (0.43) 0.29ϻ 0.17 -0.35, 0.68 
Knee internal/external rotation 0.09 (0.18) 0.16 (0.19) 0.25ϻ -0.38 -0.89, 0.14 
Maximum moment 
Knee flexion/extension 0.98 (1.6) 1.28 (1.75) 0.19ϻ -0.18 -0.69, 0.34 
Knee valgus/varus 0.06 (0.04) 0.06 (0.06) 0.33ϻ 0.00 -0.51, 0.51 
Knee internal/external rotation 0.25 (0.45) 0.40 (0.58) 0.18ϻ -0.29 0.80, 0.23 
Keys: Ϯ Values reported in mean (standard deviation) by independent t-test. ϻ Values reported in median (interquartile 
range) by Mann-Whitney U test. * Indicates statistically significant difference. ** Indicates a trend; difference > 0.18 
Nm/kg. SMD: standardised mean difference, CI: confidence interval. SMD of 0.2 and higher are highlighted in bold 
suggesting clinically important differences. SMD of 0.2 suggests small clinically important difference, 0.5 suggests medium 
clinically important difference, and 0.8 suggests large clinically important difference (Cohen, 1988). 
 
• Ankle jump moment; curve graphs, descriptive statistics and interferential 
analysis: 
Figure 5.21 summarises the difference between the two groups in ankle jump 
kinematics in the sagittal plane. V3D was not programmed to produce frontal and 
transverse planes ankle moment graphs. 
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Ankle jump moment 
 JHS group (n = 29) Control group (n = 30) 
Sagittal plane 
  
Figure 5.21: Curve graphs showing the moment of the ankle joints during the jump test in the sagittal 
plane for the JHS and the control groups. The solid line illustrates the mean and the semi-transparent 
line illustrates the standard deviation. Red ovals highlighted the differences between the two groups. 
The vertical line separated between the compression phase; left side and push phase; right side. The 
plantar flexion curve was lowered in the JHS group during terminal compression to initial-mid push 
phase, confirming a reduction in the ankle plantar flexor moment in the JHS group when compared 
with the control group. 
 
Figure 5.21 illustrates a reduction in plantar flexors’ moment during jump in the 
JHS group. Similarly, a significant reduction in maximum plantar flexors’ moment has 
been found in the JHS group, and the SMD suggests a medium clinically important 
difference (Table 5.38). No other significant findings have been identified. During the 
compression phase, a trend toward reduction in ankle internal progression moment has 
been found in the JHS group, and the SMD suggests a large clinically important 
difference (Table 5.38). During the push phase, trends toward reductions in mean plantar 
flexors’ and external rotators’ moments have been highlighted, and the SMD suggests 
small to medium clinically important differences (Table 5.38). 
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Table 5.38: Jump moment acting on the ankle joint during the compression and push phases for the 
JHS and control group. 
Moments parameters (Nm/kg) JHS group 
n = 29 
Control group 
n = 30 
p-value SM
D 
95% CI 
Compression phase 
Mean moment 
Ankle dorsi/planar flexion 0.18 (0.33) 0.33 (0.34) 0.14Ϯ -0.45 -0.96, 0.08 
Foot progression -0.25 (0.37) 0.34 (0.48) 0.32Ϯ** -1.37 -1.92, -0.79 
Ankle internal/external rotation -0.09 (0.17) -0.15 (0.17) 0.33Ϯ 0.35 -0.17, 0.86 
Maximum moment 
Ankle dorsi/plantar flexion 0.52 (0.81) 1.09 (0.94) 0.02Ϯ* -0.65 -1.16, -0.12 
Foot progression -0.11 (0.20) -0.09 (0.27) 0.75Ϯ -0.08 -0.59, -0.43 
Ankle internal/external rotation -0.01 (0.06) -0.02 (0.05) 0.92Ϯ 0.18 -0.33, 0.69 
Push phase 
Mean moment 
Ankle dorsi/plantar flexion 0.34 (0.59) 0.61 (0.19) 0.08ϻ** -0.62 -1.13, -0.09 
Foot progression -0.23 (0.45) -0.37 (0.38) 0.34ϻ 0.34 -0.18, 0.85 
Ankle internal/external rotation -.013 (0.22) -0.23(0.24) 0.27ϻ** 0.43 -0.09, 0.94 
Maximum moment 
Ankle dorsi/plantar flexion 0.72 (1.4) 1.3 (1.4) 0.09ϻ -0.41 -0.92, 0.11 
Foot progression 0.003 (0.01) 0.004 (0.01) 0.66ϻ -0.10 -0.61, 0.41 
Ankle internal/external rotation 0.007 (0.01) 0.009 (0.01) 0.70ϻ -0.20 -0.71, 0.31 
Keys: Ϯ Values reported in mean (standard deviation) by independent t-test. ϻ Values reported in median (interquartile 
range) by Mann-Whitney U test. * Indicates statistically significant difference. ** Indicates a trend; difference > 0.18 
Nm/kg. SMD: standardised mean difference, CI: confidence interval. SMD of 0.2 and higher are highlighted in bold 
suggesting clinically important differences. SMD of 0.2 suggests small clinically important difference, 0.5 suggests medium 
clinically important difference, and 0.8 suggests large clinically important difference (Cohen, 1988). 
 
• Conclusion: 
The jump moment curve graphs of the JHS group illustrate moment reductions in 
hip extensors and abductors, knee extensors and ankle plantar flexors. Statistically, 
significant moment reductions have been identified in knee extensors and internal 
rotators and ankle plantar flexors, and the SMD suggests small-medium differences 
between the groups. Various trends have been highlighted in the JHS group during the 
compression phase, pointing toward reductions in hip extensors’ and abductors’ 
moments, knee extensors’ and adductors’ moments, and ankle internal progression 
moment; also, the SMD suggests small and large clinically important differences. During 
the push phase, trends have been highlighted toward reductions in hip extensors’ and 
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abductors’ moments and ankle plantar flexors’ and external rotators’ moments, and the 
SMD suggests small and large clinically important differences between the two groups.  
            5.9.10.5 Three-dimensional power jump analysis: 
• Introduction: 
Jump power analysis has been carried out using curve graphs and statistical 
analysis for the hip, knee and ankle joints. The following sections present the differences 
identified for each joint separately. A difference of > 0.19 Watts/kg is considered to be a 
trend, as the minimal detectable change in power is 0.19 Watts/kg (Wilken et al. 2012).   
• Hip jump power: curve graphs, descriptive statistics and interferential 
analysis: 
Figure 5.22 illustrates the differences between the two groups in hip power. V3D 
was not programmed to produce transverse plane hip power curve graphs. 
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Hip jump power 
 JHS group (n = 29) Control group (n = 30) 
Sagittal plane 
  
Frontal plane 
  
Figure 5.22: Curve graphs showing the generated and absorbed power at the hip joint during the 
jump test in the JHS and the control groups. The solid line illustrates the mean and the semi-
transparent line illustrates the standard deviation. The vertical line separates between the 
compression phase; left side and push phase; right side. Red ovals highlight the differences. In the 
sagittal plane, the curve was reduced in the JHS group during terminal compression to initial-mid 
push phase, pointing out a reduction in the hip power generation. In the frontal plane, the curve was 
lowered in the JHS group during terminal compression to initial-mid push phases, indicating a 
reduction in hip power generation. 
 
The hip power curve graphs show that the JHS group jumped with reductions in 
power generation in the sagittal and frontal planes (Figure 5.22). Similarly, statistically 
significant reductions in power generation in the JHS group have been identified during 
the compression; maximum power, and push phases, and mean power in the sagittal 
plane; also, the SMD suggests small to medium clinically important differences (Table 
5.39). A statistically significant reduction in power generation has also been found in the 
transverse plane in the JHS group during the compression phase, and maximum power, 
and the SMD suggests small clinically important differences between the two groups 
(Table 5.39). Trends toward reductions in hip power generation during the push phase 
have been found in the JHS group in the sagittal and frontal planes, and the SMD 
suggests small to medium clinically important differences (Table 5.39). 
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Table 5.39: Mean and maximum jump power generated and absorbed the hip joint during the 
compression and push phase for the JHS and control group. 
Power parameters (Watts/kg) JHS group 
n = 29 
Control group 
n = 30 
p-value SMD 95% CI 
Compression phase 
Mean power 
Hip flexion/extension 0.01 (0.13) 0.04 (0.22) 0.72 -0.17 -0.67, 0.35 
Hip abduction/adduction -0.01 (0.06) -0.03 (0.10) 0.69 -0.24 -0.27, 0.75 
Hip internal/external rotation 0.00 (0.01) 0.00 (0.02) 0.44 0.00 -0.51, 0.51 
Maximum power 
Hip flexion/extension 0.21 (0.24) 0.49 (1.01) 0.00* -0.38 -0.89, 0.14 
Hip abduction/adduction 0.11 (0.18) 0.16 (0.34) 0.17 -0.18 -0.69, 0.33 
Hip internal/external rotation 0.08 (0.11) 0.12 (0.24) 0.02* -0.21 -0.72, 0.30 
Push phase 
Mean power 
Hip flexion/extension 0.05 (0.62) 0.35 (1.31) 0.04* -0.29 -0.80, 0.23 
Hip abduction/adduction 0.13 (0.25) 0.14 (0.41) 0.93 -0.03 -0.54, 0.48 
Hip internal/external rotation 0.00 (0.06) 0.01 (0.08) 0.16 -0.14 -0.65, 0.37 
Maximum power 
Hip flexion/extension 0.77 (1.37) 1.95 (2.42) 0.06** -0.60 -1.11, -0.07 
Hip abduction/adduction 0.66 (1.12) 0.97 (1.69) 0.44** -0.22 -0.72, 0.30 
Hip internal/external rotation 0.16 (0.21) 0.25 (0.54) 0.12 -0.22 -0.73, 0.30 
Keys: Values reported in median and interquartile range (IQR) by Mann-Whitney U test. * Indicates statistically significant 
difference. ** Indicates trend; difference > 0.19 Watts/kg. SMD: standardised mean difference, CI: confidence interval. 
SMD of 0.2 and higher are highlighted in bold suggesting clinically important differences. SMD of 0.2 suggests small 
clinically important difference, 0.5 suggests medium clinically important difference, and 0.8 suggests large clinically 
important difference (Cohen, 1988). 
 
• Knee jump power: curve graphs, descriptive statistics and interferential 
analysis:  
Figure 5.23 shows the differences between the JHS and the control group in knee 
jump power in the sagittal plane. V3D was not programmed to produce curve graphs for 
knee power in the frontal and transverse planes.  
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Knee jump power 
 JHS group (n = 29) Control group (n = 30) 
Sagittal plane 
  
Figure 5.23: Curve graphs showing the generated and absorbed power at the knee joint during the 
jump test in the JHS and the control groups. The solid line illustrates the mean and the semi-
transparent line illustrates the standard deviation. The vertical line separates between the 
compression phase; left side and push phase; right side. Red circles/ovals highlight the differences 
between the two groups. The curve was higher in the JHS group during the mid-compression phase, 
illustrating a reduction in knee power absorption. During the push phase, the curve was lower in the 
JHS group, evidencing a reduction in knee power generation.  
 
The curve graph of the JHS group shows that that JHS group jumped with 
reductions in knee power absorption and generation when compared to the control group 
(Figure 5.23).  The statistical analysis highlights significant reductions in knee power 
generation in the JHS group during the compression phase sagittal; maximum power, and 
transverse planes, and mean and maximum power; also, the SMD suggests small 
clinically important differences (Table 5.40). Additionally, a trend toward reduction in 
power absorption in the JHS group during the compression phase for mean power has 
been found, and the SMD suggests a small clinically important difference (Table 5.40).  
During the push phase, the JHS group showed trends toward reductions in power 
generation; maximum power in the sagittal and frontal planes, and the SMD suggests 
small to medium clinically important differences between the two groups (Table 5.40). 
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Table 5.40: Mean and maximum jump power generated and absorbed the knee joint during the 
compression and push phase for the JHS and control group. 
Power parameters (Watts/kg) JHS group 
n = 29 
Control group 
n = 30 
p-value SMD 95% CI 
Compression phase 
Mean power 
Knee flexion/extension -0.24 (0.56) -0.49 (0.89) 0.17** 0.33 -0.18, 0.84 
Knee valgus/varus 0.00 (0.04) 0.00 (0.04) 0.81 0.00 -0.51, 0.51 
Knee internal/external rotation 0.00 (0.03) 0.01 (0.04) 0.03* -0.28 -0.79, 0.23 
Maximum power 
Knee flexion/extension 0.14 (0.31) 0.71 (2.11) 0.00* -0.37 -0.88, 0.14 
Knee valgus/varus 0.11 (0.18) 0.16 (0.20) 0.16 -0.26 -0.77, 0.25 
Knee internal/external rotation 0.08 (0.16) 0.17 (0.29) 0.03* -0.38 -0.89, 0.14 
Push phase 
Mean power 
Knee flexion/extension 0.75 (1.40) 1.85 (2.22) 0.054 -0.59 -1.10, -0.06 
Knee valgus/varus -0.04 (0.18) -0.14 (0.26) 0.20 0.45 -0.08, 0.96 
Knee internal/external rotation 0.00 (0.04) 0.00 (0.08) 0.43 0.00 -0.51, 0.51 
Maximum power 
Knee flexion/extension 3.8 (5.84) 5.75 (9.02) 0.15** -0.26 -0.76, 0.26 
Knee valgus/varus 0.07 (0.44) 0.40 (0.78) 0.17** -0.52 -1.03, 0.01 
Knee internal/external rotation 0.12 (0.30) 0.15 (0.39) 0.45 -0.09 -0.60, 0.43 
Keys: Values reported in median and interquartile range (IQR) by Mann-Whitney U test. * Indicates statistically significant 
difference. ** Indicates trend; difference > 0.19 Watts/kg. SMD: standardised mean difference, CI: confidence interval. 
SMD of 0.2 and higher are highlighted in bold suggesting clinically important differences. SMD of 0.2 suggests small 
clinically important difference, 0.5 suggests medium clinically important difference, and 0.8 suggests large clinically 
important difference (Cohen, 1988). 
 
• Ankle jump power: curve graphs, descriptive statistics and interferential 
analysis:  
Figure 5.24 illustrates the differences between the JHS group and the control 
group in ankle power during the jump in the sagittal plane. V3D was not programmed to 
produce frontal and transverse planes ankle power curve graphs.   
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Ankle jump power 
 JHS group (n = 29) Control group (n = 30) 
Sagittal plane 
  
Figure 5.24: Curve graphs showing the generated and absorbed power during the jump test at the 
ankle joint in the JHS and the control groups. The solid line illustrates the mean and the semi-
transparent line illustrates the standard deviation. The vertical line separates between the 
compression phase; left side and push phase; right side. Red circles/ovals highlight the differences 
between the two groups. The ankle curve was reduced in the JHS group during the initial-mid push 
phase, pointing out a reduction in ankle power generation.    
 
Figure 5.24 illustrates a reduction in ankle power generation in the JHS group 
during the push phase in the sagittal plane. Similarly, a significant reduction in ankle 
power generation has been illustrated in the JHS group during the push phase in the 
sagittal plane; mean power, and the SMD suggests a medium clinically important 
difference (Figure 5.41). No other significant finding has been identified. A trend toward 
a reduction in ankle power generation has been found in the JHS group during the push 
phase in the sagittal plane; maximum power, and the SMD suggests a small clinically 
important difference (Figure 5.41). 
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Table 5.41: Mean and maximum jump power generated and absorbed the ankle joint during the 
compression and push phase for the JHS and control group. 
Power parameters (Watts/kg) JHS group 
n = 29 
Control group 
n = 30 
p-value SMD 95% CI 
Compression phase 
Mean power 
Ankle dorsi/plantar flexion -0.04 (0.11) -0.06 (0.12) 0.34 0.17 -0.34, 0.68 
Foot progression 0.00 (0.04) 0.00 (0.03) 0.36 0.00 -0.51, 0.51 
Ankle internal/external rotation 0.00 (0.02) 0.01 (0.02) 0.40 -0.50 -1.01, 0.02 
Maximum power 
Ankle dorsi/plantar flexion 0.04 (0.15) 0.10 (0.41) 0.14 -0.19 -0.70, 0.32 
Foot progression 0.08 (0.27) 0.13 (0.32) 0.73 -0.17 -0.68, 0.34 
Ankle internal/external rotation 0.06 (0.19) 0.14 (0.22) 0.11 -0.39 -0.90, 0.13 
Push phase 
Mean power 
Ankle dorsi/plantar flexion 1.01 (2.01) 2.29 (2.37) 0.02* -0.58 -1.09, -0.05 
Foot progression -0.09 (0.40) -0.20 (0.46) 0.33 0.25 -0.26, 0.76 
Ankle internal/external rotation -0.08 (0.14) -0.15 (0.20) 0.09 0.40 -0.12, 0.91 
Maximum power 
Ankle dorsi/plantar flexion 3.47 (9.29) 8.39 (12.86) 0.10** -0.44 -0.95, 0.08 
Foot progression 0.03 (0.19) 0.12 (0.40) 0.34 -0.29 -0.79, 0.23 
Ankle internal/external rotation 0.06 (0.19) 0.10 (0.23) 0.21 -0.19 -0.70, 0.32 
Keys: Values reported in median and interquartile range (IQR) by Mann-Whitney U test. * Indicates statistically significant 
difference. ** Indicates trend; difference > 0.19 Watts/kg. SMD: standardised mean difference, CI: confidence interval. 
SMD of 0.2 and higher are highlighted in bold suggesting clinically important differences. SMD of 0.2 suggests small 
clinically important difference, 0.5 suggests medium clinically important difference, and 0.8 suggests large clinically 
important difference (Cohen, 1988). 
 
• Conclusion:  
The jump test has been analysed in terms of power generated and absorbed by the 
lower limb joints. During the compression phase, the results show a significant reduction 
in the hips’ maximum power generation in the sagittal and transverse planes in the JHS 
group, and the SMD suggests small clinically important differences. Additionally, there 
were statistically significant reductions in the knee joint in mean power generation; 
transverse plane, and maximum power generation; sagittal and transverse planes, in the 
JHS group, and the SMD suggests small clinically important differences between the 
groups. During the push phase, the JHS group displayed a significant reduction in the 
mean power generation in the hip and ankle joints in the sagittal plane, and the SMD 
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suggests small to medium clinically important differences between the two groups. 
Various trends have been noticed and all these suggest that people with JHS jumped with 
reduced power in the hip, knee and ankle joints, and the SMDs suggest small to medium 
differences between the groups.  
5.9.10.6 Summary: 
In summary, various differences have been observed visually from the curve 
graphs, and statistically, for the JHS group’s kinematics and kinetics during both walking 
and the vertical jump. The gait kinematics of the JHS group were predominantly reduced 
at the pelvis, hip, knee and ankle joints during various planes of motion, yet a few 
kinematics were found to increase including anterior pelvic tilt, hip adduction and knee 
valgus. However, only two movements were significantly reduced in the JHS group: 
pelvic upward obliquity and hip abduction. Similarly, the jump kinematics of the JHS 
group were mostly reduced in the pelvis, knee and foot. Additionally, some kinematics 
were found to increase in the JHS group’s curve graphs, including pelvic tilt, hip external 
rotation, and knee valgus. The increase in knee valgus has been noticed in the JHS group 
during walking as well as during the vertical jump. However, the differences noticed in 
the JHS group’s kinematics during the jump are not statistically significant.  
As shown in the gait and vertical jump analysis sections, the JHS group walked 
and jumped with reduced moments at the hip, knee and ankle joints. The curve graphs 
show that people with JHS walked and jumped with reduced knee extensor moment. 
However, during walking, moments were reduced at the hip flexors and adductors and 
knee flexors and adductors during different stages of the gait cycle. Similarly, but in 
different muscle groups, moments were reduced in the JHS group during the vertical 
jump in the hip extensors and abductors, and the ankle plantar flexors. Regardless of 
these observations, a few observations have been found to be statistically reduced, 
including hip and knee extensor moment, and knee internal rotator moments for the JHS 
group during walking. Statistically significant reductions have also been found during the 
vertical jump for the JHS group for knee extensors’ and internal rotators’ moments, as 
was found during walking. In addition to the statistically significant reduction in ankle 
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dorsi-flexors’ moments in the JHS group during the vertical jump task, this has not been 
found to be statistically significant during walking.  
Regarding power generation and absorption, all the curve graph observations 
highlight that the participants with JHS walked and jumped with reduced power 
generation and absorption at the hip, knee and ankle joints. Moreover, some of these 
observations are statistically significant. During walking, powers were statistically 
reduced at the hip and ankle joints. In a similar manner, those were found to be 
significantly reduced during the vertical jump, besides the reduction in ankle power. 
 
5.10 The feasibility of sonoelastography for studying gastrocnemius 
medius: 
Ten participants from the JHS group, and ten participants from the control group 
were included in the feasibility sonoelastography (SEG) study. Table 5.42 presents the 
demographic characteristics of the participants. The two groups were similar in term of 
sex, age, height, weight and BMI; p ≥ 0.05 (Table 5.42). In contrast, significant 
difference was found in the Beighton score between the two groups (Table 5.42).  
Table 5.42: The demographic characteristics of the JHS and the control groups who participated 
in the feasibility sonoelastography study. 
Demographic characteristics JHS group 
n = 10 
Control group 
 n = 10 
p-
value 
Sex 9 women 1 man 9 women 1 man 1.00 
 Mean SD Mean SD  
Age (years) 39.2 15.64 38.9 13.04 0.54 
Height (cm) 164.80 9.84 163.07 8.61 0.68 
Weight (kg) 74.26 20.15 70.27 12.78 0.61 
BMI 27.15 6.20 26.37 3.75 0.74 
Beighton score 6.50 1.58 1.10 0.73 .001 
Keys: SD: standard deviation. BMI: body mass index. 
 
The dominant gastrocnemius medius (GM) muscle of each participant (20 
participants) was scanned three times resulting in 60 SEG images. Four images were 
excluded due to asymmetrical curves displayed beneath the SEG images. The curves 
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reflected the four compression magnitudes and symmetry applied by the examiner. If 
these curves were not symmetrical, it would mean that the examiner was applying 
inconsistent pressure during the test, and that might risk the test’s reliability. 
Additionally, two images included artefacts, which meant that there was a false blue 
colour displayed at the bottom of the image probably because the SEG waves did not 
reach that area. Therefore, 54 images were analysed instead of 60 images, where the 
mean was calculated using the results of two images instead of three for six participants; 
three participants from the JHS group and three participants from the control group. As 
explained earlier in the method chapter, the blue colour in the SEG image refers to hard 
tissues, the green colour refers to tissues with intermediate elasticity, and the red colour 
refers to soft tissues. The descriptive statistics indicated a higher percentage of red (soft) 
colour pixels and lower percentage of green (intermittent) colour pixels in the JHS 
group’s SEG images when compared with the control group (Table 5.43). Yet, no 
statistical differences were found in the three colour’; red, green, and blue, mean 
percentages of colour pixels (Table 5.43). Additionally, SMDs suggested no difference 
between the groups (Table 5.43). Independent samples t-tests were used to compare the 
two groups’ results, as the assumptions for operating the parametric test were met. 
The SEG was feasible for exploring the elasticity of GM in people with JHS. SEG 
required a reasonable amount of training for a clinician with sufficient background in 
musculoskeletal anatomy; four hours of observations and practical training. The 
examination was completed in less than five minutes for each participant, so it may be 
reasonable for clinical practice, and it was well tolerated by patients. In addition, the SEG 
image was analysed in less than five minutes. 
Table 5.43: Mean percentage of the pixel numbers of the red, green and blue colours displayed in the 
SEG images for the JHS and control group. 
Mean percentage of 
pixel numbers 
JHS group (n = 10) Control group (n = 10) p-
value 
SMD 95% CI 
Mean % Standard 
deviation% 
Mean % Standard 
Deviation% 
Red (soft) 14.99 10.58 13.48 6.40 0.70 0.17 -0.71, 1.04 
Green (intermittent) 42.17 9.57 43.59 10.85 0.75 -0.14 -1.01, 0.74 
Blue (hard)  42.80 11.77 42.89 12.66 0.98 -0.01 -0.88, 0.87 
Keys: SMD: standardised mean difference, CI: confidence interval. SMD of 0.2 and higher indicates clinically important 
differences (Cohen, 1988). 
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5.11 Conclusion: 
In summary, the Results Chapter has identified various impacts from JHS on 
impairment, activity and participation. Pain was significantly greater in the JHS group 
when compared to the control group during both rest and movement in the lower back, 
hip, knee and ankle joints. Moreover, JHS had a significant impact on physical and 
psychological wellbeing when measured with SF-12, and that was also identified in the 
BIoH questionnaire. Plantar flexor strength was found to be significantly weaker in the 
JHS group, along with a significant reduction in Achilles tendon stiffness. Furthermore, 
the results identified a significant reduction in non-dominant knee proprioception when 
measured in a weight bearing position. The three-dimensional gait analyses highlighted a 
significant reduction in the JHS group’s speed, stride and step length, while stance time 
duration was found to be significantly increased. Gait and vertical jump kinematics were 
found to be predominantly reduced in the JHS group, but a few measures were found to 
increase. Various kinetic parameters: moments and powers, of the JHS group during 
walking and the vertical jump were reduced during the various sub-phases of each 
activity. The vertical jump test showed that the JHS group jumped to a comparable height 
to the control group, with comparable lower limb stiffness. However, the 
sonoelastography scanning of the GM identified no statistical differences between the 
two groups, but the descriptive statistics showed a higher percentage of the red (soft) 
colour pixels in the JHS group’ SEG images when compared to the control group. 
The next chapter, the discussion chapter, discusses the entire results of the current 
project, which have been presented in Chapter Five. Moreover, the limitations, clinical 
implications and recommendations for future research are also explained in the next 
chapter. 
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6. CHAPTER SIX: DISCUSSION 
6.1 Introduction: 
The discussion chapter is divided into sections according to the variables being 
explored, which are pain, physical activity level, general health and participation, muscle 
strength, and stiffness. Stiffness has been measured on two levels: using ultrasound and 
the jump test. Therefore, stiffness measured on the two levels has been compared. 
Additionally, several sections have been developed to discuss knee proprioception and 
gait spatiotemporal, kinematic and kinetic-related parameters. Lastly, jump kinematics 
and kinetics, and medial gastrocnemius elasticity measured, using the sonoelastography 
(SEG), are discussed. The results regarding each variable have been summarised and then 
related to the previous literature where this exists. Several theories and justifications have 
been put forward to possibly explain the results. At the end of this chapter, the limitations 
of the current research, clinical implications and recommendations for future research are 
presented. 
A summary of the main findings and interpretation were shared with a patient 
research partner (PRP_S). Unfortunately, it was not possible to discuss these in detail, but 
she provided some very useful feedback via e-mail. In general, the findings made sense to 
her in the context of her own experiences of living with JHS and what she observed in 
others with the condition, including her own daughter. There were some exceptions, 
however, such as her observation that walking distance as opposed to walking speed was 
more of an issue for her. These were very helpful perspectives on the findings which are 
presented in this chapter, although they do represent the opinions of just one person. 
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6.2  Pain: the impact of JHS on pain in the lower limb joints: 
Joint pain is a major complaint of people with JHS, as well as an important 
diagnostic measure (Grahame, 2009; Rombaut et al. 2010; Fatoye et al. 2012). As has 
been illustrated in the current research, the JHS group experienced significantly greater 
pain intensity during rest and movement in the lower back, bilateral hips, knees and 
ankles when compared with the control group; p = 0.001, and SMDs suggested large 
clinically important differences for all of the joints tested. 
Joint pain in people with JHS has been explored in various previous studies. 
However, the quantifications of previous studies were either generic or limited to one 
joint. For example, Sacheti et al. (1997) have presented one mean value as a generic 
indication of the pain experienced in the upper and lower limb joints. Similarly, Rombaut 
et al. (2010) used one question as a general measure for pain in all joints by asking “How 
severe is your pain today?” (pp. 1340), and the answer was based on a 0-10 VAS. Fatoye 
et al. (2012) focused on the knee joint in children aged eight to 15 years. PRP_S 
commented: 
“Each joint affects me differently so answering in general would not necessarily be a true 
representation of my pain whereas asking about each joint would give a more realistic 
picture of my whole body.” 
In contrast, two studies performed joint-specific assessment; Albayrak et al. 2015 and 
Palmer et al. 2016. Albayrak et al. (2015) focused on pain severity, while Palmer et al. 
(2016) explored the presence of pain in each joint. All of the previous studies support the 
current study’s findings and highlighted the significant complaints of joint pain by people 
with JHS. 
The current study is one of few studies to specifically measure pain intensity in 
the lower back, and lower limb joints in people with JHS during both rest and movement. 
Moreover, the current study is the first to assess pain bilaterally. Fourteen joint-specific 
questions were used for the pain assessment, and significant elevations in pain intensity 
were found in all the tested joints in the JHS group- the lower-back, hip, knee and ankle 
joints, bilaterally. PRP_S commented: 
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“Over flexing of the joint causes me pain as I feel a lack of support around the joint.” 
Joint hypermobility and instability could explain joint pain in people with JHS. 
Joint instability alters joint biomechanics and changes the strategy of joint neuromuscular 
control (Wendy and Snyder-Mackler, 2007). Such biomechanical and neuromuscular 
alterations elevate the intra-articular contact stress, which may cause intra-articular 
damage and micro-trauma, and therefore pain (Dieppe and Lohmander, 2005; Blalock et 
al. 2015).  
A vicious cycle of instability and pain could be induced by muscle weakness due 
to reduced physical activity in people with JHS. As has been found in the current study 
and in previous studies, people with JHS face a significant reduction in their physical 
activity levels, and that could further induce disuse muscle weakness (Rombaut et al. 
2010; Fatoye et al. 2012; Palmer et al. 2016). Muscles are major dynamic joint 
stabilisers, so disuse muscle weakness could further increase joint instability and pain 
(Sakai et al. 2000). Additionally, statistically significant muscle weakness has been 
identified in the current study in the JHS group. 
Additional sub-analysis was performed in the current study to identify the 
prevalence of pain in the lower back and lower limb joints. The results indicate that 
77.4% of the participants in the JHS group complained of pain in the previous week in all 
the tested joints, with pain present in all the tested joints. Pain in the lower back area was 
the most prevalent during both rest and movement (93.54% for both) and the prevalence 
of pain during movement in the left hip and during rest in the left knee joints was similar 
to the lower back. Pain prevalence during rest was greater in the lower back and left knee, 
followed by the right knee, then bilateral hips, followed by the ankle joints, bilaterally. 
Pain prevalence during movement was greater in the lower back and left hip joint, 
followed by the right hip, left knee and bilateral ankle joints; all at similar prevalence of 
90.32%. The prevalence of pain in the right knee joint was the lowest during movement. 
Severity sub-analysis was also performed, which indicated that the lower back area was 
the most painful area, followed by the hips, knees and ankles. Two studies carried out 
sub-analysis for pain distributions and severity patterns in the lower body of people with 
JHS- Albayrak et al. 2015 and Palmer et al. 2016- and they are in agreement with the 
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results of the present study, as the lower back, followed by the knee then the ankle joint 
were the most severely affected joints in the lower limbs in people with JHS. However, 
pain in the hip joint was not considered by Albayrak et al. (2015). Similarly, but with a 
slight difference between hip and knee joint pain prevalence, the lower back was found to 
be the most commonly affected joint in people with JHS at 89.7%, followed by the knee 
at 85.8%; hip 83.0%, and then the ankle joint 66.3% (Palmer et al. 2016).      
The results show that lower back pain is the most common type, and it is the most 
severely affected joint in the lower body in the JHS group. This supports the fact that 
lower back pain is the most frequent cause of absences from work in the general 
population (Wilke et al. 1999).  There are various reasons which could explain such 
findings. First, the spine is in constant anterior bending moment during upright activities 
as the center of gravity is anterior to the spinal column (Hall, 1999, Chow et al. 2010). 
Second, the spinal muscles have the smallest moment arms, so larger muscle force is 
generated to counteract the load on the spine, and such large force generation places the 
spine under constant compression load during upright activities (Hall, 1999; Cappozzo, 
2005). Third, intra-abdominal pressure produces an additional load for the lower back 
area (Cholewicki, Juluru and McGill, 1999). More importantly, several factors could 
convert the normal physiological loads on the lower back to symptomatic in people with 
JHS. Collagenous fragility of the joint supportive structures has been suggested by 
previous genetic reports in people with JHS (Malfait et al. 2006). These genetic 
mutations cause weakness of the connective tissues, which compromises the physical 
integrity of the joint’s supportive structures, making the joints vulnerable to trauma and 
over-use injuries, and therefore pain (Hakim and Grahame, 2003; Grahame, 2009). 
The differences in maximum force generation during activity at the hip, knee and 
ankle joints may explain the differences in the pain intensity experienced in those joints. 
Biomechanically, during activity, maximum force is generated mainly at the hip joint 
followed by the knee and then the ankle joint. Specifically, maximum force generation at 
the hip joint is equivalent to four times the body weight during walking (Hall, 1999). 
Maximum force generation at the knee joint is equivalent to three times the body weight 
during walking, while the maximum force generated at the ankle joint and foot is 
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equivalent to 1.6 times the body weight (Hall, 1999). Such differences in maximum force 
generation might explain the higher intensity of pain experienced during movement at the 
hip, then the knee, followed by the ankle joint in the JHS group. Specifically, the fragility 
of the joint supportive structures causes joint instability in people with JHS, which could 
turn the normative force generation at the lower limb joint into symptomatic load (Hakim 
and Grahame, 2003; Malfait et al. 2006; Grahame, 2009; O’Connell et al. 2010).     
The results show that pain experienced during movement is significantly higher 
than pain experienced during rest for all the tested joints, as p = .001. The SMDs for pain 
measured during movement and rest were ≥ 0.8, which suggests a large clinically 
important difference (Cohen, 1988). However, the SMDs for pain measured during 
movement showed higher values than the SMDs for pain measured during rest, which 
suggest that pain during movement demonstrate a higher clinically important difference. 
This finding supports the previous findings for people with osteoarthritis, where pain on 
movement is more severe than pain experienced during rest (Perrot et al. 2009). For 
people with osteoarthritis, it has been postulated that pain during rest associated more 
with subchondral bone pressure (Berenbaum, 2013; Sayers et al. 2016). In contrast, pain 
experienced during movement in osteoarthritis is associated more with inflammation, 
which is local and related to synovitis (Berenbaum, 2013; Sayers et al. 2016). In the 
absence of significant bony involvement, it may be that inflammation and synovitis play 
an important role in the generation of pain during movement in people with JHS 
(Grahame, 2001).  
 
6.3 The impact of JHS on physical activity level, general health and 
participation:  
The JHS group scored significantly lower than the control group on the SF-12 
questionnaire for all of the Physical Component Score: physical function, physical role, 
bodily pain, general health and vitality, as well as for the Mental Component Score: 
social function, emotional role and mental health, and the SMDs suggest large clinically 
important differences for all the physical and mental components. The findings from the 
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current study support the previously reported findings for adults, which highlight the 
great impact of JHS on people’s physical and psychological lives (Rombaut et al. 2010; 
Albayrak et al. 2015; Johannessen et al. 2016; Plamer et al. 2016). All of the previous 
studies have reached the same conclusion, which support the findings of the current 
study, in that JHS significantly impacts on physical activity, general health and 
participation. Moreover, all of the previous studies support the findings of the current 
study as they highlight the psychological impact of JHS, including reduced mental health, 
vitality, social functioning and emotional role.  
Three factors could help to justify the deterioration in the physical and 
psychological status of people with JHS: pain, fatigue and autonomic symptoms. Pain is a 
stressful sensory input, and the feeling of pain associated with direct/indirect tissue 
damage acts as a warning sign to prevent further tissue damage (Gatchel et al. 2007; 
Debono, Hoeksema and Hobbsm, 2013). Feeling and experiencing multiple joint pain 
with JHS could lead to withdrawal from physical activity, which has been reflected in all 
the components of the physical activity status. Specifically, negative moderate to strong 
correlations were originally identified in the current study between the Physical 
Components of the SF-12 questionnaire and pain. Pain could also cause deterioration in 
the psychological status of the person, and the psychological aspect is essential in 
understanding chronic pain following the biopsychosocial concept (Gatchel et al. 2007). 
Similarly, negative moderate correlations were identified in the current study between the 
Mental Component Score of the SF-12 questionnaire, and pain experienced in the lower 
back and hip joints. Moreover, a bi-directional relationship between pain and 
psychological deterioration could worsen the situation, as negative emotions can increase 
the perception of pain (Debono, Hoeksema and Hobbsm, 2013), similarly, positive 
emotions promote a therapeutic response to pain (Debono, Hoeksema and Hobbsm, 
2013). Fatigue could be the second justification for the negative impact of JHS on 
physical and psychological conditions. This is because fatigue is common in people with 
JHS, and that could impact on their physical activity levels (Gazit et al. 2003; Palmer et 
al. 2016). High levels of psychological distress have been reported in people with JHS 
who complained of severe fatigue (Voermans and Knoop, 2011).  Additionally, an inter-
relationship could exist between pain and fatigue (Meeus and Nijs, 2007). Thirdly, people 
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with JHS complain of autonomic symptoms such as heat intolerance, palpitations, 
orthostatic hypotension and tachycardia (Gazit et al. 2003). Such autonomic symptoms, 
as identified in people with JHS, could lead to a reduction in their physical and 
psychological status.          
The BIoH questionnaire was used to determine the impact of JHS. The mean ± 
standard deviation was 211.51 ± 39.28, where the score for the most severe impact on 
people’s lives is equivalent to 360. The result of the BIoH questionnaire is approximately 
equivalent to the mean score reported by Palmer et al. (2016) of 234, which suggest that 
the current study sample might be representative of a larger JHS population of 615 
HMSA members examined by Palmer et al. (2016). BIoH showed high concurrent 
validity when correlated to the SF-12 questionnaire in the current study. Specifically, 
good correlations were identified for the SF-12 items of physical function, physical role, 
bodily pain and social function: 0.748, 0.615, 0.570 and 0.622, respectively. The reported 
concurrent validity in the current study is comparable to those reported by Palmer et al. 
(2016) for similar categories: physical function, physical role, bodily pain, and social 
function for the SF-36. 
 
6.4  Stiffness measured with ultrasound and jump tests: the impact of 
JHS on stiffness: 
One of the main purposes of the current project was to investigate the impacts of 
JHS on stiffness at two levels: the specific level (muscle-tendon unit) and the generic 
level (the entire stiffness at the lower limbs). At the specific level of stiffness, diagnostic 
ultrasound was used to track the elongation of the muscle-tendon unit of GM while 
measuring muscle force with the digital myometer. Therefore, the stiffness has been 
calculated from the ratio of muscle force to muscle-tendon lengthening (Fukashiro et al. 
1995; Rombaut et al. 2012a). At the generic level, lower-limb stiffness was measured 
from the ratio of peak vertical ground reaction force and vertical displacement through a 
vertical jump test. Regarding the specific level of stiffness, the results demonstrate that 
people with JHS exhibited a significant reduction in their Achilles tendon stiffness when 
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compared to the control group, and the SMD suggests a small clinically important 
difference. Conversely, no significant difference was found between the two groups in 
terms of lower-limb generic stiffness measured through the vertical jump test, and the 
SMD suggests no clinically important difference. 
The internal validity of the stiffness study is appropriate due to several reasons. 
First, the groups were homogenous in terms of gender, age, BMI, height and weight. 
Second, the sample size was based on a sample size calculation. Third, the methods 
followed are well established based on valid theoretical concepts, and high clinimetric 
properties of the instrumentation and assessment method used, which were discussed in 
the methods chapter. In particular, the active method demonstrated high reliability for 
plantar flexors stiffness measurements: ICC 0.89 (Kubo, Kanehisa and Fukunage, 2001). 
The ultrasound involves high resolution, precision, accuracy and reliability levels for 
musculoskeletal examination (Kawakami, Abe and Fukunaga, 1993; Mahieu et al. 2004; 
Reeves, Maganaris and Narici, 2004; Vlychou and Teh, 2008; Barber, Barrett and 
Lichtwark, 2009). Fourth, the examiner in the current research demonstrated excellent 
intra-rater reliability in measuring Achilles tendon stiffness using the ultrasound and the 
digital myometer; ICCs of 0.981 and 0.984 for assessing the JHS and the control group, 
respectively. The examiner in the current research also showed good to excellent intra-
rater reliability for kinematic measurements using the Qualisys system; ICCs ranged from 
0.625 – 0.996. However, a significant difference was found at Achilles tendon stiffness 
when measuring the JHS group at trial one when compared to trial two. Therefore, the 
significant reduction identified in Achilles tendon stiffness in the JHS group could be 
related to intra-rater error. 
            6.4.1 Achilles-tendon stiffness; measured with the ultrasonography method: 
There are only two studies available in terms of studying the mechanical 
properties of the muscle-tendon unit in people with JHS; Rombaut et al. (2012a) and 
Nielsen et al. (2014), and the current study is in agreement with Rombaut et al. (2012a), 
suggesting a deficiency in the mechanical properties of the Achilles tendon in people 
with JHS. However, the means ± standard deviations of the current study- 16.80 ± 7.12 
N/mm for the JHS group and 21.16 ± 9.09 N/mm for the control group- are greater than 
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the means ± standard deviations of Romabut et al. (2012): 12.3 ± 4.84 N/mm for the JHS 
group and 15.6 ± 4.43 N/mm for the control group. There are two factors which might 
explain the discrepancies. First, the current study eliminated estimation error (over-
estimation and under-estimation) by not estimating the contribution of the medial 
gastrocnemius from the plantar flexors. In particular, the measured force was not reduced 
to 18% of the measured value, the estimated GM contribution of the cross-sectional area 
to all the plantar flexors, as Rombaut et al. (2012a) did. Such mathematical 
considerations would reduce the overall stiffness values. Second, Rombaut et al. (2012a) 
studied only women, whereas the current study also included men, and that may have 
inflated the stiffness values due to gender differences. 
In the current study, the stiffness of the Achilles tendon has been calculated using 
the force of the plantar flexors. In contrast, the stiffness of the Achilles tendon has been 
calculated using the force of the gastrocnemius medius by Rombaut et al. (2012a).  Also, 
Rombaut et al. (2012a) estimated the gastrocnemius medius contribution in force 
production from the physiological cross-sectional area of the gastrocnemius medius to all 
the plantar flexors. However, this estimation was not considered in the current study for 
several reasons. The investigation of the current study and the study by Romabut et al. 
(2012a) aimed to measure the stiffness of the Achilles tendon. However, tension and 
strain in the Achilles tendon is not only created by the gastrocnemius medius but also by 
the lateral head of the gastrocnemius and soleus muscle (Snell, 2000). In particular, the 
bellies of the medial and lateral heads of gastrocnemius join at the posterior part of the 
Achilles tendon, while the soleus muscle joins at the anterior part of the Achilles tendon 
(Snell, 2000). Therefore, considering only the gastrocnemius medius force neglects the 
contribution of the lateral head of the gastrocnemius muscle and the soleus muscle. This 
is further supported by Muramatsu et al. (2002) who found that the mean exerted force 
during isometric plantar flexion contraction was linearly related to the mean 
electromyographic activity of the gastrocnemius; medial and lateral, and soleus muscles 
(Muramatsu et al. 2001). More importantly, the stress and stiffness in the aponeurosis is 
similar to the stress and stiffness in the Achilles tendon (Scott, and Loeb, 1995; 
Muramatsu et al. 2001). No significant difference was found in the maximum strain 
between Achilles tendon and aponeurosis (Muramatsu et al. 2001). Therefore, strain 
 252 
 
measured in the gastrocnemius medius reflects the strain in the Achilles tendon. 
Ultimately, Achilles tendon stiffness might be more accurately measured using the ratio 
of the plantar flexors’ strength to Achilles tendon lengthening calculated from the 
gastrocnemius medius aponeurosis.  
The findings of the current study, and the one by Rombaut et al. (2012a), 
contradict the findings of Nielsen et al. (2014), as they did not identify significant 
differences in patellar tendon stiffness in the JHS group when compared to the control 
group. Such a discrepancy between the results could be related to the small sample size of 
Nielsen et al. (2014), who included eight participants in each group. In contrast, larger 
sample sizes were included by Romabut et al. (2012a) and the current study; 25 and 31 
respectively. Ultimately, the findings of Nielsen et al. (2014) have been risked to type II 
error, by reporting false negative results (Crombie, 2010). Additionally, Nielson et al. 
(2014) have focused on the patellar tendon, while Rombaut et al. (2012a) and the current 
study have focused on the Achilles tendon. As different structures were examined, this 
might make the comparison more difficult. However, Nielson et al. (2014) provide 
another possible justification. The stiffness of the Achilles tendon might have been 
underestimated by Romabaut et al. (2012a) because they only tracked the elongation of 
the proximal part of the tendon (Nielson et al. 2014). In contrast, the proximal and distal 
parts of the patellar tendon were tracked by Nielson et al. (2012). Even so, this point 
should be confirmed with a justified sample size study. 
The reduction in Achilles tendon stiffness identified in the current project could 
be related to the genetic basis of JHS. Although the genetic basis for JHS is not 
conclusive, and sometimes contradictory, there are various reports which could explain 
the findings. Collagen is the dominant constituent in tendons, making up 65-80% of 
tendon composition, and the tendon mediates force transmission through the muscle-
tendon complex to generate the required angular motion (Kannus, 2000). Genetic reports 
have identified abnormalities in the genes encoding collagen as well as the enzymes 
responsible for collagen modification in people with JHS (Narcisi et al. 1994; Malfait et 
al. 2006). Likewise, a mutation has been found in the genes encoding collagen in a family 
with EDS-HT (Narcisi et al. 1994). Consequently, these genetic abnormalities could 
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distort the muscular-tendon force transmission capability, and that might lead to a 
significant reduction in Achilles tendon stiffness. In contrast, other studies have found no 
deficits in collagen genes subtypes in people with joint hypermobility (Henney et al. 
1992). Therefore, such an explanation might not apply to all cases.  
The reduction in Achilles tendon stiffness identified in people with JHS could be 
related to abnormalities in the genes encoding protein. In Particular, 5-10% of the women 
with JHS in the study carried out by Zweers et al. (2003) had a mutation in tenascin-X: 
extra-cellular glycoprotein (Malfait et al. 2006). However, the percentage identified is 
small and might not be relevant to the wider population with JHS. Indeed, a complete 
lack of tenascin-X was revealed in a seven year old boy with EDS-HT (O’Connell et al. 
2010). Specifically, tenascin-X is highly presented in musculoskeletal tissues and it 
bridges between the collagen fibers (O’Connell et al. 2010). Additionally, tenascin-X 
also contributes towards collagen formation and regulation (O’Connell et al. 2010). 
Therefore, a reduction/absence of tenascin-X could change the mechanical stiffness of the 
muscle-tendon unit. Additionally, a molecular defect has been identified in four genes 
encoding protein in 34 members from a three generation family with EDS-HT (Syx et al. 
2015). These genes are essential for collagenous formation and regulation, which might 
be responsible for the deficiency in Achilles tendon stiffness. 
Ultimately, the genetic basis behind JHS is heterogeneous. However, various 
reports, reviews and studies have suggested that there are abnormalities in the muscle-
tendon complex at the cellular level, and that may explain the deficit in the mechanical 
properties of the Achilles tendon in people with JHS. 
Muscle weakness could explain the reduction in Achilles tendon stiffness in the 
JHS, as Achilles tendon stiffness is determined by the ratio of muscle-tendon lengthening 
and muscle strength (Rombaut et al. 2012a). The most compelling evidence is that a 
significant reduction in the plantar flexors’ strength used to calculate Achilles tendon 
stiffness has been highlighted in the JHS group in the current study, with no statistically 
significant difference in muscle-tendon lengthening. However, this justification might not 
be conclusive as the p value for muscle-tendon lengthening was 0.06, which only shows a 
trend towards a significant reduction in the JHS group, which could be a type II error. 
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6.4.2 Lower-limb stiffness; measured by vertical jump: 
Contrary to the significant reduction identified in the Achilles tendon in people 
with JHS, the same group demonstrated lower-limb stiffness comparable to the control 
group when measured using the vertical jump. This is the first study which has examined 
the lower-limb stiffness of people with JHS using a vertical jump test. Therefore, the 
results cannot be compared to other studies.  
Stiffness measured using the jump test is an indication of the average stiffness of 
the musculoskeletal system of the lower limbs. Specifically, the vertical jump test 
quantifies the overall stiffness of the lower limb structures (Butler, Crowell and Davis, 
2003, p. 511, based on Latash and Zatsiorsky, 1993):  
“Most biomechanics agree that true stiffness of the human body is the combination of all 
the individual stiffness values contributed by muscles, tendon, ligament, cartilage, and 
bone” 
This is unlike the stiffness measured by the ultrasonography, which is specific to 
the muscle-tendon structure of the Achilles tendon. Such differences in the target 
structures might support the controversy in the results attained. 
The contradiction between the results of the stiffness measured with the 
ultrasonography and the jump test might be related to the stretch-shortening cycle. The 
stretch-shortening cycle is a cycle of eccentric contractions followed by concentric 
contractions as a mechanism used to enhance performance (Horita et al. 1996). During 
the jump test, muscle-tendon structures went through this physiological cycle, and that 
allowed elastic energy storage in the tendon during the eccentric contraction before 
initiating the jump (Horita et al. 1996). Conversely, stiffness measured with 
ultrasonography was during isometric contraction, so the stretch-shortening cycle could 
not be employed. During the jump test, the pre-activation of the muscles before initiating 
the movement, prepares the muscles to work by storing the elastic energy which has been 
utilised during concentric contraction (Horita et al. 1996). This might have enhanced 
lower-limb stiffness in the JHS group.  
The low intensity of the jump test may also have reduced its sensitivity, which 
may explain the insignificant differences between the two groups in the stiffness 
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measure. Specifically, the participants were asked to jump to their preferred height rather 
than their maximal height, to ensure that the test was safe for JHS participants. However, 
a significant difference was previously found in lower-limb stiffness when measured at 
the preferable height compared to the maximum height for healthy participants (Farley 
and Morgenroth, 1999). However, this methodological consideration cannot be 
overcome, as asking people with JHS to jump to their maximum height is challenging 
and involves increased risk.    
Musculoskeletal geometry might have enhanced the JHS group’s lower-limb 
stiffness to be comparable to the control group. Leg geometry during a jump has great 
influence on lower-limb stiffness, as it alters muscle-tendon length and muscle activation 
(Farley and Morgenroth, 1999). In particular, reduction in the angular displacement of the 
lower limb joints during the jump compression phase results in greater lower-limb 
stiffness (Farley and Morgenroth, 1999). In addition, in a more extended joint, the ground 
reaction force vector is closely aligned with the joint, and that decreases joint moments 
and in turn increases the stiffness (Farley and Morgenroth, 1999). Although it was not 
statistically significant, it was observed in the current study that the JHS group had lower 
knee flexion in the compression phase: 64.230 ± 9.220, when compared to the control 
group: 66.310 ± 9.160, p = 0.38. This indicates reduced knee flexion in the JHS group 
during the compression phase of the jump. Therefore, the reduction in knee geometry 
might increase the JHS lower-limb stiffness to be comparable to the control group. 
Although it might be hard to standardise angular displacements during the jump, such 
methodological issues should be considered. 
Muscle-tendon elasticity in people with JHS could enhance their lower limb 
stiffness. Specifically, people with compliant tendons have a greater pre-stretch effect, 
which enhances the performance of the stretch shortening cycle (Kubo, Kawakami and 
Fukunaga, 1999). Additionally, a correlation was previously identified between stiffness 
and tendon compliance in healthy participants during an activity using the stretch 
shortening cycle; r = 0.46 (Kubo, Kawakami and Fukunaga, 1999). This is mainly due to 
greater storage and utilisation of elastic energy in the compliant tendon, which in turn 
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enhances the efficacy of the jump (Anderson and Pandy, 1993; Kubo, Kawakami and 
Fukunaga, 1999). 
As the current study implemented a cross-sectional design, it is hard to 
acknowledge cause and affect relationships (Bailey, 1997). Consequently, it is not known 
if the observed reduction in Achilles tendon stiffness was caused by JHS, or resulted 
from disuse muscle weakness, as their physical activity level and participation were 
reduced. Additionally, the muscle cross sectional area has not been found to be 
compromised in people with JHS (Rombaut et al. 2012a), which might eliminate the 
disuse muscle weakness factor. Magnusson et al. (2008) stated in their review that 
muscle-tendon unit problems might not be related to changes in the muscle-tendon’s 
metric dimension, but related to changes in the quality of their connective tissues, 
involving decreased collagen turnover and density, and decreased water content. 
However, future research is needed to confirm the causes of muscle-tendon unit stiffness 
deficiency.  
It was hypothised that stiffness measured at the muscle-tendon level, as addressed 
by Rombaut et al. (2012a), may not reflect the stiffness during functional weight-bearing 
activity. As has been noted, this hypothesis has been proven in the current study. Notably, 
a significant reduction in Achilles tendon stiffness was illustrated in the prone testing 
position but normal lower-limb stiffness was found during the weight-bearing testing 
position- the vertical jump test. However, no correlation was found between stiffness 
measured in the two testing positions. The lack of correlation might be related to the fact 
that stiffness measured using the ultrasonography method reflects muscle-tendon unit 
only, while stiffness measured with the jump test reflects muscle-tendon, ligament, 
cartilage and bone (Butler, Crowell and Davis, 2003). 
           6.4.3 Conclusion: 
In summary, multiple joint hypermobility and instability are dominant and severe 
in people with JHS (Hakim and Grahame, 2003; Hakim et al. 2004; Simmonds and Keer, 
2007). Specifically, mutations have previously been identified in the genes responsible 
for muscle-tendon structure formation (Narcisi et al. 1994; Malfait et al. 2006; Syx et al. 
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2015). Consequently, the mechanical properties of the muscle-tendon unit may explain 
the severe characteristics of joint hypermobility and instability in people with JHS. 
Diagnostic ultrasonography, along with a digital myometer, has been used to gauge 
muscle-tendon unit stiffness as a measure of the mechanical behaviour of those 
structures. It has been shown in the current study that people with JHS have a significant 
reduction in their muscle-tendon unit stiffness, which could explain the joint instability in 
people with JHS. However, people with JHS demonstrated normal lower-limb stiffness 
when measured using the jump test. 
 
6.5  Muscle strength: the impact of JHS on plantar flexor muscle 
strength: 
This is the first study to have explored plantar flexor strength in people with JHS. 
The results illustrated significant weakness in plantar flexor strength in the JHS group 
when compared to the control group, and the SMD suggests medium clinically important 
difference. Similarly, previous studies have also identified muscular weakness in people 
with JHS, but in different muscle groups of the lower limbs in both children and adults, 
namely knee flexors and extensors (Fatoye et al. 2009; Sahin et al. 2008b; Rombaut et al. 
2012b). Similarly, Engelbert et al. (2003) found weakness in children with symptomatic 
GJL, but presented one generic measure for the total muscle strength, which presented 
the summation of shoulder abductors, hand grip, hip flexors and foot dorsal extensors. 
PRP_S commented:  
“I do go to the gym twice a week for 45 mins with a personal trainer to maintain my 
fitness and notice muscle weakness if I miss a few sessions through illness.” 
There are two factors which could explain plantar flexor weakness in people with 
JHS. First, evidence from Rombaut et al. (2012a) and the current study points to a 
significant reduction in muscle-tendon unit stiffness, which could explain the weakness in 
the plantar flexors. Additionally, this is further supported by the good correlation 
identified in the current study between Achilles tendon stiffness and plantar flexor 
strength. Second, multiple joint pain experienced during rest and exaggerated during 
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movement could lead to a significant reduction in physical activity level and 
participation, and that in turn might induce dis-use muscle weakness.  
There are various complications which might be related to plantar flexor 
weakness, including balance impairment and reduced walking efficacy. Plantar flexor 
weakness could explain balance impairment in people with JHS as it is essential for 
postural orientation (Lichtwark and Wilson, 2005). In particular, plantar flexor weakness 
is highly associated with balance loss and increased risk of falling, although this is in 
geriatric samples (Fukagawa et al. 1995; Ribeiro et al. 2009). Thus, plantar flexor 
strengthening can improve balance and function (Ribeiro et al. 2009). Moreover, gait 
speed is affected 17-22% by leg strength, where in weak people an association exists 
between leg strength and walking speed (Buchner et al. 1996). This could be explained 
by the essential role of the plantar flexors as they support and progress the legs and trunk 
during locomotion (Neptune, Kautz and Zajac, 2001). In addition, walking speed could 
be improved by enhancing plantar flexor strength as it stores the elastic energy that is 
essential for walking (Lichtwark and Wilson, 2005).  
 
6.6 Knee Proprioception: the impact of JHS on knee proprioception: 
Proprioception has been explored in the current study mainly to examine 
proprioception integrity in a functional and weight-bearing position in people with JHS. 
It has been evidenced previously that people with JHS, both children and adults, have a 
deficiency in joint proprioception (Hall et al.1995; Sahin et al. 2008a; Fatoye et al. 2009; 
Rombaut et al. 2010). However, all previous results are related to proprioception in non-
functional and non weight-bearing positions. In contrast, the current study was the first to 
examine proprioception in a weight-bearing and functional position. Three reasons can 
risk the generalisability of the results obtained from a non-weight bearing examination. 
First, the muscle spindle is the main sensory receptor for proprioception and these are not 
sufficiently stimulated in a non weight-bearing position (Marks, Quinney and Wessel, 
1993). Second, a non weight-bearing position for proprioception examination neglects the 
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contribution of muscular activation and active articular displacement (Marks, Quinney 
and Wessel, 1993). Third, exploring proprioception integrity in a non-functional position 
neglects experience input (Gritsenko, Krouchev and Kalaska, 2007). Experience input 
refers to the enhancement of proprioception in a functional position due to having 
experience of performing the task previously (Gritsenko, Krouchev and Kalaska, 2007). 
A functional testing position reduces the estimation error by combining the current 
estimation with previous experiences (Gritsenko, Krouchev and Kalaska, 2007).  
The findings partially support the current study’s enquiry, which has questioned 
examining proprioception in a non-weight bearing position, as performed in previous 
studies. The results illustrate that people with JHS had no proprioceptive deficit in the 
dominant knee at the three testing angles (200, 250, and 300) and the SMDs suggest no to 
small clinically important differences, which contradicts previous findings. Such 
discrepancies with the previous literature may be mainly due to introducing the weight-
bearing testing position into the current study, whereby greater muscle spindle input may 
have been facilitated in the weight-bearing position (Fuentes, and Bastian, 2012).  
In contrast, a proprioceptive deficit was apparent in the non-dominant knee at the 
knee angles of 250 and 300, and the SMDs suggest a medium clinically important 
difference. Yet no proprioceptive deficit was identified in the non-dominant side at 200 of 
knee flexion, and the SMD indicates no clinically important difference. A proprioceptive 
deficit identified only on the non-dominant side might explain the higher percentage of 
injuries and osteoarthritis identified in the non-dominant side. Notably, this observation 
was noted in a different population; professional football players, where knee injuries and 
osteoarthritis are greater on the non-dominant side when compared to the dominant side: 
35% vs. 55% and 43% vs. 58% respectively (Krajnc et al. 2010).  
The proprioception deficit identified in the non-dominant knee is sensitive to the 
angle tested. Proprioception was normal at 200 of knee flexion, but was reduced at 250 
and 300 of knee flexion. Similarly, but in different populations of subjects with chronic 
ankle instability and soccer players, higher proprioceptive error was found on the non-
dominant side for the larger testing angle (Tsiganos, Kalamvoki and Smirniotis, 2008; 
Daneshjoo et al. 2012). There is evidence that muscle spindle input varies according to 
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the magnitude of muscle stretch and contraction, and these change when changing the 
testing angle (Fuentes and Bastian, 2012). Additionally, a greater amount of motion is 
required to reach the larger angle, and that requires extra motor control and 
mechanoreceptor simulation (Daneshjoo et al. 2012). Therefore, it is more challenging to 
reproduce a higher angle magnitude in a proprioception examination.  
The current study shows that proprioception is similar between those with and 
without a diagnosis of JHS in the dominant knee but significantly reduced in the non-
dominant leg in JHS. Generally, the dominant side is accepted to be stronger than the 
non-dominant side (Balogun and Onigbinde, 2009). Therefore, muscle strength might 
enhance proprioception on the dominant side. Specifically, proprioception is greatly 
associated with muscle strength (Esch et al. 2007). However, this cannot be conclusive as 
strength was not compared in the current study between the dominant and non-dominant 
sides. 
 
6.7  Three-dimensional gait analysis: the impact of JHS on gait 
spatiotemporal parameters, kinematics and kinetics: 
 
6.7.1 Spatiotemporal parameters: 
As has been demonstrated in the results chapter, most spatiotemporal parameters 
were significantly different in the JHS group when compared with the control group. 
Considering the spatial parameters, the JHS group walked at significantly lower speeds, 
with shorter stride and step length when compared to the control group, and the SMDs 
suggest medium to large clinically important differences. Additionally, many temporal 
parameters were significantly longer in the JHS group including bilateral stance time, 
double support time, right initial and terminal double support time, and the SMDs suggest 
small to large clinically important differences. Conversely, comparable values were 
found for the cycle time and bilateral swing time between the two groups.   
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The spatiotemporal parameters for people with JHS have been explored by two 
studies previously: Fatoye et al. (2011) and Galli et al. (2011). Fatoye et al. (2011) 
explored speed only and found no significant differences between the two groups; the 
JHS and the control group. Their results contradict the present study, as we identified a 
significant reduction in the JHS group’s speed. However, comparing the study of Fatoye 
et al. (2011) with the current investigation may not be appropriate, especially because 
Fatoye et al. (2011) examined children with JHS, while the current study focuses on 
adults. Comparing adult data with children’s data might be erroneous due to differences 
in articular joint structures and configuration, as cartilaginous end plates are present in 
children’s synovial joints (Hall, 1999; Spannow et al. 2010). Comparing Galli et al.’s 
(2011) study with the current study is more appropriate as both studies focus on adults. 
Galli et al. (2011) have reported a significant reduction in the EDS-HT group’s anterior 
step length with no significant difference in stance phase duration and mean velocity 
when compared to the control group. Similarly, the current study has illustrated that the 
JHS group walked with a significant reduction in step length, bilaterally. However, the 
current investigation contradicts with Galli et al. (2011), as a significant reduction in 
walking speed, and a significant increase in stance time percentage have been identified- 
factors that were similar between the two groups in the study by Galli et al. (2011). The 
contradictory findings between Galli et al. (2011) and the current study might be due to 
the sample sizes. Galli et al. (2011) used a small sample size of 12 participants with EDS-
HT versus 20 healthy controls. Such an issue could risk the results to type II error 
(Crombie, 2010). 
The factors which could explain the reduction in walking speed identified in 
people with JHS in the present investigation could be due to joint pain and reduction in 
the power of the lower limb joints. Specifically, pain significantly impacts upon walking 
speed, and so pain intensity could predict walking speed (Chen, Kuo and Andriacchi, 
1997; Simmonds et al. 2012). Additionally, a reduction in walking speed might be related 
to a reduction in joint power. Specifically, moderate to strong correlations have been 
identified in the current study between walking speed and lower limb joint power 
generation for the hip, knee and ankle, ranging from r = 0.462-0.608. Such observations 
indicate that people with JHS might walk at lower speeds due to a reduction in their 
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joints’ power generation. Moreover, such a correlation has been established by other 
authors, where maximum ankle and hip power were significantly correlated with self-
selected speed (Olney, Griffin and McBride, 1994). PRP_S commented on the correlation 
between walking speed, pain and power: 
“I think this is a fair statement as walking slowly due to pain and power of the joints may 
reduce the pain levels and enable the client to have a prolonged period of time out and 
about and have a better quality of social life”  
Self-selected walking speed has been considered the sixth vital sign (Fritz and 
Lusardi, 2009). That is walking speed reflects functional capacity, balance integrity, 
general health and quality of life (Fritz and Lusardi, 2009). Therefore, the reduction in 
walking speed identified in the JHS group might be one of the factors that lead to a 
reduction in their activity and participation. However, PRP_S commented: 
“Walking speed doesn't affect my participation in daily life as I can still meet friends for 
coffee etc and the speed I walk doesn't have any bearing on it.” 
The current study is the first to comprehensively investigate spatiotemporal 
parameters in adults with JHS. Significant reductions have been illustrated in stride and 
step length in the JHS group. Possibly, people with JHS have adopted this pattern of 
reducing their stride and step length to avoid pain. In particular, it has been demonstrated 
that there is a direct relationship between step length and joint load, where shortening the 
step length reduces the stress at the patellofemoral joint by 22.2% (Willson et al. 2014). 
That is, reducing joint stress by shortening the step length can in turn reduce joint pain. In 
addition, it has been found that changing the spatiotemporal parameters is one of the 
coping strategies used to reduce joint pain and load (Debi et al. 2009). On the other hand, 
the present study has found a significant elongation in the temporal parameters including 
stance, support, initial and terminal double support timings in people with JHS. This may 
be related to an impairment in neuromuscular control. Specifically, it has previously been 
found that stance time is significantly related to muscular strength and proprioception, 
where hip strength explains 46%, and ankle proprioception explains 24% of stance time 
variability (Allet et al. 2012). This suggests that in order to enhance walking temporal 
parameters in people with JHS, management should be directed toward enhancing 
neuromuscular control.  
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6.7.2 Gait kinematics: 
• Introduction: 
Gait kinematics have been analysed using two approaches: observational analysis 
using gait kinematic curve graphs, and statistical analysis. Although the statistical 
analysis is the most robust approach, several common trends have been found in the 
descriptive statstics and kinematic curve graphs, which are considered and discussed in 
the following sections. The current study is the first to comprehensively analyse the gait 
kinematics of the lower limb joints for people with JHS in three planes of movement, 
including spatiotemporal, kinematics and kinetics; moment and power, separating 
between the swing and stance phases, bilaterally. Therefore, there are several parameters 
that could not be compared with the previous literature. 
Three statistically significant findings have been identified in the JHS group; 
reduced pelvis upward obliquity and reduced right hip abduction both during the swing 
phase, and increased hip adduction at initial contact, and the SMDs suggest medium 
clinically important differences. However, two theories are dominant when exploring the 
entire gait kinematics of the JHS group: ‘stiffening theory’ and ‘swing control theory’. 
The following sections discuss and justify the theories highlighted.  
• Stiffening theory: 
Three parameters only were found to be increased in the JHS group: 
a) Anterior pelvis tilt throughout the gait cycle, illustrated graphically by the 
descriptive statistics, and SMD suggests small difference.  
b) Hip adduction at initial contact, illustrated graphically, statistically significant, 
and the SMD suggest medium difference. 
c) Knee valgus throughout the gait cycle; illustrated graphically, descriptive 
statistics and SMD suggested small difference. 
All the other graphical observations, trends and statistical significant findings 
from the JHS group’s kinematics are either comparable to the control group or found to 
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be reduced in the JHS group. In particular, the graphical observation suggests reductions 
in the JHS group’s pelvis upward/downward obliquity and internal/external rotation, hip 
extension, abduction and internal/external rotation, knee flexion/extension and ankle 
plantar flexion. Similarly, trends toward reductions in the JHS group’s descriptive 
statistics have been highlighted: difference ≥ 20, in pelvic internal rotation, hip 
extension/flexion, abduction and internal rotation and knee flexion, where the SMDs 
suggest small to medium clinically important differences. Statistically, significant 
reductions have been highlighted in the JHS group in pelvic upward obliquity and hip 
abduction. Joint hypermobility is a prevailing feature in JHS, and walking with 
comparable and reduced kinematics when compared to the control group has raised the 
idea of stiffening theory as a possible explanation for the JHS gait pattern observed. 
Stiffening theory refers to stiffening of the hypermobile joints to act as a normal mobile 
joint during walking. 
Gait kinematics in adults with JHS has been explored in two studies previously: 
Galli et al. (2011) and Celletti et al. (2013b). The results of Galli et al. (2011) support 
stiffening theory, as no significant differences between EDS-HT and the control group 
were found for the pelvis, hip and knee kinematics during the stance phase, and ankle 
dorsiflexion was significantly reduced. However, exploring the results of the second 
available study, Celletti et al. (2013b), in which gait kinematics were investigated, is 
difficult as they administrate a different data extraction tool– the Gait Profile Score 
(GPS). GPS is an easy tool used to extract gait deviations by summarising the overall 
differences using the root mean square difference between a gait variable at a specific 
time and the mean score of the control variables calculated throughout the gait cycle. 
Celletti et al. (2013b) state that the higher the GPS value, the lower the physiological 
pattern is. GPS indicates that the JHS/EDS-HT gait was significantly different when 
compared to the control group by walking with a less physiological gait pattern. GPS 
shows that all the values were higher in JHS/EDS-HT, indicating less physiological 
motion. In particular, four parameters were found to be physiologically reduced by 
Celletti et al. (2013b): knee flexion/extension, pelvic obliquity, hip abduction/adduction, 
and pelvic rotation. Pelvic tilt and foot progression were comparable to the control group. 
The current study is in agreement with Celletti et al. (2013b), in terms of reductions in 
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knee flexion/extension, pelvic obliquity, hip abduction, and pelvic rotation. The findings 
from Celletti et al. (2013b) further support stiffening theory, as the parameters were 
physiologically reduced. However, comparing the current results with those of Celletti et 
al. (2013b) might be inappropriate due to differences in data extraction and presentation. 
In addition, Celletti et al. (2013b) conducted three walking trials for each side instead of 
the recommended five trials for three-dimensional gait analysis. Specifically, five trials 
are recommended to obtain a good reliability level for gait analysis; ICC > 0.7 (Laroche 
et al. 2011). This issue could risk the reliability of Celletti et al.’s (2013b) study. 
To summarise the previous section, joint hypermobility is a dominant feature of 
JHS. However, people with JHS mostly walked with reduced/comparable lower limb 
joint kinematics when compared to the control group. This has been called stiffening 
theory, which refers to stiffening the hypermobile joints to act as a normal mobile joint. 
The findings in the current study and that of Galli et al. (2011) support stiffening theory. 
Moreover, and in spite of differences in the data extraction approach, the findings of 
Celletti et al. (2013b) support stiffening theory as well. This indicates that people with 
JHS do not exhibit joint hypermobility during walking. PRP_S commented: 
“I think I have developed over time my own way of walking but don't know what the 
difference is.” 
There are two possible factors which might explain stiffening theory: stiffening to 
avoid pain, and stiffening to improve balance. The following sections discuss these two 
factors. 
- Stiffening to avoid pain: 
People with JHS might adopt stiffening as a pain-avoiding behaviour, where they 
walk with normal mobility to avoid over-stressing the joints and thereby prevent inducing 
pain. Importantly, joint laxity and hypermobility are major contributors to the 
pathogenesis of pain (Acasuso-Diaz and Collantes-Esteez, 1998). In particular, 
overstretching the joint structures could induce micro-trauma, inflammation and pain 
(McMaster, 1996). Stressing joint structures could be complicated with repetitive over-
stretching during activity causing overuse injuries and a vicious cycle of pain (McMaster, 
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1996; Smith, 2005). As an illustration, over-stretching induces cellular hypoxia and 
chemical release, which sensitises pain receptors (Smith, 2005). Moreover, the resultant 
swelling places pressure on free nerve endings and that induces further pain (Smith, 
2005). However, people with JHS could adopt stiffening during walking to control such a 
hypermobility-pain cycle. Additionally, no correlation has been identified in the current 
study between pain and gait kinematics, which suggests that people with JHS might be 
able to avoid pain by adopting a stiffening gait pattern.   
- Stiffening to improve balance: 
People with JHS might adopt stiffening during walking due to their fear of falling, 
as controlling their walking kinematics could improve their balance. In particular, 
postural instability has been identified in people with JHS, which is associated with 
increased falling frequency (Rombaut et al. 2011). 95% of the participants in the EDS-
HT group in Rombaut et al.’s (2011) study had fallen during the last year. Such a high 
percentage of falling could be the reason for adopting stiffening during walking as a fall-
avoiding and balance improving behaviour. This theory is further supported by Rigoldi et 
al. (2012) who suggests that people with JHS/EDS-HT reduce the use of their joints to 
enhance balance and stability (Rigoldi et al. 2012). Significant reductions in mediolateral 
sway and sway area have been determined in people with JHS during unconstrained 
standing (Bates, McGregor and Alexander, 2016a). The reductions in mediolateral sway 
and sway area could be related to the proposed stiffening theory, where people with JHS 
could stiffen their hypermobile joints to maintain balance.   
• Swing control theory:  
“Swing control theory” refers to the reduction in gait kinematics during the swing 
phase. In particular, the following reductions were illustrated during the swing phases: 
a) Pelvic downward obliquity during initial swing phase, shown graphically, and 
pelvic upward obliquity, statistically significant. 
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b) Hip abduction during the initial swing phase, shown graphically, and the SMD 
suggests medium differences, and external rotation, shown graphically, and hip 
extension; SMD suggests a small difference. 
c) Knee flexion during mid-swing phase, illustrated graphically, and the SMD 
suggests a small difference. 
d) Ankle plantar flexion during the initial swing phase, illustrated graphically. 
All the highlighted features of kinematic reduction during the swing phase point 
to swing control theory. Three explanations might justify swing control theory: load 
reduction behaviour, maintaining equilibrium behaviour and force insufficiency. The 
following sub-sections go through each explanation separately. 
- Swing control for load reduction: 
Kinematic reduction in the swing limb could be adopted as a load reduction 
behaviour to reduce the load in the contralateral limb. Specifically, gait modification 
could be a load reduction strategy employed to reduce the stress and pain in the lower 
limb (Mundermann, Dyrby and Andriacchi, 2005; Simic et al. 2011). Kinematic 
reduction during the swing phase, as highlighted in the present investigation, could aid in 
reducing the swing phase duration, which could reduce the load and stress on the 
contralateral limb. This may be supported by the findings of the current study, where the 
descriptive statistics show a slight reduction in the swing time in the JHS group, and the 
SMD suggests a small clinically important difference. The magnitude of joint load can be 
evaluated from joint moments (Mundermann, Dyrby and Andriacchi, 2005; Simic et al. 
2011). For example, the increase in knee joint load in the medial compartment in patients 
with osteoarthritis is relevant to an increase in knee adductor moment, which forces the 
knee into varus (Simic et al. 2011). However, knee adductor moment and the findings of 
the current study related to gait moments were reduced in the JHS group, which could be 
evidence for the effectiveness of the gait modification adopted by the JHS group to 
reduce joint load. 
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- Swing control for equilibrium: 
As has been discussed in the previous section, balance is a critical problem in 
people with JHS, and it is associated with increased falling frequency (Rombaut et al. 
2011). However, kinematic reductions in the swing limb could be adopted to improve and 
maintain equilibrium. Such a strategy of reducing the leg opening by reducing pelvis 
upward obliquity and hip abduction maintains the center of mass within the base of 
support, which maintains equilibrium (Lee and Farley, 1998; Rigoldi et al. 2012). 
Moreover, medio-lateral trajectory of the center of mass is mainly influenced by hip 
abduction/adduction to control medio-lateral equilibrium (Winter, 1995). Such a reason 
might explain reducing the hip opening and abduction during the swing phase.   
- Swing control due to force insufficiency: 
Swing control theory refers to reducing gait kinematics during the swing phase, 
which could be related to force insufficiency. In particular, agonists might fail to produce 
the sufficient magnitude of force to attain the physiological movement. Muscle weakness 
is dominant in people with JHS, as has been found in the current study and in previous 
studies, which might support the force insufficiency theory (Fatoye et al. 2009; Sahin et 
al. 2008b; Scheper et al. 2013).   
• Increased gait kinematics: 
Three kinematic parameters only were found to be increased in the JHS group, 
where increased kinematics was expected in people with JHS due to joint laxity. Yet, 
some other factors could explain the increase in kinematic parameters. First, anterior 
pelvis tilt was increased throughout the gait cycle, which has been illustrated graphically, 
through the descriptive statistics and SMD suggests a small difference. Increased anterior 
pelvis tilt could result from muscular imbalance; tightness in the hip flexors, and 
weakness in the hip extensors (Liebenson, 1996). Increased anterior pelvis tilt increases 
lumbar lordosis, and that increases the stress in the lower back and hip joint, which could 
explain the significant increase in lower back and hip pain identified in the current study 
(Liebenson, 1996). Second, hip adduction at initial contact was increased in the JHS 
group, which has been illustrated graphically, and found to be statistically significant, and 
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the SMD suggests a medium difference. Increasing hip adduction could be related to 
“maintaining equilibrium” theory, as explained previously. Increasing hip adduction can 
maintain the centre of mass within the base of support, which can enhance equilibrium 
(Lee and Farley, 1998; Rigoldi et al. 2012). Third, knee valgus was increased throughout 
the gait cycle, which has been illustrated graphically, with descriptive statistics and SMD 
suggesting a small difference. Increased knee valgus could be related to a reduction in 
gluteal muscle activity, which in turn increases hip internal rotation and tibial rotation, 
and that in turn increases knee valgus (Hollman et al. 2009). This hypothesis may be 
partially supported by the findings of the current study, where hip extensor moment was 
significantly reduced, but this was not accompanied by an increase in hip internal 
rotation. Therefore, the reason for the increased knee valgus is not clear, but could be 
related to foot pronation, which was not assessed. However, the influence of gluteal 
weakness on hip internal rotation might be obvious if walking is challenged, or after a 
prolonged time of walking.  
• Kinematics and walking speed: 
Significant reduction in walking speed was identified in the JHS group and that 
could reduce some of their walking kinematic values (Lelas et al. 2003; Kwon, Son and 
Lee, 2015). Previous authors identified that some of the kinematic parameters were 
significantly dependent on walking speed; the coupling motion of the knee joint; knee 
flexion and external rotation, and ankle plantar flexion all during the swing phase, and 
knee flexion during the loading response (Lelas et al. 2003; Kwon, Son and Lee, 2015). 
However, hip kinematics were not dependent on walking speed (Lelas et al. 2003; Kwon, 
Son and Lee, 2015). The results of Lelas et al. (2003) and Kwon, Son and Lee’s (2015) 
studies are relevant to the current study as they compared slow walking speed with 
normal speed. In the current study reductions were identified in knee flexion and ankle 
plantar flexion during the swing phase, which could be related to the reduction in the 
walking speed in the JHS group (Kwon, Son and Lee, 2015). However, knee external 
rotation was not considered in the current study. The gait graphs show minimal reduction 
in knee flexion during loading response which could be related to speed factors (Lelas et 
al. 2003). Regression equations can be used to predict gait kinematics in relation to speed 
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(Lelas et al. 2003). However, they have not been used as poor relationship was identified 
between speed and gait kinematics which could lead to poor predictability (Lelas et al. 
2003).  
            6.7.3 Gait moment: 
Moment is the rotational force acting at the joint, which is the result of muscle, 
ligament and joint constraints, and friction (Hall, 1999). The usual unit for moment is N-
m, but in gait analysis research the moment is normalised to body weight, therefore the 
moment unit is N-m/Kg. Moment is influenced by the ground reaction force, 
acceleration, moment arm and muscles, which counteract the upward directed ground 
reaction force (Hall, 1999). More importantly, muscles are the main moment producers 
during walking. Therefore, differences in moment mainly reflect differences in muscle 
activity.  
The JHS group walked with significant reductions in their hip extensors’, flexors’ 
adductors’ and external rotators’ moments, and the SMDs suggest medium clinically 
important differences. Moreover, moment reductions were also significant for knee 
adductors and internal rotators and the SMD suggests medium clinically important 
differences. Yet moments acting at the ankle joints were comparable to the control group. 
The moment curve graphs support the moment reductions identified in the hip flexors’ 
and adductors’ moments, and knee flexors’ and adductors’ moments. There has been no 
report published on exploring hip and knee moments during the gait cycle in people with 
JHS. Therefore, a comparison with the previous literature with a similar population is not 
possible. Galli et al. (2011) have reported the maximum ankle plantar flexors moment, 
where a significant moment reduction was identified, and that contradicts the results of 
the current study. Yet, this contradiction might be mainly related to the including of 
heterogeneous groups by Galli et al. (2011) in terms of age: 43.08 ± 6.78 years in the JHS 
group and 37.23 ± 8.91 years in the control group (mean ± SD). This issue could risk 
Galli et al.’s (2011) study to type I error, as the reduction in ankle plantar flexor moment 
in the JHS group could be related to the age factor, as they were older than the control. 
However, the means ± SDs of the current study of ankle plantar flexors moment were 
lower in the JHS group, and the SMDs suggest small clinically important differences. 
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This may indicate that type II error might have risked the current study’s results. The 
sample size of the current study for this investigation was 29 participants in the JHS 
group and 30 participants in the control group, which is larger than the sample size of 
Galli et al. (2011), which was 12 in the JHS group and 20 in the control group. This 
suggest that the current study has been more powerful in detecting true differences. The 
fact that Galli et al. (2011) examined an older patient group could make the difference 
between the two groups more profound.  
Moment analysis has revealed moment reductions in people with osteoarthritis, 
where both JHS and osteoarthritis are chronic musculoskeletal conditions (Hurwitz et al. 
1997). However, the literature on osteoarthritis reveals significant increases in knee 
adductor moment (Foroughi, Smith and Vanwanseele, 2008). Knee adductor moment is 
one of the major factors which increase knee osteoarthritis severity (Foroughi, Smith and 
Vanwanseele, 2008). In spite of that, the reduction in knee adductors moment identified 
in the current study can also change knee joint alignment, and this could be a reason for 
joint degenerative changes, and therefore, osteoarthritis. Yet for people with ACL 
injuries, moments were reduced and that is similar to the current study, which might be 
because ACL injuries are more comparable with JHS than osteoarthritis due to sharing 
the instability feature (Hart et al. 2009).   
There are various factors which could explain the reduction in hip and knee 
moments identified in the JHS group. Moment reductions could be related to collagen 
and protein genetic abnormalities, muscle weakness, reduction in muscle-tendon unit 
stiffness, and dis-use due to pain. All these factors are explained and discussed in the 
stiffness and muscle strength sections (section 6.4 and 6.5). The current study highlights 
significant reductions in Achilles tendon stiffness, plantar flexors strength and hip and 
knee gait moments. The three variables reflect the status of the muscle-tendon structure, 
and the three findings highlights a deficiency in the muscle-tendon structure in people 
with JHS.    
Reduction in moments in the gait of people with JHS could be explained as an 
avoiding behaviour. In particular, moments might be reduced intentionally as a way to 
avoid joint hypermobility and pain. This theory was first described by Berchuck et al. 
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(1990) as “quadriceps avoidance” theory, and further was supported by a recent study in 
people with ACL injuries (Hart et al. 2009). This pattern is adopted by people with ACL 
by reducing the contraction of the quadriceps to control tibial forward translation 
(Berchuck et al. 1990; Hart et al. 2009). Such a theory could be applied to people with 
JHS as they share the instability feature with the ACL population. Specifically, at the 
same timing of the gait cycle, during loading response, three actions were noticed in the 
current study: reduction in knee flexor, extensor and adductor moments and reduction in 
knee power absorption. This pattern suggests that people with JHS might control their 
hypermobility and joint instability by inhibiting muscle action. Furthermore, such 
behaviour is also noticed in people with osteoarthritis, where moments are reduced 
during walking and this has been referred to as a pain coping strategy (Hurwitz et al. 
1997). That is, reduced hip moment in people with osteoarthritis is highly correlated to 
pain; r = 0.78 (Hurwitz et al. 1997). However, such a mechanism could cause disuse 
muscle weakness, and maybe stiffness. However, such a theory should be confirmed 
through electromyographic studies.  
6.7.4 Gait power:  
Both gait moment and power reflect muscular capability, but power further 
reflects the velocity component, which is more related to speed-related activities such as 
high speed walking (Hall, 1999; Sadeghi, Allard and Duhaime, 2000). The current study 
is the first to comprehensively analyse gait power in people with JHS. The power 
exploration involved power generation and absorption at the hip, knee and ankle joints 
bilaterally, and in the frontal, sagittal, and transverse planes. Additionally, the current 
study originally built power curve graphs for detailed comparisons between the two 
groups.  
Regarding power generation, the descriptive statistics and the power curve graphs 
illustrate reductions in power generation parameters in the JHS group. Specifically, the 
power curve graphs highlight reductions in power generation in the frontal and sagittal 
planes of the hip joint during the terminal stance. Similarly, knee power generation in the 
sagittal plane was also reduced in the JHS group during loading response to terminal 
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stance. Ankle power generation was reduced during terminal stance in the sagittal plane. 
Significant reductions were demonstrated in the JHS group mainly in the knee joint in 
both frontal and sagittal planes and the SMDs suggest a small clinically important 
difference. Therefore, power generation reduction predominated, and mainly during 
terminal stance. 
Ankle power generation is the only gait power parameter explored in the previous 
literature on people with EDS-HT by Galli et al. (2011); replicated by Celletti et al. 
(2012b), and Rigoldi et al. (2012), as indicated in section 3.7.2. A significant reduction in 
ankle power generation was identified in the EDS-HT group (Galli et al. 2011), but that 
contradicts the results of the current study. This contradiction could be related to the 
including of heterogeneous groups by Galli et al. (2011) in terms of age: 43.08 ± 6.78 
years in the JHS group and 37.23 ± 8.91 years in the control group (mean ± SD), which 
could risk Galli et al.’s (2011) study to type I error. In particular, the reduction in ankle 
power generation in the JHS group could be related to the age factor, as the JHS group 
was older than the control group. However, the curve graphs of the current study point 
toward a reduction in ankle power generation in the JHS group during terminal stance; 
the means ± SDs were lower in the JHS group, and the SMDs suggest a small clinically 
important difference. This could indicate that false negative results may have been 
presented in the current study, as there are various indications of ankle power reduction, 
yet the reduction did not reach statistical significance. 
Power generation during gait is equivalent to energy generation, which mainly 
originates from muscles and soft structures, reflecting muscular concentric activity 
(Judge, Ounpuu and Davis, 1996). The reduction in power generation identified in the 
current study suggests that people with JHS have a deficiency in their muscle-tendon 
complex. In particular, energy generation takes place in the muscle-tendon complex 
where the muscle shortens and the tendon lengthens to transfer the energy/power from 
the muscle through the tendon to the bone to initiate the required motion (Judge, Ounpuu 
and Davis, 1996). As has been found in the current study and by Rombaut et al. (2012a), 
people with JHS have a significant reduction in their muscle-tendon unit stiffness, which 
could explain the reduction in their power generation during walking. Probably, this 
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might be related to mutations in the collagen and protein genes, as reported in previous 
studies, and these two structures are the main compositions in the muscle-tendon 
complex (Narcisi et al. 1994; Malfait et al. 2006; Syx et al. 2015). Moreover, the 
reductions in the JHS power generation could be related to muscle weakness, which has 
been discussed in the muscle strength section. 
During terminal stance, in the push off phase, the muscular system undergoes the 
second largest power propulsion. From the curve graphs, during this phase, the JHS 
group exhibited a reduction in power generation in the three joint musculatures: hip, knee 
and ankle. In particular, the results indicate that the JHS group had reductions in the 
concentric contraction of hip flexors, knee flexors, and ankle plantar flexors during 
terminal stance. However, during pre-swing, only the hip joint showed a reduction in 
power generation, while during loading response, only the knee extensors’ concentric 
contraction was significantly reduced in the JHS group. Such identification of reduced 
power generation during specific phases of the gait cycle could be used to improve 
walking efficacy. Further details will be discussed in the implications section.   
Power absorption is equal to energy absorption, which occurs mainly in the 
muscles and soft tissues, reflecting muscle eccentric contraction (Judge, Ounpuu and 
Davis, 1996). The current study has highlighted that the JHS group walked with reduced 
energy absorption capacity in the hip and knee joints’ musculatures, and the SMDs 
suggest a medium to large clinically important difference. Specifically, energy absorption 
deficiencies were noticed mainly during the loading response to terminal stance in the hip 
flexors and knee extensors. Such reductions in power absorption could be related to the 
deficiency in the muscle-tendon unit identified in the current study and by Rombaut et al. 
(2012a). This might be related to the genetic abnormalities identified in collagen and 
protein genes, the basic constituents of the muscle-tendon complex, along with the other 
possibilities discussed in the muscle-tendon unit stiffness section. However, the genetic 
factor is not conclusive due to the controversy between the studies of Henney et al. 
(1992), Narcisi et al. (1994), Malfait et al. (2006), and Syx et al. (2015). Moreover, 
muscle weakness could explain the reduction in power absorption during gait, and factors 
related to muscle weakness have been discussed in detail in the plantar flexors strength 
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section. In addition, gait speed is related to power and moment (Lelas et al. 2003). 
Therefore, the reduction in power and moment during gait could be due to reduced speed 
or vice versa (Lelas et al. 2003). This observation has also been noticed in the current 
study, where moderate to strong correlations have been identified between walking speed 
and power generation in the hip, knee and ankle joints. Moderate correlation has been 
identified between walking speed and knee power absorption.   
6.7.5 Gait kinetics and walking speed: 
Statistically significant reductions have been highlighted in the current research in 
the JHS group for gait kinetics; moments, and powers. However, the JHS group walked 
at significantly lower speed when compared to the control group. The identified gait 
kinetic reductions in the JHS group could be related to walking at slower speed (Lelas et 
al. 2003). The predicted difference in kinetic parameters have been therefore calculated 
using the regression equations of Lelas et al. (2003) using the walking speed of the JHS 
group (1.14 m/s) and the walking speed of the control group (1.33 m/s) observed in the 
current research (Table 6.1). All the predicted differences between the two groups were 
less than the actual differences identified in the current study; except for the left knee 
power generation which was the same (see Table 6.1). This may suggest that, although 
the speed factor could have influenced gait kinetics, the differences identified between 
the two groups are larger than the differences induced by speed. Comparison cannot be 
comprehensively established, however, as regression equations are not available for some 
of the kinetic parameters.   
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Table 6.1: The predictable and actual differences between the JHS and the control group 
in gait kinetic parameters found to be statistically significant in the current research.   
Kinetic parameters found statistically significant in 
the current research 
Predictable 
difference 
Actual 
difference 
Maximum right hip extensor moment 0.06 Nm/kg 0.15 Nm/kg 
Maximum left hip extensor moment 0.06 Nm/kg 0.16 Nm/kg 
Maximum left hip flexor moment 0.09 Nm/kg 0.13 Nm/kg 
Maximum left hip adductor moment Prediction 
equation not 
available 
0.13 Nm/kg 
Maximum left hip external rotator moment 0.04 Nm/kg 
Maximum right knee extensor moment 0.01 Nm/kg 0.10 Nm/kg 
Maximum right knee internal rotator moment  
Prediction 
equation not 
available 
0.03 Nm/kg 
Maximum right knee external rotator moment 0.02 Nm/kg 
Maximum left knee adductor moment  0.06 Nm/kg 
Maximum left knee external rotator moment 0.04 Nm/kg 
Maximum left hip power absorption sagittal plane 0.09 Watts/kg 0.25 Watts/kg 
Maximum left hip power absorption transverse plane Prediction 
equation not 
available 
0.12 Watts/kg 
Maximum right knee power generation sagittal plane 0.11 Watts/kg 0.15 Watts/kg 
Maximum left knee power generation sagittal plane 0.11 Watts/kg 0.11 Watts/kg 
Maximum left knee power generation frontal plane Prediction 
equation not 
available 
0.03 Watts/kg 
Maximum right knee power absorption transverse plane 0.04 Watts/kg 
Maximum right knee power absorption transverse plane 0.04 Watts/kg 
Maximum left ankle power absorption transverse plane 0.02 Watts/kg 
Keys: The predictable difference calculated using the control group’s gait parameter predicted from Lelas 
et al. (2003) regression equations using their walking speed of 1.33 m/s, and the JHS group gait parameter 
predicted from Lelas et al.’s (2003) regression equations using their walking speed of 1.14 m/s.  
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6.8  Vertical jump biomechanics: the impact of JHS on vertical jump 
kinematics and kinetics: 
 
The jump test was implemented in the current study as it is a higher level test 
compared to walking. Previous studies have found that people with JHS exhibit 
compensatory behaviours during walking, which cover the underlining deficiencies and 
make it hard to understand the condition and its impairments during activity. Therefore, 
the current author has hypothesised that the jump test could reveal the underlying 
deficiencies, as it is a more advanced activity compared to walking. Therefore, the jump 
test has been analysed in terms of kinematics, moments and powers of the lower limb 
joints. This was the first study to introduce the jump test for people with JHS. Two 
previous studies implemented the jump test, but to examine people with GJL (Juul-
Kristensen et al. 2012; Junge et al. 2015). Moreover, both Juul-Kristensen et al. (2012) 
and Junge et al. (2015) did not analyse the jump task from a biomechanical perspective. 
Therefore, a comparison with previous studies is not possible. Moreover, to my 
knowledge, the literature is limited to studies involving people with osteoarthritis with 
kinematic and kinetic jump analysis. Some studies are available on people with ACL 
injuries, but they mainly focus on the landing phase of the jump, while the compression 
and push phases are the scope of the current study.   
The vertical jump test is capable of identifying functional limitations (Petschnig, 
Baron, and Albrecht, 1998). However, the JHS group jumped to a comparable height to 
the control group, which might indicate normative functional ability. But children with 
GJL jumped to comparable lengths when compared to a control group, albeit with altered 
neuromuscular control; hyperactive GM and an underactive semitendinosus muscle 
(Junge et al. 2015). Similarly, adults with osteoarthritis have jumped to a comparable 
height when compared to a control group (Arokoski et al. 2004). The current study found 
differences between the two groups in terms of jump moments and powers. Therefore, 
despite the similarities between the two groups in jump height, this might not indicate a 
normal functioning ability.  
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6.8.1 Jump kinematics: 
The results show that there were no significant differences between the two 
groups in kinematics during the compression and push phases of the jump test. A 
previous study explored the jump test but that was carried out with children with GJL and 
they looked at the jump from an electromyographic perspective (Junge et al. 2015). Junge 
et al. (2015) identified significant hyperactivity of GM of 32%, and a significant 
reduction in semitendinosus activity of 33%. However, their findings cannot be directly 
compared to the current study.  
The kinematics findings of the jump test support the findings identified during 
walking, as both tests indicate that people with JHS performed their physical tasks using 
comparable kinematics to the control group. Indeed, the jump test further supports the 
stiffening theory identified during walking. That is, people with JHS were not 
manifesting joint hypermobility during activity. As has been explained in the gait 
kinematics analysis section, this could be as a pain avoiding behaviour or as an 
equilibrium maintaining mechanism.   
6.8.2 Jump moments: 
Similar to the findings revealed in the gait analysis test, the JHS group has shown 
a significant reduction in lower limb joint moment during the jump test. In spite of that, 
there were differences between the two tests- walking versus jumping- in terms of the 
affected moment. Notably, during walking, moments were mainly reduced for hip 
flexors/extensors, hip abductors/adductors, hip internal/external rotators, knee 
flexors/extensors and knee internal/external rotators and knee varus/valgus. During the 
jump, moments were reduced for knee flexors/extensors, knee internal/external rotators 
and ankle dorsi/plantar flexors. However, the differences in the moment reductions could 
be mainly related to the task’s demands, where walking might require a different 
muscular activation level when compared to the jump’s muscular requirements. 
Moreover, the participants were asked to avoid trunk motion during the jump, which 
might have reduced muscular moment in the hip joint.   
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Moments deficiencies observed during the jump test could be related to the same 
factors discussed for moments reduction during walking. As muscles are the major 
moment generator, deficiency in moments could be related to muscle-tendon deficiency, 
as muscle-tendon unit stiffness is significantly reduced in people with JHS (Rombaut et 
al. 2012a). At the cellular level, genetic abnormalities in collagen and protein genes were 
reported in people with JHS, which could explain the reduction in moment during 
jumping (Malfait et al. 2006). However, the genetic basis of JHS is not conclusive. 
Moreover, muscle weakness in people with JHS could also explain the reduction in 
moment during jumping (Fatoye et al. 2009; Scheper et al. 2013). In addition, as pain is 
the main complaint, people with JHS could reduce their muscular activity level in order 
to avoid pain, as has been found in people with ACL injuries and osteoarthritis (Berchuck 
et al. 1990; Hurwitz et al. 1997; Hart et al. 2009). Thus, the reduction in moments could 
be an unconscious inhibition of muscular activity employed to control hypermobility and 
therefore pain. 
6.8.3 Jump powers: 
Knee power generation was significantly reduced in the JHS group. Moreover, 
power absorption was significantly reduced in the hip, knee and ankle joints. These 
findings support the reduced power generation and absorption highlighted during 
walking. As this is the first study that has analysed the jump test in terms of power 
generation and absorption in people with JHS, any comparison with previous studies is 
limited.   
There are various factors which could explain the significant reduction in jump 
power for people with JHS. These factors have been discussed in the gait power section, 
including reduced muscle-tendon stiffness, muscle weakness, and reduced muscle 
activity as a pain coping strategy. Another factor which could explain the reduced power 
is the arthrokinetic reflex, which refers to muscle stimulation/inhibition resulting from 
changing the stimulation pattern of the joint mechanoreceptors when joint position is 
changed (Yerys et al. 2013). That is, joint hypermobility could inhibit muscle activity due 
to the arthrokinetic reflex, which could explain the reduced power during the jump test. 
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This factor could also explain moment and power reductions during both walking and the 
jump test. 
Obviously, biomechanical alteration and neuromuscular adaptation in people with 
JHS are consistent during ordinary as well as during advanced physical tasks. Therefore, 
these changes can be considered dominant features and should be targeted to improve the 
activity and participation of people with JHS. Further details have been discussed in the 
implications and recommendations for future research section.    
 
6.9 The impact of JHS on the elasticity of the gastrocnemius medius 
and the feasibility of sonoelastography for studying gastrocnemius 
medius in people with JHS. 
The present study is the first to explore the elasticity of the medial gastrocnemius 
muscles (GM) in people with JHS compared to healthy controls. The descriptive statistics 
of the current study have shown that GM elastictity in the JHS group was increased when 
comparted to the control group. However, this was not statistically significant, which 
could be a type II error due to reporting false negative results. Specifically, ten 
participants only were examined from each group, as the main aim of this study was to 
explore the feasibility of the SEG.  
This finding supports the original hypothesis, as a softer medial gastrocnemius 
muscle was expected in the JHS group, where structural softness has been determined 
previously in a case with GJL using SEG (Kocyigit et al. 2015). However, this 
observation cannot be related to the present study as they observed the Achilles tendon of 
a 10 year old boy with GJL. In contrast, the current study has focused on the muscular 
part of the GM (proximal 30% of GM length), and limited the examination to adults with 
JHS. 
The increased elasticity observed in the GM in people with JHS might be related 
to several factors. At the cellular level, collagen is rich in the connective tissue 
surrounding the muscles as well as in the anchoring system connecting the muscle cells 
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together, which gives the muscle its mechanical durability and rigidity (Kannus, 2000; 
Fratzl, 2008). However, abnormalities in the genes encoding collagen and the enzymes 
responsible for collagen modification have been found in people with JHS (Narcisi et al. 
1994; Malfait et al. 2006). Moreover, muscular abnormalities are more related to the 
quality of the connective tissues involving collage (Magnusson et al. 2008), which could 
explain the increased elasticity noticed in GM. At the structural level, the identified 
reductions in the plantar flexors strength and Achilles tendon stiffness in the current 
study could explain the increased elasticity of the GM muscle. Furthermore, pain could 
be a major factor in changing the normative elasticity of the GM. In particular, pain could 
enhance the disuse behavior which could explain the reductions in muscle strength and 
Achilles tendon stiffness (Sakai et al. 2000). The disuse factor could be also supported by 
the finding of the current study, where significant reduction in the physical activity level 
was identified in the JHS group. However, the observed differences between the two 
groups need to be confirmed by a larger sample size study. 
As illustrated in section 5.10, the SEG was feasible for examining the elasticity of 
the GM in people with JHS in terms of training requirements, examination and image 
analysis time, practicality and tolerance by the patients. 
 
6.10 Limitations: 
It is acknowledged that there are various limitations in the present study that 
should be considered. These limitations are as follows:   
• A cross sectional design was used in the current study to achieve the study 
purposes. Although this kind of design is practical, quick for studying a large 
number of variables at one point of time, and appropriate for identifying 
prevalence and in-between factors associations (Heiman, 2002; Mann, 2003), 
by using a cross-sectional design it is not possible to distinguish between 
cause, effects and the sequence of events (Hennekens and Buring, 1987; 
Mann, 2003).  
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• One of the limitations of the current study is the lack of blinding. It was not 
possible or practical to blind the researcher at the data collection stage or at 
the data analysis stage. First, the researcher had to confirm the diagnosis of 
the participants in the JHS group, and also confirm that the participants in the 
control group had no GJL. Second, most of the data collection procedures and 
the data analysis methods required specified training; therefore, a trained 
researcher had to conduct the whole procedures to ensure accuracy and 
adherence to the guidelines. However, lack of blinding might have risked the 
credibility of the results due to expectation bias (Day, 2000). 
• Data collection procedures were not randomised which might have risked the 
results to an order effect. However, randomising the procedures was not 
practical, and would have increased the burden on the participants and the 
researcher. Specifically, some data collection procedures required marker 
application, and this took 5-10 minutes, so randomising the procedures would 
have required removing and then reapplying the markers. Randomisation 
would increase the examination time, which in turn could risk the participants’ 
adherence to the study. Even so, potential order effects were minimised by 
providing adequate rest periods, and the same order was used for all the 
participants. 
• Men’s response rate was low, resulting in only two male participants in each 
group. Despite the effort in trying to increase men’s representation in the 
study, such efforts failed. Therefore, the results may not represent men with 
JHS well. However, it has been reported by Beighton et al. (1998) that 90% of 
those with JHS are women and 10% are men. In the current investigation, 
women presented 93.5% versus 6.45% for men. Therefore, the women to men 
proportion might be appropriate in terms of reflecting the prevalence in the 
general population.  
• Joint pain was assessed using VASs. The high psychometric properties of 
VAS and its practicality, made it easier to gauge pain intensity in the lower 
back, and all of the lower limb joints bilaterally, during rest and movement. 
However, the VAS does not consider the multidimensional nature of pain 
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which could involve discriminative/sensory, effective/motivational and 
evaluative/cognitive domains as by using the McGill Pain Questionnaire 
(Melzack, 1975; Bruce et al. 2004).  
• Diagnostic ultrasound was used to track muscle-tendon elongation. Measuring 
muscle-tendon unit stiffness using ultrasound is well established; however, it 
may be limited due to one main issue; B-mode ultrasonography provides two 
dimensional measurements for the aponeurosis and that may miss deformation 
in a three-dimensional manner (Magnusson et al. 2008).     
• Proprioception examinations were performed at angles from 200-300. 
Therefore, the findings of the current study might not well represent 
proprioception at greater knee flexion angles.   
• A three-dimensional motion analysis system was used, and this involves some 
areas of limitation. First, there is the possibility of soft tissue artefact, where 
the retro-reflective markers might not present the underlying bony landmarks 
well enough. Second, the fact of examining walking in a laboratory 
environment might not fully represent walking outdoors. Third, to attain 
kinematic measurements of the ankles and feet, the participants were asked to 
walk barefoot in order to apply the markers over the skin. Yet, walking 
barefoot might be different to walking with shoes. Specifically, a couple of 
participants from the JHS group reported that they walked better in high heels. 
• One of the main limitations in the current study was that gait kinematic and 
kinetic were not normalised to speed. In particular, gait speed might influence 
gait kinematics and kinetics (Lelas et al. 2003). However, Galli et al. (2011) 
identified a significant reduction in ankle power in the JHS group before and 
after normalising ankle power to walking speed, indicating that the 
normalisation to speed did not change the final results. However, the 
significant reduction in walking speed in the JHS group could influence their 
gait kinematics and kinetics (Lelas et al. 2003).       
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• People who were able to walk 10 m for ten times, and perform the vertical 
jump task were included in the study. However, this point in the inclusion 
criteria limited including people with JHS who could not perform these 
physical tasks. Therefore, the results of the current study might not well 
present a cohort with a higher impact of JHS who cannot walk for short 
distances, cannot jump and are wheelchair dependent.  
• Not applying a Bonferroni correction in the current study could be considered 
a limitation by many researchers, particularly because the current study 
conducted multiple comparisons and statistical tests, specifically when 
analysing the gait and vertical jump data. Some statisticians recommend using 
a rigorous method when applying multiple tests to decide the statistical 
significance, rather than implementing the standard significance of < 0.05, 
which could be done using Bonferroni correction (Perneger, 1998; Pallant, 
2010). Furthermore, by implementing a statistical significance of p < 0.05, 
with a multiple comparison study, there might be one significant observation 
by chance from 20 observations (Bland and Altman, 1995; Greenhalgh, 1997). 
Therefore, the aim of the Bonferroni correction is to reduce the risk of type I 
error and reporting false positive results (Perneger, 1998; Pallant, 2010). For 
example, an adjustment to the alpha level could be applied for the gait data in 
the current study. For each joint plane of motion five comparisons were 
performed: maximum kinematics during stance, maximum kinematics during 
swing, minimum kinematics during stance, minimum kinematics during swing 
and kinematics at initial contact; therefore, the alpha level of 0.05 could be 
divided over five: 0.05/5 resulting in a smaller statistical significance of 0.01 
(Pallant, 2010). However, the Bonferroni correction was not applied in the 
current study for several reasons. First, the Bonferroni correction, invented by 
Neyman and Pearson in 1920, was developed to aid in decision making, not 
for assessing evidence in data (Perneger, 1998). Moreover, the Bonferroni 
correction increases the risk of type II error, which refers to accepting a null 
hypothesis in error (Rothman, 1990). Reducing the significance level by using 
the Bonferroni correction would compromise the study’s ability to detect 
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actual true differences, and lead to missing important findings (Rothman, 
1990; Glickman, Rao, and Schultz, 2014). Moreover, Perneger (1998) states in 
his debate about the negative consequences of Bonferroni correction (p. 
1237): 
“What would happen to biomedical research if Bonferroni adjustments become routine? 
Cynical researchers would slice their results like salami, publishing one P value at a time 
to escape the wrath of the statistical reviewer, idealists would conduct studies to examine 
only one association at a time-wasting time, energy and public money.”   
• The standardised mean difference (SMD) was reported for the study’s 
outcome measures to suggest clinically important differences between the two 
groups (Samsa et al. 1999; Walker, 2007). However, the concept of clinical 
significance is much wider than meeting an operational definition based on 
mathematical variability (Kazdin, 1999). Clinical significance is instead 
largely related to an actual improvement in function and feeling as described 
by the patient (Kazdin, 1999). The SMD should therefore be interpreted with 
caution, particularly where there is high variability in the data and/or a lack of 
statistically significant differences between groups. 
• The results of the SEG were risked to type II error, mainly due to the small 
sample sizes: 10 participants in each group. However, the main aim of this 
study was to explore the feasibility of the SEG, and there were no resources 
for sample size calculation. Additionally, the SEG scanning should take place 
during muscular rest, and the participants were asked to relax during the 
examination. However, it is not known if the participants were able to relax 
their muscles during the examination. An electromyography could control this 
factor. 
• The intra-rater reliability for measuring plantar flexor strength, muscle-tendon 
lengthening and muscle-tendon unit stiffness with the ultrasound were high, 
where the intra-rater reliabilities were ≥ 0.951 for both the patient and control 
group. However, the intra-rater reliability for measuring muscle-tendon unit 
stiffness for the patient group was 0.721. Although reflecting high reliability, 
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the reason for such a difference compared to the other reliabilities is not 
known. 
• Engaging with the PRP was not sufficient, where all the responses were 
through emails. Face to face meeting would be more informative as it would 
give a greater chance for discussion and input. The researcher approached the 
first PRP for her long experience with the condition which was > 30 years. 
This might not be the appropriate reason for approaching the PRP, where 
willingness to attend face to face meeting should be the first criteria to assign 
the research partner. One of the main rights for the participants is the right to 
withdraw without giving any reason. Therefore, when PRP_J did not respond 
to two emails, the researcher has considered this as a withdrawal condition, 
and decided not contact the PRP_J by any other means respecting her rights. 
The second patient research partner was approached in a critical timing where 
the researcher did not have the opportunity to arrange face to face meeting. 
This would be solved if the researcher acted earlier to replace the research 
partner, and did not lose the time by waiting for a reply from the first research 
partner.     
 
6.11 Clinical implications: 
• The clinical manifestations in people with JHS are potentially related to each 
other, creating a kind of vicious cycle; that is, pain, reduction in muscle-
tendon unit stiffness, muscle weakness, impaired proprioception as well as 
the participation levels, all influence each other. Therefore, designing 
management programs for people with JHS should follow a multidisciplinary 
and multidimensional approach.    
• Joint pain dominated and was severe in the lower back and all the lower limb 
joints. Therefore, it is recommended that a clinical management program 
should be directed toward reducing pain. Pain in the lower back area was the 
most common and severe. Thus, management programs should emphasise 
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the lower back area. Anterior pelvis tilt is increased in people with JHS 
during walking, which could cause lumbar hyperlordosis and increase the 
stress on the lower back area. Moreover, moment and power reductions 
around the pelvis and hip joints could be related to muscular imbalance. 
Therefore, lower back pain in people with JHS could be managed by 
balancing the muscle around the pelvis and the hip joint, aiming to reduce 
anterior pelvis tilt and hyperlordosis.  
• Although pain intensity in certain joints was higher than the joints in the 
lower limbs, 77.41% of the participants complained of pain in all the lower 
limb joints and the lower back area. This strongly suggest that management 
programs should not be joint-specific but generic, considering the pain in all 
the lower-limb joints. 
• Pain was moderately to strongly correlated to most of the items of the SF-12 
questionnaire, which suggests that the successfulness of pain management 
programs could be monitored by using the SF-12 questionnaire. 
• The muscle-tendon unit stiffness of the GM was significantly reduced in the 
JHS group. Muscle-tendon unit stiffness should be enhanced by using the 
stiffness enhancement programs found to be effective in the previous 
literature on different populations, such as by using the plyometric training 
described by Foure, Nordez and Cornu (2010). Moreover, stiffness was 
measured using diagnostic ultrasound and a strain gauge myometer. This 
method could be clinically applicable for those with musculoskeletal 
ultrasound experience to monitor the progression of stiffness enhancement 
programs.  
• Muscle weakness should be considered in management programs for people 
with JHS, and should be combined with stiffness enhancement and pain 
reduction programs. Concentric training was found to reduce stiffness in the 
previous literature (Morrissey et al. 2011). Therefore, muscle strengthening 
strategies should not be in conflict with stiffness reduction programs. 
• Knee proprioception should be examined in a functional weight-bearing 
position. Moreover, the non-dominant knee in the JHS population should 
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receive extra attention when designing a management program. The 
dominant knee proprioception was intact in people with JHS probably, 
perhaps because it is most used. This might suggest that the non-dominant 
knee proprioception could be improved by practicing and designing specific 
proprioceptive enhancement programs aiming to improve joint stability. 
• Walking speed should be considered in the clinical management plan. 
Improving walking efficacy may be achieved by improving the power in the 
lower limb muscles, as moderate to strong correlations were found between 
walking speed and power generation in the hip, knee and ankle joints.  
• There were some kinematic deviations which were noticed during the entire 
gait cycle or during prolonged periods of the gait cycle: increased knee 
valgus and pelvis anterior tilt. These deviations should be the first to consider 
for gait re-education programs. Knee valgus could be improved by improving 
the gluteal muscle activity where significant reduction in hip extensor 
moment which could induce tibial internal rotation then valgus.    
• VASs, SF-12 and BIoH questionnaires were found to be practical and 
required a feasible time- a maximum of 10 minutes. These measurement 
tools would appropriately fit clinical settings and needs, as initial 
examination tools and for assessing the progression of the condition. 
 
6.12  Recommendations for future research: 
• Joint pain is significant and severe in people with JHS. It is recommended for 
future studies to consider the multidimensional aspects of pain including 
discriminative/sensory, effective/motivational and evaluative/cognitive 
dominos as considered in the McGill Pain Questionnaire (Melzack, 1975; 
Bruce et al. 2004). Further understanding of pain in people with JHS would 
aid in its management. 
• It has been proven that resistive loading can increase muscle-tendon stiffness 
(Reeves et al. 2003a; 2003b and 2005). Therefore, a randomised controlled 
trial could be designed to introduce resistive exercises to improve muscle-
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tendon unit stiffness in people with JHS. Moreover, resistive training should 
aim to improve the quality of the muscle-tendon unit rather than increasing 
the muscle metric dimensions. That is, muscle-tendon unit stiffness might be 
improved by improving the quality of the tendon, not by inducing muscular 
hypertrophy (Reeves et al. 2003a; 2003b and 2005). The effect of improving 
stiffness on the overall symptoms and pain could also be an area for further 
research. 
• It is recommended to assess proprioceptive integrity in a weight-bearing 
position in higher testing angles; ˃ 300 of knee flexion. 
• There were some kinematics and kinetics that were statistically significant in 
the JHS group’s gait. However, various trends of reduced range of motion, 
moments and power can be observed in the gait curve graphs, but did not 
reach statistical significance. Such trends might be more obvious statistically 
with a larger sample size study, where the current study would aid in future 
sample size calculations.  
• Gait analysis has suggested that people with JHS may adopt various gait 
coping strategies and modifications. These strategies might be adopted to 
reduce joint load and pain. Future research is needed to determine the benefit 
of these coping strategies, training methods and adherence in the long term. 
Moreover, future research is needed to determine the effect of adopting gait 
modifications on the symptoms and the progression of the condition.    
• Knee valgus is significantly increased in people with JHS. Increased knee 
valgus is a major reason for increasing knee pain and risk of injury such as 
ligament injury, joint structure damage and osteoarthritis. Therefore, future 
research should determine the causes of knee valgus and possible solutions. 
• Obviously, biomechanical alterations and neuromuscular adaptations in 
people with JHS are consistent during ordinary, as well as during advanced 
physical activities of walking and jumping. Therefore, these changes can be 
considered dominant features and should be targeted to improve the activity 
and participation of people with JHS. Prolonged static positions such as 
sitting and standing during certain tasks have not been studied. Moreover, the 
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effect of fatigue on dynamic and static activity has not previously been 
studied. These areas are recommended for future research.  
• Sonoelastography is a promising examination tool for musculoskeletal 
practice. It is recommended to examine the elasticity of various muscles and 
tendons in people with JHS to possibly introduce new visual diagnostic tools 
for people with JHS. Moreover, the scanning should cover the muscle and 
tendon areas. It is recommended to determine the potential contribution of 
muscle activity to stiffness measures through using electromyography. 
• Longitudinal studies are required to determine cause and effect relationships, 
specifically in relation to variables related to joint neuromuscular control 
such as stiffness, muscle weakness and proprioception. 
• Electromyography studies are required to possibly explain moment and 
power reductions during activity.     
 
6.13 Conclusion: 
In summary, this chapter has created and suggested various theories and 
possibilities for explaining the impact of JHS on impairment, activity and participation. 
Additionally, the findings in the current study have been compared to relevant previous 
studies where they exist. The current study has provided specified pain quantification for 
the lower limb joints in terms of intensity and prevalence. Joint pain in people with JHS 
has been shown to be significantly higher, which could be related to hypermobility, joint 
instability and muscle weakness. Moreover, JHS had a significant impact on participation 
when assessed using SF-12 and BIoH questionnaires, which could be related to joint 
pain, fatigue and autonomic symptoms. A significant reduction in plantar flexors’ 
strength and Achilles tendon stiffness have been found, which could be related to 
abnormalities in the genes encoding collagen and protein, and muscle weakness. In 
contrast, lower limb stiffness in the JHS group was comparable to the control group, 
which could be related to differences in the structures examined, the stretch-shortening 
cycle, differences in test sensitivity, and musculoskeletal geometry. Knee proprioception 
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has been found to be reduced on the non-dominant side, but within normal range on the 
dominant side, which highlights the importance of introducing a weight-bearing position 
into the examination. Various significant differences have been highlighted in gait 
spatiotemporal parameters, which could be mainly related to joint pain and reduced 
power, as well as strategies used to reduce joint stress.  
Despite the dominant feature of joint hypermobility in JHS, no statistically 
significant differences have been found between the JHS and control group in gait 
kinematics. That has raised the idea of the stiffening theory to avoid pain, as well as to 
improve balance. Additionally, reduced gait kinematics during the swing phase in the 
JHS group has highlighted swing control theory for load reduction and maintaining 
equilibrium. Gait moments and powers were mostly shown to be reduced in the JHS 
group, which could be related to collagen and protein gene abnormalities, reduction in 
muscle-tendon unit stiffness and muscle weakness, or to pain and load avoiding 
behaviour. The vertical jump task has been implemented as an advanced physical task to 
reveal underlying problems in people with JHS. People with JHS jumped to comparable 
heights and with similar kinematics when compared to the control group, but with a 
significant reduction in joint moments and powers. This further supports the theories 
found in the gait analysis, where joint hypermobility is controlled to avoid pain and 
maintain equilibrium. Finally, the SEG seems to be a feasible tool in examining the 
elasticity of the GM. 
The next chapter, the conclusion chapter, will summarise the main findings and 
present the overall significance of the study. 
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7. CHAPTER SEVEN: CONCLUSION 
7.1 Introduction: 
JHS is a disabling multi-systemic condition with severe manifestations; however, 
it was clear from the literature review that little was known about the true impact of JHS. 
Therefore, the purpose of the current research was to determine the multi-dimensional 
impact of JHS in adults following the ICF. The first dimension focused on neuromuscular 
impairments, including joint pain, muscle strength, muscle-tendon unit stiffness and joint 
proprioception. The second dimension explored activity limitations by focusing on gait as 
an ordinary physical task, as well as the vertical jump as an advanced physical task. The 
third dimension focused on participation restrictions by using the SF-12 and BIoH 
questionnaires. Therefore, a series of outcome measures were identified to try to 
determine the impact of JHS.  
In comparison with a matched control group, the following features and patterns 
have been identified in adults with JHS: 
• Increased pain intensity and prevalence. 
• Reduced plantar flexors strength. 
• Reduced Achilles tendon stiffness. 
• Deficiency in the non-dominant knee joint proprioception.   
• Impaired gait spatiotemporal measures. 
• Stiffened gait and jump kinematics. 
• Impaired gait and jump moments and power generation and absorption.  
• Reduced participation in both physical and mental functioning. 
Additionally, the SEG is feasible for examining people with JHS. 
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7.2 Overall Significance:  
The current study is one of the first studies conducted on joint-specific pain 
quantification in adults with JHS. Significant and clinically important impacts from JHS 
on pain have been identified for the lower back and lower limb joints. A comprehensive 
and original exploration has been conducted by studying the intensity of pain and 
establishing its prevalence in the lower limb joints in people with JHS during both rest 
and movement, on both the dominant and non-dominant side. Moreover, the current 
study is the first to evidence that pain in JHS has moderate to strong correlations with 
essential factors related to activity and participation.  
Planter flexor strength in people with JHS has not been explored before. Plantar 
flexor strength provides dynamic joint stability, and it is an essential component for 
balance, energy transmission and walking forward progression. A significant and 
clinically important impact of JHS on the plantar flexors strength has been illustrated in 
the current study. 
The study is one of the first to evaluate the impact of JHS on Achilles tendon 
stiffness using ultrasonography combined with a strain gauge myometer. Improper 
neuromuscular strategies in the muscle-tendon complex could explain joint instability in 
people with JHS. It has been demonstrated in the current study that JHS has a significant 
impact on reducing the stiffness of the Achilles tendon. Additionally, the current study 
has originally introduced the vertical jump test for measuring stiffness to provide a 
comprehensive understanding of Achilles tendon stiffness during its essential role in 
lifting the entire body weight. Measuring stiffness using the vertical jump test also reflect 
the stiffness in the muscle, tendon, ligament, cartilage and bone. It has been found that 
people with JHS have comparable lower limb stiffness to the control group.  
No previous studies have examined knee proprioception in people with JHS using 
a functional weight-bearing testing position, which is a better position for stimulating the 
joint mechanoreceptors. A significant and clinically important impact of JHS has been 
evidenced in reducing the non-dominant knee proprioception using the squat test and the 
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Qualisys three-dimensional motion analysis system. No significant reduction in 
proprioception was found in the dominant knee.   
The current study is the first to comprehensively examine the impact of JHS on 
activity by conducting three-dimensional gait analysis using the Qualisys motion capture 
system combined with a Kistler force platform. The entire joints of the lower limbs were 
analysed bilaterally in terms spatiotemporal, kinematic and kinetic; moments and powers, 
parameters. JHS has been found to have a significant and clinically important impact on 
gait spatiotemporal parameters, as speed and spatial parameters were significantly 
reduced, while temporal parameters were significantly increased. Kinematics analysis 
revealed that people with JHS walked with stiffening and control patterns, as most of 
their kinematics were found to be reduced. Gait curve graphs have been built to provide 
visual indications of the kinematic parameters, which supports the differences identified. 
The curve graphs have aided in identifying two areas of kinematics increased in people 
with JHS throughout the gait cycle -anterior pelvis tilt and knee valgus. A moderate 
correlation has been identified between pain and stance duration, and moderate to strong 
correlation has been identified between speed and gait kinetics. Both statistical analysis 
and kinetic curve graphs have evidenced the significant and clinically important impact 
of JHS on gait kinetics involving moments and power generation and absorption.   
The current study is the first to examine the impact of JHS on an advanced 
physical task to make it more difficult to employ compensatory strategies by people with 
JHS. A three-dimensional motion analysis of the vertical jump task was performed using 
the Qualisys motion capture system combined with Kistler force platform. People with 
JHS employed similar kinematic stiffening and control patterns as was observed during 
walking, but no significant differences were illustrated between the two groups for jump 
kinematics. Kinematics curve graphs have supported the kinematic stiffening pattern, and 
further highlight the increased knee valgus and anterior pelvic tilt observed in the gait 
analysis. A significant impact from JHS has been revealed for vertical jump kinetics 
including both moments and power generation and absorption in the lower limb joints.  
The SEG has been originally introduced by the current study as a new and 
promising tool for diagnosing people with JHS. It has been found in the current study that 
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the SEG is feasible as it requires a reasonable amount of training, and appropriate time 
for examination and analysis; also it is well tolerated by patients. A larger study is 
required to determine the ability to distinguish between those with and without JHS.  
A significant and clinically essential impact of JHS on participation has been 
identified. The current study has originally introduced the SF-12 questionnaire, which is a 
practical tool for assessing the impact of JHS on participation on both the physical and 
mental levels. JHS has been found to have a significant and clinically essential impact on 
both the physical and psychological domains of participation. Moreover, the current 
study is one of the first studies to have implemented the BIoH questionnaire, which is 
designed specifically to assess people with JHS. 
One of the main strengths of the current study is its generalisability, as the JHS 
group is representative of the target population. This has been ensured by comparing the 
values of the BIoH questionnaire obtained in the current study in relation to a larger 
sample of 615 HMSA members. Moreover, two empirical studies have been conducted to 
ensure the repeatability of Achilles tendon stiffness and kinematic measures, and 
moderate to excellent intra-rater reliability has been demonstrated.  
 
7.3 Conclusion: 
The findings from the current study revealed that JHS was a multi-dimensional 
condition associated with neuromuscular impairment with a negative impact on activity 
and participation. Consequently, the assessment and diagnostic strategies for people with 
JHS should consider this multi-dimensional impact. Moreover, interventional programs 
should be multi-factorial, aiming to attenuate the neuromuscular impairments, and 
enhance activity and participation. Additionally, the SEG seems a highly feasible 
technological tool, which could serve people with JHS. However, future studies are 
needed to assess the reliability of the SEG results for confirming the diagnosis of JHS. 
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The findings reported in the current thesis should enhance the knowledge of 
healthcare professionals and enable them to optimise their management strategies. 
Additionally, future research can be guided by the findings of the current research to 
propose the best plans to benefit people with JHS. 
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Appendix 1: The Beighton score. 
                                                             
 
The effects of Joint Hypermobility Syndrome on impairment, activity 
and participation in adults 
(Beighton score) 
 
The nine-point hypermobility score (Beighton) 
The ability to: Right Left 
1- Passively dorsiflex the fifth metacarpophalangeal joint > 
900 
1 1 
2- Oppose the thumb to the volar aspect of the ipsilateral 
forearm 
1 1 
3- Hyperextend the elbow to > 100 1 1 
4- Hyperextend the knee to > 100 1 1 
5- Place hands flat on the floor without bending the knees 1 
Total 9 
Score: one point may be gained for each side for manoeuvers 1-4, so that the 
hypermobility score will have a maximum of nine points if all are positive. 
 
 
• Reproduced from Beighton, Solomonand and Soskolne, 1973 and Sanches et al. 
2012.  
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Appendix 2: Brighton criteria. 
                                                             
 
The effects of Joint Hypermobility Syndrome on impairment, activity 
and participation in adults 
(Brighton Criterion) 
 
The Brighton criteria for joint hypermobility syndrome 
 
Major criteria 
• A Beighton score of 4/9 or greater (either currently or historically) 
• Arthralgia for longer than 3 months in 4 or more joints 
Minor criteria 
• A Beighton score of 1, 2 or 3/9 (0, 1, 2 or 3 if aged 50+) 
• Arthralgia (>3 months) in one to three joints or back pain (>3 months), 
spondylosis, spondylolysis/spondylolisthesis 
• Dislocation/subluxation in more than one joint, or in one joint on more than one 
occasion 
• Soft tissue rheumatism >3 lesions (e.g. epicondylitis, tenosynovitis, bursitis) 
• Marfanoid habitus (tall, slim, span/height ratio >1.03, upper:lower segment ratio 
<0.89, arachnodactyly [positive Steinberg/wrist signs]) 
• Abnormal skin: striae, hyperextensibility, thin skin, papyraceous scarring 
• Eye signs: drooping eyelids or myopia or antimongoloid slant 
• Varicose veins or hernia or uterine/rectal prolapse 
Joint hypermobility syndrome is diagnosed in the presence of two major criteria, or one 
major and two minor criteria, or four minor criteria. Two minor criteria will suffice where 
there is an unequivocally affected first-degree relative. 
Joint hypermobility syndrome is excluded by the presence of Marfan or Ehlers–Danlos 
Syndrome, other than the EDS hypermobility type (formerly EDS III). 
Criteria Major 1 and Minor 1 are mutually exclusive, as are Major 2 and Minor 2 
 
 
♦ Reproduced from Simmonds and Keer (2007). 
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Appendix 3: Revised Nosology of Villefranche. 
                                                           
 
The effects of Joint Hypermobility Syndrome on impairment, activity 
and participation in adults 
(Revised Nosology of Villefranche) 
 
Ehler’s Danlos syndrome 
Hypermobility type: 
i) Inheritance 
Autosomal dominant 
ii) Major diagnostic critetria 
Skin involvement (hyperextensibility and/or smooth, velvety skin) 
Generalized joint hypermobility 
iii) Minor diagnostic criteria 
Recurrent joint dislocations 
Chronic joint/limb pain 
 Positive family history 
iv) Special comments. 
1- Skin extensibility is variable. The presence of atrophic scars in individuals 
with joint hypermobility suggests the diagnosis of classical type. 
2- Joint hypermobility is the dominant clinical manifestation. Certain joints, 
such as the shoulder, patella, and temporomandiblar joints, dislocate 
frequently. 
3- In rheumatologic practice, large numbers of patients present with 
generalised joint hypermobility [Brighton et al., 1983]. It is important to 
distinguish these individuals from those affected with the hypermobility 
type of EDS. There is considerable debate as to the casual 
interrelationships, if any, between the phenotypes in such persons and in 
those with the hypermobility type of EDS. 
4- Musculoskeletal pain is early in onset, chronic, and possibly debilitating 
[Sacheti et al., 1997]. The anatomical distribution is wide and tender 
points can sometimes be elicited. A tender point is defined as an area that, 
when palpated with the thump or 2 or 3 fingers, will be painful at a 
pressure of 4 kg or less [Wolf et al., 1998]. 
5- For management, see Steinmann et al. [1998]. 
 
● adapted from Brighton, P., Paepe, A., Steinmann, B., Tsipouras, P. and 
Wenstrup, R. (1998). Ehlers-Danlos syndrome: Revised Nosology, 
Villefranche, 1997. American Journal of Medical Genetics. 77, pp. 31-37.    
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Appendix 4: Figure permission. 
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Appendix 5: Visual Analogue Scales (version 3, date 6th May 2014). 
                                                                                    
 
The effects of Joint Hypermobility Syndrome on impairment, activity 
and participation in adults  
(Visual Analogue Scales) 
 
From a scale ranging from 0-10, please identify the level of your pain- if zero is no 
pain at all and 10 is the worst imaginable pain. Please indicate your pain experience 
by placing a vertical mark over the line below: 
 
1- Pain averagely experienced over the last week while at rest: 
 
Lower back 
                  No                                                                                                  Worst 
                pain                                                                                                possible 
                                                                                                                           pain  
Right hip 
                   No                                                                                                 Worst 
                 pain                                                                                                possible 
                                                                                                                           pain 
Left hip 
                  No                                                                                                  Worst 
                pain                                                                                                possible 
                                                                                                                           pain 
Right Knee 
                   No                                                                                                 Worst 
                 pain                                                                                                possible 
                                                                                                                           pain 
Left Knee 
                  No                                                                                                  Worst 
                pain                                                                                                possible 
                                                                                                                           pain  
Right ankle 
                   No                                                                                                 Worst 
                 pain                                                                                                possible 
                                                                                                                           pain  
Left ankle 
                   No                                                                                                 Worst 
                 pain                                                                                                possible 
                                                                                                                           pain 
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2- Pain averagely experienced over the last week during movement: 
 
Lower back 
                  No                                                                                                  Worst 
                pain                                                                                                possible 
                                                                                                                           pain  
Right hip 
                   No                                                                                                 Worst 
                 pain                                                                                                possible 
                                                                                                                           pain 
Left hip 
                  No                                                                                                  Worst 
                pain                                                                                                possible 
                                                                                                                           pain 
Right Knee 
                   No                                                                                                 Worst 
                 pain                                                                                                possible 
                                                                                                                           pain 
Left Knee 
                  No                                                                                                  Worst 
                pain                                                                                                possible 
                                                                                                                           pain  
Right ankle 
                   No                                                                                                 Worst 
                 pain                                                                                                possible 
                                                                                                                           pain  
Left ankle 
                   No                                                                                                 Worst 
                 pain                                                                                                possible 
                                                                                                                           pain 
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Appendix 6: The 12-Item Short Form Health Survey (SF-12). 
 
 
Copy right 
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Copy right 
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Copy right 
 354 
 
Appendix 7: The Bristol Impact of Hypermobility questionnaire (BIoH). 
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Appendix 8: Figure permission. 
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Appendix 9: Invitation letter (version 3, date 6th May 2014) 
                                                    
 
The effects of Joint Hypermobility Syndrome on impairment, activity 
and participation in adults 
(Invitation Letter) 
(JHS group) 
 
Dear Sir/Madam, 
 
Researchers from the University of the West of England are carrying out a research 
project on the effects of Joint Hypermobility Syndrome on impairment, activity and 
participation in adults.   
 
We are asking you to help us because you have been diagnosed with Joint Hypermobility 
Syndrome and you may be eligible to take part in the research. Please note that the 
researchers have not had any access to your personal or medical details at this point. 
Please feel free to contact me if you have any concerns about why you have received this 
information. 
If you are interested in the project: 
• Please read the enclosed information sheet that explains the project in more detail. 
• Complete the enclosed reply slip and return it in the pre-paid envelope. 
 
If you have any questions about taking part, please contact Najla Siri on 07462910104 or 
at Najla.Siri@uwe.ac.uk  
 
Thank you for your consideration. 
 
Yours sincerely 
Najla Siri                                                                                Sin-ti Towlson 
Physiotherapist at Musculoskeletal Rehabilitation                            Senior Physiotherapist in Rheumatology 
PhD student at the Department of Allied Health Professions,          Royal National Hospital for Rheumatic 
University of the West of England,                                                   Diseases 
Blackberry Hill, Bristol                                                                     Rheumatology Department 
BS16 1DD                                                                                         Upper Borough Walls  
                                                                                                           Bath 
Rachel Lewis                                                                                    BA1 1RL 
Clinical Specialist Physiotherapist 
North Bristol NHS Trust 
Rheumatology Department 
The courtyard, Old building 
Bristol 
BS2 8HW 
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The effects of Joint Hypermobility Syndrome on impairment, activity 
and participation in adults 
(Invitation Letter) 
(Healthy group) 
Dear Sir/Madam, 
 
Researchers from the University of the West of England are carrying out a research 
project on the effects of Joint Hypermobility Syndrome on impairment, activity and 
participation in adults.   
 
We are asking you to help us because you do not have Joint Hypermobility Syndrome and 
you may be eligible to take part in the research. Please note that the researchers have not 
had any access to your personal or medical details at this point. Please feel free to contact 
me if you have any concerns about why you have received this information. 
 
If you are interested in the project: 
• Please read the enclosed information sheet which explains the project in more 
detail. 
• Complete the enclosed reply slip and return it in the pre-paid envelope. 
 
If you have any questions about taking part, please contact Najla Siri on 07462910104 or 
at Najla.Siri@uwe.ac.uk  
 
Thank you for your consideration. 
 
Yours sincerely 
 
Najla Siri                                                                            
Physiotherapist at Musculoskeletal Rehabilitation 
PhD student at the Department of Allied Health Professions,  
University of the West of England,  
Blackberry Hill, Bristol 
BS16 1DD 
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Appendix 10: Participant information sheet (version 4, dated 22nd July 2014) 
                              
 
The effects of Joint Hypermobility Syndrome on impairment, activity 
and participation in adults 
(Participant Information Sheet) 
 
 
 
 
 
 
1- What is the purpose of the study? 
● Joint Hypermobility Syndrome (JHS) is a condition where many joints in the body 
move beyond the normal range due to an increase in the laxity of the joint structures. This 
can cause pain and degenerative changes at the joints, which may disturb day to day 
activities and consequently affect patients’ quality of life. This study will identify the 
problems that people with JHS experience by a comparison against people without this 
condition. 
● There is no strong evidence explaining the problems that people with JHS experience. 
Without fully understanding the problems, we cannot develop proper treatment. 
● This research will study the lower limbs intensively. We will therefore explore things 
such as muscle stiffness and strength; muscle elasticity; knee position sense; computer 
images of how people walk and jump; pain, and general levels of health. At the end of the 
study, we will know the effect of JHS on the joints of the lower limbs to recommend 
management and interventions for people with JHS. 
 
 
We would like to invite you to take part in our research which will be conducted at the 
University of the West of England, Bristol and approved by the NHS Research Ethics 
Committee and NHS R&D.   
Before you decide to participate, please take your time to read this sheet which will help 
you to understand the research you are invited to be included in and what it would involve 
for you. Please do not hesitate to contact us if you need any clarification: Najla Siri: 
07462910104 or at Najla.Siri@uwe.ac.uk, for further details you can contact Prof. Shea 
Palmer on 01173288919 or at Shea.Palmer@uwe.ac.uk    
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2- Why I have been invited? 
● The study will involve people with and without JHS so we can make a comparison and 
identify the problems. You have been invited to participate because of one of two 
reasons: 1. You may have been diagnosed with “JHS” or the Hypermobility type of 
Ehlers-Danlos Syndrome. Or 2. You do not have JHS so we can compare your 
performance with people with JHS. 
● You may be able to take part and be in the JHS group if you are over 18 years and meet 
the Brighton Criteria (used to confirm a diagnosis of JHS). The Brighton criteria will be 
checked by the researcher if you decide to take part in the research. However, if you 
answer yes to two or more of the following questions, you have a 90% chance of meeting 
the Brighton criteria. 
5 point hypermobility questionnaire (Hakim and Grahame 2003). 
● Can you now [or could you ever] place your hands flat on the floor without 
bending your knees? 
● Can you now [or could you ever] bend your thumb to touch your forearm? 
● As a child, did you amuse your friends by contorting your body into strange 
shapes or could you do the splits? 
● As a child or teenager, did you kneecap or shoulder dislocate on more than one 
occasion? 
● Do you consider yourself “double-jointed”? 
● You may be able to take part and be in the non-hypermobile group if you are over 18 
years and do not have a history of injuries, previous surgeries or problem with your legs. 
Having any previous history with your legs will make the comparison with the JHS group 
difficult.  
3- How can I know if the study procedures are acceptable to me? 
You will be asked to do the following, when you attend to the research site: 
1- walk approximately 100 metres at normal walking speed. 
2- jump up and land on both feet . 
3- stand on both feet, bend your knees slightly, and hold that position for 5 seconds. 
4- lie on your front for 10 minutes, while the researcher tests your ankle strength and 
scan your ankle muscle. 
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5-  push a stationary pad by your ankle. 
You can assess your acceptability to the study procedures by assessing your acceptability 
and ability to perform the five mentioned tests above. 
4- Do I have to take part? 
Participation is voluntary and it is totally up to you to decide whether to take part in the 
study, which will be explained in this sheet. If you agree to take part, we will ask you to 
sign a consent form when you attend to the research site, but you will keep the right to 
withdraw at any time without the standard care you receive being affected.  
5- What will happen to me if I take part? 
● If you are interested in taking part in this study, please return the reply slip in the pre-
paid envelope. 
● We will contact you to discuss the study, answer your questions and confirm your 
eligibility to take part. 
● If you then confirm that you would like to take part, you will be given an appointment 
to attend the Human Analysis Laboratory at the Glenside Campus at the University of the 
West of England, Bristol. You will only be asked to attend once and the examination 
session will take a maximum of 60 minutes. 
● You will be required to wear shorts so that some tiny markers (as shown in the picture 
below) can be placed on your hips, knees and feet using sticky tape. A special changing 
facility is available at the Human Analysis Laboratory in UWE, which will provide total 
privacy and dignity to the participant. Moreover, different sizes of shorts will be available 
to the participants, and the cleanliness, modesty and appropriateness of the provided 
shorts will be considered.  
 
●You will be asked to do some mini-squatting, walking and jumping tests so that special 
cameras can record and build up a computer image of how you move. These cameras can 
only record the markers motion which will be applied on your joints, and the cameras are 
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unable to see the participant in person.  Some additional examinations will also be 
performed such as taking ultrasound images of ankle muscle, measuring ankle muscle 
strength, and answering few questionnaires about pain and your general health.   
● We will need some of the participants (if agreed) to stay longer than the original time 
for approximately 30 minutes. This is to repeat two procedures: ultrasound images with 
strength assessment of the ankle muscle, and walking test. That is to assess the 
consistency of the measurement. If you are happy to have a longer examination session, 
the whole examination session will take a maximum of 90 minutes.  
● One of the needed devices, the sonoelastography to measure ankle muscle elasticity, is 
large and hard to be brought to the examination area at the Human Analysis Laboratory. 
The sonoelastography device is available at the Radiography Department at the 
University of the West of England; few meters walking from the original site of the 
study. However, we don’t need all the participant to undergo this examination. If you are 
happy to undergo this examination that will take a maximum of ten minutes, including 
the rest period. If you agreed to go to the Radiography department to measure ankle 
muscle elasticity, you will be asked to re-dress your own clothes before leaving the 
Human Analysis Laboratory. The examination at the Radiography department does not 
require wearing shorts, therefore you will not be asked to change at the second 
examination site. 
6- What are the disadvantages of taking part? 
● The time needed to attend the examination laboratory and being tested.  
● The examination may be little difficult as you will be asked to squat, walk and jump. 
That may make you tired. However, tiredness will be minimised by providing frequent 
rest periods between trials (20 seconds to two minutes) and between different procedures 
(five minutes). In addition, you can ask to take a rest at any time during the examination 
process. 
● There is a small risk of developing muscle strain where the study involves strength 
testing, as well as walking, assisted mini-squatting and jump test. However, the risk of 
developing muscle strain is minimal where each test will start with practicing which will 
warm-up your muscles. Moreover, rest periods will be provided frequently and you can 
ask for rest at any time. 
● The markers (tiny balls) that will be placed over your joints will be attached to you 
using sticky tape; sometimes this tape may cause some skin irritation but that is very rare. 
However, if you developed skin irritation due to those tapes, it will go by its own within 
24 hours.   
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● The researcher of  the study will contact each participant after one week of the 
examination day by telephone. That is to ensure that there is no side effect of study tests. 
In case of reporting any side effect, the participant will be directed to the appropriate 
care, and extra precautions will be considered with the remaining participants and 
reported for future research.  
7- What are the benefits of taking part? 
● We cannot promise you that taking part will benefit you directly, however your 
participation will help us understand the effect of JHS. The results of this study will be 
published in scientific journals and presented at conferences, which will help people with 
JHS and will guide clinicians and researchers towards better management and 
intervention. 
● The performance of each participant and a lay summary of the study will be posted to 
the participants. 
8- What will happen to my information and data if I cannot finish the 
entire examination procedure? 
● If you decide to take part in the study, but then you cannot finish all of the examination 
procedure for any reason, your data will be retained for five years after the completion of 
the study and used for research purposes. 
9- Will my taking part in the research be confidential? 
● Yes, your participation and information will be totally confidential and stored securely 
on a University password protected database. 
● Neither your name nor personal information will be used for analysis or in the research 
reports (your data will be assigned a number instead). 
● By taking part, you give permission to the relevant regulatory authorities to access the 
data obtained from you for the purpose of this study. 
10- How about the travel expenses? 
● We will refund your travel expenses for attending to the Glenside Campus at the 
University of the West of England.  
● Refreshments will be available. 
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11- What if I want to withdraw? 
● Your participation is voluntary and if you agree to take part you have the right to 
withdraw at any time without giving a reason or explanation, and that will not affect your 
medical care or result in any legal consequences. 
12- What about the results of the research? 
● The results of the research will be published in scientific journals and presented at 
conferences to help patients with JHS; guide clinicians towards better management, and 
advise researchers on further research. 
● A copy of the results will be sent to all participants.  
13- Who is organising and funding this research? 
● The University of the West of England, Bristol is overseeing the quality of the research 
as part of a PhD qualification, while the research is being funded by the Kuwaiti 
government. 
14- To whom I can make a complaint? 
● For any concerns about the study you can contact Najla Siri on 07462910104 or at 
Najla.Siri@uwe.ac.uk or Prof Shea Palmer on 01173288919 or at 
Shea.Palmer@uwe.ac.uk. 
● If you remain unhappy and wish to complain formally, you can do this through the 
NHS Complaints Procedure. Details can be obtained from Advice & Complaints Team 
(0117 3403741).  
● Advice on deciding whether or not to take part can be received from the Research & 
Innovation Department at North Bristol NHS Trust (details below). Although R&I staff 
are employed by NBT, this advice will be completely independent from the researchers.  
Research & Innovation Department: Learning & Research Building, Southmead 
Hospital, Bristol, BS10 5NB. Tel: 0117 3236468 or email: research@nbt.nhs.uk. 
● Participants from RNHRD can have further advice from R&D Office, RNHRD, Upper 
Borough Walls, Bath BA1 1RL, Tel. 01225 481156, ext: 201 or email: 
research@rnhrd.nhs.uk  
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15- Who has reviewed this study? 
● The scientific quality of the research has been reviewed and approved by the Faculty’s 
Research Degree Committee of the University of the West of England. 
● An independent individual from the Research Ethics Committee will look at the study 
to ensure participants’ safety, rights, wellbeing and dignity. The University of the West of 
England is also monitoring the design and conduct of the research on an ongoing basis. 
16- What will happen next? 
● If you agree to take part in this research, you will need to fill in the reply slip and 
return it in the pre-paid envelope provided. Then the researcher will contact you to 
discuss the study and arrange an appointment. 
● For further questions please do not hesitate to contact Najla Siri on 07462910104 or at 
Najla.Siri@uwe.ac.uk 
● Further advice on deciding whether you want to participate or not can be obtained from 
the Research, Business and Innovation Department (RBI) at the University of the West of 
England: Research Administration, 1st Floor, Wallscourt House, The Avenue, Bristol 
Business Park, Bristol BS16 1EJ, Tel: 0117 3281644 or email: Res.admin@uwe.ac.uk . 
The RBI staff are independent from the researchers. 
Thank you very much for your time to read this sheet and please keep a 
copy of this information sheet. 
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Appendix 11: Reply slip (version 1, date 6th May 2014). 
 
  
 
 
 
The effects of Joint Hypermobility Syndrome on impairment, activity and 
participation in adults 
Reply Slip  
Please complete this reply form and return it to us in the pre-paid envelope provided. The 
researcher will be in touch with you shortly to discuss the study with you. 
Please complete your details below: 
 
Name: 
 
 Daytime Number: 
 
 
Best time to phone:   
 
 
 
Address: 
 
 
 
 
Postcode: 
 
 
Email address:  
 
 Evening Number: 
 
 
Best time to phone:   
 
 
 
Gender (please tick):   Male   Female  
 
I agree to my details being passed to the researcher 
 
Signature:                                                           Date:  
 
 
If you require any further information, please contact Najla Siri on 07462910104 or at 
Najla.Siri@uwe.ac.uk  
 
Please return this reply slip in the enclosed pre-paid envelope.  
Thank you for your interest in this research project. 
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Appendix 12: Advert email and poster. 
 
 
Volunteers are required to participant in a PhD project entitled: “The 
effect of Joint Hypermobility Syndrome on impairment, activity and 
participation in adults” 
 
Healthy participants are required. We will be mainly 
conducting physical examination, 3D motion analysis and 
ultrasound imaging. Your performance will be compared 
against the performance of people with Joint hypermobility. 
 
You may be able to take part in the study if you are: 
1- Aged over 18 years 
2- Healthy 
3- Have no recent complaint or pain at your lower limbs 
4- Have no recent injuries or surgery at your lower limbs 
5- Have no connective tissue disorder  
 
You will be required to attend the Human Analysis Laboratory at the 
University of the West of England, Glenside Campus just once. 
 
If you are willing to take part in the study or have any questions, please do 
not hesitate to contact the chief investigator: Najla Siri at: 
Najla.siri@uwe.ac.uk or at 07462910104. 
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Appendix 13: NRES ethical approval. 
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Appendix 14: R&D approval from North Bristol NHS Trust. 
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Appendix 15: R&D approval from the Royal National Hospital of Rheumatic 
Diseases. 
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Appendix 16: Ethical approval from The University of the West of England, Bristol. 
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Appendix 17: NRES ethical approval for substantial amendment. 
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Appendix 18: Consent form (version 3, date 6th May 2014) 
                                                                
 
The effects of Joint Hypermobility Syndrome on impairment, activity 
and participation in adults 
(Consent Form) 
Name of the researcher: Najla Siri. 
Please tick the boxes 
1- I confirm that I have read and understood the information sheet, dated [28-7-2014] 
(version 3) for the above study. I have had the opportunity to consider the information, 
ask questions and have had these answered satisfactory.  

2- I understand that my participation is voluntary and that I am free to withdraw at any time 
without giving any reason, without my medical care or legal rights being affected.  
 
3- I understand that relevant sections of my personal information and data collected during 
the study may be looked at by individuals from the University of the West of England, 
Bristol, from relevant regulatory authorities where it is relevant to my taking part in this 
research. I give permission for these individuals to have access to my records for the 
purpose of research, monitoring and ensuring proper conduct. 
 
4- I understand that if I cannot complete the examination procedures for any reason, the 
researcher will retain and make further use of the data for research purposes.  
 
 
5- I understand that information about me will kept in a confidential way and will be used 
only for the purpose of the study, and I am giving my consent in understanding that the 
university is complying with its obligations and the duties of the Data Protection Act 
where my information will be destroyed after the study is completed. 
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6- I agree to take part in this study. 
  
 
Name of the participant:  
Signature:                                                                                  Date:  
Name of Witness (Researcher):  
Signature:                                                                                           Date:  
When completed, 1 for patient, 1 for researcher site file 
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Appendix 19 
Confidentiality, health and safety arrangements. 
Participant and society risks and anticipated benefits. 
Voluntary participation will be clearly explained in the participant information 
sheet and will be explained verbally to reassure the patients that their participation is 
voluntary and their received care will not be adversely affected by any means. 
Confidentiality concerning participant’s personal information and data will be 
maintained at all times to prevent any possible identification of the participants. That will 
be clearly explained through the patient information sheet as well as verbally. 
  The study does not include any intervention, so there is no potential intervention 
risk, and the risk from conducting the examination procedures is minimal. First, 
participants may feel tired due to the physical examination. However, that will be 
minimised by providing frequent rest times between trials and the examination 
procedures. Additionally, the participants will be informed that they have the right to ask 
for rest at any time. Secondly, there is a small risk of developing muscle strain where the 
study involves strength testing, as well as walking, assisted mini-squatting and jump test. 
However, the risk of developing muscle strain is minimal where each ]test will start with 
familiarisation and that will warm-up the muscles and prepare it for the test. Moreover, 
the tests have been ordered from the easiest to a relatively more difficult: ankle pushes, 
walking, assisted mini-squat then jump test, and that will minimise the risk of developing 
muscle strain. Moreover, rest periods will be provided in a frequent manner and the 
participant can ask for rest at any time. The risk of developing muscle strain will be 
mentioned in the participant information sheet. Although unlikely, should an injury 
occur, first aid equipment is available in the Human Analysis Laboratory. A trained first 
aider will be contacted immediately using the laboratory telephone. More serious injuries 
will be dealt with by calling an ambulance by dialling 9999 from the laboratory 
telephone. The chief investigator will maintain a proper immobilization position to the 
injury site, if required, while waiting for the ambulance, as she is certified for sport 
trauma management. A full risk assessment has been conducted and these procedures 
have been documented. Third, there is a minimal risk of developing skin irritation from 
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the used tape for sticking the Qualisys markers at the lower limb joints. However, that is 
minimal where the adhesive material is light, the application area is small; 1.4 cm, and 
the time of application is short; maximally 30 minutes where the markers will be 
removed immediately after using the Qualisys motion capture system (McNichole et al. 
2013). Moreover, each participant will be contacted by telephone after one week of the 
examination day to ensure that the examination does not involve any side effect. In case 
of reporting any side effect, participant will be directed to the appropriate care. An 
appropriate prevention procedure will be considered for the remaining participants and 
for future research. 
The examination procedures will take a maximum of 100 minutes and that will 
include an appropriate number of rest periods between the examination procedures to 
assure participant convenience. Refreshments will be available and in addition travel 
costs will be refunded.  
There will not be a direct benefit to the study’s participants. However, they will 
be informed that their participation will help in comprehensively understanding the effect 
of JHS on the impairment, activity and participation in adults. This study can be a base to 
recommend management strategy for further search and can aid the clinicians’ clinical 
decision making and that consequently may help patients with JHS.  
Informing potential participants of possible benefits and risks: 
The “participant information sheet” will be sent to the participant explaining the 
potential risks and benefits from the study. Additionally, participants will have the 
opportunity to discuss any aspect of the study with the researcher and with an 
independent person.  
Obtaining informed consent from participants whenever possible or proposed 
action where fully informed consent is not possible (e.g. emergency settings). 
According to established principles of Good Clinical Practice (GCP) a full 
informed consent form will be checked for each participant. The Chief Investigator is 
responsible for informed consent and she has received full Good Clinical Practice (GCP) 
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Training. If fully informed consent is not obtained, that will be considered as an 
exclusion criterion. 
Proposed time period for retention of relevant trial documentation. 
Data collection, recording and its quality will be upon the researcher and that will 
be monitored by the Chief Investigator’s supervisor: Prof Shea Palmer. Collected data, 
personal information and questionnaires will be locked and saved in a filing cabinet at the 
University of the West of England, Bristol according to the Data Protection Act (1998). A 
back-up copy of electronic data will be saved on UWE H drive with password protection. 
All collected data and completed questionnaires will be kept for five years after the end 
of the study according to UWE data management requirement. Data and documents will 
be directly accessed for the purpose of monitoring, auditing, reviewing as well as for the 
research ethics committees. The relevant Research Ethics Committee can obtain access to 
the research documents upon request for the purpose of monitoring and auditing. 
Research Governance: 
The research will be conducted upon the approval of the Research Ethics 
Committee (REC) including Site specific assessment (SSA) and NBT and RNHRD 
Research & Innovation Department approval and that according to the Research 
Governance Framework for Health and Social Care and Good Clinical Practice. The 
research team involving the Chief Investigator and the supervisory team will meet 
monthly to monitor the project. 
Resources and costs: 
The research is funded by Kuwait government and sponsored by the University of 
the West of England (UWE) and will be conducted at the Human Analysis Laboratory 
(HAL) at the Glenside Campus (UWE). The Qualisys motion capture system is available 
at the HAL, and that also includes the required stationary dynamometer, goniometer and 
height and weight scales. The required ultrasound machine is available at Glenside 
Campus in the physiotherapy department and it is portable and can be brought to the 
HAL, which has already been arranged the individuals in charge. The sonoelastography is  
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available in the Radiology Department in UWE. The fees for papers photocopying, travel 
expenses and refreshments will be upon the researcher.  
Risk assessment: 
Hazard identification (sources for potential harm): 
(√) indicates applicable and (X) indicates inapplicable: 
1- Manual handling single/occasional task X 
-regular/repeated task √ 
      2- Fall 
            -On level X 
            -From height X 
            -Of item/structure X 
      3- Machinery - moving parts of X 
      4- Electricity live contact with √ 
      5- Hazardous substance: (toxic, corrosive, irritant, sensitiser) X 
      6- Microorganisms: (pathogens, bacteria, viruses) X 
      7- Dusts/fibers, airborne: (wood, mineral, metal) X 
      8- Hand tools cutting, shearing, impact X 
      9- Posture seated, standing √ 
     10-Pressure uncontrolled release of: (air, steam, gas) X 
     11- Hot/cold surfaces contact with X 
     12- Thermal environment X 
     13- Radiation: (ionising, nonionising) X 
     14- Noise/vibration X 
     15- Weather including extremes of temperature X 
     16- Animals: (insects, dogs, humans) X 
     17- Fires/flames X 
     18- Confined space ¨C atmosphere in X 
     19- Explosions: (dust, flammable gas/vapour) X 
     20- Human/behaviour factors (eg. bullying, aggression) X 
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     21- Organisational factors (stressors eg. overload, change) √ 
     22-Traffic X 
"List extracted from Health and safety standard HSS14 Risk assessment" 
There will be minimal potential risks for the researcher as the following: 
1-Manual handling: this risk will be minimal where the Qualisys motion capture system 
is already fitted in the Human Analysis Laboratory (HAL). There will not be any need for 
carrying or placing any part of that system. The ultrasound machine is portable and it is 
similar to laptop size. The diagnostic ultrasound machine will be brought from a storage 
room near to the HAL. However, since the diagnostic ultrasound is portable (similar to 
laptop size) and light weight, there will not be any manual handling risk. However, a 
trolley can be used if the researcher prefers not to carry the ultrasound to the HAL. 
2-Fall: The HAL floor is even, so there will not be any risk for falling. However, the area 
will be inspected frequently to ensure that there is no objects on the way or slippery 
materials. 
3-Electriciy: Some of the required instrumentation for this project including the 
diagnostic ultrasound, Qualisys motion capture system, and the sonoelastography are 
electricity dependent equipment. However, care will be taken at all time when turning the 
instrumentation on and off. In addition, the electricity wires and plugs will be inspected 
frequently to ensure that they are at good condition at all time. 
4-Posture: the data collection site will be organized and divided into three parts: 
questionnaire answering area, ultrasound area and the Qualisys motion capture system 
area. The three areas will be equipped with chairs for both the examiner and the 
participant. At the questionnaire answering area, the examiner will be seated to answer 
any question for the participant. At the ultrasound area, the participant will lie down at a 
pinch. The pinch height is adjustable to ensure comfortable examination position for the 
researcher. In addition, a chair will be available for the researcher to rest at any time. At 
the Qualisys motion capture system area, the examiner will be sitting on a chair in front 
of the Qualisys computer to operate the system, most of the time. In addition, that will 
also involve standing in frequent occasions. That frequent position changes from sitting 
to standing will provide sufficient comfortable positioning for the examiner rather than 
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staying in one position for the entire examination process. In addition, an adjustable 
plinth and chair will be also provided during the sonoelastography measurement. 
5-Organisation factor: the work load will be organised to reduce the stress and load upon 
the researcher. Two participants will be examined maximally per day to reduce the work 
load. In addition, sufficient period will be given to the examiner for data collection, data 
analysis and other works, where a range of two and a half years will be provided for the 
research completion. 
6-Lone working: The risk assessment for the primary risks, mentioned above, are 
minimal and the precautions for avoiding these risks have been addressed. Lone working 
could increase the severity of the primary risks if occurred. However, as the primary risks 
are minimal and precautions were considered, lone working could not increase the risk. 
Therefore, providing a second person is not necessary according to the UWE Bristol 
(G033) guidelines. Moreover, the chief investigator has received full Good Clinical 
Practice in research training, including an appreciation of avoiding coercion and 
maintaining professional and ethical standards of behaviour. The research will be 
overseen by the supervision team, which will include periodic observation of practice. 
 
Lone working risk assessment: according to the University of the West of England, 
Bristol “the safety of social researcher guidelines (G017).  
1- The research site cannot be considered a risky site as it is in the middle of 
Glenside campus of the University of the West of England. Contact points are 
available, telephone is available at the laboratory and the radiography department, 
transportation is accessible including taxis and buses and also parking for private 
cars. The Human Analysis Laboratory is surrounded by the clinic room as well as 
teaching rooms. That is also include the sonoelastography room. 
2- When booking an appointment with the participant, the three members of the 
supervisory team will be notified by email, and they will be asked if anyone could 
be available during the data collection procedure either in person or by phone. 
The chief investigator will keep the telephone number in the speed dial option in 
her mobile phone. A reminder email will be sent to the supervisory team at the 
date of the data collection.  
 388 
 
3- The recruitment method requires contacting potential participants via telephone, 
which will allow assessing the respondent and their circumstances.  
4- Time tabling will be closely considered to take account of the tiring effects of 
spells of intensive field work. A more relaxed schedule will be set to keep the 
researcher more alert to better handle incidents.  
5- The study does not involve any sensitive questions which may provoke angry 
behavior.  
6- The researcher mobile phone will be used to call instant help, a contact telephone 
will be assigned, there is a mobile phone coverage in the laboratory,  
7- According to the UWE guidelines the researcher will avoid engaging in 
inappropriate or provocative behaviors by the following: 
a- Appreciate the use of body language and the acceptability or not of physical 
contact. 
b- Establish the right social distance- neither over-familiar nor too detached. 
If the incidents have occurred, these will be recorded on the University Accident 
Report Form and investigated by the research manager, and further reported to the Health 
and Safety Unit. If violent incident have occurred which may have some impact on the 
well-being of the researcher, these will be reported using the Aggressive Incident Report 
form and to the local police force. 
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Appendix 20: Demographic data sheet (version 3, date 6th May 2014)  
                                           
 
 
The effects of Joint Hypermobility Syndrome on impairment, activity and 
participation in adults 
(Biographical Data) 
 
Name:  
 
Date of birth: 
 
Height:                                                   *will be measured 
 
Weight:                                                  *will be measured 
 
Gender: male             female 
 
Have you been diagnosed with Joint Hypermobility syndrome? Yes           No 
 
Have you been diagnosed with Ehlers’ Danlos Syndrome of the hypermobility type?                                                                                       
Yes            No  
 
 
Do you have any previous injuries or previous complaints regarding your lower 
limbs?                                                                          Yes           No 
 
If yes, please specify: 
………………………………………………………………………………..……………
……………………………………………………………...........                                                                                                                            
Do you have any recent complaints about your lower limbs? 
                                                                                    Yes           No  
If yes, please specify: 
………………………………………………………………………………………………
…………………………………………………………...........                                                                    
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Appendix 21: Certificate for calibration for the digital strain-gauge myometer. 
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Appendix 22: Data collection sheet 1 (version 1, date 26th May 2014). 
                                                                                    
 
The effects of Joint Hypermobility Syndrome on impairment, activity 
and participation in adults  
 
Data collection sheet 
Muscle-tendon stiffness study 
Participant ID:……………………………… 
Trial Ankle 
moment 
arm 
Plantar 
flexor 
strength 
Sub-max 
Plantar 
flexor 
strength 
Max 
Muscle-
tendon 
length 
(Rest) 
Muscle-
tendon 
Length 
(Max) 
Muscle-tendon 
length 
Difference 
1       
2      
3      
4      
5      
 
Muscle-tendon stiffness study 
Intra-rater reliability study 
Trial Ankle 
moment 
arm 
Plantar 
flexor 
strength 
Sub-max 
Plantar 
flexor 
strength 
Max 
Muscle-
tendon 
length 
(Rest) 
Muscle-
tendon 
Length 
(Max) 
Muscle-tendon 
length 
Difference 
1       
2      
3      
4      
5      
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Appendix 23: Data collection sheet II (version 3, date 6th May 2014). 
                                                                   
 
The effects of Joint Hypermobility Syndrome on impairment, activity 
and participation in adults 
Data collection sheet (Comparison part/Qualisys system) 
Participant number  Jump 1  
Date  Jump 2  
Sign consent  Jump 3  
Brighton/ Villefranche 
Criterion 
 Jump 4  
Biographic Q and measuring 
height and weight 
 Jump 5  
VAS Q    
SF-12 and BIoH    
Measuring muscle-tendon 
stiffness 
    
Static trial    
Removing static markers    
Familiarisation Squat:     
Squat 1 (20 degrees)    
Squat 1 repeat    
Squat 2 (30 degrees)    
Squat 2 repeat    
Squat 3 (25 degrees)    
Squat 3 repeat    
Rest two minutes    
Familiarizing walk    
Walk one    
Walk two    
Walk three    
Walk four     
Walk five    
Walk six    
Walk seven    
Walk eight     
Walk nine    
Walk ten    
Rest two minutes    
 393 
 
                                                                
 
The effects of Joint Hypermobility Syndrome on impairment, activity 
and participation in adults 
 
Data collection sheet (Comparison and Reliability parts/Qualisys system) 
Participant number  Jump 1  
Date  Jump 2  
Sign consent  Jump 3  
Brighton/Villefranche 
Criterion 
 Jump 4  
Biographic Q  Jump 5  
VAS Q  Rest five 
minutes 
 
SF-12 and BIoH  Marking   
Height:  Walk 1  
Weight:  Walk 2  
Static trial  Walk 3  
Removing static markers  Walk 4  
Familiarisation Squat:   Walk 5  
Squat 1 (20 degrees)  Walk 6  
Squat 1 repeat  Walk 7  
Squat 2 (30 degrees)  Walk 8  
Squat 2 repeat  Walk 9  
Squat 3 (25 degrees)  Walk 10  
Squat 3 repeat    
Rest two minutes    
Familiarizing walk    
Walk one    
Walk two    
Walk three    
Walk four     
Walk five    
Walk six    
Walk seven    
Walk eight     
Walk nine    
Walk ten    
Rest two minutes    
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Appendix 24: Poster presented in the Health Research for Impact Conference, 
Bristol; 5th Nov. 2014 (gained 1st Prize poster award).  
“The effects of Joint Hypermobility Syndrome on impairment, activity and 
participation: the developed methodology” 
Presenter: Najla Al-sirri, P.T, M.Sc, PhD Student 
Co-authors: Prof. Shea Palmer, PhD, BSc (Hons), MCSP, FHEA. Dr. Mary Cramp, 
PhD. MCSP. Dr. Sue Barnett, PhD, MSc, BSc(Hons). SRCh, DPodM, MChS, Cert 
Health Education.  
Joint hypermobility Syndrome (JHS) is a heritable connective tissue disorder in 
which multiple synovial joints demonstrate symptomatic, painful and extraordinary 
motion due to genetic and pathologic factors (Simmonds and Keer, 2007). JHS 
commonly involves multiple chronic joint arthralgia and instability, myalgia, chronic 
fatigue and osteoarthritis (Remvig, Jensen and Ward, 2007a; Mulvey et al., 2013; Schmid 
et al., 2013). The reported symptoms could be related to the aetiological identifications in 
JHS, where a mutation at the genes responsible for the mechanical properties of the joint 
surrounding structures has been highlighted (Narcisi et al., 1994; Zweers et al., 2003; 
Voermans et al., 2009). Thus, does JHS have an effect on factors responsible for joint 
control? Does JHS have an effect on activity and general health levels? Recent narratives 
and systematic reviews indicate a limited quality and quantity of research evidence to 
support JHS diagnosis and management (Scheper et al., 2013; Smith et al., 2013). 
Therefore, a methodology has been developed to explore diagnostic criteria and identify 
deficiencies to recommend management strategies.  
A critical literature review has been conducted to justify studying a range of 
different factors responsible for joint control and coordination. The proposed poster will 
present the methodology developed in order to explore the effects of JHS on impairment, 
activity and participation. The methodology has been designed to explore muscle-tendon 
stiffness at two different levels, and to analyse 3D joint biomechanics. Moreover, the 
methodology of studying knee proprioception, tissue viscoelasticity, pain and general 
health levels will be presented 
 
 395 
 
Appendix 25: Poster presented in Rheumatology 2016 Conference, Glasgow, UK 
(published in Rheumatology v.5, Supplement 1, April 2016). 
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Appendix 26: Presented as an oral presentation for the Health and Applied Sciences 
Annual Postgraduate Conference, Bristol; 23rd June 2016.  
(The presentation won a Commendation Award) 
Severe and needs serious attention: the effects of Joint Hypermobility Syndrome on 
pain and participation in adults. 
Purpose: Joint hypermobility Syndrome (JHS) is a heritable connective tissue disorder in 
which multiple joints in the body demonstrate symptomatic and extraordinary motion due 
to genetic and pathologic causes (Simmonds and Keer, 2007). The purpose of this 
research was to identify the impact of JHS on pain intensity and participation including, 
physical activity and mental health status. 
Methods/Analysis: A cross-sectional research design was employed. Sixty two 
participants were included: 31 participants with JHS and 31 healthy age and sex-matched 
controls. All participants in the JHS group met the Brighton criteria for the diagnosis of 
JHS. The JHS group included 29 women and two men (mean age ± SD: 38.52 ± 14.14 
years). The control group included 29 women and two men: 39.06 ± 12.43 years. Visual 
Analogue Scales (VAS) were used to gauge pain intensity during rest and on movement 
for the lower back, hip, knee and ankle joints bilaterally. A 12 item short form health 
survey (SF-12) questionnaire was used to quantify the physical and psychological health 
of participants. 
Results: The two groups were homogenous in terms of sex and age. The JHS group 
scored significantly higher pain intensity during rest and movement for all the tested 
regions; all p < .001. Additionally, the JHS group had significantly lower scores for all 
items in the SF-12 questionnaire; physical components, ans mental components all p < 
.001. 
Discussion and conclusions: A diagnosis of JHS is associated with a major negative 
impact including multiple joint pain and adverse physical and mental health.  
Key words: Joint Hypermobility Syndrome, pain, participation.  
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Appendix 27: Presented in the 4th European Congress of the European Region of the 
World Confederation of the Physical Therapy (UR-WCPT), Liverpool, 11-12th 
Nov.2016. 
Title: The effects of Joint Hypermobility Syndrome on pain and participation in adults.  
Presenter: Najla Al-sirri, P.T, M.Sc, PhD Student 
Co-authors: Prof. Shea Palmer, PhD, BSc (Hons), MCSP, FHEA. Dr. Mary Cramp, 
PhD. MCSP. Dr. Sue Barnett, PhD, MSc, BSc(Hons). SRCh, DPodM, MChS, Cert 
Health Education.  
 
Relevance to ER-WCPT Congress 2016 themes: Research, education and practice.  
Ethics approval: The research has been conducted with the approval of the East 
Midlands Research Ethics Committee (REC) (14/EM/1008). 
Preferred presentation method: oral presentation (rapid 5) or all will be acceptable. 
Abstract (500 words) 
Title: The effects of Joint Hypermobility Syndrome on pain and participation in adults.  
Authors: Najla Al-sirri, P.T, M.Sc, PhD Student. Prof. Shea Palmer, PhD, BSc (Hons), 
MCSP, FHEA. Dr. Mary Cramp, PhD. MCSP., Dr. Sue Barnett, PhD, MSc. BSc(Hons). 
SRCh. DPodM. MChS. Cert Health Education.  
Relevance: Research, education and practice. 
Purpose: Joint hypermobility Syndrome (JHS) is a heritable connective tissue disorder in 
which multiple synovial joints demonstrate symptomatic and extraordinary motion due to 
genetic and pathologic causes (Simmonds and Keer, 2007). The purpose of this research 
was to identify the impact of JHS on pain intensity and participation including, physical 
activity and psychological health status. 
Methods/Analysis: A cross-sectional research design was employed. Sixty two 
participants were included: 31 participants with JHS and 31 healthy age and sex-matched 
controls. All participants in the JHS group met the Brighton criteria for the diagnosis of 
JHS. The JHS group included 29 women and two men (mean age ± SD: 38.52 ± 14.14 
years). The control group included 29 women and two men: 39.06 ± 12.43 years. Visual 
Analogue Scales (VAS) were used to gauge pain intensity during rest and on movement 
for the lower back, hip, knee and ankle joints bilaterally. A 12 item short form health 
survey (SF-12) questionnaire was used to quantify the physical and psychological health 
of participants. Independent samples t-tests were used to compare the results between the 
two groups, as the parametric assumptions were met. 
Results: The two groups were largely homogenous in terms of sex and age. The JHS 
group scored significantly higher pain intensity during rest and movement for all the 
tested regions when compared with the control group; all p < .001. Additionally, the JHS 
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group had significantly lower scores for all items in the SF-12 questionnaire. Specifically, 
the JHS group scored significantly lower on the physical components, including physical 
function, physical role, bodily pain, general health and vitality; all p < .001. The 
psychological components of the SF-12 questionnaire were also significantly lower, 
including social function, emotional role and mental health; all p < .001. 
Discussion and conclusions: The results show that a diagnosis of JHS is associated with 
a major negative impact including multiple joint pain and adverse physical and 
psychological health.   
Impact and Implications: Pain, and physical and psychological health should be 
monitored as an indication of the successfulness of any management regimes for those 
diagnosed with JHS. In addition, future research is needed to more fully understand the 
impact of JHS and its management.  
3 key words: JHS: Joint Hypermobility Syndrome, pain, participation. 
Funding acknowledgments: This research has been funded by the Kuwaiti government 
as part of a PhD project. The research was sponsored by the University of the West of 
England, Bristol.  
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Appendix 28: Accepted as a classic presentation for the World Confederation of the 
Physical Therapy (WCPT), South Africa, 2-4th July. 2017. 
 
Title: 
The impact of Joint Hypermobility Syndrome on lower limb joint kinematics during 
walking and vertical jumping. 
Background:  
Joint hypermobility syndrome (JHS) is a heritable connective tissue disorder associated 
with symptomatic multiple joint laxity with a 30% prevalence found in one 
musculoskeletal triage service in the UK. Gait is essential for functional capacity, general 
health, and participation. Only two studies have explored gait in adults with JHS, 
although their external validity has been risked by small sample sizes. The current study 
assessed gait and challenged the lower limb joints by introducing an advanced task, 
vertical jump, to make it difficult to employ compensatory strategies and identify any 
underlying problems. The aim was to explore the impact of JHS on the lower limb joint 
kinematics.  
Methods:  
The JHS group included 27 women and 2 men (mean (SD) age 37.57 (13.77) years) and 
the control group included 28 women and 2 men (39.27 (12.59) years). The Brighton 
criteria were used to confirm JHS. Patients were recruited from the Hypermobility 
Syndromes Association and two secondary care hospitals in South West England. The 
research was approved by the East Midlands Research Ethics Committee (14/EM/1008). 
Joint kinematics were assessed using the Qualisys motion capture system. Participants 
were asked to walk at their normal walking speed for ten times, and jump to their 
comfortable height for three times. Independent sample t-tests and Mann-Whitney U tests 
were used to identify differences between groups. A difference ≥ 20 between the two 
groups in kinematics was considered as a trend, having previously been established as the 
magnitude of intra-session variability.  
During the swing phase of walking, the JHS group showed significantly lower mean (SD) 
pelvic obliquity [3.62 (2.28)0] and right hip abduction [-2.91 (3.49)0] when compared to 
the control group [4.88 (2.13)0 and -4.73 (2.71)0 respectively] (p = 0.03 and 0.02). 
Increased left hip adduction at initial contact was identified in the JHS group [3.10 
(2.97)0] when compared to the control group [1.37 (3.36)0] (p = 0.04). Trends toward 
kinematic reductions were found in the JHS group during the stance phase in pelvic 
rotation, right hip flexion and bilateral hip extension. During the swing phase, trends 
toward kinematic reductions were found in the JHS group in left hip internal rotation and 
abduction, right hip extension and left knee flexion. Regarding the vertical jump test, no 
statistically significant differences were found. Trends toward kinematic reductions 
(range of motion reductions) were found in the JHS group in hip flexion and knee flexion 
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during the compression phase, and in hip extension, knee extension and external rotation 
during the push phase. 
Conclusion:  
The JHS group walked and jumped with a kinematic ‘stiffness’ pattern and their joint 
hypermobility was not evident, which could be a pattern to avoid pain and improve 
balance. Future research is needed to determine the benefit of these strategies if they 
persist in the long term, and their effect on activity and participation. 
Implications: 
People with JHS compensate by stiffening their lower limb joints during walking and 
jumping. Future research is required to understand how this impacts on activity and 
participation and if movement reeducation can improve kinematics. 
 
